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Rheumatoid arthritis (RA) is a chronic autoimmune disease, for which presently available 
treatments are unsatisfactory; a substantial proportion of patients continue to experience 
symptoms in addition to adverse treatment side-effects. Understanding of the relationship 
between the commensal microbiota and human health has developed exponentially in recent 
years, secondary to the establishment of next generation sequencing of the bacterial genome. 
It is now clear that there is intricate crosstalk between microbiota and human host, affording 
quite extensive influence on health and disease. Overall, human physiology cannot be 
adequately understood in the absence of consideration of the microbiome. There is much 
interest in the link between the microbiome and RA - a primary influence of the microbiota 
is host immune development and maintenance - and  a rich story has been 
uncovered. However, disentangling of the complex link between the commensal microbiota 
and RA presents a challenge.  
   
Primarily, epidemiological studies of the RA microbiome are needed to indicate the disease 
associated microbiota differences, the driving factors behind these, and the temporal 
trajectory. Only through understanding of these factors can we have a basis from which to 
link the microbiota with RA aetiology. Prospectively, modulation of the commensal 
microbiota may be applicable to prevention, and treatment of RA.   
   
In this thesis I apply novel epidemiological approaches to investigate the link between the 
microbiome and RA, with a focus on host genetic factors. I first consider appropriate 
methods for pre-processing of 16S sequence data which informs analysis and interpretation 
throughout the thesis and apply these methods to develop a core dataset for use in further 
work. To capture genetic risk of RA in Twins UK, I construct a polygenic risk score (PRS), 
using UK Biobank to additionally confirm efficacy. I calculate taxonomic heritability of the of 
the gut (stool) and oral (saliva) microbiota, demonstrating substantial heritability of both. This 
provides an evidence base for subsequent studies in which I investigate the association 




between RA PRS and the commensal microbiota. I demonstrate that Prevotella within the 
gut microbiota, which has to date received by far the most attention within the field 
for it’s relevance to RA aetiology, is associated with host genotype. I successfully validate this 
finding in a separate cohort. The study identified genotype as a factor in key aspects of 
microbiota composition in RA, the pervasive nature of which lends extrapolation to 
temporal trajectory; this work indicates that microbiota differences are present before onset 
of clinical RA. In this instance, the commensal microbiota may potentially be  a feasible target 
for prevention of progression from arthralgia to clinical RA. The study of the oral (saliva) 
microbiota was less conclusive as to association with genotype. However I made 
advancements in understanding of factors which influence the oral (saliva) microbiota, 
understanding of which is much less developed compared to the gut microbiota. In particular, 
I demonstrate that saliva microbiota are substantially heritable, and diversity is associated 
with age after controlling for other factors including general health. I move on to apply the 
converse approach, of investigating microbiota differences whilst controlling for host 
genotype within a disease discordant twin study design – a powerful method afforded 
through working with a twin cohort: TwinsUK. Despite practical limitations of recruitment 
of RA discordant twins, this is the largest study of the gut microbiome of established (treated) 
RA patients to date. Whilst host genotype and other important factors including diet were 
controlled for within the study, there were detectable differences in the microbiota. Species 
level identification of taxa associated with RA was not possible, and interpretation is 
therefore challenging. Tentatively, these results supported the hypothesis that taxa which are 
found in higher abundance in control participants in prior studies of the RA microbiome, are 
associated with treated RA, and therefore a portion of the efficacy of RA medication may 
be attributed to the microbiome. This paves the way for future studies which are underway 
to Interrogate of the relationship between the microbiota and RA medication;  there is 
interest in the link between the microbiota and response to RA treatment.  
   
In summary this thesis provides clarity to understanding of the link between the microbiome 
and RA aetiology, by providing evidence for the key areas required for the  field to progress. 
The work has relevance beyond the RA microbiome field, in general understanding of factors 




influencing the gut and oral (saliva) microbiome, and therefore can inform future studies of 
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Chapter 1  
 
Introduction part 1  
 
1.1 Thesis Overview 
 
There is mounting interest in the commensal microbiota as a factor in the aetiology of 
rheumatoid arthritis (RA). The potential influence of host genetic factors has been little 
explored. In this thesis, I investigate the link between the microbiome and RA, with 
particular regard to the influence of host genetic factors. 
 
I begin by synthesising and reviewing prior relevant literature. I next consider appropriate 
methods for analysis of the microbiome. I consider in particular detail, the method for pre-
processing the raw sequencing data, which is influential for the resolution of all further 
analyses in this thesis. I use polygenic risk scoring to capture participants’ genetic risk of RA. 
I take a novel approach of exploring microbiota association with genetic risk of RA in 
unaffected participants, and juxtapose this by investigating the difference in the microbiota 
between RA discordant twins, thereby focussing on genetic association in the first 
approach and controlling for genetic factors in the second. 
 
In this chapter, I introduce the subject areas for the thesis – rheumatoid arthritis and the 
microbiome. I begin by describing the clinical features, pathophysiology, and treatment of 
rheumatoid arthritis. I then introduce the microbiome, in the context of human physiology. 
I consider examples of links between the microbiome and health and disease. In Chapter 2: 
Introduction 2, I present a literature review in which I consider in detail the current 
evidence for a link between the microbiome and rheumatoid arthritis, through the lens of 
host genetics. Thesis aims are presented in Chapter 2. 








Rheumatoid arthritis (RA) is a systemic autoimmune condition affecting 1% of the 
population, conferring life altering disability, and reduced life expectancy (Guo et al., 2018). 
It is characterised by synovial inflammation, cartilage and bone destruction, angiogenesis, 
and production of autoantibodies – anti-citrullinated protein antibody (ACPA) and 
rheumatoid factor (RF). In addition to articular involvement there are systemic effects 
including cardiovascular, psychological, renal, pulmonary, ocular, and musculoskeletal 
pathology (Firestein and McInnes 2017). RA confers life-altering disability for those 
affected. RA affects both younger and older people, particularly women, and has a typical 
age of onset between 30 and 80 years (Mueller et al. 2014).    
 
Despite considerable advances in treatment in the last two decades, there remain unmet 
needs with regards to the treatment of RA. In particular, current therapeutic options show 
varying efficacy between patients, with some patients being fully or partially unresponsive 
to disease modifying anti-rheumatic drugs (DMARDs). Complete remission is achieved only 
in the minority of patients, and instead is maintained via ongoing pharmacological 
management (Guo et al. 2018). Further, there are a lack of reliable biomarkers for 
prognosis, therapeutic response, or toxicity.  
 
Herein lies the motivation to further understand rheumatoid arthritis and particularly the 
implication of modifiable risk factors such as the microbiome; there is a requirement for 
advancement of understanding regarding the aetiology of RA, to facilitate improvement in 
preventive measures and clinical management. 
 
 




1.2.2 Clinical features of rheumatoid arthritis 
 
RA patients present with arthralgia and associated joint swelling. Rheumatoid arthritis 
typically affects the hands initially, and particularly the metacarpophalangeal and proximal 
interphalangeal joints in a symmetrical fashion. Other joints – wrist, elbow, ankle, and knee 
- may also be affected and over time characteristic RA hand deformities may develop 
(swan neck, boutonniere, Z deformity of the thumb and ulnar deviation).  
 
There is extensive extra-articular involvement in RA, secondary to sequalae of systemic 
inflammation. Cardiovascular implications are the most common, in particular there is an 
increased incidence of stroke and myocardial infarction, secondary to aggravation of 
atherosclerosis, which leads to the shorter life expectancy associated with RA. Renal 
implications are characterised by an increase in circulating C reactive protein (CRP), 
Hepcidin and incidence of anaemia. Neurological complications are an increase in incidence 
of fatigue and depression. There are wider musculoskeletal complications in addition to the 
classical development of bony erosions which is described below in Section 1.1.4.  
Osteopenia may develop, with potential to progress to osteoporosis. In muscle cells, insulin 
resistance occurs leading to muscle weakness.  
 
 
1.2.3 Aetiology of rheumatoid arthritis 
 
RA is a heterogeneous condition and the detailed aetiology has not been clearly 
characterised. RA has a strong genetic component and is estimated to be 65% heritable 
(Kim et al. 2017). Current understanding of the genetic aetiology of RA is discussed in 
detail in Chapter 2. Genetic factors are necessary, but not sufficient, for disease 
development. Additional factors are also required: smoking, diet, hormone fluctuation 
(there is a higher prevalence in women) and more recently suggested  the mucosal 
microbiota. RA disease is subclassified into subsets: seronegative RA, and seropositive RA in 




which circulating RA IgG autoantibodies - anti-citrullinated protein antibody (ACPA) and 
rheumatoid factor (RF) - are present. ACPA is also present in around 1% of the RA 
unaffected general population, however these individuals are understood to be on the 
pathway to RA development; ACPA is specific for RA (Finckh et al. 2020). 
 
In RA there is a move to a pro-inflammatory phenotype, in which there is systemic, 
chronic low-grade inflammation involving both innate and adaptive immune system 
components, with insidious disease development over decades, finally reaching the 
fulfilment stage in which classical RA pathological features present. Systemic autoimmunity, 
evidenced by circulating RA autoantibodies ACPA and less specifically RF, can be detectable 
years before onset of full clinical RA. There is incremental development of the pathology, 
prior to the point at which symptoms are evident secondary to inflammation of the 
synovium, bone and cartilage erosion, and angiogenesis. The phases of RA development 
are summarised in Figure 1.1.  
 
 
Figure 1.1 The natural history of rheumatoid arthritis  
Adapted from Raza K. et al. (2012) 
 




There is interplay between the strongest genetic risk factor - HLA-DR4 shared epitope 
(SE) and the strongest environmental risk factor - smoking - which leads to development 
of autoimmunity and production of ACPA auto-antibodies, a cardinal feature of RA. As 
mentioned prior, smoking leads to post translational modification of peptides within the 
lung mucosa - specifically citrullination - the conversion of arginine to citrulline. 
Concurrently, HLA-DR4 SE RA risk alleles encode for amino acids in the binding site of 
major histocompatibility complex class II (MHC-II), and alter the tertiary structure of the 
peptide in such a way as to confer higher affinity for citrullinated protein antigens. Other 
factors leading to protein citrullination in RA are peptidyl arginine deiminase (PAD4) 
positivity, commensal microbiota (discussed  in Section 1.3) and dietary factors (Guo et al. 
2018). Citrullinated proteins bound to MHC-II on antigen presenting cells bind CD4+ B 
and T cells, leading to production of ACPA and T cell activation, respectively. ACPAs 
promote loss of tolerance to self-antigens, form immune complexes which promote 
inflammation, and contribute to osteoclastogenesis leading to articular bone degradation 
and development of bony erosions (Figure 1.2). 
 





Figure 1.2 Suggested model of RA aetiological development 
Adapted from McInnes and Schett (2011) 
 
 
It is hypothesised that an additional event is required to move aberrant RA characteristic 
immune activity into the threshold of disease. This is sometimes referred to as the “two hit 
hypothesis”. Triggers suggested include injury causing mechanical insult, infection, neuro-
immune factors or dysfunction of the microvasculature (Figure 1.2). These events may 
trigger the immunological cascade seen in clinical RA, and in particular may trigger articular 
involvement (McInnes and Schett 2017). 




1.2.4 Immunopathogenesis of rheumatoid arthritis 
 
As RA is a heterogeneous condition, the detailed immuno-pathogenesis has not been 
demonstrated. However common key immune cells involved have been established; a 
broad framework of the cell types and aetiological cascade beginning from the stage at 
which synovial inflammation occurs is as follows. Within the synovium, macrophages 
secrete pro-inflammatory cytokines including tumour necrosis factor alpha (TNF-α), 
interleukin 1 (IL-1) and interleukin 6 (IL-6). Cytokines stimulate fibroblast-like synoviocytes 
(FLS), cells comprising the membrane of the synovium, which when activated begin to 
proliferate, and together with pro-inflammatory cytokines, stimulate receptor activator of 
nuclear factor-κB ligand (RANKL) expression, and osteoclastogenesis, leading to bone 
erosion. Activated FLS also secrete proteases, which degrade cartilage. T cells comprise 
50% of immune cells in the inflamed joint and pro-inflammatory Th17 cells secrete IL-17, 
leading to downstream macrophage activation in addition to further stimulation of FLS and 
expression of RANKL. Activated FLS can migrate to other joints, proliferating pathology at 
other sites (Figure 1.3). 
 





Figure 1.3 Articular immunopathogenesis of RA 
Adapted from McInnes and Schett (2011) 
 
Positive feed-back loops drive the pathology forward. Inflammation drives further 
inflammation, in the context of suppression of regulatory immune elements. 
 
1.2.5 Therapeutic Regime for Rheumatoid Arthritis 
 
Rheumatoid arthritis is primarily managed using a collection of therapeutics termed disease 
modifying antirheumatic drugs (DMARDs), comprised of synthetic and antibody based 




(biologic) drugs. Available DMARDs and their mechanism of action, and key known 
adverse effects are summarised in Table 1.1. However first-line treatment with the aim of 
initial pain relief and mediation of inflammation is via non-steroidal anti-inflammatory drugs 
(NSAIDs) (Bullock et al. 2019). Corticosteroids are more potent anti-inflammatories 
compared to NSAIDs and may be used systemically (usually by mouth or intra-muscularly) 
or given intra-articularly in the short term to manage a single painful joint. However, the 
side effects of corticosteroids are recognised to be too severe to allow their inclusion in a 
long-term treatment regime. Rapid progression to treatment with DMARDs is usually 
required, and of these, methotrexate is the first-line treatment.  
 
The European League against Rheumatoid Arthritis (EULAR) recently released updated 
recommendations for the management protocol for RA (Smolen et al. 2020). After clinical 
diagnosis of RA, methotrexate is to be started in combination with a glucocorticoid. If 
methotrexate is contraindicated, leflunomide or sulphasalazine are recommended instead. 
If improvement is apparent at 3 months and target treatment achieved at 6 months, this 
regime is continued with dose reduction throughout sustained remission. If the target is 
not achieved, it must next be established if there are poor prognostic factors for the 
patient. Poor prognostic factors comprise RF or ACPA seropositivity at high levels; high 
disease activity score; early joint damage and failure of 2 or more synthetic DMARDS. If 
poor prognostic factors are present, addition of a biologic DMARD or JAK inhibitor is 
indicated. Following another 6 months of this regime, if the target is achieved then (as 
above) the treatment combination can be continued at a dose reduced in intervals to 
achieve sustained remission. If after 6 months the target is not achieved, different biological 
DMARDs may be tried, until treatment is successful and remission achieved, at which point 
the dose can be reduced as above. If poor prognostic factors are absent, a second 
synthetic DMARD can be added. 
 
In RA research, there is a focus on the pre-clinical stages of the disease – treating the 
pathology before it is fully established is likely to be the most effective option (Cope 2017). 









Name Mechanism Known Adverse Effects 
Synthetic Methotrexate Folic acid inhibitor 










Gastrointestinal, central nervous 
system, and hematologic adverse 
effect. 
Synthetic Hydroxychloroquine Immunomodulation 
Gastrointestinal tract, skin, central 
nervous system adverse effect and 
retinal toxicity 
Biologic Infliximab TNF-α inhibitor 
Infection (pneumonia and atypical 
tuberculosis) injection-site reaction. 
Biologic Adalimumab TNF-α inhibitor Hypertension 
Biologic Etanercept TNF-α inhibitor 
Severe anaphylactoid transfusion 
reaction. 
Biologic Golimumab TNF-α inhibitor  
Biologic Certolizumab Pegol TNF-α inhibitor  
Biologic Rituximab B cell depletion 
Infection, hypertension, 
hypogammaglobinaemia, viral 
reactivation, vaccination responses. 
Biologic Abatacept CD28/CTLA4 system Infection, malignancy 
Biologic Tocilizumab IL-6 inhibition 
Infections (most notably skin and 
soft tissue), increases in serum 
cholesterol, transient decreases in 
neutrophil count and abnormal 
liver function. 
Biologic Anakinra IL-1 inhibition 
Injection site reactions, infections, 
neutropenia, malignancy 
Biologic Tofacitinib JAK1 &JAK3 inhibition Zoster infection 
Biologic Baricitinib JAK1 & JAK2 inhibition Zoster infection 
 
Table 1.1 Pharmacological therapies used in treatment of RA  








1.3 The human microbiome 
 
The human microbiome is the collective term for the community of commensal micro-
organisms which co-exist within the human body and encompasses their collective genome 
and the host habitat. The term microbiota refers more specifically to the collection of 
micro-organisms which constitute the microbiome (Marchesi et al. 2016). Bacteria 
constitute a substantial portion of the microbiota and are the most characterised, however 
viruses, archaea, protozoa and fungi are also present and likely hold important roles 
(Nishida et al. 2018, Sadanand 2019). 
  
Traditionally, bacteria have been viewed as an opponent to health, and instigators of 
disease. However, it is now understood that the relationship is infinitely more complex. In 
conceptualising human medicine, commensal microbiota are integral: they are integral to 
diverse aspects of development and physiological function, and thus health and disease. The 
microbiota are required for the development of a normal immune system and continue to 
shape the immune state throughout life (Kabat et al. 2014). They produce up to one third 
of metabolites detectable in blood including signalling molecules (Menni et al. 2017). They 
are capable of post-translational peptide modification (Konig et al. 2015), induction of 
morphological change and alteration of mucosal cell connectivity (Lin et al. 2015). There is 
therefore scope for the microbiome to influence diverse pathologies – not only those in 
which inflammation plays a central role. In turn, factors relating to the human host 
influence the composition of the commensal microbiota: age, diet, xenobiotics, 
geographical environment, genetic factors, neonatal factors, and disease state. The bi-
directional relationship between microbiota and host is summarized in Figure 1.4. 







Figure 1.4 Interaction between human host and commensal microbiota 
 
 
Whilst there is some limited evidence of a pre-natal microbiome, the present paradigm 
considers that seeding of the microbiome occurs at birth. In babies delivered vaginally, this 
occurs via ingestion of maternal faecal material and other bio-fluids (Combellick et al. 
2018). Influence of host genotype on the microbiome occurs via a variety of factors: the 
immune and metabolomic microbial environment, dietary preferences and disease state, 
and determination of biological sex. However, diet is the most influential known 
determinate of microbiota composition, providing substrates which lead to propagation of 
the oral and gut microbes which comprise the majority of the commensal microbiota 
(Singh et al. 2017). Ingestion of xenobiotics such as drugs and synthetic vitamins alters the 
composition of the microbiota, and accounts for some of the microbiota association with 
disease (Carmody and Turnbaugh 2014, Vila et al. 2020). Difference in microbiota 
composition compared to the general population is also a generalised feature of disease. In 
particular, a lower alpha (within sample) diversity of the gut microbiota is a frequent 
feature of a diseased state (Jackson et al. 2018a).  
 
The microbiota in turn influence host physiology in a manner that is dependent on the 
above influencing factors. In particular, the microbiota metabolise nutrients and xenobiotics 
(Vila et al. 2020) and microbial metabolites are a key mechanism via which the microbiota 




influence host physiology (Visconti et al. 2019). The microbiota are an important 
determinate of the host immune state via numerous mechanisms such as activation of 
antigen presenting cells (APCs), Th17 cell differentiation and influencing mucosal 
permeability via intestinal epithelial cell (IEC) tight junctions (discussed in Sections 1.3.1, 
1.3.2 and 1.3.3). Commensal microbiota are also capable of post translational modification 
of host peptides, leading to differential immune response (Konig et al. 2015). A more novel 
suggested mechanism by which the microbiota may influence host physiology is via outer 
membrane vesicles (OMVs), which are the bacterial equivalents of lysosomes. OMVs are 
ubiquitously produced by gram negative bacteria, they function as a transport mechanism 
for bacterial peptides within the host and maintain the microbial ecosystem. It was recently 
demonstrated that intestinal epithelial cells are able to uptake OMVs via endocytosis, and 
also that OMVs can transmigrate through IECs (Jones et al. 2020). 
 
 
1.3.1 The commensal microbiota and the immune system 
 
An important mode of influence of the microbiota on host physiology is via the immune 
system. The microbiome is integral to the induction, training and homeostasis of the host 
immune system (Lazar et al. 2018). This relationship is particularly prominent with the gut 
microbiota, which constitutes the majority of the commensal microbial load, and has the 
closest interaction with the immune system via the gut associated lymphoid tissue (GALT), 
which is a sub-category of the mucosa associated lymphoid tissue (MALT). However, 
microbiota at other sites have important immune relevance (Colombo et al. 2016). 
Throughout life the commensal microbiota inform both local tissue specific, and systemic 
immune tone, achieved through complex interactions between intestinal epithelial cells 
(IECs), microbiota derivatives and leukocytes (Kabat et al. 2014). Therefore, the host 
microbiota relationship may provide a mutual pin-hold underlying chronic inflammatory 
conditions.  
 





1.3.2 The commensal microbiota and innate immunity 
 
The largest interface between host and microbiota comprises the epithelial cells of the 
intestinal tract which in healthy conditions form a physical barrier, enforced by numerous 
intercellular tight junctions. The intestinal epithelial cells are a frontline site of microbial 
monitoring, secondary to compartmentalised expression of toll like receptors (TLRs). TLRs 
belong to the pattern recognition receptors (PRRs) family (Németh et al. 2016a, p. 9). 
Ligands for these receptors are pathogen associated molecular pattern molecules (PAMPs), 
damage-associated molecular pattern molecules (DAMPs) and microbe associated 
molecular pattern molecules (MAMPs), with the latter being characteristic of commensal 
microbiota. TLRs detect derivatives of potentially harmful pathogens, leading to innate and 
adaptive immune activation. Conversely, TLRs function to inhibit the inflammatory cascade 
which may otherwise be triggered by presence of commensal microbiota. TLR expression 
by IEC shows a polarized pattern, with expression at the basolateral surface, thereby 
minimising the inflammatory response during healthy conditions. TLR2 and TLR4 are 
predominantly expressed within the small intestine, whilst TLR5 is expressed on the 
basolateral surface of colonic IECs (Hug et al. 2018). Commensal microbiota also 
contribute to the maintenance of the integrity of the IEC barrier in infection or adverse 
conditions, by inducing anti-inflammatory cytokines and anti-apoptotic signalling cascades 
(Kabat et al. 2014). 
 
Specialised goblet cells of the IEC barrier synthesise mucus and produce a thick mucus 
layer which covers the apical surface of the intestinal epithelium. This 150 μm thick layer 
serves as a protective barrier and is augmented with IEC derived anti-microbial peptides 
(AMPs). Structurally, the mucus layer is organised around a hyper-glycosylated mucin 
MUC2 (Shan et al. 2013). The colonic mucus layer comprises two sub-layers: a dense inner 
layer that is relatively sterile, and a looser outer later in which commensal microbiota 
reside (Kabat et al. 2014).  





The mucus layer is not simply a structural barrier, but it is also molecularly involved in the 
induction of immune tolerance to commensals, particularly via the innate immune system 
(Figure 1.5). In addition to bactericidal properties, AMPs modulate cell function via 
chemotaxis, TLR signalling and during wound healing (Kabat et al. 2014). The mucus layer 
encourages a more balanced commensal colonisation, and MUC2 is capable of mitigation 
of dendritic cell mediated inflammatory response (Shan et al. 2013). Whilst some AMPs 
such as α-defensin are constitutively expressed by IECs, others are regulated by IEC 
sensing of pathogen-associated molecular patterns (PAMPs). The commensal microbiota 
inform IEC mediated immune tissue development of isolated lymphoid follicles. 
Peptidoglycan derived from the cell wall of commensal bacteria activates the cytoplasmic 
PRR NOD1 in IEC and induces b-defensin 3 and CCL20 secretion, which drive formation 




Figure 1.5 Examples of commensal microbiota influence on innate immune responses 








1.3.3 The commensal microbiota and adaptive immunity 
 
The commensal microbiota are also widely influential in the recruitment, activation and 
differentiation of adaptive immune cells (Figure 1.6). Overall, the commensal microbiota 
influences the local immune milieu to promote immune tolerance by limiting pro-
inflammatory Th1 and Th17 responses, promotion of Th2 responses and differentiation 
and function of regulatory T cells (Tregs). Examples of interactions between the 
commensal microbiota and adaptive immunity are as follows. Signals from commensal 
microbiota induce production of B cell activating factor of the TNF family (BAFF), a 
proliferation–inducing ligand (APRIL) and transforming growth factor β (TGFβ) in IEC and 
dendritic cells (DC), which in turn promotes the differentiation of B cells into 
immunoglobulin (Ig) A+ plasma cells (Goto 2019). Following activation by commensal 
bacteria, follicular dendritic cells (FDC), which are the primary source of TGF-β in Payer's 
patches, also promote the differentiation of B cells into IgA+ plasma cell. The intestinal 
microbiota can regulate function of the innate lymphoid cells (ILC), which in turn promote 
T cell-independent IgA induction through the interaction of membrane bound lymphotoxin 
with DC. The soluble form of ILC-derived lymphotoxin supports T cell-dependent IgA 
induction by promoting homing of T cells to the lamina propria, thereby influencing the T 
follicular helper (Tfh) population (Gutzeit et al. 2014). Polysaccharide A (PSA) produced by 
Bacteroides fragilis directly promotes Treg cell differentiation directly via TLR2 and indirectly 
by conditioning DCs. Microbiota-derived short-chain fatty acids (SCFA), a by-product of 
metabolism, may promote Treg cell generation either directly through signalling via G 
protein-coupled receptor (GPCR) 43 or indirectly via IEC. Clostridium species induce TGF-
β production in IEC, which promotes Treg cell differentiation in the colon (Bauché and 
Marie 2017). 
 





Figure 1.6 Examples of commensal microbiota influence on the adaptive immune system  
Adapted from Kabat et al. (2014) 
 
 
Overall, when operating optimally, this immune system–microbiota alliance allows the 
induction of protective responses to pathogens and the maintenance of regulatory 
pathways involved in the maintenance of tolerance to innocuous antigens (Belkaid and 
Harrison 2017). However, there is a hypothesis that facets of modern living in 
Westernised countries, particularly the overuse of antibiotics, banishing of helminths and 
move to highly processed and lower fibre diet have selected for a microbiota that lack the 
characteristics required to establish balanced immune responses (Rodriguez-Castaño et al. 
2017). This phenomenon is proposed to account for some of the dramatic rise in 
autoimmune and inflammatory disorders in parts of the world (Broussard and Devkota 
2016). 
 
1.3.4 The oral microbiome: environmental niches 
 
Microbiota composition is secondary to its host environment, for example the oral cavity, 
skin, or intestinal tract, and there is therefore substantial variation between body sites. 
Tissue-specific microbiota have differing associations with disease. The human microbiome 
project (HMP), which represents a ground-breaking effort to characterise the healthy 
human microbiome, has investigated the microbial population of 5 major body areas – oral 




cavity, intestinal tract, nasal cavity, vagina and skin. Of these, the oral microbiome is one of 
the most diverse; the oral cavity provides at least 9 distinct environmental niches – 
subgingival sulcus, supragingival tooth surface, gingiva, hard palate, buccal mucosa, tongue, 
saliva, throat and tonsils (Figure 1.7). 
 
 
 Figure 1.7 Environmental niches of the oral cavity 
Adapted from Sampaio-Maia et al. (2016) 
 
 
Within the oral microbiota there are 150 genera identified comprised of 700 species of 
which 51% are officially named, 13% are unnamed but cultivated and 34% of which are 
known only as uncultivated phylotypes (Chen et al. 2010). Most habitats within the oral 
cavity are dominated by Streptococcus, followed in abundance by Haemophilus in the buccal 
mucosa, Actinomyces in the supragingival plaque and Prevotella within subgingival plaque. 
 
In contrast to the lower gastro-intestinal tract, the oral cavity is well suited to the 
formation of biofilms, having far lower motility and a lack of a mucus layer. Congregation 
of bacteria within biofilms allows a greater array of interaction between bacteria, such as 
horizontal gene transfer, and interspecies functional modulation (Alseth et al. 2019).  
 





1.3.5 The oral microbiome:  physiological influence 
 
The oral microbiota have an important physiological role in nitric oxide homeostasis. Nitric 
oxide has diverse functions and is a facilitator of vasodilation, nerve impulse transmission, 
host defence mechanisms and cellular energetics. The classical pathway for nitric oxide 
generation is via nitric oxide synthases. However, an alternative pathway also having an 
important role is the nitrate to nitrite to nitric oxide pathway. Here, nitrate present in food 
such as leafy green vegetables is sequestered by the salivary glands and released in saliva, 
where conversion to nitrite is facilitated by the oral microbiota which use these molecules 
in respiration as the final electron acceptors in the electron transport chain. Key oral 
bacteria identified as having a role in nitrate reduction are Streptococcus salivarus, 
Streptococcus mitis, Streptococcus bovis, Veionella spp., Staphylococcus epidermis, Staphylococcus 
aureus, Nocordia spp and Corynebacterium (Hezel and Weitzberg 2015). 
 
 
1.3.6 The oral microbiome examples of pathophysiological influence outside 
the mouth: Alzheimer’s disease 
 
Understanding the microbiome and the nuances of its influence on disease is a task of 
considerable proportions, and one which we are only beginning to address. 
 
To date there are numerous disease associations with the oral microbiome, and the oral 
microbiota is increasingly appreciated as having important pathyophysiological systemic 
consequences (He et al. 2015, Gao et al. 2018). Within the oral cavity, diseases in which 
the oral microbiota are causally implicated are caries, periodontal disease of the tooth 
supporting periodontium, oral mucosal diseases, oral cancer and peri-implantitis.  
 




The systemic diseases associated with altered  oral microbiota include obesity, rheumatoid 
arthritis (Chapter 2; Chapter 7), HIV infection, liver cirrhosis, inflammatory bowel diseases 
(IBD), polycystic ovary syndrome (PCOS), diabetes, atherosclerosis and cardiovascular 
disease and more recently Alzheimer’s disease. A frequent feature underlying many 
conditions is chronic low-grade inflammation, however there are also numerous more 
disease-specific mechanisms. 
 
In genetically susceptible individuals, periodontal disease is initiated by the oral microbiota 
and particularly the dental biofilm formation which constitutes plaque. Chronic periodontal 
disease is characterised by gingival swelling preceding erosion of the gingiva, bone, and 
ligaments, leading to tooth loss as the supporting structures disintegrate. Chronic 
periodontitis is classified as general chronic periodontitis when more than 10 teeth are lost, 
and localised periodontitis below this threshold. In both instances there is systemic 
inflammatory involvement (Kinane et al. 2017). Risk factors for periodontal disease include 
genetic predisposition to systemic inflammation (having overlap with RA genetic risk 
factors, discussed in Chapter 2), smoking, diabetes mellitis, low educational attainment and 
psycho-social variables (Kinane et al., 2017; Figure 1.8).  
 
 
Figure 1.8 Susceptibility factors for periodontal diseases 
Adapted from Kinane et al. (2017). 





Periodontal disease has been historically associated with a group of bacteria known as the 
‘red complex’, which comprises Porphyromonas gingivalis, Treponema denticola and 
Bacteroides forsythus, which were reported as particularly associated with clinical measures 
of periodontal disease – dental pocket depth and gingival bleeding on probing (Socransky 
et al. 1998). It has since been advanced that wider microbiota associations or specific gene 
combinations thereof converge to shape and stabilise a disease provoking microbiota. The 
detailed aetiology and microbiota involvement is yet to be characterised, but disease 
development is likely to be secondary to presence of a pathogenic oral microbiota in the 
context of other pre-disposing risk factors and genetic propensity for inappropriate 
immune response. 
 
Recently the commensal microbiota more generally have been implicated in Alzheimer’s 
disease (Dominy et al. 2019) and also in the cognitive decline that precedes it. Longitudinal 
studies have shown that periodontal disease is associated with declining cognitive function 
and may be a contributory factor (Pritchard et al. 2017). A recent retrospective cohort 
study showed that a 10-year exposure to periodontal disease was associated with 
subsequent AD (Chen et al. 2017). This is in accordance with understanding that chronic 
low-grade inflammation is a risk factor for AD. Whilst PD is associated chronologically with 
AD, there is some question as to the direction of effect - a two-way relationship is likely. 
 
Alzheimer’s disease (AD) is the most common form of dementia, accounting for 60-70% 
of cases. AD is characterised by an insidious and progressive decline in cognitive ability 
which confers loss of independent functioning (Fernández et al. 2010). The pathological 
hallmarks of AD are extracellular amyloid beta (Aβ) plaques and intracellular tau 
neurofibrillary tangles (NFTs) within the brain (Emery et al. 2017). More recently microglial 
activation has been identified as a hallmark of Alzheimer’s disease and inflammatory 
mechanisms associated with microglial activation may play a pivotal role in neurotoxicity. 
Tau is a microtubule associated protein, which in AD is hyperphosphorylated within 
neurons and accumulates in the neuronal cytosol. The mechanism of tau 




hyperphosphorylation in AD is yet to be determined, however, evidence suggests that 
neuronal cell stress responses to pro-inflammatory cytokines may be important. Aβ is a 4 
kDa peptide, formed by the sequential cleavage of amyloid precursor protein (APP), a 
large transmembrane protein, by beta secretase1 (BACE1) and gamma secretase (Emery 
et al. 2017). There are various isoforms of Aβ, varying by length (Aβ40, Aβ42), solubility 
and post translational modification. Insoluble Aβ accumulates to form AD characteristic 
extracellular plaques. The level of soluble Aβ42 oligomers has been demonstrated to 
correlate most closely with clinical severity (Condic et al. 2014). The neurotoxicity of Aβ in 
AD is secondary to multiple mechanisms including oxidative stress, Aβ associated receptor 
mediated mitochondrial dysfunction and excitotoxicity (Picone et al. 2014, Cheignon et al. 
2018).  
 
Porphyromonas gingivalis (P.gingivalis), a key periodontal disease bacterium, which is also 
associated with RA (Chapter 2; Chapter 7) has been associated with Alzheimer’s disease. 
P.gingivalis has been demonstrated to be present in the saliva and cerebrospinal fluid (CSF) 
of probable AD patients with mild to moderate cognitive impairment. Virulence factors 
produced specifically by P.gingivalis known as gingipains – cysteine proteases which are 
transported by OMVs, have been found in the brains of AD patients. Specifically, within the 
hippocampus of deceased RA patients, arginine gingipain B (RgpB) co-localised with 
neurons and astrocytes (but not microglia), and was found to be intracellular. RgpB co-
localised with phosphorylated and un-phosphorylated tau, and with intracellular soluble 
Aβ42. In vitro cultured neuronal cells expressing high molecular weight tau demonstrated 
tau truncation in response to the addition of both P.gingivalis and gingipains - RgpB and 
lyseine gingipain (Kgp). Tau truncation and fragmentation is a likely precursor to generation 
of insoluble and hyperphosphorylated tau. Tau truncation was abated by addition of a 
cysteine protease inhibitor but not by broad spectrum antibiotics, indicating that the 
reaction is mediated by gingipain virulence factors of P.gingivalis as opposed to other 
bacterial peptides. In murine models, after oral infection with P.gingivalis every other day 
for six weeks, the P.gingivalis 16s rRNA gene was detectable in the brain suggesting 
bacterial translocation. Presence of P.gingivalis in the brain was associated with levels of 




Aβ42 (Dominy et al. 2019). Further supporting this link, Aβ is an anti-microbial peptide 
and can be considered a component of the innate immune system (Pritchard et al. 2017). 
This places the potential link with translocated oral microbiota and microbial peptides 
feasibly early in the disease pathogenesis. In this scenario, oral microbiota are likely to 
contribute to microglial activation – microglia are inflammatory mediator immune cells of 
the brain, activation of which are now identified as a third hallmark of AD in addition to 
Aβ and tau pathology. A suggested sequence of events is oral microbe translocation, Aβ 
deposition and glial cell activation, but substantial further work is needed to shed light on 
the association. There is a link here with RA; quite extenstive work on the oral microbiota 
and RA has focussed on P.gingivalis and associated gingipains (discussed in Chapter 7). 
 
Overall, the oral microbiota are of great interest having systemic influence and also 
relevance in an array of clinical conditions. With regards to rheumatoid arthritis, the oral 
microbiota may provide the link between RA and one of the primary RA risk factors 
periodontal disease. This is discussed in detail in the literature review in Chapter 2, and 
further in Chapter 7: Genetic risk for RA and association with the oral microbiota. 
Regarding research studies, the oral microbiota holds a methodological advantage in that it 
is readily sampled: microbiota from each of the oral sites are easily obtained. In contrast, 
microbiota sampling of the gastro-intestinal tract represents a substantial methodological 
challenge (see Section 1.4.4). 
 
 
1.4 The gut microbiome composition and example of 
physiological and pathophysiological influence 
 
The term ‘gut microbiome’ refers to the microbiome of the gastro-intestinal (GI) tract. The 
GI tract encompasses the oral cavity, oesophagus, stomach, duodenum, small intestine, 
cecum, large intestine, colon and rectum (Figure 1.9). However, ‘gut microbiome’ is widely 
used to refer to the colonic microbiome. 





1.4.1 The gut microbiome: environmental niches 
 
Within the colon, it is estimated that hundreds of thousands of bacterial species co-habit 
(Almeida et al. 2019). The GI tract is the largest interface between the internal and 
external environment. The gut (colon) microbiota constitute the majority of the 
commensal microbiota. Over 99% of the gut microbiota belong to the four phyla 
Actinobacteria, Proteobacteria, Firmicutes and Bacteroidetes, of which the latter two 
predominate (Nishida et al. 2018, Almeida et al. 2019). As is observed with the oral 
microbiome, the gastro-intestinal tract represents an array of microbial niches and 
environmental variation, which confers variation in microbiota composition along the GI 

















Figure 1.9 Overview of microbiota variation along the GI tract 
 Adapted from Vuik et al. (2019)  
 





The most marked shift in microbiota composition along the GI tract occurs between the 
distal ilium and the colon and is secondary to a gradient shift in pH, oxygen concentration 
and the abundance of anti-microbial peptides among other factors (Hall et al. 2017). In 
addition to compositional changes, there is marked variation in micro-organism abundance 
along the GI tract. Microbiota abundance in bacterial cells per gram going down the gut 
within the lumen is estimated at an order of 10^1 in the stomach, increasing to 10^3 in the 
duodenum, 10^4 in the jejunum, 10^7 in the ileum and finally 10^12 in the colon reflecting a 




1.4.2 The gut microbiome: physiological influence 
 
Gut bacteria are key regulators of digestion along the gastrointestinal tract; commensal 
bacteria play an important role in the extraction, synthesis, and absorption of many 
nutrients and metabolites, including short-chain fatty acids (SCFA), vitamins, bile acids, lipids 
and amino acids. These factors are in addition to those described above in Section 1.2.1 in 
regulating the development, homeostasis, and function of innate and adaptive immune cells. 
 
SCFA, the most abundant of which are acetate, propionate and butyrate hold diverse 
physiological roles. Butyrate is integral to Gl function as it is the primary metabolic 
substrate for colonic epithelial cells, and it also holds wider roles via epigenetic function 
having histone modification capability thus altering gene expression and induction of 
apoptosis of colonic cancer cells (Nishida et al. 2018, Rowland et al. 2018). Butyrate and 
propionate have been demonstrated to influence gluconeogenesis conferring a beneficial 
role in glucose homeostasis. Propionate is suggested to be important for achieving satiety. 
It is a substrate for intestinal G protein – coupled receptors (GPCRs) which are also 
known as fatty acid receptors. Propionate is produced typically by Bacteroides species and 




particularly Negativicutes, and also Clostridium species. Acetate supports the microbial 
community as it is an essential co-factor for the growth of other bacteria. For example,  
Faecalibacterium prausnitzi (F.prau), a bacterium uniformly associated with health, requires 
acetate. F.prau is a key producer of butyrate alongside other members of the Firmicutes 
phylum.  Acetate also has a physiological role in cholesterol metabolism and lipogenesis. 
Acetate is the most abundant SCFA and is a metabolite produced by many taxa. The gut 
microbiota are the primary source of circulating serotonin neurotransmitter production. In 
total the gut microbiota produce up to one third of the metabolites detectable in the 
bloodstream, which enter the systemic circulation largely via the hepatic portal vein 
(Sharon et al. 2014).   
 
The commensal gut microbiota have an important role in vitamin synthesis. It is long 
established that gut microbiota are responsible for synthesis of vitamin K and act as the 
primary source. Vitamin K is required for the function of the clotting cascade. In addition, 
the gut microbiota are capable of synthesis of B group vitamins – biotin, cobalamin, folates, 
nicotinic acid, pantothenic acid, pyridoxine, riboflavin, and thiamine. A recent study showed 
that 40-65% of gut microbiota taxa are capable of synthesis of all eight B vitamins 
(Magnúsdóttir et al. 2015). It was previously identified that bacteria belonging to the 
Bacteroidetes phylum hold around 90% of B vitamin synthesis capability. B vitamins of 
microbial source are primarily utilised across the gut microbiota, contributing to microbiota 
community stability, and therefore contributing indirectly to host homeostasis.  
 
Another function of the gut microbiota is proteolysis of proteins from dietary sources and 
endogenous proteins from enzymes, mucins and sloughed intestinal cells. This produces 
shorter peptides, singular amino acids, fatty acids, and gases. Conversely, gut microbiota 
synthesis of polypeptides from free amino acids contributes to amino acid bioavailability 
(Ma and Ma 2019). 
 
Bile acid composition and abundance is heavily influenced by the gut microbiota. In addition 
to their classical role in lipid digestion and absorption in the small intestine, and cholesterol 




homeostasis, bile acids also function as hormones which are implicated in a variety of 
metabolic processes (Staels and Fonseca 2009). Bile acids have systemic effects – through 
reabsorption they are transported via the circulatory system to act as ligands for bile acid 
receptors which are expressed in multiple cell types throughout the body. Bile acids are 
considered an important class of bioactive molecule. Within the intestine, the commensal 
microbiota are determinants of bile acid metabolism secondary to bacterial excretion of 
bile salt hydrolases. Synthesis of the primary bile acids cholic acid and chenodeoxycholic 
acid occurs in the liver, and these are converted to deoxycholic acid and lithocholic acid, 
respectively, by bile salt hydrolases produced by the gut microbiota. Gram positive bacteria 
and, in particular Lactobacillus, Bifidobacterium, Clostridium and Enterococcus, have been 
identified as major producers of bile salt hydrolases. In turn, bile acids influence bacterial 
proliferation, and therefore can be considered mediators of host-microbiome crosstalk 
(Foley et al. 2019). 
 
Commensal gut microbiota have a crucial role in impeding pathogenic bacteria colonization 
by inhibiting their growth, for example by consuming available nutrients and producing 
bactericidins, and successful competition against pathogens via nutrient metabolism, pH 
modification, antimicrobial peptide secretion and effects on cell signalling pathways. Gut 
microbiota also prevent bacteria invasion by maintaining the integrity of intestinal 
epithelium tight junctions. These factors are in addition to those described above regarding 
regulating the development, homeostasis, and function of innate and adaptive immune cells. 
 
 
1.4.3 The gut microbiome: example of pathophysiological influence - 
Inflammatory Bowel Disease 
 
IBD, encompassing Crohn’s and ulcerative colitis (UC), are chronic relapsing and remitting 
conditions in which there are varying degrees of intestinal inflammatory damage with 
extra-intestinal complications. Symptoms include stomach pain, bloating, fatigue and fever. 




Patients may show signs of blood in the stool, altered bowel habit, weight loss and 
anaemia. A pathophysiological link with the microbiota is not surprising: GI immune tone, 
colonocyte mucus barrier and tight junction defects are centrally implicated in the 
pathology (Ungaro et al. 2017). The pathogenesis of IBD is not clearly characterised, 
however a leading hypothesis is that in genetically susceptible individuals there is an 
abnormal immune response to commensal gut microbiota, following exposure to multiple 
environmental factors. UC, in particular, has been associated with differences in the gut 
microbiota compared to controls, and particularly an expansion of facultative anaerobes of 
the Enterobacteraceae family (Zhu et al. 2018, Lo Presti et al. 2019). There is aetiological 
crossover between IBD and RA, including shared genetic susceptibility factors and as such 
it is not uncommon for IBD patients to develop an IBD arthropathy which is RA-
reminiscent. The joint pathology of IBD patients who also have arthropathy tends to differ 
from that of RA, with affectation primarily of the large joints – knees, ankles, wrists, elbows 
and hips (Orchard 2012). Faecal microbiota transfer (FMT) – the transfer of faeces from 
healthy donors to IBD patients, has been posited as a promising option for treating IBD 
(Tian et al. 2019). FMT is already employed for the treatment of Clostridium difficile 
infections and may have much wider use in the future. Nevertheless, this ‘blanket’ 
approach carries risks; given our current state of knowledge of the microbiota, there is 
potential for unforeseen and damaging effects (König et al. 2017). A more targeted 
approach has been suggested for IBD, specifically, ‘precision editing’ of the gut microbiota 
using tunstate. Here, Enterobactereceae which are particularly associated with IBD are 
metabolically inhibited by tunstate, which replaces the final electron acceptor in the 
electron transfer chain of these facultative anaerobes. In this way, the electron transport 
chain in Enterobacteraceae is rendered obsolete, but the wider microbiota are unaffected. 
Implementation of this method in murine models showed promise, however it has yet to 
be trialled in humans (Zhu et al. 2018). 
 
 




1.4.4 The gut microbiome: challenges in sampling 
 
In contrast to the oral microbiota, the gut microbiota represent a substantial challenge with 
regards to sampling – samples of GI tract tissue are not readily accessible. For this reason, 
the gut microbiota are routinely measured using the faecal microbiota as a proxy. It is 
worth noting that the faecal microbiome and the colonic microbiome taken with colonic 
biopsies are different. For example, it is evident from studies comparing biopsies with 
faecal samples that taxa with adhesive pili which provide anchorage to the mucosa and 
epithelia are under-represented in stool compared to the colon (Mora Ortiz 2019). 
However, as faecal samples are uniformly used for the study of the gut microbiota, 
because of ease of collection compared to the invasive procedure needed to collect 
colonic biopsies, the differences between the colon and faecal microbiota should be 





In conclusion, RA is a heterogeneous condition, in which there is aberrant activity of the 
immune system. There is a requirement to further understand the condition in order to 
improve clinical management. The oral and gut commensal microbiota are intimately 
implicated in many facets of host physiology including, but not limited to immune function. 
This thesis seeks to examine the relationship between RA and the oral and gut microbiota. 
It is very timely because recent studies have provided tantalising evidence of this 
aetiological link. In the following chapter, I critically examine the prior evidence for the link 











Introduction 2: Literature Review & Thesis Aims 
 
In this chapter I present a review of published evidence with regards to the link between 
the microbiome and RA, through the lens of host genetic factors. In this work I evaluate 
the genetic aetiology of RA; the association of the microbiome with RA; the potential 
influence of host genetic factors in the link between the microbiome and RA. Following 
this, I present the aims which will be addressed within this thesis. 
 
The literature review is presented as a paper, originally published in the Journal of 
Autoimmunity in February 2019. 
 







































































































Figure 2.3 Summary of potential mechanisms by which molecular mimicry of the gut microbiota 
and CARD9 genotype can contribute to systemic inflammation. 
 















































2.2 Thesis Aims 








2) Apply appropriate methods to the study of the commensal microbiota in RA. 
  
3) Investigate the gut microbiota association with RA with regards to host genetic factors.   
 



















General Methods 1: Generation of ASVs in TwinsUK 
 
Within this chapter I introduce and describe in detail the core methods used in this thesis. I 
first introduce the TwinsUK cohort, the data from which has been used extensively 
throughout the thesis.  
 
I introduce the concept of, and analysis for 16S rRNA gene sequence microbiome data, 
hereafter referred to as 16S data. I detail the overall steps for microbiome analyses, with 
particular depth regarding the processing of raw sequencing data: I applied a novel method 
for the Department of Twin Research for processing of the raw sequencing data to 
generate the taxon count table which comprises the core 16S microbiome dataset, used 
for all downstream analyses.  
 
I demonstrate the use of heritability estimation to assess resolution of TwinsUK amplicon 
sequence variants (ASVs) compared to operational taxonomic units (OTUs), following on 
from the method applied by Matthew Jackson with regards to OTU generation methods, 
described in Jackson et al. (2016).  
 
 
3.1  TwinsUK cohort 
 
The TwinsUK cohort is the largest adult twin registry in the UK, with 14,838 participants, 
recruited during the past 27 years (Verdi et al. 2019). The TwinsUK cohort, is appropriate 
for the study of rheumatoid arthritis: the majority of participants are female (82%) and the 




mean age of participants is 59. The cohort is deeply phenotyped, using data collected 
during ongoing visits to the Clinical Research Facility at St Thomas’ hospital, managed by 
King’s College London. An array of associated ‘omics’ datasets have been generated (Verdi 
et al. 2019)  Volunteers within the TwinsUK are particularly engaged and forthcoming in 
participating in ongoing research.  
 
 
3.2 Background: Facilitation of microbiome studies by 
development of next generation sequencing platforms 
 
Until recently, microbial studies were limited to culture dependent techniques. Substantial 
technological advancements have facilitated progression in the characterisation of micro-
organisms from culturing, to genomic sequencing. Following the success of the human 
genome project, massively parallel sequencing systems were developed to improve 
sequencing efficiency (Chial 2008). Scientific advances in genomic sequencing proceeded 
through three major technical revolutions, comprising first generation sequencing - whole 
genome shotgun sequencing, next generation high throughput sequencing (NGS) and third 
generation of sequencing, single molecule long read sequencing (Cao et al. 2017). Since the 
natural economic progression leading to reduction in cost following the initial development 
of NGS circa 2007, there has been exponential interest in the application of these 
techniques to study the microbiome. Subsequently the microbiome field of study has 
rapidly expanded, constituting a tipping point concerning understanding of human 
physiological function in health and disease. This is described in further detail in Chapter 1: 
Introduction. The main platforms which have been developed for high throughput 
sequencing are, in order of evolution, ROCHE 454, SOLiD, Ion Torrent, Illumina Hi-Seq 
and Illumina MiSeq (Pillai et al. 2017). 
 
 




3.2.1  16S rRNA gene sequencing  
 
The most widely employed method for measuring the microbiome composition of 
biological samples is the sequencing of the 16S ribosomal RNA (rRNA) marker gene. The 
efficacy of this approach and lower cost relative to metagenomics methods, underlies its 
popularity. The 16S rRNA gene encodes for a component of the 30s small subunit of the 
prokaryotic ribosome (Figure 3.1) and is therefore ubiquitous amongst bacteria: it is a pre-
requisite for synthesis of all bacterial proteins. Hence it is an ideal marker gene candidate. 
The structure of the 16S rRNA gene (described below) confers suitability for use as a 
taxonomic marker. 
 





Figure 3.1 Secondary structure of 16S rRNA of Escherechia coli   
Adapted from Yarza et al. (2014) 
 
Within the 16S rRNA, there are 9 hypervariable regions, the sequence of which is 
(predominantly) taxon specific, and each is flanked by highly conserved, non taxon-specific 
regions. Following DNA extraction from samples, the use of conserved region-specific 
primers allows amplification with polymerase chain reaction (PCR), of the targeted variable 
regions (Figure 3.2).  
 





Figure 3.2 16S rRNA gene sequence showing conserved and hypervariable regions  




PCR generated amplicons are sequenced using a next generation sequencing platform.  
Initially Roche 454 platforms were most widely used, but have now been superseded by 
Illumina MiSeq. Of the 9 hypervariable regions V1 – V9, V4 is the most frequently used 
within 16S studies, and is used in TwinsUK. The V4 region is 253 base pairs in length, and 
full-length sequencing can be achieved using paired (forward and reverse) reads generated 
on an Illumina MiSeq. Once sequence reads are generated, pre-processing steps are 
undertaken. At this stage, a count table is generated (generation of OTUs or ASVs, 
described below), and sequence groups are compared to a reference ribosomal RNA gene 




3.2.2  Generation of sequence counts: ASVs  
 
Sequencing data must be converted to a table of taxonomic counts present per sample, 
prior to statistical analysis. Traditionally, this has been achieved via generation of OTUs, in 
which reads are grouped together according to a similarity threshold (Edgar 2017).  More 
recently, higher resolution methods have been developed: ASVs (Callahan et al. 2016, 
2017). The principle of ASVs is that sequencing errors are resolved to reveal the original 
biological sequence, allowing exact matching of sequences as opposed to grouping 




according to a similarity threshold. This overcomes some limitations of OTU grouping 
based methods (Callahan et al. 2017). Sequences which would otherwise have been 
contained within the same OTU - but are from different taxa - can be separated and more 
accurately identified. The broad concept of this is illustrated in Figure 3.3. Sequences which 
vary by just one nucleotide may also be (arbitrarily) assigned to different OTUs; this is not 
the case with ASVs. Additionally, as the original biological sequence has been resolved, it is 
possible to assign taxonomy at species level in a proportion of the data. A final advantage 
of ASVs representing a true biological entity is that they can be directly compared between 





Figure 3.3 Graphical representation of the theory of increased resolution of ASVs versus OTUs 
Adapted from Callahan et al. (2016). In the centre are shown amplicon reads with different sequences. Each 
colour of amplicon reads in the centre partition are derived from the same bacterial species. The blue and 
the grey, and the red and the green are sequentially similar to each other (>97% similarity) but represent 
different taxa. On the right, the similar sequences are grouped together to form two OTUs, derived from 
the amplicon reads from four different taxa. On the left, four ASVs have been devised representing the four 









Figure 3.4 Validity of ASVs and OTUs within and between datasets 
Adapted from Callahan et al. (2016).  On the right, ASVs represent a true biological entity, and are therefore 
directly comparable between different datasets. Closed reference OTUs are limited in the biological 
information captured owing to initial direct comparison with incomplete reference databases during 
generation. De-novo OTUs have higher bandwidth for capturing biological information compared to closed 
reference OTUs but are not directly comparable between datasets. 
 
 
ASVs are generated by using the sequencing error pattern of reads generated by next 
generation sequencing to infer the original biological sequence. The method, developed by 
Callahan et al. (2016), is optimised for Illumina MiSeq V4 16S rRNA data, though can be 
applied to other data types such as fungal nuclear ribosomal internal transcribed spacer 
(ITS).  
 
Due to variation in errors between sequencing runs, each run is dealt with separately. 
Reads (organised into per sample forward and reverse files) are first trimmed, as quality 
deteriorates toward the ends of reads secondary to reagent degradation. The data is then 
de-noised using the following 5-step process.  
 
First, sequences are first dereplicated (matched with identical sequences and assigned an 
abundance value) to increase computational efficiency. Second, sequences are compared, 
and at this stage the data-specific error pattern is modelled. Third, sequences are 
partitioned by applying the divisive partitioning algorithm: the most abundant unique 
sequence is used as the central comparator, and data is divided until all unique sequences 




within the partition are statistically deemed to have likely originated from the central 
unique sequence, statistical likelihood is determined via calculation of the sequence 
abundance P value (Figure 3.5). The sequence abundance P value also identifies (leading to 
exclusion of) reads which are likely to be sequencing errors. By default, all singleton reads 
will be identified as potential sequencing errors, as it is not possible to determine the 
likelihood that a singleton read represents a biological entity. The fourth step is error 
model parameterisation, using non-parametric polynomial based Loess modelling and 
application to resolve sequencing errors to finally reveal (theoretically) the original 
biological sequences of the reads. Fifth, forward and reverse reads are joined (and because 
errors have been resolved, exact base pair matches are made), and ASVs from different 
sequencing runs are then merged. 
 
After denoising, chimera removal is undertaken. Chimeras in this context are artefacts of 
PCR (discussed in detail in Chapter 8). A conservative chimera removal method is applied. 
Finally, taxonomy of the ASVs is assigned, using a reference database such as SILVA or 
Greengenes (Table 3.1). 
 
 
3.2.3  Evidence of comparative efficacy of ASVs: Benchmarking 
 
Callahan and colleagues undertook comprehensive benchmarking of ASVs compared to 
other methods for inference of sample composition using 16S rRNA gene sequencing 
(Callahan et al. 2016). Using mock reference bacterial communities for which the 
taxonomic composition was known, they compared the performance of ASVs generated 
using DADA2 to other algorithms which produce OTUs: UPARSE, MED, Mothur and 
QIIME. The same variable region as is used within TwinsUK (V4) was sequenced using also 
the same primers (F515 and 806R; Section 3.4.1). Also in accordance with TwinsUK, 250 
base pair pared end reads were used. Three types of mock community were used – 
balanced, HMP and extreme. In all three datasets, DADA2 demonstrated higher sensitivity 




and specificity compared to other methods. The HMP dataset is the most comparable to 
the data in this thesis, consisting of intestinal bacteria. When comparing efficacy in 
identification of sequences for all types of mock community across each algorithm, 




Figure 3.5 Comparison of output sequences inferred from HMP mock community by HMP, 
UPARSE, DADA2, MED, Mothur (average-linkage) and QIIME (Uclust) 
On the Y axis is plotted frequency of output sequences from the HMP merged dataset. On the Y axis is 
Hamming distance from each sequence to its nearest more-abundant neighbour sequence. UPARSE is used 
as a baseline with which to compare the methods. Algorithms largely concur (black) in identifying sequences 
that are abundant and very different from other sample sequences. However - DADA2 detects additional 
variation (blue), which is accurate (square or circle). MED does also detect some fine-scale variation (green), 
but at the cost of some additional false positives, and MED demonstrates more lost data as it does not 
detect low abundance sequences (grey). Mothur (orange) and QIIME (red) also both report a substantial 
number of additional spurious sequences (which was not the case for DADA2). 
Adapted from Callahan et al. (2016). 
 
 
3.3 TwinsUK 16S data 
3.3.1 Sample collection and pre-sequencing steps 
 
 




Faecal samples for participants within the TwinsUK cohort were collected during clinical 
visits from 2010-2015. Samples were produced during the two days prior to the visit in 
15mm canonical tubes and stored in a refrigerator for up to two days prior to clinical visit. 
When bowel movement was not possible, a faecal sample was produced at a later date as 
soon as possible and posted to the department of twin research in a sealed ice pack. Upon 
arrival, samples were frozen at -80 degrees C.  
 
Frozen samples were shipped on dry ice to Cornell University, where DNA extraction, 
polymerase chain reaction (PCR) and sequencing was undertaken. Prior to DNA 
extraction, samples were removed from the freezer. Physical abrasion of samples with 
bead beating was included in the protocol in order to improve yield from gram positive 
bacteria, which have a robust cell wall. Genomic DNA extraction was performed on 100 
mg sample aliquots using the PowerSoil® - htp DNA isolation kit (MoBio Laboratories Ltd, 
Carlsbad, CA). PCR amplification of the 16S rRNA gene was applied in triplicate. Primers 
targeting the V4 hypervariable region were used: F515 and 806R, as described in Caporaso 
et al. (Caporaso et al. 2011). PCR replicates were combined and purified using a magnetic 
bead system (Mag-Bind® EZPure, Omega Bio-Tek, Norcross, GA). Quantification of PCR 
amplicons was undertaken using the QuantiT PicoGreen dsDNA Assay Kit (Invitrogen, 
Carlsbad, CA), followed by combining aliquots of amplicons (at equal masses) at a final 
concentration of approximately 15 ng/μl. DNA was sequenced using the Illumina MiSeq 
platform, generating 250 base pair (bp) paired-end reads, at Cornell Biotechnology 
Resource Centre Genomics Facility. 
 
 
3.3.2  Generation of ASVs in TwinsUK  
 
Generation of ASVs is a multiple step process, described above in Section 3.2.2. In the 
present section I provide a description of the preparatory computational steps and detail 




the problem-solving steps specific to the application of the technique to TwinsUK 16S data 
(Table 3.1).  
 
The first step was to produce demultiplexed FASTQ files containing read sequence, sample 
ID and read quality information. Reads for each sequencing run (n=35) were first 
demultiplexed (assigned to samples according to identifier barcodes; Figure 3.6) in QIIME 
with minimum thresholding parameters as specified in the DADA2 protocol (Figure 3.7).  
 
 
Figure 3.6 Representation of barcodes linking multiplexed raw sequencing and meta-data 




After demultiplexing, the forward and reverse file for the sequencing run was split 
according to sample ID, producing separate forward and reverse files for each sample 









Raw Multiplexed Data Mapping File
TGGAGAGGAGAT







Figure 3.7 Generation of sequencing files for input to DADA2 package 
 
In total there were 35 sequencing runs requiring independent custom filtering thresholds, 
due to variation in quality of the reads between runs. Following filtering, reads should 
ideally be of good quality throughout (Figure 3.8). The thresholds used for each sequencing 
run are given in the ASV script in Appendix A. 
  
 
Figure 3.8 Quality plots of sequencing reads prior to and post trimming 
On the y axis is shown the phred quality score of the sequencing read. On the x axis is shown the number 
of bases. In A, higher quality reads from an example sequencing run are shown. In B, an example of poorer 
quality sequencing reads are shown, containing fluctuation in quality throughout the read, as opposed to 
towards the end of the read, as would be usual. In C, an example of trimmed reverse read is shown, with 
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 ASVs were generated as described above in Section 3.2.2, and taxonomy was assigned 
using the SILVA 1.3.2 database. A phylogenetic tree was generated for the ASVs using the 
Phangorn package in the programming language R with default parameters (Schliep 2011). 
During the generation of the ASVs there were several issues which required resolution. In 
particular, there were problems with the barcodes and overall quality of the reads (Figure 
3.8). These problem-solving steps were the rate limiting factor for this work. The 










Previous work on this data began 
from demultiplexed FASTA files. 
For DADA2, FASTQ files 
containing quality score 
information is required.  The 
correct demultpiplexing method 
and commands for the data 
needed to be devised. 
 
Troubleshooting through trial and error 
was required. An additional flag:  
--Rev_comp_barcode was added to 
the script (identified by Maria Stalteri). 
Plate 16 barcodes 
 
Demultiplexing was not successful 
for plate 16. The barcodes in the 
mapping file were incorrect for 
this sequencing run.  
 
I wrote an R script to extract the 
barcodes from existing FASTA files for the 
same data, and insert the correct barcodes 
into the mapping file (Appendix A). 
Demultiplexing using the updated 
barcodes was successful 
Only reverse read 
available – forward 
read missing 
 
For one sequencing run, only the 
reverse sequencing file was 
available. 
 
In order to avoid the need to remove this 
sequencing run entirely, I amended the 
script to generate ASVs from the reverse 
read only. 








deteriorates in quality at the ends 
of the read, as the reagents 
degrade. It is therefore suggested 
in the manual to trim the reads. 
Little guidance was available with 
regards to choosing the 
parameters. 
 
There is a balance between removing 
spurious quality data, and maintaining 
sufficient read length and overlap between 
forward and reverse reads.  
 
Sequence runs 
crashing: quality of 
reads too low for 
DADA2 algorithm 
 
Some samples were of 
particularly low quality, such as is 
depicted in example B in Figure 
3.8.  
 
For affected sequencing runs, I sequentially 
removed the worst quality samples until 
the script was able to run. 
 
Only reverse read 
available – forward 
read missing 
 
For one sequencing run, only the 
reverse read was available. 
 
I adapted the ASV script to generate ASVs 








Within the DADA2 workflow the 
chimera removal step serves to 
identify not just chimeras (non-
biological artefacts of PCR), but 
also whether there were non-
biological instertions (e.g. 
adapters) present in the data. If 
present, this would indicate that 
the data required further steps of 
adapter removal, before re-
running the workflow. 
 
I checked the proportion of reads 
removed at the chimera removal step 
using the following calculation: 
sum(seqtab.nochim)/sum(seqtab) 
This identified that 10% of reads were 
removed. I contacted the creator of 
DADA2 (Ben Callahan) regarding this, and 
he confirmed that this is comfortably 





Taxonomic classifications of 16S 
rRNA gene sequences is usually  
undertaken using one of four 
 
The SILVA database has been most 
recently updated compared to the other 
resources. In the SILVA database, where 
species assignment is not possible due to 




resources: SILVA, RDP, 
Greengenes or NCBI. 
constraints of the data, further efforts 
have been made to sub-classify sequences 
in a level between genus and species, by 
assigning according to group of species, 
increasing resolution of taxon assignment. 
The SILVA database was therefore 
selected as the most appropriate database. 
Missing taxonomies 
 
A greater than expected number 
of sequence taxonomies were 
unassigned initially. 
 
I identified that in some instances ASVs 
are the reverse complement of the 
reference, and I re-ran the step adding an 
additional flag: tryRC == TRUE. 
 
Some ASVs not 
merging. 
 
Some ASVs not merging when 
sequencing runs were combined. 
 
 
I identified that this was due to the 
differing sequence lengths, and I re-ran the 
step adding an additional flag: 
collapseNoMismatch. 
 
Table 3.1 Problem solving undertaken during generation of ASVs in TwinsUK 16S data 
 
 
3.4  Efficacy of ASVs 
 
Heritability estimation provides the scope to compare resolution within and between 
OTU and ASV based methods. The hypothesis is that methods which perform better are 
more likely to produce units (ASVs or OTUs) which represent a true biological entity, and 








3.4.1 Calculation of narrow sense heritability estimates for ASVs 
 
Heritability estimation calculations utilise correlation of a phenotype between monozygotic 
(MZ) and dizygotic (DZ) twin pairs, with respect to the average expected shared genetic 
and environmental within and between pair variance. Narrow sense heritability is the ratio 
of additive genetic variance to the total phenotypic variance. Dizygotic twins share on 
average 50% of their heritable genetic material, whilst monozygotic twins share 100%. 
Classical twin modelling relates the observed variance of a trait to the effects of 
unobserved (latent) factors, which are linked to functional effects of genes (A), shared 
environment (C) and unique individual-specific environment (E) (Figure 3.9). A key (but 
sometimes criticised) assumption of the model is that DZ and MZ twin pairs share the 
same level of environmental influence. Overall, it is an elegant technique for the purpose of 










Figure 3.9 ACE model for calculating genetic and environmental influence from MZ and DZ twin 
correlations 
Adapted from (Bunyavanich et al. 2013) 
 
Prior to model fitting, the powerTransform package in R was used to estimate a Box–Cox 
transform lambda producing approximately normally distributed residuals from a linear 
model with OTU abundance as a response variable and gender, age, sequencing run, 
sequencing depth, postal or non-postal sample collection, technician responsible for DNA 
extraction and technician responsible for preparing the sequencing plate as predictor 
 




variables. This was undertaken for each ASV and the transformed residuals were used as 
input for heritability estimation. 
 
Maximum likelihood model fitting, adjusting for age, sex and technical factors was applied 
to estimate A (additive genetic), C (shared environmental), and E (unique environmental) 
contributions to ASV abundance, from data for monozygotic and dizygotic twins, the using 
the openMX R package. 
 
Heritability estimates were calculated as described above, at both the ASV level and the 
genus level. Genus level refers to grouping together ASVs with the same genus level 
annotation. The genus group annotations from the SILVA database includes subdivisions of 
ASVs into predicted groups of species, and these were grouped together. These 
annotations are useful for differentiating ASVs from the same genus, where annotation at 
species level was not possible due to insufficient sequence resolution or length. There are 
both advantages and disadvantages to calculation at ASV or genus level.  At the ASV level, 
heritability estimates of multiple ASVs with the same annotation represent independent 
findings in the context of other heritability estimates within the analysis. However, it is 
impossible to ascertain whether these are members of the same taxa, or whether there is 
divergence at the species or strain level. Due to the lower numbers of each ASV 
compared to the genus group to which it belongs, confidence intervals of heritability 
estimates at the ASV level will be wider. Heritability estimates at the genus level 
demonstrate narrower confidence intervals, due to higher power where these grouped 
ASVs represent the same taxa. This is illustrated in the study by Goodrich et al. (2016) in 
which heritability of OTUs in TwinsUK was calculated in a smaller and subsequently larger 
sample of the cohort, and in the latter, confidence intervals were narrower (Figure 3.2.4). It 
is also evident in the heritability of ASVs (Figure 3.2.1 and Figure 3.2.2) compared to ASVs 
grouped at the genus level (Figure 3.5). 






Figure 3.2.1 Heritability of ASVs present in more than 5% of samples. 
There were 200 significantly heritable ASVs present in more than 5% of samples. The most heritable ASV 
was Intestinibacter bartletti (49%, 95%CI 43-56). 
 
       
       
 

















Figure 3.2.2 Significantly heritability ASVs present in more than 15% of samples 
There were 159 significantly heritable ASVs present in more than 15% samples. The most heritable ASV was 















Figure 3.2.3 Significantly Heritable  ASVs at genus level, present in more than 5% of samples 
At genus level, of ASVs present in more than 5% of samples, 47 were significantly heritable. The most 


















Figure 3.2.4 Heritability of 58 OTUs collapsed to genus level 









3.4.2 Comparison of narrow sense heritability estimates for ASVs and OTUs 
 
Direct comparison between heritability estimates of OTUs and ASVs is challenging, 
because of the differences in the methods, and particularly the resolution and grouping of 
the sequences. In addition, in the ASVs there is a merge step in which ASVs with the same 
sequence are merged across sequencing runs to include all samples. On the other hand, 
OTUs are created in the entire dataset, producing a greater number of units which may 
represent the same taxon compared to ASVs. OTUs also contain taxa within the same 
OTU which are sequentially 97% similar to each other, the 3% leeway in sequence 
difference sometimes confers that they represent different species. Apparent heritability of 
some of the taxa represented as OTUs may rather reflect the increased power afforded 
by grouping together of sequentially similar taxa. OTUs were considered at the genus level, 
so although there were more OTUs than ASVs all with the same genus annotation were 
considered as one entity; The prior comment on power would not apply if individual 
OTUs had been analysed. Finally, the OTUs have been annotated using the Greengenes 
database, whereas the ASVs have been annotated using the SILVA database.  
 
Overall, there are four key factors to consider: heritability (A), confidence intervals, 
sequence clustering differences and success regarding taxonomy assignment. 
 
The ASVs showed higher heritability compared to the OTUs. The most heritable ASV 
(Rumicoccaceae_UCG_010) was estimated to be 45% heritable whereas the most 
heritable OTU (Christensellenaceae, genus unclassified) was estimated to be 38% heritable. 
Rumicoccaceae_UCG_010 was not identified amongst the significantly heritable OTUs, 
however a genus unclassified OTU from the Ruminococcaceae family was one of the most 
heritable OTUs (35%) and is potentially the same taxon. 
 
 




In the OTUs, in the study by Goodrich et al., the most heritable taxa at the genus level was 
Christensellenaceae, genus unassigned. This was not replicated in the ASV heritability 
analysis at the genus level, however genus grouped ASVs assigned to Christensellenaceae 
R7 group were the 10th most heritable taxon. In addition, at the ASV level, many ASVs 
belonging to the Christensellenaceae family were significantly heritable, it is likely that in the 
OTUs, some of these are grouped within the same OTU. The equivalent result in ASVs 
demonstrated that whilst Christensellenaceae is substantially heritable, it is not the most 
heritable taxon. Further, using OTUs, it was not possible to taxonomically identify the 
Christensellenaceae OTU beyond family – genus was unassigned. In addition, using ASVs, I 
have demonstrated that multiple ASVs assigned to the Christensenellaceae family are 
significantly heritable. As suggested above, it is possible that some of these were grouped 
into the same OTU, rendering the higher heritability estimate demonstrated for 
Christensellenaceae in the OTUs. 
 
In the OTUs, the second most heritable taxon was Turicibacter with a heritability estimate 
of 38%. In the ASVs, Turicibacter was the 5th most heritable taxon, but this genus showed 
higher heritability in the ASVs (41%) than in the OTUs. The third and fourth most 
heritable taxa in the OTUs – Erysipelotrichaceae _Cc115 and SHA-98 were not replicated 
in the ASVs. As OTUs do not identify novel information compared to ASVs, it is instead 
likely that some samples containing higher abundance of these taxa were not of high 
enough quality to successfully produce ASVs and were excluded from the data (Table 3.1). 
Our collaborator at the University of Stanford, Daniel Sprockett, undertook similar analysis 
of heritability of his independently created ASVs and replicated this (results not shown).  
 
Amongst the results for the OTU heritability estimates there are 11 OTUs which were 
unclassified at the genus level. In the ASVs, ASVs which were unclassified at the genus level 
have been removed, however some OTUs which could not be classified at the genus level 
were possible to identify using ASVs. This is potentially because the denoising algorithm 
extrapolates to the original biological sequence before sequencing errors were introduced, 
and therefore comparison of sequences to the reference database is more successful. 




However it could also potentially represent ASVs and OTUs from the same family but 
different genus. 
 
In the OTUs, Prevotella genus is identified as one of the significantly heritable taxa, 
whereas in the ASVs, use of the SILVA database has allowed this taxon to be more 
accurately identified as comprising of Prevotellaceae NK3B31 group and Prevotella_7. The 
latter only just reached significance - the 95% CI was only just greater than 0. 
 
 
3.4.3 Summary  
 
In summary, ASVs generated in TwinsUK contained novel information to OTUs generated 
from the same raw sequencing data, supporting the demonstration by Callahan  et al. 
(2017)  that ASVs offer substanbitally higher resolution. The TwinsUK ASVs contain novel 
information compared to OTUs, which will be valuable when considering association with 
phenotypes. Annotation of the ASVs with the SILVA database allowed differentiation of 
some taxa above genus level in instances where species annotation was not possible. For 
example, it can be deduced that the heritable Prevotella OTU is not Prevotella_copri; the 
heritable Prevotella ASV was assigned to Prevotella_7 . A limitation identified was that ASVs 
require higher quality sequence reads as input compared to OTUs - some samples were 
removed as it was not possible to apply the method to them -  and this was not the case 
with OTUs. However, the ASV methods are higher resolution and more accurate. In 
addition, creating the ASVs afforded development of a greater personal depth of 











 ASVs are the optimal method presently available for the pre-processing of 16S data. The 
large ASV dataset that I generated will improve resolution of results in the following thesis, 
in comparison to use of OTUs. Publications in which the ASVs have been utilised are listed 
in the beginning of the thesis: all non-review articles include analyses of these data. In the 





























General Methods 2:  Statistical analysis of the microbiota 
 
In this chapter I describe the challenges for statistical analysis of the microbiota as 
represented by ASVs, and I provide the background for the choice of techniques used in 
this thesis. 
 
4.1 Core downstream statistical analysis workflow 
 
The ASV counts which represent the core microbiome dataset present a challenge with 
regards to statistical analysis; There are several schools of thought with regards to the most 
appropriate approach (Gloor et al. 2017, Weiss et al. 2017). Analysis of microbiome data 
is a rapidly expanding field. Microbiome analysis holds specific challenges and specialised 
techniques have been developed to account for the high dimensionality of the data. There 
are an array of approaches available for each category of analysis. A particular challenge is 
the selection of an appropriate normalisation technique (discussed below in Section 4.2.2). 
 
The broad measures derived to understand microbiome composition are alpha diversity 
(within sample) and beta diversity (between sample), and taxonomic associations (Figure 
4.1). A schematic of the workflow for understanding association of the microbiota with the 

















Figure 4.1 Key measures of interest in microbiome studies:  Alpha and beta diversity, and taxon 
associations 
 
Alpha diversity represents in the within-sample microbial diversity, which can be used to 
compare from one sample to another, whilst beta diversity quantifies the overall 
dissimilarity between samples. These measures are discussed below in Section 4.2 and 
Section 4.4, respectively. Taxon associations provide more fine-scale information regarding 
association of the microbiome with a phenotype and may be present in the absence of 
detectable diversity differences. In all analyses, variation in sequencing depth between 



















4.2 Alpha diversity 
 
Alpha diversity metrics capture the microbial diversity within a sample, which can be used 
to investigate association of sample diversity with a phenotype. Alpha diversity metrics 
were originally developed by ecologists, but are now widely applied to microbiome studies, 
as the microbiome represents an ecological community which have been suggested to 
share many of the principles of classical ecology (Fierer et al. 2012). However this 
assumption has been criticized (Reese and Dunn 2018). Alteration in alpha diversity of the 
gut microbiota, and typically a lower alpha diversity, is a frequently demonstrated feature 
of disease, but is not ubiquitous. Correspondingly, disease treatment with prescription 
medications is associated with lower gut microbiota alpha diversity (Jackson et al. 2018a). 
Different alpha diversity metrics demonstrate comparative variation in one or more 
different aspects of microbial diversity: species richness, species evenness and phylogenetic 
variation. Species richness refers to the number of different taxa present in the sample, 
without regard to their frequencies. Evenness refers to the variation or lack thereof in 
abundance of taxa within a sample (Wagner et al. 2018). Alpha diversity measures include 
Shannon’s diversity index, Chao1, Observed ASVs, Simpson index and Faith’s phylogenetic 
diversity (Shannon and Weaver 1949, Simpson 1949, Chao 1984, Faith 1992). 
 
Shannon diversity (Shannon and Weaver 1949) accounts for both richness and evenness 
of species. The Shannon index is an information statistics index, and carries the 
assumptions that all taxa in the ecosystem from which the sample originates are present in 
the sample, and that they have been randomly sampled. These assumptions are partially 
violated by high throughput sequencing techniques which rely on primers, this issue is 
described in greater detail in Chapter 8, Discussion. To calculate the Shannon index, the 
proportion of each taxa relative to the total number is multiplied by the natural logarithm 
of the proportion. The product is then summed across species and multiplied by -1. 
 




The Simpson index (Simpson 1949) also takes into account both richness and evenness of 
species, however it is a dominance index – it gives more weight to common taxa, which 
are dominant within the sample. This index measures the probability that two organisms 
from the same sample will be members of the same taxa. Using the Simpson index, 
presence of rarer taxa with few representatives within the sample would not affect the 
measure of diversity for that sample – more weight is given to the more abundant taxa. 
This may be of use for, or a hindrance to the study, depending on the biological question 
at hand. 
 
Observed ASVs is simply the total number of ASVs present in a sample, and as such is a 
measure of species richness. Faith’s phylogenetic diversity (Faith 1992) is a measure of how 
phylogenetically diverse taxa are within a sample, and this measure does not incorporate 
taxon richness or evenness; here, the number branches of the phylogenetic tree linking 
taxa within the sample are summed. More phylogenetically diverse samples will contain a 
greater number of linking branches in the phylogenetic tree and will demonstrate higher 
Faith’s phylogenetic diversity. Chao1 (Chao 1984) relies on singleton ASVs or OTUs to 
calculate the measure. As singletons are not a feature of ASV data owing to the first step 
for each ASV which is comparison of the two most similar sequences which leads to the 
primary discarding of singletons, Chao1 has not been applied in this thesis. 
 
In this thesis, Alpha diversity is calculated using untrimmed ASVs (including all ASVs in the 
sample), and non-normalised count tables, as recommended by McMurdie and Holmes 
(McMurdie and Holmes 2014). Sequencing depth is accounted for as a fixed-effect 









4.3 Normalisation of sequence counts 
 
 Prior to application of other techniques to investigate beta diversity or taxonomic 
associations, the sequence counts must first undergo normalisation. There are two key 
reasons for this; the first is to transform the distribution of the sequence counts which are 
sparse, zero inflated, and with a negative skew, so that they are suitable for input to 
statistical tests without violating the assumptions of the model, and the second is to 
account for the substantial difference in reads per sample.  Normalisation of microbiome 
(and other types of high throughput sequencing data) represents a considerable 
methodological challenge and is a statistical research area in its own right.  
 
There is unavoidable irregularity between the proportion and abundance of taxa detected 
in sample data, compared to the ecosystems from which the samples originate, and this is 
referred to as “compositionality” (Gloor et al. 2017). This is reflected in the variation in 
number of reads obtained for each sample, generally referred to as “sequencing depth” or 
“library size” and must be addressed in addition to the more standard challenges of 
distribution. A primary aim of normalisation of microbiome data is to approximate the true 
sequence abundances in the original sample. Secondary aims are to limit false inference and 
deal with sequence count sparsity. There are numerous methods available for 
normalisation of the count table, each of which holds relative advantages and 
disadvantages; no currently available method is without considerable limitations. Further 
methods are under development. 
 
A widely used method for accounting for sequence depth prior to undertaking 
downstream analyses is rarefying. This refers to subsetting the sequencing data to a 
sequencing depth that is common to all samples. For example, in samples within a dataset 
contain between 10,000 and 100,000 reads, rarefying the samples would remove 90,000 
reads from samples containing 100,000, 80,000 from those containing 90,000 and so on, 
so that all samples are represented by 10,000 reads. Whilst this is arguably the most 




effective method possible for dealing with variation in sequencing depth, a prominent 
criticism of rarefying is that it disregards much data containing useful information. In fact, it 
exacerbates a general issue inherent to high throughput sequencing techniques; the 
sequenced sample represents a subset of the ecosystem and is unlikely to be fully 
representative. This is referred to compositionality – there is an arbitrary total imposed by 
the instrument (Gloor et al. 2017). This problem can be partially abated by performing 
multiple rarefying steps on the dataset, for example 500 times, and subsequently taking the 
average for each ASV or OTU. 
 
Another widely employed method is to calculate relative abundances of taxa. Here, 
abundances are scaled so that the total abundance of all taxa sums to 1. The theory is that 
the proportion within the sample should be similar to the proportion in the original 
sample, and in addition should be directly comparable to taxa abundances in other 
samples. The assumptions of this technique are that there is a majority random taxon 
component, and that there is balanced differential abundance between samples; for each 
number of taxa that increase across samples, there should be the same number of 
decreasing taxa (Weiss et al. 2017). Calculation of relative abundances results in over 
inflation of counts of some taxa, with corresponding under-estimation of counts of other 
taxa. Whilst it is a useful tool for visualisation, other techniques may be preferable for 
normalisation. 
 
The variance stabilising transformation (VST) which is inherent in DESeq2 and DESeq was 
originally designed for the analysis of RNAseq data but is now widely employed in 
microbiome studies. A recent study suggested that the VST provided the most consistent 








4.4 Beta diversity 
 
Beta diversity metrics quantify the dissimilarity between samples, and as such are measures 
of the overall compositional difference. Prior to calculation of beta diversity, the data must 
be normalised – including an adjustment for sequencing depth. This is because an 
assumption of the model is that samples to be compared are of the same size, either in 
area or volume (Ricotta and Podani 2017). In this thesis, the count data were normalised 
using the VST, described above in Section 4.3. Beta diversity was calculated using Bray 
Curtis, Weighted UniFrac and Unweighted UniFrac metrics.  
 
Bray Curtis is a commonly used non phylogenetic method for measuring beta diversity. It is 
calculated using two components. Considering two samples, the first component is the 
abundance of each taxa from sample one minus the abundance of each in sample two, and 
the second component is the abundance of each taxa in sample one added to the 
abundance of each taxa in sample two. If a species is absent, its abundance should be 
recorded as zero. Bray Curtis dissimilarity is then calculated as the sum of the first 
component divided by the sum of the second component (Bray and Curtis 1957).  
  
UniFrac metrics use phylogenetic information to give an estimate of beta diversity and can 
be used to detect whether phylogenetic lineages between samples are significantly 
different. When comparing two samples, Unweighted UniFrac is measured as the fraction 
of branch lengths in the phylogenetic tree which leads to taxon descendants in one sample 
or the other, but not both. Weighted UniFrac is similar to Unweighted UniFrac, but with 
the added component of accounting for differences in the relative abundance of taxa 
(Lozupone and Knight 2005).  
  
In this thesis, the statistical significance of beta diversity dissimilarity between groups is 
measured using a permutational multivariate analysis of variance (PERMANOVA) test 
(Anderson 2001).  




4.5 Taxonomic analysis: differential abundance 
 
Microbiota sequence count tables, in which each count represents the number of ASVs or 
OTUs per sample, are particularly challenging datasets to interpret. However key 
challenges are common to other comparative high-throughput sequencing assays. These 
are: small replicate numbers; large dynamic range; discreteness; and presence of outliers. 
For the purpose of assessing microbiota taxon associations with a phenotype - differential 
abundance - DESeq2 has become established in the microbiome field. Differential 
abundance calculation with DESeq2 addresses key challenges for microbiome data and 
offers a quantitative analysis which focuses on the strength as opposed to presence of 
differential sequence abundance. DESeq2 uses shrinkage estimation for dispersions and fold 
changes, to improve stability and reliability of interpretations of estimates. The statistical 
steps for differential abundance analysis with DESeq2 are as follows. 
 
The DESeq2 model has 3 parameters – (1) a normalisation parameter, (2) a variance 
parameter and (3) parameters representing group differences. Normalisation in DESeq2 is 
achieved using the variance stabilising transformation, which goes some way towards 
addressing variation induced by differences in sequencing depth: some samples will 
demonstrate higher counts of ASVs simply because more amplicon sequences were 
yielded for that sample. Application of the variance stabilising transformation yields values, 
the variances for which are approximately the same throughout the dynamic range within 
the whole dataset. Fit 2 uses maximum likelihood estimation to estimate sequence-wise 
dispersion. Dispersion captures the variability between replicates and is critical for statistical 
inference of differential abundance. After estimation of sequence wide dispersion, a 
smooth curve is fitted, providing an estimate for the expected dispersion value for 
sequences but does not represent deviations of sequences from the overall trend. 
Shrinkage of estimates is then applied, guided by Bayes theorem. The strength of the 
shrinkage - the extent to which the estimate is moved towards the curve - is dependent 




on sample size. In fit 3, DESeq2 employs empirical bayes shrinkage for log fold change 
estimation (Love et al. 2014a). 
 
 
4.6 Overview of methods applied in this thesis 
 
Within this thesis an array of approaches are applied to investigate the association 
between the commensal microbiota and RA. The broad work undertaken within each 
chapter containing primary analysis is presented in Table 4.1.  
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Table 4.1 Summary of methods applied 




In this chapter I have described the microbiome-specific general methods used within this 
thesis: alpha diversity, beta diversity and differential abundance. An explanation of other 
techniques used which are not applicable to the wider thesis are described within the 
respective chapters: heritability analysis of ASVs is described in Chapter 3, and analysis of 


















Genetic risk of rheumatoid arthritis and association with 




In this chapter I investigate the association between genetic risk of RA and the composition 
of the gut microbiota, using measures of diversity, taxon abundance association and 
ecological community interaction. 
 
This chapter is presented as a paper, originally published in The Lancet Rheumatology on 
the 26th June 2020. 
 



















































Figure 5.2 Differential abundance of the gut microbiota per unit increase in rheumatoid arthritis 
PRS in TwinsUK participants 
Figure 5.3 Differential abundance of the gut microbiota in patients with preclinical rheumatoid 
arthritis compared with unaffected controls in the SCREEN-RA cohort 
 





Figure 5.4 Differential abundance of the gut microbiota in HLA-DRB1 shared epitope-positive 















































Analysis of the gut microbiota in rheumatoid arthritis 
discordant twin pairs 
 
In the prior chapter, I focus on the association of the RA gut microbiota with host 
genotype. In this chapter, I take the opposite approach, considering the differences in the 
intestinal microbiota whilst taking account of host genotype. To achieve this, I undertake 
comparison of the intestinal microbiota of RA affected participants of TwinsUK, with their 





Flore Zuffery created a subset of RA discordant twins for a prior study and carefully 
phenotyped them; these participants formed a subset of the present study, sample defined 
below. In this process, Catherine Redshaw, Rachel Horsfall, Quincy D’Souza and I recruited 
twins using an algorithm to attend study visit, including sampling of their faecal microbiome.  










6.1    Introduction 
 
RA is associated with compositional differences in the intestinal microbiota with potential 
aetiological relevance, however it is unclear which factors may underlie the variation 
observed; there is an interest, sparked by encouraging findings which support a role of the 
intestinal microbiota in early RA in promoting inflammation generated over the past 
decade (Scher et al. 2013, Zhang et al. 2015, Maeda et al. 2016). This work has focused on 
P.copri and T cell differentiation, though the picture is far more complex (reviewed in 
Chapter 2). Inspired by these findings, there is considerable research effort to understand 
the microbiota and its potential pathogenic relevance during the several different stages of 
RA development and its treatment. Two prior studies of the intestinal microbiome in RA 
have included an established (treated) RA group (Scher et al. 2013, Zhang et al. 2015). 
Both studies indicated that the microbiota is different in established (treated) RA versus 
new-onset (untreated RA), while the intestinal microbiota of  new-onset RA individuals 
was  more similar to healthy controls than that of established RA patients (Zhang et al. 
2015). This pattern of treatment of a condition resulting in a “normalisation” of the 
microbiota is quite unusual, and merits further investigation. Overall, the study of the 
microbiome in RA is in the exploratory phase. This is particularly true with regards to 
established (treated) RA, as prior work has largely focused on early, untreated RA (Scher 
et al. 2013, Zhang et al. 2015, Kim and Kim 2016, Larsen 2017).  
 
Moving forward, studies are required to further characterise and provide clarification of 
the differences in the RA intestinal microbiota compared to healthy controls. In doing so, it 
will be important to understand which factors may be driving these differences – which 
constituents of the RA microbiota are driven by modifiable factors, and which are driven 
by intrinsic or early-life factors. This will provide insight into the aetiological process. It will 
also be important to understand if there are robust differences in the RA microbiota, 
whether these aggravate the pathology, and if so what are the potential means of 
modifying the microbiota with respect to the pathology of RA. As part of this, it will be 




informative to derive which differences are associated with the disease state itself, and 
which are associated with other influences. Picking apart this information constitutes a 
challenge.  
 
In order to understand the association of the microbiota with the RA diseased state, it is 
necessary to consider confounding factors. There are multiple factors which influence the 
composition of the commensal microbiota, including age, sex, BMI, diet, bowel habit, 
genetics, xenobiotics, birth mode and other early life factors, and geographical environment 
(discussed in Chapter 1). Most studies of the human intestinal microbiota include statistical 
consideration of age, sex and BMI within the study design. However other important 
influences are almost impossible to control for within a standard case and control study: 
host genotype, and early life factors such as birth mode, childhood diet, and childhood 
domestic and geographical environment.  
 
Disease discordant twins – where just one of a twin pair is affected by the disease of 
interest - share crucial physiological influences: genetic factors, pre-natal environment, birth, 
and childhood environmental and lifestyle factors, but diverge on disease phenotype. The 
use of same sex twin pairs therefore provides a powerful means to account for 
confounding factors, which limit classical case-control studies.  
 
A challenge regarding identification of differentially abundant taxa in relation to a 
phenotype is that taxon abundances are biologically interdependent. That is, the abundance 
of one taxon may influence the abundance of another or could flourish in related niches 
without directly influencing one another. Whilst investigation of individual taxon 
associations has advantages, such as the detection of lower abundance of differentially 
abundant taxa, there are key underlying biological tenets that are largely ignored using 
these approaches; bacteria do not exist as single entities but as communities. The co-
abundance of bacteria may be understood from an ecological perspective, with 
competition for resources, adaptation to the environment and interdependence as 
prominent driving factors. Broadly, microbial interactions can be classified as parasitism, 




competition, predation, or mutualism (Morton et al. 2017). Where the environment 
allows, bacteria form intricate community structures known as biofilms. Within biofilms, 
bacteria communicate with and influence each other via quorum sensing and outer 
membrane vesicles (OMVs), to form a specialised community, with different functional 
areas within the biofilm, encapsulated by a protective polysaccharide layer. The healthy 
intestinal tract provides a hostile environment for the formation of biofilms having a thick 
mucosal layer and higher motility. However high-turnover biofilm formation may occur 
within the colon – some taxa form mucin adhesive pili, which serve as anchors, and 
polysaccharides, which serve to stabilise the microbial environment (Macfarlane et al. 2011, 
Vos 2015).  
 
In this chapter I investigate the association of the gut microbiota with RA, using RA 
discordant TwinsUK twin pairs. This is a novel approach in understanding the RA 
microbiome. I investigate the association of microbiota diversity and taxa abundance with 
RA. Further, I investigate the intestinal microbiota ecological community differences 
between RA affected and control twins. 
  
6.2  Methods 
 
6.2.1 Study Participants  
 
Participants in the TwinsUK database who are likely to have RA, based on self-report 
measures, were identified using responses to self-report questionnaires. Participants were 
asked as part of a wider survey if they had been diagnosed with RA by a doctor. This was 
asked repeatedly to participants in 7 questionnaires between the years 1999 and 2014. 
Participants were also asked using a self-report questionnaire whether they had been 
prescribed medication for RA, and if so to specify the medications. This was asked during 
visits to the clinical research facility between the years 2004 and 2014. Response rates and 
consistency of responses varied considerably. In addition, self-report questionnaires are 




limited in accuracy. For example, participants may be confused as to which type of arthritis 
they have been diagnosed with, with osteoarthritis being much more prevalent across all 
age groups except the youngest. This presented a challenge in determining which 
participants within the database are affected by RA. To address this problem, I collated 
responses to RA diagnosis questions, and calculated the sum of positive responses for each 
participant. Within the medication data, participants who had been prescribed disease 
modifying antirheumatic drugs (DMARDs) and biologic therapies, which have a high 
specificity for RA, were identified using a fuzzy matching method; this approach identifies 
words within a large dataset, in which words (in this case drug names), may be misspelt by 
identifying similar groups of characters. After cleaning the medication data, the medication 
and diagnosis data were collated. Participants who had responded positively to the most 
recent RA diagnosis question, participants who had given at least three repeated positive 
responses to RA diagnosis questions, and participants who had given at least one positive 
response to RA diagnosis questions and who had also reported prescription of DMARDs 
or biologics for RA, were listed as potential RA cases within the dataset. This approach 
was used to generate lists of potential RA discordant twin pairs within the TwinsUK 
dataset. Participants were then contacted by phone by a research assistant or myself, and 
asked to confirm whether they had been diagnosed with RA. Those who confirmed an RA 
diagnosis, and their co-twin (who also confirmed that they had not been diagnosed with 
RA), were invited to attend a clinical visit in which RA diagnosis was confirmed by a 
rheumatologist or trained research assistant, and stool and blood samples taken for 
rheumatoid factor and anti-CCP antibodies. Postal samples were used for one of the RA 
affected participants (previously identified by Flore Zuffery) and two of the control 
participants as they were unable to attend the clinical research facility in person. The 
protocol for study recruitment is summarized in Figure 6.1. 
 
 





Figure 6.1 Flow diagram of study recruitment protocol.  
 
 
Participants were predominantly female (90%) and entirely Caucasian, with a median age 

























































T test .. .. 0.96 0.78 .. 
 
Table 6.1 RA discordant TwinsUK participant characteristics 
The study included 60 participants in total, comprised of identical monozygotic (MZ) and non-identical 




















































6.2.2  Sample processing 
 
Faecal samples were processed as described for the core TwinsUK 16S rRNA dataset in 
Chapter 3, Methods 1.  Briefly, on arrival at the laboratory 
samples were aliquoted, and frozen at -80°C. Later, DNA was extracted, amplified using 
PCR primers 805F and 615R, and sequenced on an Illumina MISEQ platform. 
 
 
6.2.3 Generation of ASVs & Phylogenetic Tree 
 
The 16S rRNA reads were demultiplexed using minimum threshold parameters in QIIME. 
Files were divided according to per sample forward and reverse reads.  Reads were 
trimmed and filtered according to parameters detailed in Appendix 3: Chapter6, and ASVs 
generated as described in Chapter 3, Methods 1 for the core TwinsUK 16S dataset. 
Taxonomic assignment was undertaken using the Silva 1.3.2 reference database (Callahan 
2018), and a phylogenetic tree calculated using the Phangorn R package (Schliep 2011), 
with default parameters. 
 
 
6.2.4  Statistical Analysis 
 
Analyses were undertaken both using the full cohort, including both MZ and DZ twin 








6.2.5 Comparison of alpha diversity in RA affected versus unaffected 
participants 
 
The same statistical approach for measuring alpha diversity and differences in taxa 
abundances was used when considering the full cohort (MZ and DZ twin pairs together), 
and in analysis of MZ twins only.  Alpha diversity was calculated using the untrimmed and 
un-normalised ASV table, as these steps may bias the resultant measures (described in 
further detail in Chapter 4, Methods 2). In this study sequencing depth was not significantly 
different between case and control samples (Full cohort, P = 0.1, MZ twins only, P = 0.07) 
and therefore did not require adjustment. Observed ASVs, Simpson index and Shannon 
index were calculated using the Phyloseq package in R (McMurdie and Holmes 2013).  
 
In the full cohort, observed ASVs were normally distributed (Shapiro Wilk P = 0.39), 
whereas Shannon diversity (Shapiro Wilk P = 0.04) and Simpson diversity (Shapiro Wilk P 
= 2.518e-7) demonstrated a negative skew. As Shannon diversity was almost normally 
distributed, a transformation was not performed. A square root transformation was 
applied to Simpson diversity measures, after which the negative skew was abated, but 
distribution remained non-normal (Shapiro Wilk P = 0.0002). The difference in alpha 
diversity between RA affected and RA unaffected twins was measured for observed ASVs 
and Shannon diversity using a paired Student’s t-test. For Simpson diversity, the Wilcoxon 
rank sum test was applied. 
 
When considering MZ twins only, observed ASVs were normally distributed (Shapiro Wilk 
P = 0.342), whereas Shannon diversity (Shapiro Wilk P = 0.017) and Simpson diversity 
(Shapiro Wilk P = 2.553e-6) demonstrated a negative skew. A square root transformation 
was applied to Shannon and Simpson diversity measures, after which the negative skew 
was abated, but distribution remained non-normal (Shannon, Shapiro Wilk P = 0.006; 
Simpson, Shapiro Wilk P = 1.806e-6). The difference in alpha diversity between RA 
affected and RA unaffected twins was measured for observed ASVs using a paired 








6.2.6 Taxonomic differential abundance in RA affected versus unaffected 
participants 
 
Differential abundance of ASVs between RA and control twins was estimated using the 
DESeq2 R package. Both the full cohort (MZ and DZ twins) and MZ twins only were 
considered: two sets of analysis for taxa differential abundance were undertaken using 
similar approaches. The following methods apply to both cohort sets, unless otherwise 
stated. Filtering of the ASV tables was first applied. ASVs present in less than 5% of 
samples were removed, in order to focus on taxa which are not overly rare, and in 
addition as these less abundant taxa are more likely to represent contaminants. Prior to 
differential abundance estimation, ASVs were transformed using the negative binomial 
variance stabilising transformation (described in detail in Chapter 4). Regarding covariates, 
age and sex were inherently accounted for within the twin pairs (and therefore between 
the groups), as only same sex twin pairs were involved in the study. BMI was not 
significantly different between case and control groups, and so was not included within the 
model (Table 6.1).  In analysis of the MZ twins, diet was additionally considered. Dietary 
variance of TwinsUK participants was captured using the healthy eating index (HEI) 2010 
(Bowyer et al. 2018). Within MZ twins, the difference in HEI measure between the RA 
and control twins was not statistically significant (P = 0.78; Table 6.1), and was therefore 









6.2.7 Abundance of Prevotella spp. between RA discordant twins 
 
As Prevotella has been established as a taxon of interest in RA (Scher et al. 2013, Maeda et 
al. 2016, Larsen 2017, Alpizar-Rodriguez et al. 2019, Iljazovic et al. 2020), I investigated the 
abundance in our cohort. The following steps were applied both to the full cohort and to 
the subset cohort containing only MZ twins. ASV counts were converted to relative 
abundance, where the total for all taxa in a sample sums to 1, and subset to contain only 
Prevotella spp. The relative abundance of all Prevotella spp. present in RA compared to 
control samples and of Prevotellaceae family in RA compared to control samples was 
calculated and visualised using the Phyloseq R package (McMurdie and Holmes 2013).   
 
 
6.2.8 Microbiota ecological community relationship and association with 
rheumatoid arthritis 
 
Statistical approaches have been developed to model the community and niche 
differentiation of taxa. Construction of balance trees in relation to a phenotype of interest 
is an elegant approach which allows inference of both community relationship and niche 
differentiation. Balances - based on degree of proportionality between taxa - originate 
between pairs of taxa in the dataset, and extrapolate upwards, creating multilevel clades 
that are inter-related in terms of interaction and niche differentiation. Balances at each level 
can be investigated in relationship to a phenotype (Morton et al. 2017). Construction of 
balances sidesteps a key challenge in abundance-based analysis of compositional data. 
Compositional data varies substantially in the total reads which represent each sample, and 
consequently the reads for each taxon within the sample. An unknown proportion of the 
variation is biological, some is artefact secondary to sequencing depth, and additionally taxa 
with different comparative abundances within samples will respond differently to 
approaches aimed at addressing compositionality. Further, when considering the change in 
abundance of two or more taxa between samples, the question arises as to which is 




considered the baseline for the relationship. For example, we consider a scenario where 
duplicate samples were taken containing taxa A and B, representing two time points for 
the same participant. There are therefore four samples representing two time points, of 
which 2 are duplicates. At time point two, the proportion of taxon A and taxon B is the 
same in both of the representative samples, however the counts are different. When 
comparing these samples, it could be concluded either that taxon A has doubled, or that 
taxon B has halved. This concept is illustrated in Figure 6.2. The direct comparison of taxon 
abundances is therefore challenging. The calculation of balances sidesteps this issue. The 
concept here is that the balance between taxa would be constant, and therefore the 
question of whether taxon A doubled or taxon B halved is nullified, and the information is 
captured by the balance. Balances can be calculated to capture the degree of 
proportionality between taxa, allowing the inference that for taxa which share a balance, 
the abundance of each is interdependent. Balances may be extrapolated upwards from the 










Figure 6.2 Concept of Balances  
Hypothetical scenario where 2 samples of 2 taxa in differing proportion may account for different scenarios 
in the environment (a, b). The balance between the 2 proportions is consistent for both scenarios (c).  
Adapted from Morton et al. (2017).  
 
 
Balances were generated using the full dataset, including MZ and DZ twins, in order to 
maximise power. Ward hierarchical clustering was applied to isometric log ratio 
transformed balances generated using the Gneiss plugin in QIIME2 (Bolyen et al. 2018), 
after filtering of ASVs present in less than 10% of samples and addition of a pseudo count 
of 1. The higher filtering threshold used here is in line with the statistical constraints of the 
method, which employs correlation of taxa with each other. Including rarer taxa would 
produce spurious results (Morton et al. 2017). Balances are constructed based on the 
degree of proportionality between features. Within each balance, the proportion of taxon 
A, located on the left of the balance, is higher compared to taxon B, located on the right. 
Association of balances with RA diagnosis was assessed using linear models in QIIME 2 
(Bolyen et al. 2018, p. 2). If RA (as opposed to genetic potential for RA) creates a changed 
ecological niche, we may expect to find differences in the balances between established RA 
patients and their unaffected twins. However given the similarity of the microbiota of 
established (treated) RA patients to healthy controls demonstrated previously (Zhang et al. 




RA discordant twin pairs from the TwinsUK cohort attended clinical visits and contributed 
faecal samples for this study. Several associations were observed between gut (faecal) 
microbiota variance and RA, both when considering the dataset as a whole - including MZ 
and DZ twin pairs - and when considering MZ twin pairs only. There were 30 twin pairs in 
total, comprising 19 MZ pairs and 11 DZ pairs. 




6.3.1 Alpha Diversity 
 
There were no statistically significant differences in alpha diversity between RA affected 
and unaffected participants. This was true when considering the full cohort, MZ twin pairs 
only or DZ twin pairs only. However, visualisation demonstrated that there is a (non-
significant) trend towards lower alpha diversity in RA affected participants compared to 











Figure 6.3 Alpha diversity in RA affected participants versus their unaffected twin siblings 
In (A) MZ and DZ twins are analysed together (N=60). No significant differences in alpha diversity were 
demonstrated (Observed ASVs, P= 0.415; Shannon diversity, p = 0.107; Simpson diversity, P = 0.142). In (B) 
MZ twins only were analysed (N=38). No significant differences in alpha diversity were demonstrated 
(observed ASVs, P= 0.568; Shannon diversity, P= 0.202; Simpson diversity, P = 0.172). Whilst there is a trend 
towards lower diversity in RA affected twins compared to unaffected, no measures were statistically different 















6.3.2  Differential Abundance of ASVs between RA affected and control 
twins: Monozygotic and dizygotic pairs 
 
Taxonomic differences between the RA affected group compared to the RA unaffected 
group were demonstrated. There were nine ASVs which were significantly associated with 
RA when considering the full cohort (N=60 pairs), including both MZ (N=38 pairs) and 





Figure 6.4. Taxonomic association with RA in full cohort: MZ and DZ twins 
Differential Abundance of ASVs in RA affected compared to unaffected DZ and MZ twins (n=60). 
Upregulated in RA samples were Lachnospiraceae (genus unassigned) (q = 4.74e-15), Terrisporobacter (q = 
5.59e-13) and Bacteroides (q = 6.9e-13). Downregulated in RA were Ruminoclostridium_6 (q = 5.06e-15) and 









6.3.3 Differential Abundance of ASVs between RA affected and control twins: 
Monozygotic twins 
 
There were eight ASVs which were significantly associated with RA when considering the 




Figure 6.5 Differential Abundance of ASVs in RA discordant MZ twins 
Log fold change in abundance in significantly differentially abundant ASVs in RA affected compared to 
unaffected participants is shown (N=38). ASVs upregulated in RA were Bacteroides (q = 2.59e-15), 
Terrisporobacter (3.096e-15), Ruminococcaceae, genus unassigned (q = 1.087e-14), Barnsiella intestinihominis (q 
= 1.24e-14), Coriobacteriales_Incertae_Sedis, genus unassigned (q = 1.366e-14), Lachnospiraceae, genus 
unassigned (q = 5.41e-12), Parabacteroides distasonis (q = 1.717e-11) and Lachnospiraceae, genus unassigned 










6.3.4 Abundance of Prevotella spp. within RA discordant twins 
 
Motivated by the association of Prevotella with RA reported previously, the relative 
abundance of Prevotella spp. in established treated RA versus RA unaffected participants 
was calculated. No Prevotella spp. were significantly different regarding abundance in RA 
affected compared to unaffected participants. This was true both in all pairs and in MZ 
twins only. However, variation in abundance of Prevotella spp. was suggested. Prevotella_9, 
which is predicted to be Prevotella copri, was found to have lower relative abundance in 
control participants compared to RA affected participants (Figure 6.6). When considering 
all Prevotella spp. together at family level, a higher relative abundance of Prevotellaceae was 
demonstrated in RA unaffected than  
RA affected participants (Figure 6.7). This suggested difference was not statistically 
significant. 
 
Figure 6.6 Relative abundance of Prevotella spp in RA affected versus control participants 
Relative abundance of Prevotella spp.  in A) MZ and DZ twins (N=60), and B) MZ twins only (N=38). Black 

















Figure 6.7 Abundance of Prevotellaceae in RA affected versus RA unaffected participants 
The relative abundance of Prevotellaceae was higher in control participants than participants with RA. This 





6.3.5  Clustering analysis showing community and niche relationship of core 
microbiota 
 
Balances represent the ecological community relationship between core taxa .  These were 
calculated in the full cohort, including both MZ and DZ twins .  Briefly, there was no 
difference demonstrated in balances between the group of established RA patients and the 
group of unaffected twin siblings.  
 
Appendix C shows the taxa which demonstrate compositional interdependence in the 
dataset. Balances are depicted on the outermost aspect of the tree at the lowest level, 
containing here 2 taxa per balance. Within each balance, the ratio of the taxon located on 
the left-hand side of the balance is increased compared to the taxon on the right-hand side 
of the balance. It is inferred that the abundance of both taxa are inter-dependent, and that 
both taxa share an ecological niche preference. The above relationship can be extrapolated 
upwards in the bifurcating tree, in which higher level balances comprising many lower level 
 








6.4  Discussion 
6.4.1 Comparison of the intestinal microbiota of RA discordant twins. 
 
In this chapter, I compared differences in diversity, taxon abundance and community niche 
differentiation between RA discordant twin pairs. Differences in taxonomic abundance 
were demonstrated in RA affected verses unaffected MZ twins. Same-sex female RA 
affected twins were compared as a group to RA unaffected twins with inherent control 
for age, sex, genotype within the study design. Additional covariates - BMI, diet as 
measured by HEI and sequencing depth of samples - were not significantly different 
between case and control groups, and they were not included in the model. 
 
In accordance with other studies, there was a trend towards lower alpha diversity in RA 
affected versus unaffected participants, however none of the alpha diversity measures 
demonstrated significant difference between the groups. To date, no prior study has 
demonstrated a significantly lower alpha diversity in RA affected compared to control 
participants (Scher et al. 2013, Zhang et al. 2015, Alpizar-Rodriguez et al. 2019), despite 
large sample sizes, suggesting this is not a power issue. Indeed, many studies demonstrate 
no difference in alpha diversity between diseased and non-diseased individuals (Reese and 
Dunn 2018). In the present study, the discordant twin design affords additional power. 
 
The comparison of the intestinal microbiota of monozygotic, same sex RA discordant twin 
pairs is a strong study design, which circumvents problems of confounding factors, to 
reveal which In this study, age, sex, genotype, diet, BMI, and early life factors were 
accounted for within the analysis. This is the first study of the gut microbiota in RA to 
include consideration of these factors – in prior studies only age, sex and BMI were 




considered as covariates. It is therefore interesting to observe that even when the above, 
including the novel factors of genotype and diet are controlled for, significant taxon 
differences are observable in the gut microbiota of RA affected participants compared to 
their RA unaffected twin counterparts. All RA affected twins were assessed against all RA 
unaffected twins, as opposed to paired testing. Taxa which were associated with RA in 
monozygotic RA discordant twin pairs were Bacteroides, Terrisporobacter, Barnsiella, 
Terrisporobacter, Parabacteroides, Lachnospiraceae spp. and Cioriobacterales Insertae-Sedis spp. 
 
Intriguingly, despite having the most carefully considered study design affording control of 
additional important factors, this is the first study to report significant differences in 
between the intestinal microbiota of established (treated) RA patients and healthy control 
participants. This may be due in part to prior studies having focussed of treatment naïve 
RA, and the broad shift in intestinal microbiota towards a more “normal” composition in 
those undergoing treatment with DMARDS (Scher et al. 2013, Zhang et al. 2015). Thus, 
prior work has focussed on similarity as opposed to differences in established RA patients. 
The current study had comparable sample size, having 30 established (treated RA 
participants), where the prior studies included 28 and 21 established RA patients.  Only 
the study by Scher et al. included a differential abundance analysis (using LEFSE) between 
established RA participants and controls, and they did not report any significant difference. 
 
There are some key similarities, but also notable differences, between the findings of our 
study and those previously reported. In the metagenomic study by Zhang et al., the gut 
microbiota of treatment naïve Chinese RA patients was compared to that of control 
participants. Bacterial families enriched in the gut microbiota of RA patients were, in order 
of abundance, Bacteroidaceae, Lactobacillaceae, Clostridaceae, Coriobacteraceae and 
Erysipelotrichaceae. Taxa represented by metagemonics linkage groups (MLGs) which 
were enriched in RA patients or controls are presented in Table 6.2. 
 





New onset (un-treated) / 
Established (treated) 
Higher abundance in RA Higher abundance in Controls Ref. 
New-onset 
(n = 44 ) 
Healthy Controls 
(n = 28) 
Prevotella copri Not reported. (Scher et 
al. 2013) 
New-onset RA 
(n = 94) 
 
Healthy Controls 
(n = 97) 
Bacteroides, Bacteroides 
stercoris ATCC 43183, 
Parabacteroides, Bacteroides 
vulgatus ATCC 8482, 
Bifidobacterium dentium 
JCVIHMP022, Burkholderiales 
bacterium 1_1_47, Citrobacter 
freundii 4_7_47CFAA, 
Citrobacter sp. 30_2, 
Clostridiales sp. SS3/4, 
Clostridium asparagiforme DSM 
15981, Clostridium glycolicum 
ATCC 14880, Clostridium 
leptum DSM 753, Clostridium 
scindens ATCC 35704, 
Clostridium sp M62/1, 
Coprobacillus sp. 29_1, 
Eggerthella Lenta, Enterobacter 
cloacae, Enterococcus faecium. 
Association of Prevotella copri 
with RA severity in first year 
of clinical onset. 
Bacteroides plebeius M12, DSM 
17135, Bifidobacterium bifidum, 
Capnocytophaga sp. oral taxon 
329 str. F0087, Clostridales spp., 
Clostridium saccharolyticum WM1, 
DSM 2544, Collinsella aerofaciens 
ATCC 25986, Coprococcus catus 
GD/7, Coprococcus sp. ART55/1, 
Dialister invisus DSM 15470, 
Dorea formicigenerans ATCC 
27755, Enterobacter cloacae 
cloacae NCTC 9394 and 




(n = 26) 
Healthy Controls 
(n = 28) 
No significant differences 
reported. 
Higher abundance of P.copri 
in healthy controls versus 
established treated arthritis 
(ns).  Abundance of 








Bacteroides versus Prevotella 
described as determining 
feature between new-onset 
RA and both treated RA and 
healthy controls. Abundance 
of Bacteroides highest in 
established RA, but not 
significant when compared to 
either other group. 
Established RA 
(n = 21) 
Healthy Controls 
(n = 97) 
No significant differences 
reported. 





Table 6.2 Summary of findings of prior studies of the gut microbiota of established (treated) RA 
patients 
 
Scher et al. (2013) undertook a study using both 16S and metagenomes to assess the 
abundance of the gut microbiota in new onset RA, chronic treated RA, psoriatic arthritis, 
and healthy controls. They showed that there was a higher abundance of Prevotella spp. 
(OTUs assigned to genus level to taxa which belong to Prevotellaceae) in new-onset 
(untreated RA) compared to healthy controls. Conversely, when comparing chronic 
treated RA with healthy control participants, they showed a higher abundance of Prevotella 
spp. in healthy controls compared to chronic treated RA participants. By undertaking a 
metagenomic analysis in a subset of participants, they were able to identify that the most 
abundant Prevotella assigned OTU was Prevotella copri. They were therefore able to 
extrapolate this taxon annotation using metagenomics in a cohort subset to the 16 data 
representing all study participants. They identified that the number of samples containing 
Prevotella copri was 6/28 in healthy controls and 3/26 in chronic treated RA. These data are 
presented in Table 3, Scher et al. (2013). In accordance with this study (shown in Figure 
6.7) the difference in abundance of neither Prevotella spp., nor Prevotella copri specifically 
reached statistical significance. However, it is interesting to note the finding of lower 
abundance of Prevotella spp. is replicated across their study and ours. Potentially, treatment 




with immunomodulatory medication which suppresses the inflammatory response may 
lead to a lower abundance of Prevotella in chronic treated RA versus healthy controls. It 
would be of interest to study people who have not taken DMARDs for whatever reason. 
 
In the study by Scher et al., abundance of Bacteroides was low in new onset RA patients 
but dominated samples from healthy controls and from chronic treated RA participants. In 
accordance with the results of this study, the abundance of Bacteroides was increased in 
chronic treated RA participants compared to healthy control subjects (Supplementary 
Figure 1D, Scher et al. 2013), but did not reach a statistically significant difference (Scher et 
al. 2013). They used primers targeting the V1-V4 regions, and sequencing was via the 
Roche 454 platform. 
 
The higher abundance of Bacteroides in established, treated RA patients may have 
relevance to RA pathogenesis. In the context of commensal intestinal microbiota, 
Bacteroides have been demonstrated to have beneficial immunomodulatory function. 
Bacteroiodes fragilis, a common commensal and the dominant Bacteroides species, has 
demonstrated anti-inflammatory immunomodulatory function and has previously been 
hypothesised to be implicated in RA (Wu et al. 2016). Polysaccharide A derived from 
Bacteroides fragilis has been demonstrated in human as well as murine studies  
In support of above hypothesis, a lower level of Bacteroides is a feature of inflammatory 
bowel disease (Zhou and Zhi 2016). 
 
Overall, there are insufficient studies to establish whether uniform observations of taxon 
associations are observable during the course of RA. Adding complexity to these 
observations is that prior studies have implemented different methods and included 
participants of different ethnicities. However there is agreement that specific compositional 
differences in the intestinal microbiota between new-onset RA and established RA cases 
exist, with the latter having a composition more similar to healthy control participants than 
other (untreated) RA patients. The results of this study highlight that there may be 
differences, previously overlooked, in the intestinal microbiota of treated RA patients, 




which are associated with the disease itself, or it’s treatment. The latter is more likely, but 
longitudinal studies would be required to confirm this. At this stage, further studies are 
required to confirm taxon associations with RA. 
 
In the present study community composition was not observed to differ in RA. Microbiota 
balances, composed of core ASVs, were not significantly different between RA and control 
twins (Appendix D). However it is not possible to conclude from our results that there is 
no association between ecological community relationship and RA. We included only RA 
discordant twin pairs in the study, who are difficult to source; this has been reflected in the 
sample size and as such this could be power issue. Additionally, due to the constraints of 
the method, a higher filtering threshold was applied for the community analysis. While 
some taxa  identified in the discordant twin analysis were present, and indeed, grouped 
together in balances representing microbial communities,  some of the taxa which were 
associated with RA in the discordant twin analysis are not included in the community 
analysis. There may be differences in community structure between RA and control 
participants which were not demonstrated in this study.  
 
An additional observation from the microbial community analysis is in relation to 
Bacteroides and Prevotella, which have been suggested in prior studies to be antagonistic 
with each other (Scher et al. 2013, Gorvitovskaia et al. 2016). These are dominant taxa, 
which tend to comprise a substantial portion of the gut microbiota, and as such have been 
posited as representative taxa of opposing enterotypes (Roager et al. 2014). Antagonism is 
a category of community relationship and therefore it would be expected that taxa which 
are antagonistic would group together in the same lower level balance, suggesting either a 
direct relationship or shared environmental niche between the two taxa. Bacteroides and 
Prevotella did not group together within the same balance until higher up in the bifurcating 
tree, at balance Y6 (Appendix C). Therefore, the antagonistic nature of Bacteroides and 
Prevotella is only tentatively supported. This is of relevance to RA, as these taxa are 
associated with early onset treatment naïve, and established treated RA. Prevotella has been 
shown to dominate the gut microbiota of treatment naïve RA patients (Zhang et al. 2015), 




whereas Bacteroides dominates the gut microbiota of established treated RA patients as 
shown in the present study (Figure 6.4 and Figure 6.5) and in prior studies (Scher et al. 





The first limitation of this study is that the RA affected participants were undergoing 
treatment with DMARDs. Medication is known to affect the composition of the 
microbiota. In RA, the pattern is different to that which is usually found. As discussed, prior 
studies have indicated that the microbiota of RA patients after they begin treatment with 
DMARDs is actually largely similar to healthy control participants, and more so than when 
compared to other RA patients who are untreated. 
 
A second limitation of this work is relatively small sample size of 60. It is challenging to 
source RA discordant twin pairs for such a study and we were fortunate in having access 
to TwinsUK with its longitudinal data collection over 20+ years (Verdi et al. 2019). Even 
with this constraint, our sample of established RA patients is larger than both previous 
studies, having sample sizes of 28 (Scher et al. 2013) and 21 (Zhang et al. 2015). The more 
stringent filtering of lower abundance taxa required is one limitation of the balances and 
other clustering methods. Low abundance taxa may be of interest in relation to disease 
phenotypes but would not be included in these analyses as it would not be statistically 
appropriate.  
 
The general limitations of 16S sequencing data are given in Chapter 8, Discussion. Briefly, it 
is not possible accurately to infer the microbial genes present and it is usually not possible 
to assign taxonomy below genus level. However, in some instances accurate species 
assignment has been possible secondary to the use of ASVs as opposed to OTUs. 
 




6.4.3 Future work 
 
Regarding future work there are a number of possible approaches that could be 
implemented. Firstly, a paired analysis of taxonomic differential abundance is possible using 
the EdgeR package in R. This would allow for paired comparison of taxon abundances 
between RA discordant twin pairs. Potentially there is some justification for using the 
DESeq2 approach given that multiple taxa perform the same function it is more useful to 
detect taxa which are differentially abundant between RA affected and unaffected groups 
as opposed to a paired analysis - paired differential abundance. A paired analysis of genes 
present and their associated functions would be informative but is not possible using 16S 
data.  
 
It would be helpful to explore if the RA affected twins are on similar or different 
medication regimes for the treatment of their RA. In prior studies, as discussed above, 
DMARD treatment for RA is associated with fewer microbiome  
differences in RA patients compared to healthy controls. However, the study is likely to be 
underpowered to demonstrate association of the microbiota with RA treatment; the study 
is being expanded to include a set of newly diagnosed RA patients (sufficient twin pairs 
would be impossible). There is also suggestion that the microbiome is associated with 
differing response to DMARDs. This requires extensive further investigation and is the 
subject current projects. 
 
It will be important to look at association of RA clinical parameters with the gut 
microbiome in the RA affected twins. For example, if one obtained measurements of 
erythrocyte sedimentation rate (ESR) or C reactive protein (CRP), it would be possible to 
calculate DAS28 and assess for correlation with microbiota. Potentially taxa of interest may 
not be differentially abundant between RA affected and unaffected twins but may correlate 
with disease activity. It would also be helpful use metagenomics methods, which are being 
planned for the extension of this study. 





The balances could be calculated in MZ twin pairs only. Although this analysis would have 
lower power, it would hold the advantage of controlling for host genetic factors. However, 
as the results for this work were negative, furthermore stringent analysis may not be 
informative. Alternatively, it would be interesting to investigate in the RA affected twins 





Prior studies have focussed on the gut microbiota of new onset treatment naïve RA cases. 
However the present study demonstrated significant differences in established RA cases 
compared to controls. There were detectable taxon differences in the gut microbiota of 
RA affected twins, when compared to non-affected twins. Thus, taxon differences were 
detectable even when host genotype and early life factors shared between twin pairs, are 
controlled for. In accordance with prior studies, there was no association between 
Prevotella and established RA. Bacteroides, having been shown previously to dominate the 
gut microbiota of established RA patients, and to have anti-inflammatory 
immunomodulatory influence, demonstrated the most marked higher abundance in RA 
participants. However the species of Bacteroides was not identified in the present study, 
and results of this study were therefore inconclusive with regards to implication of the 














Association of Host Genetic Factors with the Oral 
Microbiota in Rheumatoid Arthritis 
 
In this chapter, I consider the link between oral microbiota, periodontal disease and RA. I 
investigate the association of the saliva microbiota with genetic risk of RA; as part of this, I 
demonstrate heritability of taxa of the saliva microbiota using classical twin modelling. In 
order to both contextualise findings of the present study, and to provide a wider 
contribution to the research area, I characterise the saliva microbiota including relation to a 





Daniel Sprockett, collaborator of Claire Steves and myself, performed pre-processing and 
sequencing of saliva samples and generated ASVs for this dataset at the University of 
Stanford. Ruth Bowyer generated the frailty and healthy eating indices. 
 
 
7.1  Introduction 
7.1.1 Background 
 
The oral microbiota - colonising the saliva, teeth, and buccal mucosal surfaces - has been of 
particular interest in RA, alongside the gut and pulmonary microbiota (Scher et al. 2012, 
Zhang et al. 2015). There is an intriguing suggested relationship between the oral 




microbiota and the development of RA (Bingham and Moni 2013, Eriksson et al. 2019). 
First, periodontal disease - associated with characteristic differences in the oral microbiota - 
is a major risk factor of RA. Second, bacteria which associate with periodontal disease may 
aggravate RA pathology in an aetiologically specific manner. Third, periodontal disease and 
RA, both being inflammatory mediated conditions,  may share an overlap in genetic pre-
disposition. Fourth, periodontal disease and RA share influential environmental risk factors 
such as smoking. Finally, both conditions share pathophysiologic similarity of systemic and 
local inflammation and bone erosion, affecting the joints in RA and the oral cavity in 
periodontal disease. In support of this, in patients with both periodontal disease and RA, 
severity of bone erosion at both sites, teeth and joints, has been shown to be correlated 
(Marotte et al. 2006). 
 
 
7.1.2 Association of the oral microbiota with RA 
 
The oral microbiota exert systemic influence and may have a role in RA. For example, 
within the oral microbiota a candidate keystone taxonomic association with RA is 
Poyphyromonas gingivalis (P.gingivalis) (Ceccarelli et al. 2018). P.gingivalis has been suggested 
to contribute to RA pathology - P.gingivalis may upregulate RA specific autoantibodies. 
P.gingivalis possesses peptidyl arginine deiminase (PAD), which has the uncommon ability to 
citrullinate proteins, providing a precursor step for increased production of anti-
citrullinated protein antibodies (ACPA) – a cardinal feature of RA. To date no other 
bacteria have been demonstrated to possess PAD, and potentially this enzyme is unique to 
P.gingivalis (Vermilyea et al. 2019). A hypothesis has been put forward that ACPA raised in 
response to citrullinated proteins within the oral cavity may translocate to the joints 
through epitope spreading, and contribute directly to synovium inflammation, 
osteoclastogenesis and bone erosion. In this scenario, local inflammation in the oral cavity 
associated with periodontitis may compromise the mucosal barrier, allowing ACPA to be 
transported from the oral cavity to other sites via the bloodstream (Kurowska et al. 2017).  




There is some evidence to suggest this may be feasible. In a murine collagen-induced 
model of arthritis, oral administration of P.gingivalis but not other bacteria resulted in joint 
inflammation (Jung et al. 2017). An alternative and perhaps more plausible or likely 
explanation is that there may be an influence of ACPA raised in response to P.gingivalis 
citrullinated proteins on other immune components, which in turn contribute to RA 
pathology (Holers et al. 2018). An influence of P.gingivalis via the gut microbiota has also 
been suggested (Sato et al. 2017). Overall, an influence of P.gingivalis on RA 
pathophysiology, secondary to upregulation in periodontal disease and perhaps unique 
ability of protein citrullination, is a compelling hypothesis, however it may not hold up 
under scrutiny of future studies. 
 
A concurrent mechanism which links P.gingivalis with RA, is production virulence factors, 
known as gingipains (also described in Chapter 1, Section 1.3.6) in relationship to 
Alzheimer’s disease). Gingipains are cysteine proteases which are transported in outer 
membrane vesicles (OMVs), conferring the possibility of inter-site transmission without the 
need for bacterial translocation (Dominy et al. 2019). The relevance of gingipains is two-
fold. Firstly, they are a co-factor in citrullination via PAD (Möller et al. 2020). Secondly, 
antibodies to arginine gingipain (RgpB) have been demonstrated to associate with both 
periodontal disease and RA (Kharlamova et al. 2016). Anti-RgpB IgG was significantly 
upregulated in periodontal disease patients compared to controls, and in RA patients 
compared to controls. Regarding RA, the association was stronger in participants who 
were seropositive for ACPA, compared to those who were seronegative. Surprisingly, the 
study showed that the effect size of the association between RgpB IgG and RA (OR=2.96; 
95% CI: 2.00–4.37) was stronger than for the association between smoking and RA 
(OR=1.37; 95% CI: 1.07–1.74). In addition, they demonstrated an interaction between 
RgpB antibodies with both shared epitope positivity and smoking. This supports the 
suggestion above that any interaction between RA pathology and P.gingivalis extends 
beyond PAD enzymes. Another mechanism may be translocation of proteins citrullinated 
by P.gingivalis in the oral cavity, from the oral cavity to the bloodstream, and subsequent 
generation of circulating auto-antibodies. 





In support of this link, a recent study of non-RA participants with positive ACPA (thus 
likely on the pathway of RA development and classified as at risk) demonstrated increased 
prevalence of plaque P.gingivalis at healthy non-inflamed gum sites compared to both 
healthy controls (effect size, 3.00; 95% CI, 1.71-4.29) and to participants with early RA 
(effect size, 2.14; 95% CI, 0.77-3.52) (Mankia et al. 2019).  Whilst the study reports that 
healthy oral sites were sampled, the pattern was similar to periodontal disease prevalence 
in each group: 73% in at risk participants, 38% in healthy controls and 54% in early RA 
participants. 
 
Evidence for an association of P.gingivalis in the oral microbiota with RA or periodontal 
disease is not easy to disentangle. There are conflicting findings relating to the abundance 
of P.gingivalis in RA patients compared to controls in the two major prior studies published 
to date on the oral microbiome in RA (Scher et al. 2012, Zhang et al. 2015). In the study 
by Zhang et al., no association of saliva or plaque P.gingivalis with RA was seen, but 
conversely, a significant enrichment in P.gingivalis from both sites in control participants was 
demonstrated. In the study by Scher et al., there was no association demonstrated for 
P.gingivalis with RA or controls. Clearly, more studies are needed to investigate whether 
P.gingivalis is implicated in RA. Potentially, this taxon could be pathologically relevant in RA 
development, but not found in higher abundance in established RA patients compared to 
controls; these two assertions are not mutually exclusive. Studies linking abundance of 
P.gingivalis with RA clinical parameters suggest that although P.gingivalis may not be 
upregulated in RA, it could nevertheless aggravate disease physiology in genetically 
susceptible individuals (Kharlamova et al. 2016, Sherina et al. 2019). 
 
Whilst there has been a focus on P.gingivalis as a link between the oral microbiota, 
periodontitis and RA, it is more plausible that other taxa are implicated. Indeed, there are 
numerous other taxon associations between the oral microbiota and both periodontal 
disease and RA. Regarding periodontal disease, in addition to the traditional ‘red complex’ 
of P. gingivalis, Treponema dentolica, and Tannerela forsythia, taxa which potentially possess a 




direct aetiological link with RA also include Aggregatibacter actinomycetemcomitans (Aa) and  
Prevotella intermedia (Mankia et al. 2019). Aa was demonstrated to induce the release of 
pore forming toxins, leading to neutrophil release of citrullinating enzymes. The same pore 
forming toxin induced a change in neutrophil morphology, leading to the release of 
citrullinated peptides (Konig et al. 2016). An immune response to Prevotella intermedia was 
associated with antibodies to specific citrullinated peptides in gingival crevicular fluid of 
participants with RA and periodontal disease (Schwenzer et al. 2017).  
 
 
Regarding taxon associations of the oral microbiota with RA, inverse associations include 
Veillonella and Haemophilus, Klebsiella pneumoniae, Bifidobacterium bifidum, Sutterella 
wadsworthensis and Megamonas hypermegale. Positive associations include Clostridium 
asparagiforme, Gordonibacter pamelaeae, Eggerthella lenta and Lachnospiraceae bacterium, 
Bifidobacterium dentium, Lactobacillus sp. and Ruminococcus lactaris (Zhang et al. 2015). 
Mechanisms by which these other taxa may contribute to RA pathology have not been 
widely discussed. However, a general hypothesis is that oral bacteria can influence the 
systemic immune state (Belkaid and Hand 2014). For example, transport of persistent 
bacterial components in DC and other phagocytosing cells and shaping of T cell memory 
at mucosal sites. Such events may be exacerbated by disruption of the mucosal membrane, 
which occurs more frequently in periodontal disease (Möller et al. 2020). 
 
Until recently the oral microbiota were less studied in comparison to the gut microbiota in 
relation to RA, although both the oral and gut microbiota may hold important roles in 
disease pathogenesis. In addition, the oral microbiota may provide a more accessible clinical 
target compared to the gut microbiota, as it is based at the end of the gut rather than the 
middle. A prior study demonstrated amelioration severity of RA via periodontal therapy 
(Ortiz et al. 2009). 
 
 




7.1.3 Influence of host genetic factors on the oral microbiota  
 
Host genotype is demonstrated to influence oral microbiota composition and genetic risk 
factors in RA may act partially via the oral microbiota. Prior studies have demonstrated 
that the oral microbiome is highly heritable. Whilst the heritability of the adult oral 
microbiome is yet to be characterised, a study in children of sub-gingival plaque showed 
that some OTUs were as much as 65% heritable (Gomez et al. 2017). The most heritable 
OTU was reported to be Prevotella pallens, followed by Veillonella (60% heritable) and 
Corynebacterium durum (54% heritable). The difference in these reported heritable taxa of 
the oral microbiota compared to the heritable taxa of the intestinal microbiota (Chapter 
3) is expected, as the composition of the oral and gut microbiota are influenced by 
different factors. Influence of host genetic factors of the gut microbiota (investigated in 
Chapter 5) is likely to be driven primarily by the immune milieu. This is also likely to hold 
true for the oral microbiota - immune components within the oral cavity are likely to 
influence the composition of the oral microbiota. However there are additional factors 
which may influence the composition of the oral microbiota, which would be secondary at 
least in part to genetic factors: enzymes such amylase and lysozyme; proline-rich proteins; 
saliva flow rate which affects pH and ion concentrations; small molecules present in saliva 
such as histatins and cystatins; mucins and taste receptors (Davenport 2017). Further 
studies of the heritability of the adult microbiome are required. 
 
The influence of host genetic factors on the oral microbiome in RA has not been 
investigated previously. In this chapter I investigate whether published RA risk loci are 
associated with oral microbiota differences in unaffected individuals, and whether these are 
the same as seen in RA patients. In order to isolate genetic association with the microbiota 
from RA disease physiology and treatment, which may have their own effects on the oral 
microbiome, exclusion criteria of RA diagnosis or twin sibling with RA were applied. 
Genetic risk of participants of RA was determined using polygenic risk scoring, and 
association assessed with the oral microbiota. 





In this chapter I show that elements of the salivary microbiota are heritable.  I go on to 





7.2.1 Participants  
 
Participants of this study are members of the TwinsUK cohort (Verdi et al. 2019) who had 
been previously genotyped. The majority of participants were Caucasian females. The age 
of the participants ranged from 38 to 80 (median age 68). General health of the 
participants was captured using a frailty index generated from self-report diagnoses, 
following the Rockwood frailty index method (Searle et al. 2008). Briefly, this is a measure 
of health deficit computed by dividing the number of age-associated health deficits by the 





































Ethnicity No. days 
samples 
















MZ:        
166     
DZ:      
241 
Caucasian:  
402         
Mixed:            
2* 




Table 7.1 Participant Characteristics 
* Data unavailable for some participants 
 




7.2.2 Polygenic Risk Score for RA 
 
The polygenic risk score for RA was generated as described in Chapter 5. The same 
methods for polygenic risk scoring were used for the study of the gut microbiota, and the 
present study. Briefly, genome-wide significant single nucleotide polymorphisms (SNPs) 
published as associated with RA were identified using the NCBI generated database of 
GWAS summary statistics. An inclusion criterion of European ancestry ensured studies 
were representative of TwinsUK demographics. Risk allele dosage of the identified SNPs 
were extracted within TwinsUK data using Plink 1.9. Pruning was applied to account for 
linkage disequilibrium. The risk allele frequency was then multiplied by the SNP-association 
beta, to produce a weighted PRS. The PRS was tested for its predictive value for RA in 
6,776 participants from UK Biobank – 2,686 RA cases, 4,090 controls.  Diagnosis of RA in 
the UK Biobank participants was determined using hospital episode statistics (HES) data 
supplied by NHS Digital, and logistic regression of RA cases and unselected controls with 
no evidence of HES diagnosis of RA, against PRS - adjusting for age, sex and smoking 
history - was applied.  
 
 
7.2.3 Saliva sample collection 
 
Saliva samples were collected from participants during routine volunteer visits to the 
Clinical Research Facility associated with the Department of Twin Research at King’s 
College London. Participants were requested to arrive for their volunteer visit to the 
Clinical Research Facility having fasted for six hours. Prior to collection of saliva samples, 
participants abstained from food, drinking beverages, smoking, and chewing gum for at 
least one hour, and the majority were fasted for more than 6 hours. Participants were 
instructed to spit into a 30 ml sterile Falcon tube for ten minutes, and to try and produce 
as much saliva as possible in this time. To aid saliva production, participants were instructed 
to think about their favourite foods whilst providing the sample. Completed samples were 




immediately placed in a refrigerator before being transported to the laboratory in an 
insulated cooling bag. On arrival in the laboratory, samples were aliquoted into Eppendorf 
tubes and frozen at -80°C for storage purposes. Frozen saliva samples were shipped on 
dry ice to Stanford University for DNA extraction and 16S rRNA gene sequencing. 
 
7.2.4 Saliva sample processing and sequencing 
 
For the following steps, undertaken by Daniel Sprockett, University of Stanford in 
collaboration with Claire Steves, saliva samples were randomly distributed, as opposed to 
being organised according to participant ID, as this may introduce bias due to twin pairs’ 
samples being placed adjacent to one another. Both DNA extraction and PCR blanks were 
included. DNA extraction was performed using the DNeasy PowerSoil HTP 96 DNA 
extraction kit (Qiagen) according to the manufacturer’s instructions. This includes a 
mechanical cell lysis step, of bead beating for 20 minutes. 
 
The V4 region of the 16S rRNA gene was amplified using PCR, in triplicate, using primers 
515F and 806R which include error-correcting barcodes and illumine adaptors. Prior to 
sequencing, samples were pooled in equimolar ratios. Sequencing was undertaken on an 
Illumina HiSeq 25000 platform, which generated a total of 167.8 million reads. Following 
sequencing, data were returned to the Department of Twin Research.  
 
 
7.2.5 Microbiota profiling: Generation of ASVs 
 
Reads were denoised using DADA2 to generate ASVs (Callahan et al. 2016). A similar 
approach was taken as for the TwinsUK intestinal ASVs. Chimeras were removed using 
the consensus method (described in Chapter 3). Taxonomy of ASVs was assigned using 
the SILVA database, version 1.3.2 (Callahan 2018). ASVs assigned as “mitochondria” or 
“chloroplast”, or which were unassigned at Kingdom level were removed from the dataset. 




DNA extraction and PCR blanks were utilised to detect contaminant ASVs, which 
originate from laboratory equipment, laboratory reagents or personnel, as opposed to the 
biological samples. DNA extraction and PCR blanks were used as input for the Decontam  
R package version 1.2.1 (Davis et al. 2018), which identified 46 contaminant ASVs. The 
ASVs identified as contaminants were removed from the dataset. A phylogenetic tree was 
generated for the ASVs by matching the ASVs into the SILVA nr v132 phylogenetic tree 
backbone using the fragment-insertion function (version 2018.6.17) in QIIME2. 
 
 
7.3 Statistical analysis 
 
Taxon composition of the saliva microbiota was visualised using the Phyloseq R package, 
after conversion of taxon counts to per sample relative abundance. Alpha diversity was 
calculated from the untrimmed and un-normalised ASV table (McMurdie and Holmes 
2014) using three measures – Shannon Index, Simpson Index and Observed ASVs. Bray-
Curtis distance was calculated after applying the negative binomial variance stabilising 
transformation, to account for distribution and sequencing depth (described in Chapter 4).  
 
Heritability estimates for the saliva microbiota followed the approach detailed in Chapter 
3. Heritability was calculated for ASVs present in more than 15% of samples from 344 
twin pairs (192 MZ pairs, 152 DZ pairs). Residuals derived from linear mixed effects 
models of relative abundance of ASVs, covarying for age and sex as fixed effects and 
sample storage time and sequencing depth as random effects, were box-cox transformed 
and used as input for heritability estimation. 
 
Linear mixed-effects models were used to assess association between PRS for RA and 
alpha diversity. Models were run with alpha diversity as a response variable to the PRS. 
Models were run using the lme4 package in R, (Bates et al. 2015) with fixed effect 
covariates age, BMI, diet (HEI), frailty, fasting status, storage time of sample and sequencing 




depth, and family structure as random effects. Seven samples with data thought to be 
missing at random for frailty were excluded from the analysis. Standardised coefficients are 
reported.  
 
Association of RA PRS with beta diversity was calculated using permutational analysis of 
variance (PERMANOVA)  applied via the Vegan R package (Oksanen et al. 2019), 
covarying for age, sex, BMI, HEI, frailty, fasting status and time in freezer. The 
PERMANOVA was repeated using each variable as the primary explanatory variable, and 
the remainder as covariates. Data thought to be missing at random for frailty, meant 
models were run twice, on the full dataset not including frailty, and in the subsample for 
which frailty score was available, with adjustment for frailty. 
 
Difference in abundance of ASVs present in more than 40% of samples against the PRS 
was assessed using DESeq2 (Love et al. 2014b) covarying for age, sex, BMI and family 
structure. The higher threshold was chosen as the sample size for the present study was 
small, in order to include taxa which are more likely to be found in the wider population. 
Adjustment for multiple testing was applied to all models, using false discovery rate (FDR). 
 
 
7.4  Results 
7.4.1 Taxon characterisation of the saliva microbiota 
 
Within 407 participants the saliva microbiota comprised 2,602 ASVs, comprising 15 phyla 
(Figure 7.1). Of these,155 ASVs were present in more than 40% of samples, comprising of 
ten phyla (Figure 7.2). There were 64 ASVs present in more than 80% of samples, 
comprising 7 phyla (Figure 7.3). 
 
Across both filtered and unfiltered samples, the most dominant phyla in ascending order 
were Proteobacteria, Firmicutes and Bacteroidetes. Within the total dataset, the top 20% 




most abundant taxa were Haemophilus, Streptococcus, Veillonella, Prevotella_7, Lactobacillus, 
Neisseria, Rothia and Fusobacterium (Figure 7.5). 
 
 






Figure 7.2 Relative abundance of ASVs present in more than 40% of saliva microbiota samples, at 
the phylum level 
(n=407)  










Figure 7.3 Relative abundance of ASVs present in more than 80% of saliva microbiota samples, at 
the phylum level in TwinsUK 
(n=407)  
The top 20 most abundant taxa across all samples comprised 63 ASVs assigned to seven 
phyla: Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, 
Epsilonbacteraeota, and Spirochaetes (Figure 7.4). 
 
At genus assignment level, the most prevalent taxa in the cohort, defined as presence in 
more than 80% of samples, were Streptococcus, Haemophilus, Veillonella, Prevotella_7, 
Prevotella_6, Ruminococcaceae-UCG-14, Porphyromonas, Actinomyces, Alloprevotella, Rothia, 
Fusobacterium, Oribacterium, Lachnoanaerobaculum, Campylobacter, Kingella, Lautropia, 
Cardiobacterium, Peptostreptococcus, Catonella, Mogibacterium, F0058, Bergeyella, 
Capnocytophagia, Granulicatella, and Treponema_2. Phylogenetic relationship of the top 20% 
most prevalent taxa is demonstrated in Figure 7.4. 





Figure 7.4 Phylogenetic tree of ASVs within more than 80% saliva samples  
Tip labels show genus assignment of ASVs, and phylum is denoted by colour. 
 
 
7.4.2 Characterisation of the saliva microbiota: Alpha diversity 
 
Alpha diversity of the saliva microbiota was captured using six measures: Observed ASVs, 
abundance-based coverage (ACE), Shannon index, Simpson index, Inverse Simpson, and 










Figure 7.5 Alpha diversity of the saliva microbiota 
 
 
7.4.3 Characterisation of the oral microbiota: beta diversity 
Beta diversity was captured using Bray Curtis dissimilarity. On ordination, no clear 
association with age, frailty, fasting status of participants, or sample storage time was 
demonstrated (Figure 7.6). The statistical association between beta diversity and age, sex, 
BMI, diet, frailty, participant fasting status and sample storage time is presented below in 
Section 7.5.7. 
 







Figure 7.6 PCoA ordination of Bray Curtis dissimilarity of the saliva microbiota 
Each data point represents a sample, coloured to reflect A) participants’ age, B) fasting status of participants, 
C) general health as captured using the Rockwood frailty index, and D) Freezer storage time of samples in 
days as days. 
 
 
7.4.4 Heritability estimates for taxa of the saliva microbiota 
 
The saliva microbiota demonstrated substantial heritability (Figure 7.7). Within ASVs 
present in more than 15% of 688 samples, and therefore within the saliva microbiota of at 
least 100 participants, there were 110 taxa which were significantly heritable. The most 
heritable ASV was Veillonella atypica (44%, 95% CI 9 - 79), and the second most heritable 
ASV was Campylobacter concisus (43%, 95% CI 32 – 54). Heritability was not dominated by 
















Figure 7.7 Heritability estimates for the saliva microbiota 
Estimates of heritability with 95% for ASVs, present in more than 15% of samples (n=688), adjusting for age, 
sex, sample storage time and sequencing depth. Significantly heritable taxa (n = 110) are shown. 




7.4.5 Association of the saliva microbiota with genetic risk of RA 
 
TwinsUK participants (described in Section 7.2.1) comprised 407 adult twin volunteers, the 
majority of whom were female. An inclusion criterion of having been previously 
genotyped, and exclusion criteria of I) RA diagnosis; II) twin sibling with diagnosis of RA, 
were applied. Within saliva samples from TwinsUK participants, abundance of core taxa 
was associated with genetic risk for RA. There was no difference evident in alpha or beta 
diversity in association with the PRS. 
 
 
7.4.6 Polygenic Risk Score 
 
The RA polygenic risk score is described in Chapter 5. Briefly, the polygenic risk score was 
normally distributed within the TwinsUK cohort with RA cases and twin siblings excluded 
(Shapiro-Wilk normality test P= 0.24). The score ranged from 12.6 to 71.3; the median 
score was 42.63, the interquartile range 38.89 to 48.23. In 6,776 UK biobank participants, 
of which 2,686 had a HES diagnosis of RA, the score is predictive of RA. The standardised 
odds ratio for the PRS was 1.34 (P = 4.17e-8).  
 
 
7.4.7 Alpha diversity  
 
Genetic risk of RA was assessed for association with alpha diversity. There was no 
significant association between RA PRS and Shannon Index, Simpson index or Observed 









 Shannon’s diversity Simpson’s index Observed ASVs 
 Estimate P Q Estimate P Q Estimate P Q 
PRS 0.002714 0.65 0.731 0.005634 0.351 0.731 0.002714 0.659 0.743 
BMI 0.007311 0.476 0.612 0.008038 0.439 0.612 0.007311 0.514 0.673 
Frailty -0.34179 0.457 0.612 -0.17067 0.714 0.871 -0.34179 0.544 0.721 
HEI 0.000946 0.67 0.871 -9.19E-05 0.988 0.131 0.000946 0.772 0.978 
Age 0.012649 0.029** 0.132 0.013366 0.022* 0.552 0.012649 0.029* 0.138 
Male Sex -0.25359 0.306 0.552 -0.25101 0.317 0.158 -0.25359 0.206 0.453 
Fasting Status: 
Not Fasted 
-0.39976 0.053 0.158 -0.47654 0.023* 0.552 -0.39976 0.057 0.158 
















Table 7.2 Association of alpha diversity of the saliva microbiota with participant characteristics and 
sample technical factors 
Using linear mixed-effects models, participant characteristics assessed were: Sex, Age, diet (HEI), general 
health (Frailty), BMI, and genetic risk of RA (PRS); technical factors assessed were storage time of samples 
within the freezer, and sample sequencing depth. Q value denotes adjustment for multiple testing of P values 
by application of the false discovery rate (FDR). Age was associated with all 3 measures of alpha diversity at 
nominal significance. Fasting status of participants was nominally associated with Simpson’s index. Sequencing 




Correlation between variables is shown in Table 7.3 A significant association was 
demonstrated between frailty and fasting status, whilst association between all other 
variables were non-significant. 
 
 PRS BMI Frailty HEI Age Male 
Sex  
BMI 0.075      
Frailty 0.025 -0.114     
HEI 0.039 0.079 0.002    
Age -0.007 0.059 0.011 0.065   
Male 
Sex 
0.035 0.027 -0.034 -0.038 -0.135  
Fasted -0.012 -0.090 -0.11 0.053 -0.083 0.013 
 
Table 7.3 Rho coefficients of correlation between participant characteristics 
Of all factors, only fasting status and frailty were significantly correlated with each other (p = 0.037). 




7.4.8 Beta diversity 
Beta diversity of oral microbiome samples was assessed. There was no association with RA 
PRS (Figure 7.8; PERMANOVA P = 0.387), however beta diversity was significantly 




Figure 7.8 PCoA ordination of Bray Curtis beta diversity in relation to RA PRS 
Each point represents a participant’s sample. Samples from participants with a higher RA PRS are coloured in 
red, whilst those with a lower PRS are coloured in green (n=407). 
 
 
 P value Q value 
PRS 0.304 0.447 
Age 0.001*** 0.008** 
Sex 0.624 0.624 
Relatedness 0.391 0.447 
Storage Time 0.065 0.173 
Fasting 0.337 0.447 
BMI 0.024** 0.096 
HEI 0.210 0.42 
 
Table 7.4 PERMANOVA for Bray Curtis beta diversity of the saliva microbiota 
Age was significantly associated with beta diversity after covarying for all other factors listed, whilst 
association with BMI reached nominal significance (n=407). 






 P value Q value 
PRS 0.412 0.446 
Age 0.003** 0.027* 
Sex 0.617 0.617 
Frailty 0.160 0.36 
Relatedness 0.314 0.464 
Storage Time 0.096 0.288 
Fasting 0.402 0.464 
BMI 0.085 0.288 
HEI 0.233 0.419 
 
Table 7.5 PERMANOVA for Bray Curtis beta diversity of the saliva microbiota 
Age was significantly associated with beta diversity (q = 0.027) after controlling for all other factors. In this 
analysis, 7 participants without frailty data available were removed from the cohort (n = 400).  
 
 
7.4.9 Taxonomic association between RA PRS and the saliva microbiota 
 
Genetic risk of RA was negatively associated with 5 ASVs within the saliva microbiome 
(Figure 7.9). Of the taxon associations, 3 were within the 20% most abundant taxa (Figure 
7.4). 




Figure 7.9. Difference in abundance of ASVs in relation to RA PRS 
There were two taxa significantly associated with PRS after applying FDR to adjust for multiple testing: 
Actinomyces (Q = 0.03), and Streptococcus (Q = 0.03). There were 3 nominally significant ASV associations: 






7.5.1 Association of the oral microbiota with genetic risk of RA 
 
In an RA unaffected sample of TwinsUK participants, genetic risk of RA was associated 
with composition of the saliva microbiota. The demonstration of association of saliva 
microbiota with genetic risk of RA is novel, and is consistent with an influence of RA risk 
genes with the oral microbiota; the study design excludes the possibility that the taxon 
associations are secondary to the physiology of established disease. Taxa identified as 




associated with RA in prior studies, some of which comprise core features of the saliva 
microbiota, were associated with genetic risk for RA.  
 
There were four taxa associated with RA genetic risk (Figure 7.9), all of which were 
significantly heritable (Figure 7.7). This is interesting as a stand-alone finding. Additionally, of 
the four taxa which were associated with genetic risk of RA, three have been previously 
associated with RA: Haemophilus, Streptococcus and Actonomyces. There is therefore 
potential for the taxa associations to be aetiologically relevant. Of these three, Haemophilus 
demonstrated the same direction of effect as prior studies of RA. For the other two taxa 
associations, the direction of effect is less clear: Streptococcus and Actinomyces have 
demonstrated conflicting associations with both positive and inverse associations with RA 
in prior studies (Zhang et al. 2015, Chen et al. 2018, Li, Li, et al. 2018). 
  
Of the taxa demonstrated to associate with genetic risk of RA, Haemophilus was the most 
convincing both with regards to robust association with RA, and aetiological relevance, 
based on current evidence. In a large study by Zhang et al. in which metagenomics 
techniques were used to compare the oral microbiota of RA patients and health control 
participants, Haemophilus and Streptococcus in the saliva microbiome were inversely 
associated with RA (Zhang et al. 2015). A study by Chen et al. replicated these findings, 
also demonstrating an inverse association of Haemophilus and Streptococcus with RA. 
Epidemiological evidence is important, but perhaps more convincingly with regards to 
functional relevance, Haemophilus was associated with clinical parameters of RA; abundance 
of Haemophilus inversely correlated with CRP, RF and ACPA (Chen et al. 2018). There is 
therefore some support for an aetiological link between genetic risk of RA and the saliva 
microbiota. 
 
The context of the association with Streptococcus is less clear. There are conflicting findings 
as to the direction of association with RA in prior studies (Scher et al. 2012, Zhang et al. 
2015). Streptococcus is also associated with periodontal disease, however the direction of 
effect most often reported is positive. For example, higher abundance of Streptococcus 




mutans in saliva and plaque is found in periodontal disease patients, and correlation 
demonstrated with clinical parameters (Dani et al. 2016). A probable explanation is that 
the Streptococcus in the present study is a different species or strain.  
 
For the third taxon association, Actinomyces, there is some evidence for implication in RA 
aetiology. However, it is only directionally consistent with associations demonstrated for 
periodontal disease. A lower abundance has previously been associated with periodontal 
disease (Wang, Qi, et al. 2013, Li, Li, et al. 2018). In the study by Zhang et al. a higher 
abundance of Actinomyces in the saliva microbiota of RA patients compared to healthy 
controls was reported, in contrast with the present study (Zhang et al. 2015). The 
relevance of the periodontal disease association with Actinomyces is tentative; Given that 
there is limited understanding of shared genetic loci between RA and periodontal disease 
at present, the likelihood of RA genetic risk influencing abundance of taxa which are 
characteristic of periodontal disease is unknown, though it is possible. It is difficult to draw 
conclusions without ascertainment at the species level and below. However this taxon has 
been identified as having pathophysiologic relevance in periodontal disease, having been 
identified in prior work as an important species having influence on bacterial community 
structure in subgingival plaque biofilm (Li, Li, et al. 2018). 
 
An association was not demonstrated between genetic risk of RA and P.gingivalis. As 
P.gingivalis has been found in higher abundance in periodontal disease, which is also linked 
to SE risk alleles, and has been associated with RA pathology, it was potentially feasible that 
P.gingivalis would positively associate with genetic risk of RA. However the results of the 
present study are not conclusive, as P.gingivalis did not pass the abundance filtering 
threshold and was therefore not included in the taxon association analysis; P. gingivalis was 
not present within more than 40% of the saliva samples. Three other Porphyromonas 
species passed the filtering threshold: Porphyromonas Pasteri, Porphyromonas endodontalis, 
and Porphyromonas catoniae. It is interesting to note that the ASV methods allowed for 
identification and annotation of this taxon to species level; This would not have been 
possible using OTU based methods, with which accurate determination is not possible 




beyond genus level. An ASV assigned to Porphyromonas was demonstrated to be 30% 
heritable, however here species assignment was not possible and it is unknown whether 
this ASV is P. gingivalis. 
 
There may be a link between P.gingivalis, Actinomyces and Streptococcus. In a study by 
Colombo et al., it was demonstrated that P.gingivalis outer membrane vesicles facilitate 
coaggregation of Actinomyces and Streptococcus. This suggests that there is a synergistic 
ecological community interaction, in support of the pathological biofilm hypothesis of these 
taxa (Colombo et al. 2016). 
 
In accordance with prior studies of the oral microbiota in RA (Scher et al. 2012, Zhang et 
al. 2015), no association between genetic risk of RA with alpha diversity was demonstrated. 
Directionally, the (non-significant) association was positive. Periodontal disease has been 
associated with higher alpha diversity compared to healthy controls, however, the 
implications of this are unclear. The oral microbiota do not follow a similar pattern to the 
gut microbiota, in which a lower alpha diversity is generally associated with a diseased state 
(Jackson et al. 2018a). This does not necessarily indicate that higher alpha diversity is 
beneficial in the gut microbiota, or conversely that a lower alpha diversity could lead to 
poorer health outcomes. In the oral microbiota, there is a varied pattern of association; 
higher rather than lower alpha diversity is sometimes associated with disease (Takeshita et 
al. 2016).  Replication across different cohorts, and consideration of methodological 
differences between studies is required to understand alpha diversity of the oral 
microbiota. 
 
Overall, in a relatively small sample size, a signal was evident for PRS association with the 
saliva microbiome. Replication in another dataset would make the finding more robust. 
Potentially the association of the saliva microbiota with RA PRS also captures wider 
association with ill health. In support of this, RA PRS was positively, but non-significantly, 
correlated with lower general health (higher frailty index; Table 7.4). However, neither 




frailty nor PRS were demonstrated to associate with alpha diversity of the saliva microbiota 
in the present study.  
 
It is interesting to consider the contrast in taxa microbiota association with the PRS in 
saliva versus intestine. The association of RA PRS with the gut microbiota (Chapter 5) 
demonstrated a larger effect size, and entirely different taxon associations that with the 
saliva microbiota. In addition, the association with alpha diversity demonstrated opposite 
directionality, of positive in saliva and inverse in the intestine, though in both instances 
significance was not reached and conclusions cannot be robustly drawn. In the gut 
microbiota, a key determinate of microbiota composition is inflammatory milieu, and 
genetic risk of RA is determined by immune pathways. Speculatively, in the saliva 
microbiota immune factors may be less influential. 
 
 
7.5.2 Characterisation of the saliva microbiota 
 
The micro-environments of the oral cavity and associated commensal microbiota of the 
respective niches are described in Chapter 1. However, there is an ongoing research effort 
to understand the composition of the oral microbiota. In particular, there are limited prior 
studies which characterise the oral microbiota in relation to potential influencing factors. I 
therefore undertook heritability analysis and characterisation of the saliva microbiota in 
relation to methodological factors (e.g sample storage time) and participant characteristics.  
 
To my knowledge the heritability of the adult oral microbiome has not been previously 
reported. In the present study the saliva microbiome demonstrated substantial heritability: 
of taxa (ASVs) present in at least 100 participants, 110 were significantly heritable, with 
heritability ranging from 44 % - 13 % (Figure 7.7). The most heritable phylum was 
Firmicutes. 
 




For saliva microbiota diversity, of potential influences considered - age, sex, BMI, diet, 
general health (frailty), relatedness, sample storage time, and fasting prior to provision of 
sample - association was demonstrated with three factors: age, BMI and fasting status of 
participants. Only the association with age remained significant after adjustment for 
multiple testing. Age was associated with both alpha and beta diversity. Fasting status was 
associated with alpha diversity at nominal significance, and BMI was associated with beta 
diversity also at nominal significance. 
 
In the present study, age was therefore the factor most strongly associated with saliva 
microbiota composition, having association with both alpha and beta diversity which 
remained even after adjustment for health deficit (frailty) and multiple testing. Regarding 
alpha diversity, age was significantly and positively associated with alpha diversity in all three 
measures; higher age was associated with increased alpha diversity as demonstrated by 
Shannon diversity (p = 0.029), Simpson’s diversity (p = 0.022), and observed ASVs (p = 
0.029), Table 7.2). Analysis of beta diversity (Bray Curtis) showed a significant association 
with age (Q = 0.027; Table 7.5) even after adjusting for general health (frailty).  
 
The second strongest association with beta diversity (Bray Curtis dissimilarity) was BMI, 
however only nominal significance was demonstrated (P = 0.024), the association did not 
remain after adjustment for multiple testing (Q = 0.096). After adjustment for frailty in the 
subset analysis of participants for whom frailty data were available, no association between 
BMI and beta diversity was demonstrated.  
 
Simpson’s index measure of alpha diversity was also nominally associated with fasting status 
(p = 0.022), with an inverse association of non-fasted samples, For Shannon’s alpha 
diversity, the association was approaching nominal significance (p = 0.052). This indicative 
result with a small sample size suggests that the true association is stronger, but the 
present study was underpowered to detect it: in the TwinsUK sample, only 7% (28) of 
participants had not fasted. Further work including a larger sample of non-fasted 
participants will be required to confirm the relationship with alpha diversity. Non-fasting 




participants are potentially more likely to be have type 2 diabetes, which should also be 
taken into account for association with the saliva microbiota (Sabharwal et al. 2019). 
However, these results indicate that not fasting may influence microbiota composition to 
reflect recent consumption, which could introduce study bias. In general, studies of the oral 
microbiota do not take account of fasting prior to provision of a saliva or other oral 
microbiota sample (Zhang et al. 2015), but this may be important moving forward. 
 
In a study by Wu et al.  which characterised the salivary microbiome of 62 younger adults 
in relation to obesity, an association of BMI was demonstrated with both alpha diversity 
(Chao1, P < 0.01; Shannon diversity, P < 0.05) and beta diversity (unweighted UniFrac, P = 
0.001) (Wu et al. 2018). The study design accounted for age, sex and oral hygiene, which 
were not statistically significant between cases and controls. In TwinsUK, BMI was 
nominally associated with beta diversity as calculated using Bray Curtis dissimilarity prior to 
adjustment for health deficit (frailty), but no association was demonstrated after 
adjustment. No association was observed between BMI and alpha diversity. Wu et al. used 
targeting of the V3 variable region, which could potentially account for the difference in 
results if there is higher sensitivity for taxa which associate with obesity. However the 
nominal association with composition prior to adjustment for frailty in TwinsUK suggests 
that un-measured higher multi-morbidity in the obese group in the study by Wu et al.  
could account for some of the association they demonstrated between BMI and the saliva 
microbiota. 
 
A study of the saliva microbiota by Ogawa et al. included consideration of frailty. Of 
participants, 16 lived in a nursing home and 15 lived within the general community (Ogawa 
et al. 2018). Those who were nursing home dwellers had a mean age of 87, whereas those 
who lived within the community had a mean age of 84. Participants who lived in a nursing 
home had the inclusion criterion applied of recommendation by a medical doctor to live in 
a nursing home due to frailty. The authors therefore classified the nursing home group as 
frail and the independent community dwellers as non-frail. Ogawa et al. demonstrated a 
significant inverse association of alpha diversity of the saliva microbiota with frailty. This is 




directionally consistent with the non-significant trend demonstrated in the present study. In 
the study by Ogawa et al. participant groups were selected to have a large discrepancy in 
frailty: They investigated the oral microbiota of elderly adults of comparable age living 
either in the community or in a care home setting, with the latter comprising the frail 
participants. They accounted for age, BMI and dental health, but included no adjustment 
for diet or sex. The difference in diet between the non - frail and frail groups is likely to be 
substantial, being home and institution dwelling participants, respectively. This may 
therefore represent a major limitation of the study. Nonetheless, further work is needed 
to understand the link between diet and oral microbiota composition. Sex distribution was 
different between groups: 3 out of 15 in the frail group and 9 out of 16 in the non-frail 
group were male. In the present study there may be less variation in the frailty of 
participants, which comprise TwinsUK community-dwelling volunteers and this may explain 
the discrepancy in results. However this is difficult to demonstrate, as Ogawa et al. did not 
quantitatively measure frailty as here.  
 
A recent population study by Burcham et al., considered factors which influence the oral 
microbiota in both adults and children, with separate analysis of each group  (Burcham et 
al. 2020). Oral samples were obtained using buccal swabs of the teeth, tongue, cheeks and 
gums. Therefore, multiple oral sites were included, in addition to saliva. The source of saliva 
microbiota is predominantly the biofilm on the dorsum of the tongue, however all other 
oral microbial niches contribute taxa (Davenport 2017). The buccal swabs used here are 
therefore relevant to the saliva microbiota, but may not be directly comparable. Burcham 
et al.  included 172 adults aged between 20 and 57, median age 34. They did not consider 
age within the adult or child groups, but on comparison of both groups they demonstrated 
significantly lower Shannon diversity in adult versus child groups. Within both groups they 
considered weight status, sex, prescription of antibiotics in the last 6 months and oral 
hygiene habits (visits to the dentist for professional descaling). They showed that in adults 
only oral hygiene habits were significantly associated with beta diversity. There was no 
association between weight status, sex or ingestion of antibiotics in last 6 months. 
However, youth oral microbiome beta diversity was associated with both sex and weight 




(Burcham et al. 2020). In the present study, oral hygiene habits were not accounted for, 
but could potentially be captured in part by age, with a pattern of declining oral hygiene in 
older age. 
 
Diet as captured using the HEI was not significantly associated with alpha diversity of the 
saliva microbiota. This is in contrast with findings for the gut microbiota in TwinsUK. We 
have shown that diet is significantly associated with Shannon diversity, Simpson’s index and 
observed OTUs (Bowyer et al. 2018). This is surprising as it may be expected for food 
substrates in the oral cavity to allow some bacteria to flourish relative to others, 
dependent on adaptation to metabolic factors and environmental niche pH.  
 
In TwinsUK saliva samples, the most abundant phylum within the saliva microbiota was 
demonstrated to be Proteobacteria. This was constant when considering highly prevalent 
taxa, found in more than 80% of samples (Figure 7.3), ASVs present in more than 40% of 
samples (Figure 7.2), and when considering the full dataset of all ASVs (Figure 7.1). In the 
present study, employing sequencing of the V4 16SrRNA gene variable region, the 
taxonomic composition demonstrated is in contrast with prior studies, the majority of 
which targeted the V2 variable region, and show Bacteroidetes to be the dominant 
phylum. (Tsuda et al. 2015, Gomez et al. 2017, Ogawa et al. 2018, Murugesan et al. 2020). 
 
Murugesan et al. undertook a large recent study of the saliva microbiota of 997 younger 
adults with mean age of 38, using targeting of the V2 variable region, demonstrated that 
the dominant phylum of the saliva microbiota was Bacteroidetes (Murugesan et al. 2020). 
Proteobacteria were the third most dominant phylum. This finding was replicated in 
studies by Ogawa et al., Gomez et al., and Tsuda et al. (Tsuda et al. 2015, Gomez et al. 
2017, Ogawa et al. 2018).  
 
Ogawa et al. undertook a small study of 31 elderly adults. Within community dwelling 
older adults, in contract to our results, the saliva microbiota were dominated at the 
phylum level by Bacteroidetes. Proteobacteria was the third most abundant phylum, after 




Firmicutes. There are important methodological differences compared to the present 
study, which are likely to account for the taxonomic discrepancy. Ogawa et al. used 
primers which target the V2 hypervariable region, generated de-novo OTUs and assigned 
taxonomy using the Greengenes database. In the present study, the V4 region was 
targeted, ASVs were generated and taxonomy was assigned using the Silva database. They 
also required their participants to refrain from food, drink, smoking and use of toothpaste 
for 2 hours prior to saliva collection. In the present study, participants were asked to fast 
and refrained from smoking or chewing gum for at least 6 hours, whereas there was no 
stipulation about toothpaste. Ogawa et al. undertook DNA extraction, PCR and 
sequencing immediately, whereas in the present study samples were frozen prior to these 
steps. The primary factor mediating the taxonomic discrepancy between both studies is 
likely to be choice of variable region targeted by the PCR primers. 
 
Tsuda et al. undertook a study of the saliva microbiota of 44 adults who had fasted 
overnight, using pyrosequencing after PCR targeting of the V1-V2 hypervariable region 
(Tsuda et al. 2015). The dominant phylum was Firmicutes, whilst Bacteroidetes, 
Actinobacteria and Proteobacteria were the second, third and fourth most abundant, 
respectively. Another study, by Lundmark et al. evaluated the saliva microbiota of 114 
adults, using targeting of the V3-V4 hypervariable region (Lundmark et al. 2019). They 
demonstrated that the most abundant phyla in order of dominance were Firmicutes, 
Bacteroidetes, and Proteobacteria. 
 
There are few studies of the saliva microbiota which use targeting of the V4 variable 
region, however in a small study of 20 adult participants, using this method, in accordance 
with our study, Proteobacteria was the most dominant phylum, whilst Firmicutes was the 
second most dominant (Yu et al. 2020). 
 
 In the study by Gomez et al. the dominant phylum of the subgingival plaque of children 
aged 5 to 11 is Firmicutes (Gomez et al. 2017). There are three key methodological 
differences compared to the present study: age, oral site and variable region targeted. 




Gomez and colleagues used primers which target the V2 variable region, whereas in the 
present study V4 was targeted. 
 
These high phylogenetic level taxon discrepancies between studies which employ targeting 
of different variable regions of the 16S rRNA gene indicate that primer selection is an 
important factor having influence on downstream findings. The primers used in this study, 
515F and 806R, were initially used by the Earth Microbiome Project, and have since been 
modified for use with the Illumina platform (Caporaso et al. 2011). This modification 
rectified the previously held bias against Crenarchaeota and Thaumarchaeota (Hugerth et al. 
2014). These primers have been demonstrated to perform well for characterising the gut 
microbiota, however efficacy for characterisation of the oral microbiota requires further 
investigation. A recent study showed a discrepancy in performance when applied to 
human gut versus skin microbiota (Wasimuddin et al. 2019). Most studies of the saliva 
microbiota have employed primers which target the V2 variable region. This region 
demonstrated higher resolution for Streptococcus, the most abundant genus in the oral 
cavity (Wade and Prosdocimi 2020).The performance of the primers used in this study 
with regards to the saliva microbiota requires further investigation. 
 
The work here has demonstrated overall composition of the microbiota and association 
with potential influencing factors. Of all factors, age was had highest importance with 
regards to microbiota diversity, whilst an influence of BMI and fasting status of participants 
was also suggested. It is also important to note that for all factors there may be association 
of specific taxa and ecological communities within the saliva microbiota; further work is 
required to demonstrate these.  
 
 
7.5.3 Consideration of strength and limitations of the study 
 




Some key strengths of the study lie in the technical aspects of sample processing. DNA 
extraction and sequencing was performed by the same person, samples from twin pairs 
were separated on the DNA extraction plates and all samples were included in two lanes 
of the same sequencing run. The inclusion of blank reagent only samples allowed for 
removal of potential contaminant ASVs from the dataset, sometimes referred to as the 
“kitome”. Consideration of contaminants is particularly important for lower biomass 
samples such as saliva. 
 
 
However there were also limitations to the work which are important to consider.  
We used targeting of the V4 region which, as discussed above, has lower affinity for key 
taxa of the oral microbiota, and particularly Streptococcus. We used sampling of the saliva 
microbiota, which derive predominantly from oral mucosal surfaces. However, the 
microbiota of other sites, and particularly subgingival plaque may be more pathologically 
relevant. The taxon association analysis of RA PRS and the oral microbiota did not take 
account of some potential influencing factors, the most important of which may be 
smoking, fasting prior to sample collection, oral health habits. In the study protocol, there 
was no stipulation as to oral health care just prior to providing the sample. Quite feasibly, 
participants may have deviated from their usual oral hygiene habits in anticipation of 
providing a saliva sample; this was not accounted for in our study. Periodontal disease was 
not accounted for (discussed below). There is potential bias introduced by the features of 
the TwinsUK cohort from which the study participants were sampled. The volunteer 
cohort population is predominantly female, white and of higher affluence. The limitation of 
the sex ratio of the cohort is offset as RA is more common in females. Ethnicity is a 
limitation as RA is more common in Black people and I was unable to explore association 
in different ethnicities as the study sample was 99% Caucasian. RA is more prevalent in 
areas of socioeconomic depravation, however understanding is that this is secondary to 
lifestyle factors such as smoking and diet, and this therefore should not bias a study of 
genetic factors.  
 




The present study did not include consideration of periodontal disease, this would be 
informative to explore; periodontal disease - an established risk factor for RA - and RA, are 
associated with overlapping taxon associations in the oral microbiota, and both conditions 
share some common genetic risk factors. Periodontal disease has been historically 
associated with a group of bacteria known as the ‘red complex’, which comprises 
Porphyromonas gingivalis, Treponema denticola and Bacteroides forsythus, all of which were 
reported as particularly associated with clinical measures of periodontal disease – dental 
pocket depth and gingival bleeding on probing (Socransky et al. 1998). It has since been 
advanced that wider microbiota associations or specific gene combinations thereof 
converge to shape and stabilise a disease provoking microbiota.  Disease development 
could be secondary to presence of a pathogenic oral microbiota in the context of other 
pre-disposing risk factors and genetic propensity for inappropriate immune response. 
 
Both periodontal disease and RA are pre-disposed by the HLA-DR Shared Epitope (SE) 
and in addition both conditions share SNPs and epigenetic modifications relating to 
cytokine genes, and in particular expression of IL-6, which is of key importance in both RA 
and periodontal disease (Bingham and Moni 2013). However, it is important to note that 
the strength of association of the SE with periodontal disease is much weaker than with 
RA. There may be wider overlap in the genetic aetiology of RA and periodontal disease; 
further work is required to demonstrate this. 
 
 
7.5.3 Considerations for future work 
 
Primarily, replication in another cohort is needed. To extend the study, there are additional 
analyses that would be informative: In particular, further measures of alpha and beta 
diversity, and analysis of ecological community association. For the latter, the method 
applied in Chapter 6 of balances would be appropriate. Characterisation of the oral 
microbiota in the wider dataset (N = 707) should be undertaken, as in the present study 




those who had not been genotyped were excluded. It would be informative to repeat the 
present study using samples of different oral niches, for example sub-gingival plaque, 
dorsum of tongue, teeth, and buccal mucosa. Previous associations have centred around 
plaque on the tongue, teeth and in sub-gingival pockets (Eriksson et al. 2019).  
 
Given the identified differences in salivary microbiome composition observed in this study 
with fasting status, further sensitivity analyses could be conducted to check robustness of 
the associations excluding the 7% of individuals who were non-fasted. This approach could 
also be considered for the heritability analysis. Smoking status is an additional factor which 
has not been considered in this analysis, although rates of smoking are relatively low in this 
cohort, at around 8 % (Bowyer et al. 2018). 
 
Further work is needed to investigate periodontal disease as it is suggested to be on the 
causal pathway of RA, with overlapping taxon associations with the oral microbiota. 
Understanding of the genetic aetiology is not sufficient to calculate a polygenic risk score, 
therefore a study of periodontal disease using similar methods to the present study would 
not be viable. However, quantifying the shared genetic aetiology between RA and 
periodontal disease would provide much needed clarity of the association; this could be 
achieved using bivariate classical twin modelling. To account for shared taxon associations 
between periodontal disease and RA it may be informative to extend the study by taking a 
nested model approach for periodontal disease. To investigate taxon associations with 
periodontal disease, taxon differential abundance analysis should be undertaken in which 
periodontal disease is considered as a response variable, as conducted for RA PRS in the 
present chapter and RA in Chapter 5.  
 
In order to contextualise the findings of this study, and to extend understanding of the 
general research area, it will be important for studies to continue to characterise the oral 
microbiota of RA patients. There are few studies completed to date, with discrepancy in 
findings. As above, such studies would benefit from taking into account different oral 
niches. These studies should also consider association of taxa with clinical parameters such 




as ACPA and DAS28, and also immune parameters such as antibody titre in relation to 
specific taxa, and inflammatory immune cell profile. Functional work should be undertaken, 
characterising the mechanistic link between oral taxa and RA. For example, use of in vitro 
methods including organoids, and in vivo methods including animal models. 
 
 
7.6  Conclusions 
 
The saliva microbiota of adults demonstrated substantial heritability. Composition of the 
saliva microbiota is associated with age even after adjustment for general health. In a non-
RA cohort, genetic risk of RA was associated with four taxa of the saliva microbiota. 
Whilst further work is required to offer a robust conclusion, this study tentatively supports 







Following completion of the thesis, the study to characterise the saliva microbiota has been 
expanded to include a larger sample size and an additional phenotype, periodontal disease. 
















The overarching aim of this thesis is to contribute to understanding of the link between 
the commensal microbiota and RA aetiology. In this final chapter, I consider the 
implications of the thesis findings in their entirety and evaluate whether the thesis aims 
have been addressed. For clarity, I include an overview of thesis findings, prior to a more 
detailed discussion in the context of the thesis aims and the wider research area. I consider 
limitations of the methods, and finally I suggest how the work could be developed moving 
forward for the furtherment of understanding of the link between the commensal 
microbiota and RA. 
 
 
8.1 Summary of thesis findings 
 
Within this thesis I have applied novel approaches to elucidate the link between the 
commensal microbiota and RA aetiology. I first considered 16S sequence pre-processing 
methods, and curated the TwinsUK ASV dataset, presented in Chapter 3. Heritability 
estimates for the ASVs were presented in the context of demonstrating efficacy of 
methods compared to those used previously. Whilst not conclusive in this regard, the 
analysis supported convincing prior studies benchmarking the method.  
 
In Chapter 5 I investigated the association of genetic risk of RA with the intestinal 
microbiota. I demonstrated that a group of Prevotella spp., Prevotella_7, were associated 
with genetic risk of RA in participants without the disease. As part of our collaboration 
with a Swiss group which is led by Axel Finckh and Till Robin Lesker, I found within the 




SCREEN-RA cohort a higher abundance Prevotella_9, (predicted Prevotella copri), in 
intestinal microbiota of participants with pre-clinical RA (having signs and symptoms of RA, 
but not fulfilling the clinical criteria for diagnosis), compared to healthy control participants. 
The ASV methods afforded demonstration that Prevotella_7 did not include Prevotella copri, 
however the ecological community- based analysis in this chapter provided evidence for an 
interaction between Prevotella copri and the Prevotella_7, in which abundance is 
interdependent between these taxa. This association of Prevotella _7 with genetic risk of 
RA (PRS) in Twins UK was validated the SCREEN-RA cohort, in which abundance of 
Prevotella_7 was associated with presence of shared epitope RA risk alleles. Further 
supporting this work, the heritability analysis in Chapter 3 demonstrated that Prevotella_7 
was significantly heritable, whilst Prevotella copri was not.  
 
In Chapter 6 I took an opposing approach of investigating association of the gut microbiota 
with RA, whilst controlling for host genetic factors, within a discordant twin study design. 
Here, I investigated differences in the intestinal microbiota of established (treated) RA 
patients, compared to a control group comprised of RA affected participants’ unaffected 
twin siblings. Within the sample of monozygotic twin pairs, there were four taxa which 
demonstrated a higher abundance in RA affected versus unaffected twins. The strongest 
taxon association, Bacteroides, is a dominant taxon associated with modulation of 
inflammation. Bacteroides fragilis has been previously demonstrated to have higher 
abundance in both healthy controls and treated RA patients, compared to new-onset 
(untreated) RA patients.  However it was not possible to identify to species level the taxa 
associations of this study, and interpretation is therefore unclear: if the association is with 
Bacteroides fragilis, this potentially corroborates a prior study indicating that anti-
inflammatory taxa are upregulated in the gut microbiota following RA treatment with 
DMARDs. The compositional approach of taxon balances demonstrated no significant 
differences in relationships between intestinal microbiota of RA affected versus RA 
unaffected twins.  
 
In Chapter 7, I investigated the association of the saliva microbiota with genetic risk of RA. 




As part of this I performed characterisation of the saliva microbiota in relation to a range 
of potentially important biological and technical factors. Whilst heritability of the adult oral 
microbiota has not been previously published, I demonstrated that there is substantial 
heritability of the saliva microbiota; 113 taxa of the saliva microbiota were significantly 
heritable. Age was associated with saliva microbiota diversity after controlling for other 
potential influences, including general health. The association of genetic risk of RA with the 
saliva microbiome comprised four taxa, providing some evidence of a potential link 
between host genetic factors and the saliva microbiome in RA; the literature evidence base 




8.2 Consideration of findings with regards to thesis aims  
 
The thesis aims are presented in Chapter 2. For clarity, these are also included here. 
 
8.2.1 Overarching aim: Aim 1  
 
1) Contribute to understanding of the link between the gut commensal microbiota and RA. 
 
Understanding of the link between the commensal microbiota and rheumatoid arthritis is 
presently in the exploratory phase. It is presently subject to a substantial multicentre 
research effort. In completing this thesis, I have contributed several novel findings which 
will help bring clarity to the research area; these findings are discussed in the following 









8.2.2 Specific aims: Aim 2  
 
2)  Apply appropriate methods to the study of the commensal microbiota in RA. 
 
In this thesis I have applied many different methods to appropriately analyse microbiome 
data in relation to phenotypes, including genomic and clinical data. I have applied 
appropriate statistical methods, which take into account the specific considerations for 
microbiome data.  
 
For example, ASV methods were published by Callahan et al. just prior to commencement 
of my PhD in 2017 (Callahan et al. 2016, 2017); using these novel methods I generated 
ASVs in TwinsUK data. The benefits of this approach are most clearly demonstrated by 
the results of the study in Chapter 5.  When I performed the same analysis using OTUs, 
no associations were shown. Importantly, using ASVs I was able to identify Prevotella and 
also was able to taxonomically discriminate the Prevotella associations further than is 
possible with OTUs.  This was aided by use of the SILVA database which has improved 
taxonomic assignment than previously used databases (e.g. Greengenes). Thus, the study in 
Chapter 5 demonstrated significant association between genetic risk of RA and Prevotella_7 
and Prevotella_9 with genetic risk of RA and pre-clinical RA, respectively. Using this 
additional taxonomic classification, I was able to identify that the association was not 
actually with Prevotella copri, often the most abundant Prevotella species, and previously 
reported in association with RA, but with a separate more heritable Prevotella which is in 
balance with Prevotella Copri. Methods used thus afforded further interrogation of the 
Prevotella association to avoid outputting misleading results. The interesting results of this 









8.2.3 Specific aims: Aim 3  
 
3) Investigate the gut microbiota association with RA with regards to host genetic factors.  
 
In Chapter 5, I demonstrated that there is association of RA host genetic factors with RA 
relevant taxa in the gut microbiota. The strongest taxon association with genetic risk of RA, 
Prevotella_7, and there was a suggested biological link with the primary RA taxon of 
interest, Prevotella_copri. Informatively, the heritability analysis of the ASVs which I 
presented in Chapter 3 showed Prevotella_7 to be significantly heritable, whereas 
Prevotella_9 (predicted Prevotella copri) was not. There has been prior suggestion of a link 
between presence of Shared Epitope alleles and abundance of Prevotella copri (Scher et al. 
2013), which this work lays into question. 
 
As discussed in detail in Chapter 2 and Chapter 5, there is a body of evidence indicating a 
functional link between Prevotella copri and the pathogenesis of RA. More recently the role 
of other Prevotella species have additionally been highlighted. With regards to Aim 3, this 
work is not considered conclusive. However, it supports the hypothesis that Prevotella spp. 
are involved in RA pathogenesis. To put the findings in context, it is likely that there are 
other factors which are more strongly associated with abundance of Prevotella copri. For 
example, it is established that diet is a mediator of Prevotella abundance. In TwinsUK, we 
have recorded dietary data and using this my colleagues have curated dietary indices. 
However as discussed in Chapter 5, there were missing data for a portion of the study 
sample, and when repeating the model in the subsample for whom dietary data was 
available, no association for Prevotella was shown. On further investigation, the participants 
for whom dietary data was unavailable had the samples with higher Prevotella_7 and 
repeating the model in this subset yielded no association for Prevotella_7. It is a lower-
prevalence taxon, and the excluded samples therefore affected the results. In the future I 
would like to explore different solutions such as imputation methods. However, in the 
absence of this, the convincing prior evidence for the role of diet (Gorvitovskaia et al. 




2016) generates the hypothesis that diet is more influential than host genotype with 
regards to abundance of Prevotella. Indeed, there is recent suggestion that additionally, 
regardless of difference in abundance, Prevotella spp., particularly P.copri, may function 
differently in the context of differing host diets. In a study by De Fillipis et al., carbohydrate 
active (CAZ) enzymes were associated with a diet high in carbohydrate (De Filippis et al. 
2019). De Fillipis et al. hypothesised that there is a different functionality of P. copri 
according to host diet, independent of P.copri abundance. As discussed in Chapter 5, there 
are also conflicting findings regarding pathogenicity, or conversely, beneficial status of 
Prevotella copri; there is evidence for both ends of the spectrum, spanning beyond the RA 
microbiome field. A potential explanation in addition to the CAZ enzyme evidence is that 
conflicting findings relate to different strains, with different functionalities. In support of this, 
four distinct clades have recently been identified, termed the “Prevotella copri complex” 
(Tett et al. 2019). In addition, the Prevotella copri genome contained multiple transposable 
elements, with potential to move between taxa (Moss et al. 2020). Overall Prevotella copri 
is quite an unusual and intriguing taxon. To understand it furthermore specificity in 
taxonomic identification is required as well as contextualisation in the wider ecological 
community and in relation to functions rather than presence or absence.  For this 
metagenomics, and potentially metatranscriptomic methods will need to be deployed. 
 
In Chapter 6 the converse of the above approach was taken: genotype was controlled for 
in a discordant twin study design. When potential influential factors of genotype, age, sex, 
BMI, diet, and early-life factors are controlled for between RA discordant MZ twins, 
significant taxon differences are still detectable. The largest difference in taxon abundance 
was an increase in Bacteroides in RA affected compared to control twins. It is difficult to 
draw robust conclusions, partly because prior studies have focused on early and as yet 
non-treated RA, and partly because the RA affected twins in our cohorts are taking RA 
medications which may affect their gut microbiota composition. However an unusual 
pattern within the intestinal microbiota with regards to RA treatment has been 
demonstrated: in RA patients who are undergoing treatment with DMARDS, the gut 
microbiota is more similar to healthy controls as opposed to other as yet untreated RA 




patients (Zhang et al. 2015), although this has not yet been confirmed by longitudinal 
studies (discussed in Chapter 2, Chapter 5 and Chapter 6). Bacteroides is a dominant taxon 
which has been demonstrated to promote an anti-inflammatory milieu via induction of T-
regulatory cells. Potentially, as posited in Zhang et al., some of the anti-inflammatory effects 
of DMARDs may act via the gut microbiota. The results presented in Chapter 6 would 
support this hypothesis with regards to Bacteroides. The other taxa associations require 
further functional work to provide insight into pathological relevance.  
 
 
8.2.4 Specific aims: Aim 4  
 
4) Investigate the oral microbiota association with RA with regards to host genetic factors.  
 
In Chapter 7, I set out to address the fourth aim of this thesis. To achieve this, I firstly 
characterised the oral microbiota with regards to potentially influential biological and 
technical factors, and secondly I modelled the association of the oral microbiota with 
genetic risk of RA. In undertaking the first task, I demonstrated that the saliva microbiota is 
substantially heritable. 113 ASVs were significantly heritable. The most heritable phylum 
was Firmicutes, and the three most heritable taxa were Veillonella atypica, Campylobacter 
concisus, and Selenomonas_3. Diversity of the oral microbiota was associated with age and 
fasting prior to sample collection. Conversely - and interestingly - there was no association 
with diet, frailty, BMI or any of the other covariates considered. The oral microbiota is little 
understood compared to the gut microbiota, and studies which elucidate the modulatory 
factors are valuable at this stage. The results of the Chapter 7 are therefore informative for 
the wider research area. To my knowledge, the association of age with oral microbiota 
diversity, even after controlling for other factors including general health is novel.  
 
With regards to the association of genetic risk of RA with the oral microbiota, a taxonomic 
association was shown. However, the relevance of these taxa to the pathogenesis of RA 




was not supported or refuted by the prior literature. Overall, I suggest that the study is 
presently not convincing with regards to a potential influence of host genetic factors on 
the oral microbiota in RA (discussed in Chapter 7).  
 
 
8.3 Consideration of results within the context of RA 
pathogenesis 
 
An overarching question in RA microbiome research is whether the microbiota contribute 
to RA pathogenesis. Specifically, whether the microbiota could constitute a causative 
immunomodulatory influence, contributing to the initial development of autoimmunity 
which may begin decades before the development of clinical RA. This is a complex 
question to resolve, which would potentially require interventions over many years, being 
logistically and ethically difficult to conduct. Therefore, the research field needed evidence 
of associations at different stages in the development of RA to focus both mechanistic 
experiments and further detailed observational studies in the next stage. 
 
Herein lies the key strength of the epidemiological approach of this thesis. By looking at 
those with genetic risk but no RA,  I was able to interrogate changes which could appear 
before the clinical diagnosis; by looking at a preclinical RA cohort with increased genetic 
risk (first degree relatives), we were able to clarify changes at onset of symptoms; finally I 
was able to look at changes in established RA, by comparing the gut microbiota of affected 
twins to their identical twin sisters. Thus, the thesis has added key observational data which 
enable clarifications to the fields summarized in Figure 8.1. Clearly, as observational 
evidence, this does not provide evidence of causation of any changes seen at any point 



























































The work in Chapter 5 and Chapter 7 relating genetic risk of RA to the gut (stool) and 
oral (saliva) microbiota, respectively, demonstrated a link between genetic risk without the 
actual disease and taxa which have been previously associated with  RA . My study focused 
on adults in the 55-70 age range. As host genotype is stable across the life-course,  and 
therefore such genotype-microbiota associations may hold true even from late childhood, 
well before any  onset of clinical disease in those genetically at risk. The work presented in 
this thesis is the first to provide evidence that pathophysiologically pertinent differences in 
the microbiota may potentially occur  prior to the development of RA symptoms placing 
microbiota changes plausibly early in the course of RA development. The evidence was 
stronger for the gut microbiome; the association demonstrated with Prevotella spp. in 
particular will be of interest to the wider RA microbiome research community (discussed 
in detail in Chapter 5). Whilst further work is needed, this study bolsters the feasibility of 
the microbiome as a target in pre-clinical RA, for prevention of progression to clinical RA 
of arthralgia patients (Cope 2017).  
 
The study of the microbiota of RA discordant twins, presented in Chapter 6 is the largest 
study to date of the microbiome of established RA patients. This work suggests that 
genetic and dietary factors are superseded by xenobiotic factors in the establishment of 
gut microbiota composition in RA patients. The study design uniquely afforded for control 
of host genetic factors. However, it is difficult to extrapolate findings to the earlier 
trajectory of RA development due to the effects of RA treatment on the microbiota; 
participants of the study were established RA patients undergoing treatment with 
DMARDs. The contrast between taxon differences observed in early (untreated RA) in 
prior studies, and in established RA in the present study highlight that DMARDs are likely 
to be a driving factor of microbiome composition in RA patients. It is clear that there is a 
need to investigate the microbiota of RA patients from the early stages before 
commencement of treatment, following through to longitudinally assess microbiome 
changes after DMARDs; I will be investigating this as part of Frances Williams’ team 
following completion of my PhD. The evidence base for this approach is further described 
in Section 8.5. 




8.4 Limitations of methods 
 
With regards to the work presented in this thesis, I must first acknowledge that just one 
chapter, Chapter 6, included investigation of participants who were diagnosed with RA. 
Whilst this was appropriate for the research questions addressed in this thesis, use of 
additional datasets of RA cases would increase the scope of this work. Limitations of the 
methods for each study are discussed in the respective chapters. Here I include a general 
discussion of the limits of 16S methods which are used throughout the thesis. 
 
 
8.4.1 Limitations of 16S rRNA gene sequencing  
 
16S rRNA gene sequencing is the most frequently used method for characterising the 
microbiome. The main alternate approach of metagenome sequencing yields more 
information, but is inhibited by economic factors, particularly in application to larger sets of 
samples. 16S methods provide a balance in terms of information and economics. The 
generation of ASVs from 16S yields useful and valid information regarding the taxa present 
at genus and to a lesser extent species level – the latter is now much improved following 
the introduction of ASV methods. However, there are important limitations to 16S data 
which are described below. Some of these limitations are common to high throughput 
sequencing, including metagenomic methods. 
 
The most cited limitation of 16S data is that it relies on a single marker gene, and 
secondary to this the method does not usually allow for taxonomic identification at the 
species or strain level. Further, and perhaps more frustratingly, the specific genes and 
enzymes present for each bacterium cannot be identified - these can vary substantially 
within members of the same taxon. As such, using 16S data, it is difficult to answer the 
question of ‘which bacteria are present?’, and largely impossible to answer the question of 
‘what are they doing?’.  




However, the limitations of 16S data go further than this due to: variability in constant 
regions; 16S rRNA gene copy number variations; lack of variability in ‘variable region’ of 
some species; reliance on databases; chimera formation and difficulty in effective statistical 
management of these artefacts; abundance estimation inaccuracy; sequencing 
error. Collectively, these account for the lower reliability of 16S data compared to 
metagenomics data.  
 
The first issue is that the constant regions are captured with variable success by the 
degenerate primers which are utilised. Degenerate primers are defined as a mix of 
oligonucleotide sequences in which some positions contain a number of possible 
bases, therefore comprising a population of primers with similar sequences which cover all 
possible nucleotide combinations for a peptide sequence (Li, Hingamp, et al. 2018). The 
taxa detected by 16S data is dependent on the primers which are chosen. In addition, 
depending on the variable region targeted, primers can be ineffective for binding the 
variable region of some taxa. Indeed, the V4 variable region completely fails to amplify 
Cutibacterium acnes (Long et al. 2019).  
 
Secondly, 16S relies on detection of 16S rRNA genes, however there can be multiple of 
these genes within the same genome – this is referred to as copy number. The multiplicity 
is not constant across taxa, and therefore this is a source of bias. It has been demonstrated 
members of Firmicutes and Gammaproteobacteria can possess up to 6 copies of the 16S 
rRNA gene, whilst members of Bacteroidetes possess up to 3 copies (Sun et al. 2013).  
 
Third, the variable region is not variable enough to distinguish some species. Escherechia 
spp. and Shigella spp. have distinct natural histories, but it is impossible however to separate 
these taxa based on their 16S genes - all of their variable regions are too similar (Devanga 
Ragupathi et al. 2017).  
 
Fourth, taxonomic identification is reliant on databases. These resources are improving, 
however we still have not characterised at least 50% of existing taxa, and of those that are 




classified, some are incorrectly or incompletely labelled in some instances (Konstantinidis et 
al. 2017). Researchers are working hard to curate these invaluable resources and 
advancements are being made. In this thesis, the advancements in resolution of taxon 
annotations in the SILVA database and research relevance of these have been 
demonstrated. 
 
Fifth, an unavoidable pitfall of the method is chimera formation. Chimeras are artefacts of 
the PCR process - artificial 16S sequences which are derived from multiple sources. 
Chimera formation may be caused by incomplete primer extension, disassociation of 
polymerase, and misincorporation of polymerase and secondary structures. The inclusion 
of these in the final dataset can produce spurious results, such as artificial diversity, 
incorrect taxon identification and skewed phylogenetic trees (Parks et al. 2018). 16S data 
processing methods for OTUs and ASVs include steps to exclude chimeras, however these 
are not completely effective (Callahan et al. 2016).  
 
Chimera exclusion steps are typically based on sequence comparison or low abundance. 
However database sequences can be inaccurate, and chimeras which were formed early in 
the PCR process may not be low abundance. In addition, the issues described above 
pertaining to PCR, choice of primers and copy number of the 16S rRNA gene confer that 
abundance estimates in 16S data are fallible. The abundance estimates are skewed, and 
therefore should be interpreted with caution. 
 
 It is worth noting that metagenomics methods also hold limitations, however these are 
also common to 16S data. Many of these issues are therefore unavoidable using current 
methods. However key advantages of metagenomic methods when compared to 16S is 
detection of bacterial genes present, giving invaluable insight into functionality - likely to be 
more relevant than specific taxa - and metagenomics methods allow far greater detection 
bandwidth beyond the genus level. 
 




8.5 Future directions 
 
A discussion of the development of the specific studies in this thesis are included in the 
respective chapters. Here, I suggest how the research area as a whole could be advanced. 
As the research field is in the exploratory phase, primarily, additional epidemiological 
studies, in are required in order to characterise the microbiota in RA. In order to 
understand pathological relevance of microbiota differences associated with RA, we must 
develop a robust understanding of the nature of these differences; as discussed in Chapter 
4 and Chapter 6, there are contrasting findings in prior studies. Replication of the current 
findings in other cohorts will be important. Such studies should include consideration 
where possible of confounding factors. 
 
In terms of furthering understanding of the trajectory of the link between the microbiome 
and RA, it will be important to consider temporal differences in the microbiota occurring 
during the life-course. Development of RA occurs over decades, and aetiological 
aggravation via the intestinal microbiota may be evident some time before onset of clinical 
symptoms. To investigate this, the most informative approach would a prospective 
longitudinal study of participants at higher risk of RA, for example the children of RA 
patients. However this would be an extensive and long term study. There are two 
alternative approaches with less logistical barriers. The first is investigation of the 
microbiome as part of large studies such as UK biobank, in which individuals are already 
being prospectively followed. The second is to take a similar approach as presented in 
Chapter 5 and Chapter 7, to assess association of genetic risk of RA with the commensal 
microbiota. For example, it would be interesting to investigate association of genetic risk of 
RA and the microbiota in children from the ALSPAC cohort. Here, it would interesting to 
see if the Prevotella association replicated in these younger participants. This would give 
impetus to the theory that an increase in Prevotella spp. lies earlier on the in the trajectory 
of RA pathogenesis and is more likely to be causal. 
 




In understanding the trajectory of microbiome involvement in RA, it will also be important 
to consider other non-genetic risk factors for RA. With regard to the oral microbiome, a 
first step would be to investigate concurrent periodontal disease with RA in relation to 
oral microbiome and potential for shared genetic aetiology with RA, and the microbiome 
in relation to RA treatment response. With regards to the second suggestion, further 
studies are required of the oral microbiota association with periodontal disease. In order 
to demonstrate potential overlap in genetic aetiology, bivariate classical twin modelling 
would be informative.  
 
The link between the microbiome and RA extends beyond the microbiota differences 
which potentially contribute to the pathophysiology of RA; an important area which was 
outside the scope of this thesis, but which should be addressed in future studies is the 
implication of the microbiota in efficacy of treatments. There is substantial variation 
between patients in the response to treatment, and this may be partially mediated via the 
microbiota (Sayers et al. 2018). With regards to Methotrexate response, only 31% patients 
respond satisfactorily after 3 months according to the EULAR criteria (Lie et al. 2012), and 
attempts to reliably stratify response based on age, sex, BMI, smoking history, genetic 
factors, and serum biomarkers have proved unsuccessful (Wijbrandts and Tak 2017, Sayers 
et al. 2018).  
 
There are several examples of mechanisms by which the microbiota influence drug 
bioavailability, efficacy, or toxicity. In instances where bioavailability is dependent on internal 
metabolism, drugs are referred to as prodrugs. Sulfasalazine, a common RA therapeutic, is 
a prodrug which is functionally dependent on the intestinal microbiota. It is converted 
to its bioavailable form via gut microbiota azo reductase (Sayers et al. 2018). Conversely, as 
discussed previously, medications may alter the composition of the microbiota. 
Methotrexate, which is the first line treatment in RA, exhibits anti-microbial properties. 
The mechanism of action of methotrexate is folate inhibition, however the pathways 
involved are not specific to human cells, and also affect the microbiota. In RA this is 
suggested to be a potential mechanism of action, as RA therapeutics are associated with a 




microbiota more similar to non-diseased than diseased individuals (Zhang et al. 2015). 
Work is underway to understand the longitudinal response to RA treatment in relation to 
the microbiome. 
 
When studying the microbiome, computational and wet-lab based approaches go hand in 
hand; computational data is generated using wet-lab techniques. However, there are 
numerous primarily wet lab approaches which will be required alongside computational 
methods to address the complex task of investigating the functional implication of the 
microbiota in RA pathogenesis. Studies of immune reactivity to RA associated taxa in RA 
patients and control participants will be informative. I am aware of just one such study to 
date which showed promising results: IgA or IgG immune reactivity for P.copri was 
demonstrated in 24% of RA patients compared to 2% of healthy control participants 
(Pianta et al. 2016). Further studies using a similar approach would be informative. Well-
designed studies using animal models such as murine models can be valuable, especially 
when investigating a specific aspect of microbiota-host physiology interaction. These 
approaches will need to be applied to potentially RA relevant microbiota identified through 
computational methods. This will include Prevotella spp however the taxa implicated and 
their microbial community networks are likely to be much broader than these candidate 
taxa.. A more novel approach is the use of organoids to model functionality relevant to 
humans in vitro. There is also gathering interest in bacterial constituents such as OMVs 
which wet lab methods will be required in order to understand (Jones et al. 2020). 
 
As discussed in Chapter 1, OMVs which are produced ubiquitously by gram negative 
bacteria have been demonstrated to modify the local environment to facilitate bacterial 
proliferation, signal between bacterial species and have in addition been shown to 
communicate directly with host cells (Ellis and Kuehn 2010, Kulkarni and Jagannadham 
2014, Stentz et al. 2014). In the host, OMVs affect intracellular signalling and overall 
metabolic profile (Stentz et al. 2014, Bryant et al. 2017a). Investigation of OMVs may be an 
important step in understanding the link between the microbiome and host. In support of 
this, outer membrane vesicles of pathogenic and non-pathogenic strains of the same 




species have shown differing metabolic associations (Zakharzhevskaya et al. 2017a). P.copri 
is a gram-negative bacterium which produces OMVs, however the potential role of P.copri 
derived OMVs in relation to host inflammation and immunity has not yet been reported. 
OMVs of P.copri isolated from RA patients may have differences in content from other RA 
associated taxa, may exacerbate the pro-inflammatory host environment in RA. It would 
be informative to explore the content of outer membrane vesicles of P.copri using high 
performance liquid chromatography (HPLC). In P.copri strains derived from new-onset RA 
patients, HPLC could be used to compare P.copri OMVs to OMVs of P.copri from RA 
unaffected people who also have a high abundance of this taxon. Similarly, it would be 
useful to compare to OMVs from other bacteria, to give insight into differential effects on 
the host and potential role in inflammation. 
 
With regards to microbiome studies in general, where possible studies should use 
metagenomes methods, in order to improve detection of taxa and specific genes present 
in samples. Demonstrating the specific genes present is important, as there is a substantially 
higher degree of shared functionality between individuals than shared taxa. Studies should 
also include concurrent measures which can demonstrate functionality of the microbiota: 
metabolomics and meta-transcriptomics. In addition, it will be valuable to consider non-
bacterial constituents of the microbiome, such as fungi and viruses. Viruses - including 
bacteriophages - are the most abundant constituent of the microbiome. Methods for 
investigating the virome and particular the role of bacteriophages are not well established 




The work presented in this thesis constitutes several novel findings which collectively 
support the hypothesis that the commensal microbiota have a role in the aetiology of RA. 
In particular, RA characteristic microbiota differences are indicated to occur prior to onset 
of clinical RA, and associate with host genetic factors. This work provides support for the 




concept of the microbiome as a feasible RA-preventative target for patients with arthralgia. 
Prospectively, this work paves the way for further study of microbiota implication across 
the trajectory of RA pathogenesis spanning from earlier stages of immune dysregulation, to 
response to RA therapeutics in those with established disease. Further, this work provided 
several findings of wider interest beyond the scope of RA microbiome, which provide 
insight into influential factors of the oral and gut microbiota.  
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Appendix A: Chapter 3 
 





biocLite(suppressUpdates = FALSE) 















#Demultiplex in Qiime specifying RC barcodes 
split_libraries_fastq.py -i Undetermined_S0_L001_R1_001.fastq.gz -o High2R1Dmplxed/ -b 
Undetermined_S0_L001_I1_001.fastq.gz -m High2Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 




split_libraries_fastq.py -i Undetermined_S0_L001_R2_001.fastq.gz -o High2R2Dmplxed/ -b 
Undetermined_S0_L001_I1_001.fastq.gz -m High2Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o High1R1split/ --file_type fastq 
split_sequence_file_on_sample_ids.py -i seqsR2.fastq -o High1R2split/ --file_type fastq 
#AllHigh1 
split_libraries_fastq.py -i Undetermined_S0_L001_R1_001.fastq.gz -o AllHigh1R1Dmplxed/ -b 
Undetermined_S0_L001_I1_001.fastq.gz -m AllHigh1Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsHigh1R1.fastq -o AllHigh1R1split/ --file_type fastq 
 source /macqiime/configs/bash_profile.txt 
#Dada2 
path <- file.path("~/Documents/ASVs2/TwinsUKHigh1/R1R2") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="R1", full.names = TRUE)) 
fnRs <- sort(list.files(path, pattern="R2", full.names = TRUE)) 
plotQualityProfile(fnFs) 
plotQualityProfile(fnRs) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 




mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 









path <- file.path("AllHigh1R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("AllHigh1R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/High1/AllHigh1") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 




dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 








split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o High2R1split/ --file_type fastq 
split_sequence_file_on_sample_ids.py -i seqsR2.fastq -o High2R2split/ --file_type fastq 
#Desktop 
path <- file.path("High2R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("High2R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/TwinsUKHigh2/High2Filt") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 









derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 








S0_L001_R1_001.fastq.gz -o Low1R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKLow1/Undetermined_
S0_L001_I1_001.fastq.gz -m Low1Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 
999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKLow1/Undetermined_
S0_L001_R2_001.fastq.gz -o Low1R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKLow1/Undetermined_
S0_L001_I1_001.fastq.gz -m Low1Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 
999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o Low1R1split/ --file_type fastq 




path <- file.path("Low1R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Low1R2split") 
list.files(path) 




fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Low1") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 








S0_L001_R1_001.fastq.gz -o Low2R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKLow2/Undetermined_




S0_L001_I1_001.fastq.gz -m Low2Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 
999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKLow2/Undetermined_
S0_L001_R2_001.fastq.gz -o Low2R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKLow2/Undetermined_
S0_L001_I1_001.fastq.gz -m Low2Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 
999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o Low2R1split/ --file_type fastq 





path <- file.path("Low2R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Low2R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6], title(main = Low2R1)) 
plotQualityProfile(fnRs[1:6], title(main = Low2R1)) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Low2") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 




names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 










_S0_L001_R1_001.fastq.gz -o Plate5R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate5/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate5Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate5/Undetermined
_S0_L001_R2_001.fastq.gz -o Plate5R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate5/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate5Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o Plate5R1split/ --file_type fastq 





path <- file.path("Plate5R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate5R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 




plotQualityProfile(fnFs[1:6], title(main = Low2R1)) 
plotQualityProfile(fnRs[1:6], title(main = Low2R1)) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate5") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 








_S0_L001_R1_001.fastq.gz -o Plate6R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate6/Undetermined




_S0_L001_I1_001.fastq.gz -m Plate6Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate6/Undetermined
_S0_L001_R2_001.fastq.gz -o Plate6R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate6/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate6Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o Plate6R1split/ --file_type fastq 
split_sequence_file_on_sample_ids.py -i seqsR2.fastq -o Plate6R2split/ --file_type fastq 
#Dada2 
setwd("~/Documents/ASVs2/Plate6") 
path <- file.path("Plate6R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate6R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate6") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(180,190), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 






errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 





names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 









_S0_L001_R1_001.fastq.gz -o Plate7R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate7/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate7Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate7/Undetermined
_S0_L001_R2_001.fastq.gz -o Plate7R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate7/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate7Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o Plate7R1split/ --file_type fastq 
split_sequence_file_on_sample_ids.py -i seqsR2.fastq -o Plate7R2split/ --file_type fastq 
#Dada2 
setwd("~/Documents/ASVs2/Plate7") 
path <- file.path("Plate7R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate7R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 





sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate7") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 









_S0_L001_R1_001.fastq.gz -o Plate8R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate8/Undetermined




_S0_L001_I1_001.fastq.gz -m Plate8Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate8/Undetermined
_S0_L001_R2_001.fastq.gz -o Plate8R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate8/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate8Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 




path <- file.path("Plate8R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate8R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate8") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 





dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 









_S0_L001_R1_001.fastq.gz -o Plate9R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate9/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate9Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate9/Undetermined
_S0_L001_R2_001.fastq.gz -o Plate9R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate9/Undetermined
_S0_L001_I1_001.fastq.gz -m Plate9Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq 
-r 999 -n 999 -q 0 -p 0.0001 
split_sequence_file_on_sample_ids.py -i seqsR1.fastq -o Plate9R1split/ --file_type fastq 




path <- file.path("Plate9R1split") 
list.files(path) 
 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate9R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
                                               




path <- file.path("Documents/ASVs2/Plate9") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(190,190), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 





errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 









path <- file.path("Plate9R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate9R2split") 















sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate9") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(170,170), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
head(out) 
errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
 
saveRDS(seqtab, "seqtab.Plate9.rds") 
#### copied again 






path <- file.path("Plate9R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate9R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:10]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("~/Documents/ASVs2/Plate9") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,200), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 
 





    






# File parsing 




pathR <- "~/Documents/ASVs2/Plate9/Plate9R2split"  
list.files(pathR) 
 
filtpathF <- file.path(pathF, "filtered")  
filtpathF 
filtpathR <- file.path(pathR, "filtered")  
filtpathR 
fastqFs <- sort(list.files(pathF, pattern="fastq")) 
 
fastqRs <- sort(list.files(pathR, pattern="fastq")) 
 
if(length(fastqFs) != length(fastqRs)) stop("Forward and reverse files do not match.") 
 
# Filtering: THESE PARAMETERS ARENT OPTIMAL FOR ALL DATASETS 
out <- filterAndTrim(fwd=file.path(pathF, fastqFs), filt=file.path(filtpathF, fastqFs), 
              rev=file.path(pathR, fastqRs), filt.rev=file.path(filtpathR, fastqRs), trimLeft = c(12,12), 
              truncLen=c(160,160), maxEE=2, truncQ=11, maxN=0, rm.phix=TRUE, 
              compress=TRUE, verbose=TRUE, multithread=TRUE) 
 
# File parsing 
filtpathF <- "~/Documents/ASVs2/Plate9/Plate9R1split/filtered"  
filtpathR <- "~/Documents/ASVs2/Plate9/Plate9R2split/filtered"  
filtFs <- list.files(filtpathF, pattern="fastq", full.names = TRUE) 
filtRs <- list.files(filtpathR, pattern="fastq", full.names = TRUE) 
plotQualityProfile(filtFs[1:4]) 
sample.namesR <- sample.names 
names(filtFs) <- sample.names 
names(filtRs) <- sample.names 





# Learn forward error rates 
errF <- learnErrors(filtFs, nbases=1e8, multithread=TRUE) 
# Learn reverse error rates 
errR <- learnErrors(filtRs, nbases=1e8, multithread=TRUE) 
# Sample inference and merger of paired-end reads 
mergers <- vector("list", length(sample.names)) 
names(mergers) <- sample.names 
for(sam in sample.names) { 
  cat("Processing:", sam, "\n") 
  derepF <- derepFastq(filtFs[[sam]]) 
  ddF <- dada(derepF, err=errF, multithread=TRUE) 
  derepR <- derepFastq(filtRs[[sam]]) 
  ddR <- dada(derepR, err=errR, multithread=TRUE) 
  merger <- mergePairs(ddF, derepF, ddR, derepR) 
  mergers[[sam]] <- merger 
} 
 
# Construct sequence table and remove chimeras 









d_S0_L001_R1_001.fastq.gz -o Plate10R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate10/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate10Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate10/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate10R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate10/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate10Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/Plate10") 
path <- file.path("Plate10R1split") 





fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate10R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate10") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 












d_S0_L001_R1_001.fastq.gz -o Plate11R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate11/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate11Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate11/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate11R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate11/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate11Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/Plate11") 
path <- file.path("Plate11R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate11R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate11") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 





names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 








d_S0_L001_R1_001.fastq.gz -o Plate12R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate12/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate12Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate12/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate12R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate12/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate12Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/Plate12") 
path <- file.path("Plate12R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate12R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate12") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 




filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 








d_S0_L001_R1_001.fastq.gz -o Plate13R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate13/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate13Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate13/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate13R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate13/Undetermine




d_S0_L001_I1_001.fastq.gz -m Plate13Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/Plate13") 
path <- file.path("Plate13R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate13R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate13") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 











d_S0_L001_R1_001.fastq.gz -o Plate14R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate14/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate14Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate14/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate14R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate14/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate14Map.txt --barcode_type 12 --rev_comp_barcode --





d_S0_L001_R1_001.fastq.gz -o Plate14R1Dmplxed_CorrectedBarcodes/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate14/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate14Map_CorrectedBarcodes.txt --barcode_type 12  --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate14/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate14R2Dmplxed_CorrectedBarcodes/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate14/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate14Map_CorrectedBarcodes.txt --barcode_type 12  --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/Plate14") 
path <- file.path("Plate14R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate14R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 




sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate14") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 








d_S0_L001_R1_001.fastq.gz -o Plate15R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate15/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate15Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 






d_S0_L001_R2_001.fastq.gz -o Plate15R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate15/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate15Map.txt --barcode_type 12 --rev_comp_barcode --




path <- file.path("Plate15R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate15R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate15") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,200), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 




dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 







## Extract barcodes from FASTA files 
 
library(readr) 
Plate16 <- read_delim("~/Documents/Plate16.csv",  
                      " ", escape_double = FALSE, col_names = FALSE,  
                      trim_ws = TRUE) 
 
Plate16$X6 <- gsub("bc_diffs", "", Plate16$X6) 
Plate16$X6 <- gsub("=", "", Plate16$X6) 
Plate16$X5 <- gsub("new_bc=", "", Plate16$X5) 
Plate16$X4 <- gsub("orig_bc=", "", Plate16$X5) 
plate16copy <- Plate16 
Plate16 <- Plate16[c(1, 4:6)] 
 
 
Plate16 <- as.data.frame(Plate16) 
names <- c("Sample", "Orig_Barcode", "New_Barcode", "Changed") 
colnames(Plate16) <- names 
 
odd_indexes <- seq(1,1048575,2) 
head(odd_indexes) 
Plate16sub <- Plate16[c(odd_indexes),] 
Plate16sub$Sample <- gsub(">", "", Plate16sub$Sample) 









d_S0_L001_R1_001.fastq.gz -o Plate16R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate16/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate16Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate16/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate16R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate16/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate16Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
#corrected barcodes 






d_S0_L001_R1_001.fastq.gz -o Plate16R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate16/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate16Map_CorrectedBarcodes.txt --barcode_type 12  --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate16/Undetermine
d_S0_L001_R2_001.fastq.gz -o Plate16R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_1/illumina_run_data/TwinsUKPlate16/Undetermine
d_S0_L001_I1_001.fastq.gz -m Plate16Map_CorrectedBarcodes.txt --barcode_type 12  --




path <- file.path("Plate16R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate16R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/Plate16") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 





errF <- learnErrors(filtFs, multithread=TRUE) 









derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 










mined_S0_L001_R1_001.fastq.gz -o Plate17_21R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate17_21/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate17_21Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate17_21/Undeter
mined_S0_L001_R2_001.fastq.gz -o Plate17_21R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate17_21/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate17_21Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/ReadsBatch2/Plate17_21") 
path <- file.path("Plate17_21R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate17_21R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 




sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/ReadsBatch2/Plate17_21") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 









mined_S0_L001_R2_001.fastq.gz -o Plate18_31R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate18_31/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate18_31Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 






mined_S0_L001_R2_001.fastq.gz -o Plate18_31R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate18_31/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate18_31Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/ReadsBatch2/Plate18_31") 
path <- file.path("Plate18_31R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate18_31R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/ReadsBatch2/Plate18_31") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 






mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 








determined_S0_L001_R1_001.fastq.gz -o Plate19_30_RD2R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate19_30_RD2/Un
determined_S0_L001_I1_001.fastq.gz -m Plate19_30_RD2Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate19_30_RD2/Un
determined_S0_L001_R2_001.fastq.gz -o Plate19_30_RD2R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate19_30_RD2/Un
determined_S0_L001_I1_001.fastq.gz -m Plate19_30_RD2Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/ReadsBatch2/Plate19_30_RD2") 
path <- file.path("Plate19_30RD2R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate19_30_RD2R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/ReadsBatch2/Plate19_30_RD2") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
outdf <- as.data.frame(out) 
write.csv(outdf, file = "FilterandTrim.csv") 







errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 








mined_S0_L001_R1_001.fastq.gz -o Plate20_23R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate20_23/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate20_23Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate20_23/Undeter
mined_S0_L001_R2_001.fastq.gz -o Plate20_23R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate20_23/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate20_23Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
setwd("~/Documents/ASVs2/ReadsBatch2/Plate20_23") 
path <- file.path("Plate20_23RD2R1split") 





fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate20_23RD2R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/ReadsBatch2/Plate20_23") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
outdf <- as.data.frame(out) 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 












mined_S0_L001_R1_001.fastq.gz -o Plate20_23R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate20_23/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate20_23Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate20_23/Undeter
mined_S0_L001_R2_001.fastq.gz -o Plate20_23R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate20_23/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate20_23Map.txt --barcode_type 12 --rev_comp_barcode --





mined_S0_L001_R1_001.fastq.gz -o Plate24_29R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate24_29/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate24_29Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate24_29/Undeter
mined_S0_L001_R2_001.fastq.gz -o Plate24_29R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate24_29/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate24_29Map.txt --barcode_type 12 --rev_comp_barcode --





mined_S0_L001_R1_001.fastq.gz -o Plate25_27R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate25_27/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate25_27Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate25_27/Undeter
mined_S0_L001_R2_001.fastq.gz -o Plate25_27R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate25_27/Undeter




mined_S0_L001_I1_001.fastq.gz -m Plate25_27Map.txt --barcode_type 12 --rev_comp_barcode --





rmined_S0_L001_R1_001.fastq.gz -o Plate26_RD1R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate26_RD1/Undete
rmined_S0_L001_I1_001.fastq.gz -m Plate26_RD1Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate26_RD1/Undete
rmined_S0_L001_R2_001.fastq.gz -o Plate26_RD1R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate26_RD1/Undete
rmined_S0_L001_I1_001.fastq.gz -m Plate26_RD1Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
 
#Plate28_33  
#R1 in wrong format:"Non-header line passed as input. Header must start with '@'." 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate28_33/Undeter
mined_S0_L001_R1_001.fastq.gz -o Plate28_33R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate28_33/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate28_33Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate28_33/Undeter
mined_S0_L001_R2_001.fastq.gz -o Plate28_33R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate28_33/Undeter
mined_S0_L001_I1_001.fastq.gz -m Plate28_33Map.txt --barcode_type 12 --rev_comp_barcode --





path <- file.path("Plate28_33R2split") 
list.files(path) 








sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/ReadsBatch2/Plate28_83") 
 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim( fnRs, filtRs, trimLeft = 12, truncLen= 160, 
                     maxN=0, maxEE= 2, truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
outdf <- as.data.frame(out) 











derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepRs) <- sample.names 
#Denoising 
 












determined_S0_L001_R1_001.fastq.gz -o Plate32_34_RD3R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate32_34_RD3/Un
determined_S0_L001_I1_001.fastq.gz -m Plate32_34_RD3Map.txt --barcode_type 12 --rev_comp_barcode --
store_demultiplexed_fastq -r 999 -n 999 -q 0 -p 0.0001 






determined_S0_L001_R2_001.fastq.gz -o Plate32_34_RD3R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_2/illumina_run_data/TwinsUKPlate32_34_RD3/Un
determined_S0_L001_I1_001.fastq.gz -m Plate32_34_RD3Map.txt --barcode_type 12 --rev_comp_barcode --






R1_001.fastq.gz -o Plate34.2_40R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate34.2_40/Undetermined_S0_L001_I
1_001.fastq.gz -m Plate34.2_40Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 
999 -n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate34.2_40/Undetermined_S0_L001_
R2_001.fastq.gz -o Plate34.2_40R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate34.2_40/Undetermined_S0_L001_I
1_001.fastq.gz -m Plate34.2_40Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 
999 -n 999 -q 0 -p 0.0001 
setwd("~/Documents/ASVs2/ReadsBatch3/Plate34.2_40") 
require(dada2) 




path <- file.path("Plate34.2_40R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate34.2_40R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnFs), "_"), `[`, 1) 
sample.names <- gsub(".fastq", "", sample.names) 
path <- file.path("Documents/ASVs2/ReadsBatch3/Plate34.2_40") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 




out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(200,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
outdf <- as.data.frame(out) 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, pool = TRUE, err=errF,  multithread=TRUE) 
dadaRs <- dada(derepRs, pool = TRUE, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 










1_001.fastq.gz -o Plate35_36R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate35_36/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate35_36Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate35_36/Undetermined_S0_L001_R




2_001.fastq.gz -o Plate35_36R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate35_36/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate35_36Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -





1_001.fastq.gz -o Plate37_38R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate37_38/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate37_38Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate37_38/Undetermined_S0_L001_R
2_001.fastq.gz -o Plate37_38R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate37_38/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate37_38Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -





1_001.fastq.gz -o Plate39_42R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate39_42/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate39_42Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate39_42/Undetermined_S0_L001_R
2_001.fastq.gz -o Plate39_42R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate39_42/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate39_42Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -






1_001.fastq.gz -o Plate41_43R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate41_43/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate41_43Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 






2_001.fastq.gz -o Plate41_43R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate41_43/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate41_43Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -





1_001.fastq.gz -o Plate44_45R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate44_45/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate44_45Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate44_45/Undetermined_S0_L001_R
2_001.fastq.gz -o Plate44_45R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate44_45/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate44_45Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -





1_001.fastq.gz -o Plate46_47R1Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate46_47/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate46_47Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 
split_libraries_fastq.py -i 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate46_47/Undetermined_S0_L001_R
2_001.fastq.gz -o Plate46_47R2Dmplxed/ -b 
/gpfs/home/DTR/ubiome/Cornell/gut16s/Data/raw_data/batch_3/TwinsUKPlate46_47/Undetermined_S0_L001_I1
_001.fastq.gz -m Plate46_47Map.txt --barcode_type 12 --rev_comp_barcode --store_demultiplexed_fastq -r 999 -
n 999 -q 0 -p 0.0001 
 
split_libraries_fastq.py -i Undetermined_S0_L001_R1_001.fastq.gz -o Plate46_47R1Dmplxed/ -b 
Undetermined_S0_L001_I1_001.fastq.gz -m Plate46_47Map.txt --barcode_type 12 --rev_comp_barcode --








path <- file.path("Plate46_47R1split") 
list.files(path) 
fnFs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
path <- file.path("Plate46_47R2split") 
list.files(path) 
fnRs <- sort(list.files(path, pattern="fastq", full.names = TRUE)) 
plotQualityProfile(fnFs[1:6]) 
plotQualityProfile(fnRs[1:6]) 
sample.names <- sapply(strsplit(basename(fnRs), "_"), `[`, 1) 
path <- file.path("Documents/ASVs2/ReadsBatch3/Plate46_47") 
 
filtFs <- file.path(path, "filtered", paste0(sample.names, "_F_filt.fastq.gz")) 
filtRs <- file.path(path,"filtered", paste0(sample.names, "_R_filt.fastq.gz")) 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, trimLeft = c(12,12), truncLen=c(240,160), 
                     maxN=0, maxEE=c(2,2), truncQ=2, rm.phix=TRUE, 
                     compress=TRUE, multithread=TRUE) 
outdf <- as.data.frame(out) 




errF <- learnErrors(filtFs, multithread=TRUE) 





derepFs <- derepFastq(filtFs, verbose=TRUE) 
derepRs <- derepFastq(filtRs, verbose=TRUE) 
 
names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
#Denoising 
dadaFs <- dada(derepFs, err=errF, multithread=TRUE) 
dadaRs <- dada(derepRs, err=errR, multithread=TRUE) 
dadaFs[[1]] 
dadaRs[[2]] 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs, verbose=TRUE) 
seqtab <- makeSequenceTable(mergers) 
table(nchar(getSequences(seqtab))) 
 







                                                         ############ Merge Seqtabs Batch1 ################### 
st1 <- readRDS("~/Documents/ASVs2/High1/AllHigh1/seqtab.High1.rds") 
st2 <- readRDS("~/Documents/ASVs2/High2/seqtab.High2.rds") 
st3 <- readRDS("~/Documents/ASVs2/Low1/seqtab.Low1.rds") 
st4 <- readRDS("~/Documents/ASVs2/Low2/seqtab.Low2.rds") 
st5 <- readRDS("~/Documents/ASVs2/Plate5/seqtab.Plate5.rds") 
st6 <- readRDS("~/Documents/ASVs2/Plate6/seqtab.Plate6.rds") 
st7 <- readRDS("~/Documents/ASVs2/Plate7/seqtab.Plate7.rds") 
st8 <- readRDS("~/Documents/ASVs2/Plate8/seqtab.Plate8.rds") 
st9 <- readRDS("~/Documents/ASVs2/Plate9/Plate9BD.rds") 
st10 <- readRDS("~/Documents/ASVs2/Plate10/seqtab.Plate10.rds") 
st11 <- readRDS("~/Documents/ASVs2/Plate11/seqtab.Plate11.rds") 
st12 <- readRDS("~/Documents/ASVs2/Plate12/seqtab.Plate12.rds") 
st13 <- readRDS("~/Documents/ASVs2/Plate13/seqtab.Plate13.rds") 
st14 <- readRDS("~/Documents/ASVs2/Plate14/seqtab.Plate14.rds") 
st15 <- readRDS("~/Documents/ASVs2/Plate15/seqtab.Plate15.rds") 
st16 <- readRDS("~/Documents/ASVs2/Plate16/seqtab.Plate16.rds") 
 
 
mergeTest <- mergeSequenceTables(st3, st4, st7, st8, st9) 
library(dada2) 






saveRDS(st.batch1, file = "st.batch1.rds") 
 
                       ############################# Merge Batch 2 
######################################## 
 
st1 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate17_21/seqtab.Plate17_21.rds") 
st2 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate18_31/seqtab.Plate18_31.rds") 
st3 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate19_30_RD2/seqtab.Plate19_30_RD2.rds") 
st4 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate20_23/seqtab.Plate20_23_RD2.rds") 
st5 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate22/seqtab.Plate22.rds") 
st6 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate24_29/seqtab.Plate24_29.rds") 




st7 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate25_27/seqtab.Plate25_27.rds") 
st8 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate26_RD1/seqtab.Plate26_RD1.rds") 
st9 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate28_33/seqtab.Plate28_33.rds") 
st10 <- readRDS("~/Documents/ASVs2/ReadsBatch2/Plate32_34/seqtab.Plate32_34.rds") 
 
st.batch2 <- mergeSequenceTables(st1, st2, st3, st4, st5, st6, st7, st8, st9, st10) 
  
setwd("~/Documents/ASVs2") 
saveRDS(st.batch2, file = "st.batch2.rds") 
 
 
                       ############################# Merge Batch 3 
######################################## 
st1 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate34.2_40/seqtab.Plate34.2_40.rds") 
st2 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate35_36/seqtab.Plate35_36.rds") 
st3 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate37_38/seqtab.Plate37_38.rds") 
st4 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate39_42/seqtab.Plate39_42.rds") 
st5 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate41_43/seqtab.Plate41_43.rds") 
st6 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate44_45/seqtab.Plate44_45.rds") 
st7 <- readRDS("~/Documents/ASVs2/ReadsBatch3/Plate46_47/seqtab.Plate46_247.rds") 
 
st.batch3 <- mergeSequenceTables(st1, st2, st3, st4, st5, st6, st7) 
 
############################# Merge All ######################################## 
st.batch1 <- readRDS("~/Documents/ASVs2/st.batch1.rds") 
 
merged12 <- mergeSequenceTables(st.batch1, st.batch2) 
merged23 <- mergeSequenceTables(st.batch2, st.batch3) 
merged123 <- mergeSequenceTables(merged23, st.batch1) 
 
 
TwinsUkSeqtab <- merged123 
 
saveRDS(TwinsUkSeqtab, file = "TwinsUKSeqtab.rds") 
 




saveRDS(seqtab.nochim, file = "TwinsUKSeqtab.nochim.rds") 
 




#Check Merge has worked 
seqtab.nochim.df <- as.data.frame(seqtab.nochim) 
write.csv(seqtab.nochim.df, file = "TwinsUKSeqTabNoChim.csv") 
write.table(seqtab.nochim.df, file = "TwinsUKSeqTabNoChim.txt") 
st3nochim <- removeBimeraDenovo(st3) 
st3nochim <- as.data.frame(st3nochim) 
st3nochim$Total <- NA 
st3nochim$Total <- rowSums(st3nochim) 
st3nochimtotals <- st3nochim[(4363)] 
seqtab.nochim.df$Total <- NA 
seqtab.nochim.df$Total <- rowSums(seqtab.nochim.df[c(1:36699)]) 
seqtab.nochim.totals <- seqtab.nochim.df[(36700)] 
seqtab.nochim.500 <- seqtab.nochim.df[which(seqtab.nochim.df$Total > 500),] 
st5nochim <- removeBimeraDenovo(st5) 
 
TwinsUKstnochim <- readRDS("~/Documents/ASVs2/TwinsUKSeqtab.nochim.rds") 
ASVIDs <- read.csv("~/Documents/ASVs2/ASV_IDs.csv") 
TwinsUKstnochimsub <- TwinsUKstnochim[which(rownames(TwinsUKstnochim) %in% ASVIDs$ASV_ID),] 
subcopy <- TwinsUKstnochimsub 
row.names(TwinsUKstnochimsub) <- ASVIDs$SequencingSpecificName 
saveRDS( TwinsUKstnochimsub,file = "TwinsUKASVs_Depth10000.rds") 
seqtab.nochim.df <- as.data.frame(TwinsUKstnochimsub) 
 
write.csv(seqtab.nochim.df, file = "TwinsUK_ASVs_10000.csv") 
write.table(seqtab.nochim.df, file = "TwinsUK_ASVs_10000.txt", sep = "\t") 
 
library(dada2) 
seqs <- readRDS("TwinsUKASVs_Depth10000.rds")  
taxa <- assignTaxonomy(seqs, "silva_nr_v132_train_set.fa.gz") 
taxa.sp <- addSpecies(taxa, "silva_species_assignment_v132.fa.gz") 
saveRDS(taxa.sp, file = "TwinsUK_Taxa.rds", ) 
write.csv(taxa.sp, file = "TwinsUK_Taxa.csv") 
saveRDS(taxa.sp, file = "TwinsUK_Taxa.rds") 
 






ASVs <-collapseNoMismatch(ASVs, minOverlap = 20, orderBy = "abundance", 




                   identicalOnly = FALSE, vec = TRUE, verbose = FALSE) 




saveRDS(ASVs, file = "ASVsCollapsed.rds") 
 
#Taxa Assign 
taxa <- assignTaxonomy(seqtab.nochim,"silva_nr_v132_train_set.fa.gz", multithread=TRUE) 
unname(taxa) 
#Species Assign 









seqs <- getSequences(seqtab.nochim) 
names(seqs) <- seqs # This propagates to the tip labels of the tree 
alignment <- AlignSeqs(DNAStringSet(seqs), anchor=NA,verbose=FALSE) 
 
require(phangorn) 
phangAlign <- phyDat(as(alignment, "matrix"), type="DNA") 
dm <- dist.ml(phangAlign) 
# Note, tip order != sequence order 
treeNJ <- NJ(dm)  
fit = pml(treeNJ, data=phangAlign) 
fitGTR <- update(fit, k=4, inv=0.2) 
fitGTR <- optim.pml(fitGTR, model="GTR", optInv=TRUE, optGamma=TRUE, 
                    rearrangement = "stochastic", control = pml.control(trace = 0)) 
detach("package:phangorn", unload=TRUE) 
Tree1 <- fitGTR$tree 
















Appendix B Chapter 5: Supplementary material 
 
The following supplementary materials are associated with the paper published in The Lancet Rheumatology 
on 1st July 2020, entitled “Associations between gut microbiota and genetic risk for rheumatoid arthritis in the 
absence of disease: a cross sectional study”. 
 












56.5 (12.75) 57 (18.5) 0.69 
Female Sex 
n (%) 
62 (84) 47 (85.5) 0.79 
BMI 
Median (IQR) 
24.5 (4.8) 24.4 (4.22) 0.47 
ACPA positivity 
n (%) 
20 (27) 16 (29) 0.79 
 
Supplementary Table B 5.1. Age, sex, BMI and ACPA positivity in SE positive and SE 










Resilience hypothesis: abundance of Prevotella spp. in RA discordant twin pairs in 
TwinsUK cohort. 
 
To be confident that the Prevotella spp findings in non-RA individuals with genetic risk for RA 
were not reflecting a “resilience-associated” microbiota (i.e. protective factors against 
developing disease despite having high genetic risk), we calculated the abundance of these 
species in 19 monozygotic RA discordant female twin pairs from TwinsUK, which had been 
excluded from the previous analysis because of the presence of disease. If associated with 
resilience we would expect the Prevotella spp to be preferentially expressed in the unaffected 
twin of each discordant pair.  RA diagnosis had been confirmed during a clinical visit to a 
Rheumatologist or RA-trained research assistant.  ASVs were generated as above and relative 
abundance of Prevotella spp. in RA discordant twin pairs calculated using the Phyloseq R 







Alpha diversity Estimate Std. Error R2 P  
Observed -0.011 0.021 0.251 0.6 
Shannon -0.007 0.024 0.026 0.76 
Simpson -0.023 0.034 0.006 0.41 
Faith’s -0.009 0.021 0.116 0.65 
 
Supplementary Table B 5.2. Association of genetic risk for RA (PRS) and alpha diversity of the 















Supplementary Figure B 5.1. Relative abundance of Prevotella spp. in RA-discordant twin 
pairs from TwinsUK. The RA affected twins were established (treated) RA patients. Prevotella_7 




































CHR SNP A1 A2 P OR Replicated 
1 rs624988 T C 8.00E-10 1.09 No 
1 rs840016 C T 2.00E-06 1.11 No 
1 rs923880 C T 8.00E-06 0.25 No 
1 rs72717009 T C 5.00E-07 1.12 Yes 
1 rs2317230 T G 2.00E-07 1.07 No 
1 rs6593803 T C 2.00E-07 3.13 No 
1 rs2228145 A C 4.00E-09 1.08 Yes 
1 rs12565755 C T 5.00E-08 0.39 No 
1 rs2105325 C A 0 1.12 Yes 
1 rs12140275 A T 4.00E-09 1.11 Yes 
1 rs3890745 T C 1.00E-07 0.89 Yes 
1 rs28411352 T C 0 1.11 Yes 
1 rs2301888 G A 0 1.19 Yes 
1 rs12131057 G A 4.00E-07 1.16 No 
1 rs2476601 A G 2.00E-11 1.72 Yes 
1 rs6679677 A C 0 1.79 Yes 
1 rs11121380 C A 5.00E-08 11.11 No 
1 rs998731 C T 3.00E-09 1.11 Yes 
2 rs6732565 A G 9.00E-09 1.1 Yes 
2 rs11676922 T A 0 1.12 Yes 
2 rs10865035 A G 2.00E-06 1.12 No 
2 rs9653442 C T 0 1.11 Yes 
2 rs11900673 T C 1.00E-08 1.11 No 
2 rs13385025 A G 9.00E-07 1.11 No 
2 rs6715284 G C 3.00E-09 1.15 Yes 
2 rs1980422 C T 0 1.12 Yes 
2 rs3087243 G A 1.00E-08 1.15 Yes 
2 rs231735 G T 6.00E-09 1.17 No 
2 rs12617656 T C 0 1.557 Yes 
2 rs41005 T C 4.00E-06 0.27 No 
2 rs1406428 T C 2.00E-07 2.74 No 
2 rs10175798 A G 1.00E-09 1.08 Yes 
2 rs13031237 T G 8.00E-07 1.13 No 
2 rs13017599 A G 0 1.21 No 
2 rs34695944 C T 0 1.13 Yes 
2 rs4305317 T A 2.00E-06 1.45 No 
2 rs13015080 A G 3.00E-06 0.28 Yes 
2 rs934734 G A 5.00E-10 1.13 Yes 
2 rs1858037 T A 0 1.11 Yes 
2 rs7574865 T G 2.00E-06 1.17 Yes 
2 rs11889341 T C 0 1.13 Yes 




CHR SNP A1 A2 P OR Replicated 
3 rs73081554 T C 5.00E-08 1.18 No 
3 rs2062583 G T 2.00E-06 0.63 No 
3 rs9860428 C A 4.00E-07 1.6 Yes 
3 rs3806624 G A 9.00E-09 1.08 Yes 
3 rs9826828 A G 9.00E-10 1.44 No 
3 rs6774280 C T 9.00E-07 5.5 No 
3 rs4452313 T A 5.00E-11 1.11 Yes 
3 rs7624766 G A 4.00E-07 2.28 No 
3 rs13315591 C T 5.00E-08 1.29 No 
3 rs1809529 C T 3.00E-07 0.28 No 
4 rs2867461 A G 0 1.13 No 
4 rs11933540 C T 0 1.15 No 
4 rs13142500 C T 2.00E-06 1.1 Yes 
4 rs13119723 A G 7.00E-07 1.12 No 
4 rs45475795 G A 4.00E-06 1.14 No 
4 rs11937061 T G 2.00E-07 6.7 No 
4 rs3816587 C T 9.00E-06 1.09 No 
4 rs874040 C G 0 1.19 No 
4 rs6448432 A G 4.00E-07 1.19 No 
4 rs13137105 G A 9.00E-07 6.39 No 
4 rs2664035 A G 3.00E-08 1.08 Yes 
5 rs7731626 G A 0 1.21 No 
5 rs255758 C A 7.00E-06 1.42 No 
5 rs26232 C T 4.00E-08 0.88 No 
5 rs2561477 G A 2.00E-11 1.11 Yes 
5 rs1498103 A T 6.00E-06 0.26 No 
5 rs12519788 G A 5.00E-08 1.82 Yes 
5 rs657075 A G 3.00E-10 1.12 Yes 
5 rs6859219 C A 1.00E-11 1.28 No 
5 rs12109285 C T 1.00E-07 130.2 No 
5 rs1502644 C A 1.00E-08 2.33 No 
5 rs4336372 C T 1.00E-06 0.65 Yes 
5 rs4921283 A G 1.00E-07 1.0752687 No 
6 rs6568431 A C 1.00E-07 1.14 No 
6 rs9372120 G T 8.00E-10 1.11 Yes 
6 rs3093024 A G 0 1.19 No 
6 rs3093023 A G 2.00E-11 1.11 Yes 
6 rs1571878 C T 0 1.17 Yes 
6 rs1854853 A G 0 1.4164 Yes 
6 rs12529514 C T 2.00E-08 1.14 No 
6 rs3763309 A C 0 2.3 No 




CHR SNP A1 A2 P OR Replicated 
6 rs6457617 T C 1.00E-09 2.36 Yes 
6 rs9275406 T G 0 2.1 No 
6 rs660895 G A 0 3.62 No 
6 rs7765379 G T 0 2.51 No 
6 rs13192471 G A 0 1.97 No 
6 rs6910071 G A 0 2.88 No 
6 rs9378815 C G 2.00E-10 1.09 Yes 
6 rs284515 G A 7.00E-07 0.35 No 
6 rs284511 C T 3.00E-08 0.41 No 
6 rs2233434 G A 0 1.19 Yes 
6 rs2233424 T C 0 1.24 Yes 
6 rs9373594 T C 3.00E-09 1.09 Yes 
6 rs2451258 T C 3.00E-11 1.1 Yes 
6 rs6920220 A G 0 1.22 Yes 
6 rs5029924 T C 0 1.74 No 
6 rs7752903 G T 0 1.38 Yes 
6 rs10499194 C T 1.00E-09 1.33 No 
6 rs2230926 C A 2.00E-06 1.31 No 
6 rs75908454 C T 6.00E-07 0.42 No 
7 rs42041 G C 4.00E-06 1.11 No 
7 rs4272 G A 5.00E-09 1.1 Yes 
7 rs6956740 T C 5.00E-07 3.49 No 
7 rs11761231 T C 4.00E-07 1.44 No 
7 rs10488631 C T 4.00E-11 1.16 No 
7 rs3807306 T G 3.00E-07 1.44 No 
7 rs67250450 T C 3.00E-09 1.11 Yes 
7 rs12531711 G A 0 1.45 No 
8 rs1600249 T A 5.00E-06 0.77 No 
8 rs2736340 T C 1.00E-11 1.21 Yes 
8 rs2736337 C T 0 1.11 Yes 
8 rs678347 G A 7.00E-09 1.1 Yes 
8 rs16938910 T C 4.00E-07 28.66 No 
8 rs800586 A G 2.00E-07 9.78 No 
8 rs1516971 T C 3.00E-11 1.16 Yes 
9 rs11574914 A G 0 1.13 Yes 
9 rs2812378 G A 3.00E-08 1.12 No 
9 rs951005 A G 4.00E-10 1.19 No 
9 rs12379034 G A 0 1.489 Yes 
9 rs1329568 T G 8.00E-07 19.64 No 
9 rs9299346 A G 2.00E-06 2.76 No 
9 rs2072438 T C 3.00E-09 1.142 No 




CHR SNP A1 A2 P OR Replicated 
9 rs3761847 G A 0 1.32 Yes 
9 rs10985070 C A 5.00E-11 1.08 Yes 
10 rs10821944 G T 0 1.16 No 
10 rs71508903 T C 0 1.16 Yes 
10 rs3824660 C T 3.00E-09 1.1 Yes 
10 rs1679568 A G 8.00E-07 0.35 Yes 
10 rs706778 T C 1.00E-11 1.14 Yes 
10 rs2104286 C T 1.00E-06 1.19 No 
10 rs12413578 C T 8.00E-08 1.2 Yes 
10 rs16906916 C A 8.00E-07 14 No 
10 rs12570744 T C 2.00E-07 0.49 No 
10 rs4750316 G C 4.00E-06 0.91 Yes 
10 rs947474 A G 3.00E-10 1.12 Yes 
10 rs3125734 T C 5.00E-09 1.2 No 
10 rs6479800 C G 4.00E-08 1.11 Yes 
10 rs726288 T C 9.00E-09 1.22 No 
10 rs2671692 A G 3.00E-09 1.07 No 
10 rs793108 T C 1.00E-09 1.08 Yes 
11 rs508970 A G 3.00E-06 1.07 No 
11 rs4409785 C T 1.00E-11 1.12 Yes 
11 rs10790268 G A 0 1.17 Yes 
11 rs73013527 C T 1.00E-10 1.09 Yes 
11 rs4937362 T C 8.00E-07 1.09 No 
11 rs968567 C T 2.00E-08 1.12 No 
11 rs518167 A G 2.00E-06 2.24 No 
11 rs7940423 A G 1.00E-07 10.9 No 
11 rs72991 C T 5.00E-07 2.45 No 
11 rs1079467 C G 2.00E-06 0.29 No 
11 rs3781913 T G 6.00E-10 1.12 No 
11 rs331463 T A 1.00E-07 1.12 Yes 
12 rs773125 A G 1.00E-10 1.09 Yes 
12 rs1633360 T C 7.00E-08 1.08 Yes 
12 rs11051970 T G 1.00E-06 2.08 No 
12 rs1678542 C G 1.00E-07 1.2 Yes 
12 rs11045392 C T 2.00E-06 3.3 No 
12 rs3184504 T C 6.00E-06 1.08 No 
12 rs10774624 G A 7.00E-09 1.09 No 
12 rs3794271 G A 4.00E-06 3.2 No 
12 rs12831974 C T 6.00E-06 1.27 No 
13 rs9557321 C T 6.00E-08 1.73 No 
13 rs9603612 G C 0 1.098901 No 




CHR SNP A1 A2 P OR Replicated 
13 rs9603616 C T 0 1.1 Yes 
13 rs4942242 T C 2.00E-07 0.13 No 
13 rs9604529 G A 7.00E-07 0.35 No 
13 rs3790022 A G 1.00E-06 1.4925 No 
14 rs2582532 C T 5.00E-08 1.18 Yes 
14 rs7155603 G A 1.00E-07 1.16 No 
14 rs3783637 C T 2.00E-06 1.1 No 
14 rs17118552 G A 2.00E-07 17.19 No 
14 rs1624005 G A 7.00E-06 2.59 No 
14 rs7141276 A G 2.00E-06 0.37 No 
14 rs2841277 T C 0 1.15 No 
14 rs1957895 G T 4.00E-07 1.09 No 
14 rs3783782 A G 2.00E-09 1.14 Yes 
14 rs1950897 T C 8.00E-11 1.1 Yes 
15 rs1914816 A G 7.00E-07 0.87 No 
15 rs1898036 C T 2.00E-07 7.73 No 
15 rs7164176 G A 5.00E-07 0.28 No 
15 rs17374222 A C 2.00E-06 1.13 No 
15 rs8026898 A G 0 1.15 Yes 
15 rs12901682 A C 4.00E-08 135.02 No 
15 rs8032939 C T 0 1.13 Yes 
15 rs6496667 A C 1.00E-06 1.09 No 
16 rs6500395 C T 6.00E-07 2.2 No 
16 rs2280381 T C 2.00E-06 1.12 No 
16 rs13330176 A T 9.00E-09 1.12 Yes 
16 rs16973500 T NA 9.00E-06 0.24 No 
16 rs7404928 T C 4.00E-06 1.08 No 
16 rs4780401 T G 9.00E-09 1.09 Yes 
17 rs72634030 A C 2.00E-09 1.12 No 
17 rs2872507 A G 9.00E-07 1.1 No 
17 rs1877030 C T 2.00E-08 1.09 No 
17 rs12601925 G A 6.00E-09 2.15 Yes 
18 rs2469434 C T 9.00E-10 1.07 Yes 
18 rs16977065 T C 1.00E-07 33.72 No 
18 rs2847297 G A 2.00E-08 1.1 No 
18 rs8083786 G A 0 1.14 Yes 
18 rs6506569 T C 7.00E-06 1.98 No 
18 rs2002842 A C 6.00E-06 1.15 No 
18 rs1943199 T G 2.00E-08 1.94 No 
19 rs7258015 C T 3.00E-08 1.18 No 
19 rs1273516 A G 9.00E-07 4.26 No 




CHR SNP A1 A2 P OR Replicated 
19 rs1543922 T C 3.00E-07 34.48 No 
19 rs34536443 G C 0 1.46 No 
20 rs4810485 G T 8.00E-09 0.91 No 
20 rs4239702 C T 0 1.13 Yes 
20 rs6138892 C T 3.00E-07 10.93 No 
20 rs6026990 A T 6.00E-07 0.63 No 
21 rs2075876 A G 4.00E-09 1.18 No 
21 rs73194058 C A 3.00E-08 1.13 Yes 
21 rs2837960 G T 2.00E-06 1.05 No 
21 rs8133843 A G 3.00E-09 1.08 Yes 
21 rs11203203 A G 4.00E-06 1.11 No 
21 rs1893592 A C 1.00E-11 1.11 No 
22 rs1043099 C G 7.00E-09 1.19 No 
22 rs3218251 A T 6.00E-06 1.08 No 
22 rs743777 G A 1.00E-06 1.09 No 
22 rs909685 A T 0 1.13 Yes 
22 rs2283790 G A 2.00E-11 1.22 No 
22 rs11089637 C T 2.00E-09 1.08 Yes 
 




















Appendix C Chapter 6: Dendogram of balances and 
association with RA 
  
Supplementary Figure C 6.1 Bifurcating tree representing hierarchical clustering of balances 
generated from core taxa  of the gut microbiota within MZ and DZ twins.   
 





Supplementary Table C 6.1 Linear mixed effects model  regression of balances against RA affected 
status 
 
Balance Group Var Intercept P Value  
y0 0.999999985 0.852520069 0.804 
y1 0.999999985 0.638942962 0.749 
y2 0.999999985 0.480894514 0.704 
y3 0.999999985 0.355119254 0.903 
y4 0.999999985 0.25838904 0.946 
y5 0.999999985 0.021725476 0.991 
y6 0.999999985 0.818757673 0.897 
y7 0.999999985 0.87228188 0.957 
y8 0.999999985 0.737304608 0.889 
y9 0.999999985 0.491406545 0.892 
y10 0.999999985 0.254022443 0.880 
y11 0.999999985 0.622370767 0.862 
y12 0.999999985 0.219717164 0.852 
y13 0.999999985 0.995229955 0.802 
y14 0.999999985 0.232248395 0.900 
y15 0.999999985 0.70735578 0.876 
y16 0.999999985 0.100714002 0.983 
y17 0.999999985 0.399402751 0.946 
y18 0.999999985 0.198908573 0.979 
y19 0.999999985 0.261221776 0.848 
y20 0.999999985 0.970211529 0.880 
y21 0.999999985 0.234234396 0.743 
y22 0.999999985 0.50035056 0.846 
y23 0.999999985 0.478952133 0.999 
y24 0.999999985 0.588414081 0.937 
y25 0.999999985 0.942471228 0.987 
y26 0.999999985 0.332971889 0.855 
y27 0.999999985 0.651182165 0.706 
y28 0.999999985 0.84275485 0.991 
y29 0.999999985 0.862377013 0.914 
y30 0.999999985 0.090252627 0.857 
y31 0.999999985 0.800756544 0.796 
y32 0.999999985 0.390069663 0.951 
y33 0.999999985 0.602792961 0.818 
y34 0.999999985 0.788313513 0.835 




y35 0.999999985 0.607343463 0.856 
y36 0.999999985 0.557454664 0.958 
y37 0.999999985 0.51429241 0.924 
y38 0.999999985 0.139660051 0.944 
y39 0.999999985 0.511750302 0.986 
y40 0.999999985 0.247707705 0.785 
y41 0.999999985 0.195378008 0.780 
y42 0.999999985 0.987374381 0.854 
y43 0.999999985 0.163616928 0.887 
y44 0.999999985 0.9914404 0.950 
y45 0.999999985 0.357884317 0.912 
y46 0.999999985 0.693371548 0.825 
y47 0.999999985 0.866993313 0.858 
y48 0.999999985 0.874090116 0.929 
y49 0.999999985 0.748956894 0.883 
y50 0.999999985 0.58697904 0.853 
y51 0.999999985 0.122299915 0.970 
y52 0.999999985 0.245603286 0.971 
y53 0.999999985 0.922976647 0.944 
y54 0.999999985 0.459169118 0.791 
y55 0.999999985 0.889052026 0.903 
y56 0.999999985 0.106543898 0.978 
y57 0.999999985 0.924815755 0.860 
y58 0.999999985 0.633185972 0.771 
y59 0.999999985 0.629318689 0.869 
y60 0.999999985 0.022721808 0.991 
y61 0.999999985 0.562270869 0.724 
y62 0.999999985 0.728952462 0.910 
y63 0.999999985 0.747688876 0.859 
y64 0.999999985 0.7260767 0.911 
y65 0.999999985 0.45016624 0.959 
y66 0.999999985 0.135698786 0.969 
y67 0.999999985 0.792240093 0.835 
y68 0.999999985 0.997371273 0.908 
y69 0.999999985 0.800056221 0.970 
y70 0.999999985 0.74900135 0.969 
y71 0.999999985 0.209472947 0.999 
y72 0.999999985 0.84337477 0.994 
y73 0.999999985 0.764618972 0.940 
y74 0.999999985 0.718795072 0.939 
y75 0.999999985 0.975394704 0.938 
y76 0.999999985 0.982423273 0.959 




y77 0.999999985 0.433677221 0.701 
y78 0.999999985 0.987848531 0.897 
y79 0.999999985 0.242649409 0.871 
y80 0.999999985 0.983147607 0.980 
y81 0.999999985 0.711867284 0.926 
y82 0.999999985 0.742064028 0.879 
y83 0.999999985 0.512758945 0.866 
y84 0.999999985 0.794190205 0.887 
y85 0.999999985 0.385075209 0.784 
y86 0.999999985 0.124345016 0.997 
y87 0.999999985 0.222718778 0.904 
y88 0.999999985 0.727573043 0.962 
y89 0.999999985 0.969545783 0.964 
y90 0.999999985 0.849333805 0.968 
y91 0.999999985 0.736687581 0.964 
y92 0.999999985 0.892025613 0.993 
y93 0.999999985 0.935850991 0.826 
y94 0.999999985 0.28547213 0.951 
y95 0.999999985 0.61077553 0.954 
y96 0.999999985 0.603709166 0.850 
y97 0.999999985 0.543526792 0.971 
y98 0.999999985 0.870710287 0.976 
y99 0.999999985 0.917062944 0.944 
y100 0.999999985 0.747657491 0.929 
y101 0.999999985 0.813534793 0.872 
y102 0.999999985 0.07535443 0.742 
y103 0.999999985 0.953872896 0.776 
y104 0.999999985 0.874444332 0.973 
y105 0.999999985 0.904050843 0.905 
y106 0.999999985 0.812269484 0.852 
y107 0.999999985 0.797846925 0.834 
y108 0.999999985 0.090498031 0.987 
y109 0.999999985 0.649092702 0.946 
y110 0.999999985 0.999568861 0.668 
y111 0.999999985 0.998509508 0.939 
y112 0.999999985 0.639970444 0.947 
y113 0.999999985 0.796651362 0.938 
y114 0.999999985 0.3992252 0.872 
y115 0.999999985 0.398795989 0.871 
y116 0.999999985 0.719225222 0.913 
y117 0.999999985 0.623261406 0.859 
y118 0.999999985 0.828466603 0.901 




y119 0.999999985 0.715003707 0.904 
y120 0.999999985 0.514307251 0.893 
y121 0.999999985 0.85009573 0.939 
y122 0.999999985 0.953707894 0.960 
y123 0.999999985 0.821119365 0.941 
y124 0.999999985 0.804824597 0.686 
y125 0.999999985 0.687848828 0.912 
y126 0.999999985 0.980980482 0.908 
y127 0.999999985 0.9784122 0.782 
y128 0.999999985 0.106661458 0.933 
y129 0.999999985 0.894439549 0.833 
y130 0.999999985 0.808424936 0.862 
y131 0.999999985 0.892095324 0.804 
y132 0.999999985 0.223472733 0.919 
y133 0.999999985 0.324647319 0.804 
y134 0.999999985 0.745398823 0.963 
y135 0.999999985 0.693700221 0.790 
y136 0.999999985 0.00836216 0.826 
y137 0.999999985 0.274574629 0.848 
y138 0.999999985 0.016794419 0.966 
y139 0.999999985 0.63097059 0.931 
y140 0.999999985 0.420103993 0.870 
y141 0.999999985 0.540288507 0.838 
y142 0.999999985 0.883287033 0.941 
y143 0.999999985 0.972195314 0.854 
y144 0.999999985 0.981199828 0.979 
y145 0.999999985 0.246839014 0.852 
y146 0.999999985 0.982456817 0.855 
y147 0.999999985 0.745442276 0.800 
y148 0.999999985 0.833961102 0.919 
y149 0.999999985 0.951111472 0.910 
y150 0.999999985 0.639446953 0.885 
y151 0.999999985 0.936237525 0.909 
y152 0.999999985 0.857457556 0.824 
y153 0.999999985 0.804467074 0.967 
y154 0.999999985 0.88549172 0.976 
y155 0.999999985 0.881577028 0.964 
y156 0.999999985 0.043079466 0.757 
y157 0.999999985 0.499832251 0.907 
y158 0.999999985 0.903755229 0.931 
y159 0.999999985 0.365152487 0.818 
y160 0.999999985 0.611941604 0.880 




y161 0.999999985 0.593012205 0.998 
y162 0.999999985 0.578451034 0.962 
y163 0.999999985 0.578047653 0.954 
y164 0.999999985 0.828368724 0.765 
y165 0.999999985 0.802048576 0.863 
y166 0.999999985 0.043618479 0.983 
y167 0.999999985 0.45883582 0.877 
y168 0.999999985 0.000714083 0.787 
y169 0.999999985 0.339184371 0.830 
y170 0.999999985 0.848020456 0.921 
y171 0.999999985 0.969596637 0.792 
y172 0.999999985 0.484499122 0.937 
y173 0.999999985 0.482408161 0.862 
y174 0.999999985 0.916739632 0.764 
y175 0.999999985 0.441426527 0.964 
y176 0.999999985 0.761370956 0.815 
y177 0.999999985 0.887652052 0.929 
y178 0.999999985 0.402837537 0.920 
y179 0.999999985 0.867521426 0.810 
y180 0.999999985 0.717408561 0.917 
y181 0.999999985 0.973653031 0.850 
y182 0.999999985 0.165894857 0.775 
y183 0.999999985 0.723189659 0.679 
y184 0.999999985 0.879650979 0.900 
y185 0.999999985 0.741009875 0.980 
y186 0.999999985 0.72703747 0.728 
y187 0.999999985 0.893566879 0.715 
y188 0.999999985 0.815455144 0.782 
y189 0.999999985 0.965468668 0.964 
y190 0.999999985 0.284853588 0.780 
y191 0.999999985 0.812277643 0.820 
y192 0.999999985 0.116461483 0.877 
y193 0.999999985 0.232028004 0.916 
y194 0.999999985 0.601643567 0.930 
y195 0.999999985 0.931329463 0.976 
y196 0.999999985 0.687023243 0.896 
y197 0.999999985 0.994188819 0.901 
y198 0.999999985 0.902589206 0.895 
y199 0.999999985 0.777659375 0.956 
y200 0.999999985 0.505780448 0.897 
y201 0.999999985 0.768468047 0.807 
y202 0.999999985 0.693831798 0.884 




y203 0.999999985 0.60344285 0.956 
y204 0.999999985 0.992954229 0.909 
y205 0.999999985 0.097513685 0.656 
y206 0.999999985 0.454230472 0.846 
y207 0.999999985 0.785156256 0.872 
y208 0.999999985 0.972885192 0.927 
y209 0.999999985 0.894440656 0.951 
y210 0.999999985 0.699367115 0.930 
y211 0.999999985 0.781079839 0.894 
y212 0.999999985 0.319303306 0.882 
y213 0.999999985 0.475479135 0.836 
y214 0.999999985 0.762253064 0.827 
y215 0.999999985 0.921298423 0.923 
y216 0.999999985 0.204756749 0.917 
y217 0.999999985 0.31758042 0.955 
y218 0.999999985 0.85412332 0.794 
y219 0.999999985 0.884153741 0.757 
y220 0.999999985 0.706742899 0.913 
y221 0.999999985 0.931820119 0.964 
y222 0.999999985 0.10212798 0.781 
y223 0.999999985 0.84600139 0.953 
y224 0.999999985 0.836473424 0.791 
y225 0.999999985 0.928687676 0.926 
y226 0.999999985 0.91580721 0.766 
y227 0.999999985 0.920446141 0.904 
y228 0.999999985 0.782886899 0.901 
y229 0.999999985 0.99658187 0.925 
y230 0.999999985 0.686315629 0.978 
y231 0.999999985 0.956796024 0.938 
y232 0.999999985 0.403574524 0.933 
y233 0.999999985 0.874468374 0.868 
y234 0.999999985 0.799508364 0.967 
y235 0.999999985 0.902132383 0.865 
y236 0.999999985 0.983710777 0.903 
y237 0.999999985 0.619749594 0.911 
y238 0.999999985 0.815454906 0.827 
y239 0.999999985 0.690017143 0.684 
y240 0.999999985 0.901971689 0.947 
y241 0.999999985 0.96784284 0.859 
y242 0.999999985 0.55561266 0.922 
y243 0.999999985 0.124040307 0.913 
y244 0.999999985 0.949279807 0.786 




y245 0.999999985 0.003127678 0.890 
y246 0.999999985 0.892140295 0.932 
y247 0.999999985 0.280161128 0.961 
y248 0.999999985 0.744465481 0.790 
y249 0.999999985 0.813468024 0.991 
y250 0.999999985 0.939791971 0.921 
y251 0.999999985 0.868566294 0.897 
y252 0.999999985 0.555707443 0.977 
y253 0.999999985 0.512725586 0.674 
y254 0.999999985 0.739132719 0.817 
y255 0.999999985 0.841359763 0.890 
y256 0.999999985 0.814583928 0.950 
y257 0.999999985 0.897677065 0.973 
y258 0.999999985 0.725957888 0.782 
y259 0.999999985 0.790320314 0.982 
y260 0.999999985 0.911559149 0.939 
y261 0.999999985 0.606052389 0.804 
y262 0.999999985 0.665655833 0.924 
y263 0.999999985 0.571666685 0.861 
y264 0.999999985 0.783104157 0.919 
y265 0.999999985 0.584688199 0.829 
y266 0.999999985 0.60886028 0.816 
y267 0.999999985 0.815004004 0.915 
y268 0.999999985 0.993484141 0.984 
y269 0.999999985 0.77863733 0.975 
y270 0.999999985 0.977010281 0.876 
y271 0.999999985 0.904364411 0.879 
y272 0.999999985 0.676053754 0.731 
y273 0.999999985 0.879559936 0.902 
y274 0.999999985 0.882969112 0.864 
y275 0.999999985 0.802151145 0.985 
y276 0.999999985 0.697735227 0.756 
y277 0.999999985 0.917490588 0.922 
y278 0.999999985 0.751355816 0.715 
y279 0.999999985 0.837037109 0.861 
y280 0.999999985 0.97141424 0.843 
y281 0.999999985 0.914333102 0.990 
y282 0.999999985 0.00226949 0.912 
y283 0.999999985 0.83865296 0.895 
y284 0.999999985 0.980729758 0.986 
y285 0.999999985 0.835784157 0.715 
y286 0.999999985 0.78212927 0.819 




y287 0.999999985 6.92E-08 0.803 
y288 0.999999985 0.894316001 0.989 
y289 0.999999985 0.964701354 0.809 
y290 0.999999985 0.392035769 0.941 
y291 0.999999985 0.495333594 0.917 
y292 0.999999985 0.888157433 0.994 
y293 0.999999985 0.491001016 0.883 
y294 0.999999985 0.885150184 0.977 
y295 0.999999985 0.720950519 0.715 
y296 0.999999985 0.703482236 0.946 
y297 0.999999985 0.308482111 0.989 
y298 0.999999985 0.729842661 0.786 
y299 0.999999985 0.996516895 0.937 
y300 0.999999985 0.67569961 0.970 
y301 0.999999985 0.933928506 0.906 
y302 0.999999985 0.825827937 0.940 
y303 0.999999985 0.983358757 0.730 
y304 0.999999985 0.660972859 0.933 
y305 0.999999985 0.607405238 0.797 
y306 0.999999985 0.986411542 0.936 
y307 0.999999985 0.970758911 0.941 
y308 0.999999985 0.974177516 0.901 
y309 0.999999985 0.918090702 0.913 
y310 0.999999985 0.717805097 0.855 
y311 0.999999985 0.982308528 0.937 
y312 0.999999985 0.500378222 0.813 
y313 0.999999985 0.829211886 0.980 
y314 0.999999985 0.991721666 0.967 
y315 0.999999985 0.79309614 0.894 
y316 0.999999985 0.828221371 0.647 
y317 0.999999985 0.860825249 0.858 
y318 0.999999985 0.942005062 0.942 
y319 0.999999985 0.911686834 0.985 
y320 0.999999985 0.958305313 0.997 
y321 0.999999985 0.305583301 0.914 
y322 0.999999985 0.967626324 0.723 
y323 0.999999985 0.783235569 0.941 
y324 0.999999985 0.924765707 0.846 
y325 0.999999985 0.906551214 0.964 
y326 0.999999985 0.973947142 0.866 
y327 0.999999985 0.190070482 0.849 
y328 0.999999985 0.627005713 0.895 




y329 0.999999985 0.871678726 0.978 
y330 0.999999985 0.981200228 0.982 
y331 0.999999985 0.994233682 0.885 
y332 0.999999985 0.870907518 0.865 
y333 0.999999985 0.701508749 0.840 
y334 0.999999985 0.876222887 0.989 
y335 0.999999985 0.826151083 0.928 
y336 0.999999985 0.678350623 0.910 
y337 0.999999985 0.476510013 0.768 
y338 0.999999985 0.652592276 0.732 
y339 0.999999985 0.979014035 0.906 
y340 0.999999985 0.866203364 0.850 
y341 0.999999985 0.988487726 0.963 
y342 0.999999985 0.975101657 0.998 
y343 0.999999985 0.752191486 0.672 
y344 0.999999985 0.878094528 0.744 
y345 0.999999985 0.599012111 0.882 
y346 0.999999985 0.829348962 0.845 
y347 0.999999985 0.786430104 0.938 
y348 0.999999985 0.858243908 0.955 
y349 0.999999985 0.93837301 0.841 
y350 0.999999985 0.956990321 0.992 
y351 0.999999985 0.956025386 0.813 
y352 0.999999985 0.812019053 0.957 
y353 0.999999985 0.72340461 0.999 
y354 0.999999985 0.961427015 0.768 
y355 0.999999985 0.997908491 0.994 
y356 0.999999985 0.898099464 0.923 
y357 0.999999985 0.203942398 0.767 
y358 0.999999985 0.489431373 0.955 
y359 0.999999985 0.644276057 0.949 
y360 0.999999985 0.896017201 0.784 
y361 0.999999985 0.975106746 0.970 
y362 0.999999985 0.974599255 0.844 
y363 0.999999985 0.922655646 0.945 
y364 0.999999985 0.962026041 0.980 
y365 0.999999985 0.62589146 0.638 
y366 0.999999985 0.947710532 0.936 
y367 0.999999985 0.440366073 0.985 
y368 0.999999985 0.769467387 0.947 
y369 0.999999985 0.756169703 0.836 
y370 0.999999985 0.883134383 0.889 




y371 0.999999985 0.693371095 0.924 
y372 0.999999985 0.836771632 0.967 
y373 0.999999985 0.756964821 0.904 
y374 0.999999985 0.82982928 0.805 
y375 0.999999985 0.957597157 0.909 
y376 0.999999985 0.888842249 0.956 
y377 0.999999985 0.991096365 0.837 
y378 0.999999985 0.799717914 0.749 
y379 0.999999985 0.989607228 0.961 
y380 0.999999985 0.8963122 0.816 
y381 0.999999985 0.43030966 0.981 
y382 0.999999985 0.748638201 0.922 
y383 0.999999985 0.715309703 0.977 
y384 0.999999985 0.880583055 0.912 
y385 0.999999985 0.954906919 0.800 
y386 0.999999985 0.973692331 0.999 
y387 0.999999985 0.814377741 0.731 
y388 0.999999985 0.818134988 0.711 
y389 0.999999985 0.688685777 0.809 
y390 0.999999985 0.893207768 0.839 
y391 0.999999985 0.850063108 0.931 
y392 0.999999985 0.87628495 0.871 
y393 0.999999985 0.842841773 0.792 
y394 0.999999985 0.853376889 0.811 
y395 0.999999985 0.449321856 0.850 
y396 0.999999985 0.877456846 0.939 
y397 0.999999985 0.871559542 0.882 
y398 0.999999985 0.686850499 0.922 
y399 0.999999985 0.817959537 0.805 
y400 0.999999985 0.881435296 0.821 
y401 0.999999985 0.847718874 0.904 
y402 0.999999985 0.991846667 0.958 
y403 0.999999985 0.94660447 0.999 
y404 0.999999985 0.905403911 0.932 
y405 0.999999985 0.950327277 0.953 
y406 0.999999985 0.90667855 0.939 
y407 0.999999985 0.777309803 0.864 
y408 0.999999985 0.910234916 0.952 
y409 0.999999985 0.598351633 0.986 
y410 0.999999985 0.78276153 0.831 
y411 0.999999985 0.89349957 0.950 
y412 0.999999985 0.784145216 0.855 




y413 0.999999985 0.942105966 0.822 
y414 0.999999985 0.792293875 0.744 
y415 0.999999985 0.901923459 0.991 
y416 0.999999985 0.954207362 0.985 
y417 0.999999985 0.929056132 0.801 
y418 0.999999985 0.929530884 0.829 
y419 0.999999985 0.83760109 0.862 
y420 0.999999985 0.906208796 0.832 
y421 0.999999985 0.822857786 0.960 
y422 0.999999985 0.8593319 0.833 
y423 0.999999985 0.994662153 0.968 
y424 0.999999985 0.740617433 0.815 
y425 0.999999985 0.819736854 0.912 
y426 0.999999985 0.99407927 0.604 
y427 0.999999985 0.985341131 0.971 
y428 0.999999985 0.889927803 0.928 
y429 0.999999985 0.936696751 0.970 
y430 0.999999985 0.938913702 0.795 
y431 0.999999985 0.728991811 0.691 
y432 0.999999985 0.604882305 0.837 
y433 0.999999985 0.619982804 0.724 
y434 0.999999985 0.586028913 0.724 
y435 0.999999985 0.629646187 0.730 
y436 0.999999985 0.913720068 0.979 
y437 0.999999985 0.9738023 0.857 
y438 0.999999985 0.955575963 0.786 
y439 0.999999985 0.915019473 0.918 
y440 0.999999985 0.85852196 0.881 
y441 0.999999985 0.749239768 0.994 
y442 0.999999985 0.88848126 0.948 
y443 0.999999985 0.666925271 0.794 
y444 0.999999985 0.766986863 0.912 
y445 0.999999985 0.881709086 0.965 
y446 0.999999985 0.775236332 0.887 
y447 0.999999985 0.935219921 0.916 
y448 0.999999985 0.953608993 0.920 
y449 0.999999985 0.978125959 0.996 
y450 0.999999985 0.844771476 0.830 
y451 0.999999985 0.897851407 0.955 
y452 0.999999985 0.983732084 0.950 
y453 0.999999985 0.937480318 0.712 
y454 0.999999985 0.981215259 0.734 




y455 0.999999985 0.934554563 0.916 
y456 0.999999985 0.915609627 0.808 
y457 0.999999985 0.917677329 0.895 
y458 0.999999985 0.809651243 0.778 
y459 0.999999985 0.74002356 0.848 
y460 0.999999985 0.667991648 0.915 
y461 0.999999985 0.597227918 0.949 
y462 0.999999985 0.832951417 0.801 
y463 0.999999985 0.926376338 0.802 
y464 0.999999985 0.936802864 0.910 
y465 0.999999985 0.894564308 0.901 
y466 0.999999985 0.959790262 0.991 
y467 0.999999985 0.700763508 0.825 
y468 0.999999985 0.946724641 0.991 
y469 0.999999985 0.827642665 0.806 
y470 0.999999985 0.766426546 0.841 
y471 0.999999985 0.691333266 0.943 
y472 0.999999985 0.891854896 0.946 
y473 0.999999985 0.732122427 0.898 
y474 0.999999985 0.907067447 0.903 
y475 0.999999985 0.769467647 0.864 
y476 0.999999985 0.892920025 0.980 
y477 0.999999985 0.953177875 0.980 
y478 0.999999985 0.856375929 0.989 
y479 0.999999985 0.82861851 0.904 
y480 0.999999985 0.824076611 0.991 
y481 0.999999985 0.906870144 0.964 
y482 0.999999985 0.954393173 0.987 
y483 0.999999985 0.809198256 0.884 
y484 0.999999985 0.985482567 0.977 
y485 0.999999985 0.932135631 0.957 
y486 0.999999985 0.831971439 0.945 
y487 0.999999985 0.931360342 0.916 
y488 0.999999985 0.811202927 0.853 
y489 0.999999985 0.833835539 0.975 
y490 0.999999985 0.907676164 0.924 
y491 0.999999985 0.911291104 0.998 
y492 0.999999985 0.690214719 0.977 
y493 0.999999985 0.89473239 0.804 
y494 0.999999985 0.675947646 0.919 
y495 0.999999985 0.998827868 0.929 
y496 0.999999985 0.861704956 0.998 




y497 0.999999985 1 0.809 
y498 0.999999985 0.899644949 0.846 
y499 0.999999985 0.806803074 0.921 
y500 0.999999985 0.761429683 0.825 
y501 0.999999985 0.906626923 0.997 
y502 0.999999985 0.965644688 0.945 
y503 0.999999985 0.973266025 0.889 
y504 0.999999985 0.939446196 0.976 
y505 0.999999985 0.900529973 0.725 
y506 0.999999985 0.979523372 0.997 
y507 0.999999985 0.792882814 0.792 
y508 0.999999985 0.997658215 0.959 
y509 0.999999985 0.847171749 0.881 
y510 0.999999985 0.894680542 0.820 
y511 0.999999985 0.937475701 0.948 
y512 0.999999985 0.942264131 0.883 
y513 0.999999985 0.991075965 0.875 
y514 0.999999985 0.827976496 0.942 
y515 0.999999985 0.870515939 0.873 
y516 0.999999985 0.808646253 0.877 
y517 0.999999985 0.879630538 0.947 
y518 0.999999985 0.789992453 0.882 
y519 0.999999985 0.95013883 0.846 
y520 0.999999985 0.990726009 0.800 
y521 0.999999985 0.93297616 0.892 
y522 0.999999985 0.906778795 0.849 
y523 0.999999985 0.959307932 0.994 
y524 0.999999985 0.892505149 0.875 
y525 0.999999985 0.965340646 0.973 
y526 0.999999985 0.983038985 0.922 
y527 0.999999985 0.869845388 0.751 
y528 0.999999985 0.911073607 0.977 
y529 0.999999985 0.845529356 0.845 
y530 0.999999985 0.93175352 0.870 
y531 0.999999985 0.933412133 0.990 
y532 0.999999985 0.946142945 0.965 
y533 0.999999985 0.820870869 0.843 
y534 0.999999985 0.933572592 0.885 
y535 0.999999985 0.97816254 0.933 
y536 0.999999985 0.998691142 0.793 
y537 0.999999985 0.698251278 0.762 
y538 0.999999985 0.819839928 0.814 




y539 0.999999985 0.955198206 0.974 
y540 0.999999985 0.92658717 0.889 
y541 0.999999985 0.799758136 0.858 
y542 0.999999985 0.703904386 0.719 
y543 0.999999985 0.754067377 0.932 
y544 0.999999985 0.99583151 0.995 
y545 0.999999985 0.808421426 0.950 
y546 0.999999985 0.939385256 0.972 
y547 0.999999985 0.948142874 0.887 
y548 0.999999985 0.927350512 0.988 
y549 0.999999985 0.868063267 0.984 
y550 0.999999985 0.793782033 0.924 
y551 0.999999985 0.890551813 0.960 
y552 0.999999985 0.972448799 0.933 
y553 0.999999985 0.911380366 0.847 
y554 0.999999985 0.774677061 0.877 
y555 0.999999985 0.931407565 0.988 
y556 0.999999985 0.867354537 0.861 
y557 0.999999985 0.66964595 0.788 
y558 0.999999985 0.980285405 0.995 
y559 0.999999985 0.747680616 0.822 
y560 0.999999985 0.823493512 0.776 
y561 0.999999985 0.959653254 0.992 
y562 0.999999985 0.860879554 0.825 
y563 0.999999985 0.979572851 0.928 
y564 0.999999985 0.980628716 0.971 
y565 0.999999985 0.819050891 0.823 
y566 0.999999985 0.990354004 0.938 
y567 0.999999985 0.96440238 0.927 
y568 0.999999985 0.989881483 0.902 
y569 0.999999985 0.871869824 0.974 
y570 0.999999985 0.902312323 0.860 
y571 0.999999985 0.830513876 0.740 
y572 0.999999985 0.922015619 0.896 
y573 0.999999985 0.843457421 0.774 
y574 0.999999985 0.963016741 0.921 
y575 0.999999985 0.909499771 0.904 
y576 0.999999985 0.978531035 0.999 
y577 0.999999985 0.946238203 0.982 
y578 0.999999985 0.965795828 0.981 
y579 0.999999985 0.953417217 0.963 
y580 0.999999985 0.984574293 0.949 




y581 0.999999985 0.881316544 0.785 
y582 0.999999985 0.774665563 0.993 
y583 0.999999985 0.812429311 0.708 
y584 0.999999985 0.950900947 0.949 
y585 0.999999985 0.800163612 0.747 
y586 0.999999985 0.915925876 0.885 
y587 0.999999985 0.816202726 0.855 
y588 0.999999985 0.930975628 0.844 
y589 0.999999985 0.928227998 0.954 
y590 0.999999985 0.885393751 0.998 
y591 0.999999985 0.807778457 0.700 


























Appendix D Chapter 7: Taxa of the Saliva Microbiota 
 
Supplementary table D 7.1 Taxa identified in the saliva microbiota of the cohort 
 
 Family Genus Species 
ASV1 Pasteurellaceae Haemophilus influenzae/parainfluenzae 
ASV2 Neisseriaceae Neisseria cinerea/flavescens/lactamica/meningitidis/mucosa/perflava/subflava 
ASV3 Prevotellaceae Prevotella_7 melaninogenica 
ASV4 Streptococcaceae Streptococcus anginosus/cristatus/gordonii/infantis/mitis/oralis/pneumoniae/pseudopneumoniae/sanguinis/timonensis 
ASV5 Veillonellaceae Veillonella atypica/dispar 
ASV6 Fusobacteriaceae Fusobacterium periodonticum 
ASV7 Campylobacteraceae Campylobacter concisus 
ASV8 Porphyromonadaceae Porphyromonas pasteri 
ASV9 Streptococcaceae Streptococcus australis/mitis/oralis/parasanguinis/rubneri/sanguinis 
ASV10 Prevotellaceae Prevotella_7 histicola 
ASV11 Pasteurellaceae Aggregatibacter segnis 
ASV12 Prevotellaceae Prevotella_6 salivae 
ASV13 Prevotellaceae Alloprevotella NA 
ASV14 Carnobacteriaceae Granulicatella adiacens/para-adiacens 
ASV15 Family_XI Gemella haemolysans/morbillorum/parahaemolysans/sanguinis/taiwanensis 
ASV16 Pasteurellaceae Haemophilus haemolyticus/influenzae/parainfluenzae 
ASV17 Veillonellaceae Veillonella parvula/rogosae/tobetsuensis 




ASV18 Streptococcaceae Streptococcus australis/infantis/lactarius/mitis/oralis/peroris/sanguinis 
ASV19 Prevotellaceae Prevotella nanceiensis 
ASV20 Neisseriaceae Neisseria flava/lactamica/macacae/meningitidis/mucosa/perflava/pharyngis/polysaccharea/sicca 
ASV21 Micrococcaceae Rothia mucilaginosa 
ASV22 Prevotellaceae Prevotella_7 jejuni/melaninogenica 
ASV23 Micrococcaceae Rothia mucilaginosa 
ASV24 Leptotrichiaceae Leptotrichia NA 
ASV25 Streptococcaceae Streptococcus NA 
ASV26 Micrococcaceae Rothia NA 
ASV27 Fusobacteriaceae Fusobacterium nucleatum 
ASV28 Micrococcaceae Rothia mucilaginosa 
ASV29 Pasteurellaceae Actinobacillus NA 
ASV30 Prevotellaceae Prevotella pallens 
ASV31 Veillonellaceae Veillonella atypica/parvula 
ASV32 Prevotellaceae Alloprevotella NA 
ASV33 Prevotellaceae Prevotella nanceiensis 
ASV34 Actinomycetaceae Actinomyces odontolyticus 
ASV35 Pasteurellaceae Mannheimia NA 
ASV36 Veillonellaceae Megasphaera micronuciformis 
ASV37 Prevotellaceae Prevotella_7 NA 
ASV38 Prevotellaceae Prevotella NA 
ASV39 Fusobacteriaceae Fusobacterium NA 
ASV40 Pasteurellaceae Actinobacillus porcinus 
ASV41 Prevotellaceae Alloprevotella NA 
ASV42 Veillonellaceae Selenomonas_3 NA 
ASV43 Micrococcaceae Rothia dentocariosa 




ASV44 Neisseriaceae Neisseria flavescens 
ASV45 Veillonellaceae Veillonella dispar/parvula 
ASV46 Weeksellaceae Bergeyella NA 
ASV47 Actinomycetaceae Actinomyces odontolyticus 
ASV48 Fusobacteriaceae Fusobacterium canifelinum/nucleatum 
ASV49 Neisseriaceae Kingella NA 
ASV50 Actinomycetaceae Actinomyces graevenitzii 
ASV51 Atopobiaceae Atopobium parvulum 
ASV52 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV53 Leptotrichiaceae Oceanivirga NA 
ASV54 Campylobacteraceae Campylobacter rectus/showae 
ASV55 Neisseriaceae Neisseria flavescens 
ASV56 Corynebacteriaceae Corynebacterium matruchotii 
ASV57 Neisseriaceae Neisseria NA 
ASV58 Lachnospiraceae Oribacterium sinus 
ASV59 Leptotrichiaceae Leptotrichia NA 
ASV60 Prevotellaceae Alloprevotella rava 
ASV61 NA NA NA 
ASV62 Lachnospiraceae Stomatobaculum NA 
ASV63 Lactobacillaceae Lactobacillus delbrueckii/fermentum/ingluviei/oris/parabuchneri/plantarum 
ASV64 Fusobacteriaceae Fusobacterium naviforme/nucleatum 
ASV65 Burkholderiaceae Lautropia mirabilis 
ASV66 Prevotellaceae Alloprevotella NA 
ASV67 Flavobacteriaceae Capnocytophaga leadbetteri 
ASV68 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV69 Veillonellaceae Veillonella NA 




ASV70 Lachnospiraceae Lachnoanaerobaculum orale/saburreum 
ASV71 Campylobacteraceae Campylobacter rectus/showae 
ASV72 Enterobacteriaceae Salmonella NA 
ASV73 Enterobacteriaceae Escherichia/Shigella NA 
ASV74 Streptococcaceae Streptococcus cristatus/sanguinis 
ASV75 Pasteurellaceae Aggregatibacter aphrophilus 
ASV76 Lachnospiraceae NA NA 
ASV77 Bacillaceae Bacillus altitudinis/amyloliquefaciens/firmus/halotolerans/licheniformis/mojavensis/siamensis/subtilis/tequilensis/timonensis/vallismortis/velezensis 
ASV78 Fusobacteriaceae Fusobacterium nucleatum 
ASV79 Leptotrichiaceae Leptotrichia NA 
ASV80 Campylobacteraceae Campylobacter concisus 
ASV81 Pasteurellaceae Mannheimia NA 
ASV82 Flavobacteriaceae Capnocytophaga gingivalis 
ASV83 Porphyromonadaceae Porphyromonas endodontalis 
ASV84 Pseudomonadaceae Pseudomonas aeruginosa/denitrificans/fluorescens/indica/mendocina/otitidis/protegens/putida/tropicalis 
ASV85 Erysipelotrichaceae Solobacterium moorei 
ASV86 Prevotellaceae Prevotella oris 
ASV87 Lachnospiraceae Stomatobaculum longum 
ASV88 Prevotellaceae Prevotella_6 NA 
ASV89 Prevotellaceae Prevotella nigrescens 
ASV90 Lachnospiraceae Lachnoanaerobaculum cf. 
ASV91 Porphyromonadaceae Porphyromonas gingivalis 
ASV92 Prevotellaceae Alloprevotella NA 
ASV93 Prevotellaceae Prevotella_2 shahii 
ASV94 Campylobacteraceae Campylobacter gracilis 
ASV95 Pasteurellaceae Haemophilus NA 




ASV96 Paludibacteraceae F0058 NA 
ASV97 Actinomycetaceae Actinomyces naeslundii/oris/viscosus 
ASV98 Prevotellaceae Prevotella_7 denticola 
ASV99 Fusobacteriaceae Fusobacterium nucleatum 
ASV100 Micrococcaceae Rothia aeria/dentocariosa 
ASV101 Spirochaetaceae Treponema_2 denticola/putidum 
ASV102 Flavobacteriaceae Capnocytophaga granulosa 
ASV103 Burkholderiaceae Lautropia NA 
ASV104 Campylobacteraceae Campylobacter NA 
ASV105 Pasteurellaceae Haemophilus NA 
ASV106 Prevotellaceae Prevotella NA 
ASV107 Flavobacteriaceae Capnocytophaga sputigena 
ASV108 Leptotrichiaceae Leptotrichia NA 
ASV109 Prevotellaceae Alloprevotella rava 
ASV110 Fusobacteriaceae Fusobacterium NA 
ASV111 Veillonellaceae Dialister pneumosintes 
ASV112 NA NA NA 
ASV113 Prevotellaceae Alloprevotella tannerae 
ASV114 Prevotellaceae Prevotella_7 NA 
ASV115 Lachnospiraceae Catonella NA 
ASV116 Neisseriaceae Neisseria bacilliformis/lactamica/meningitidis 
ASV117 Family_XIII NA NA 
ASV118 Neisseriaceae Neisseria oralis 
ASV119 Prevotellaceae Prevotella NA 
ASV120 Veillonellaceae Veillonella NA 
ASV121 Neisseriaceae Kingella oralis 




ASV122 Actinomycetaceae Actinomyces NA 
ASV123 NA NA NA 
ASV124 Spirochaetaceae Treponema_2 socranskii 
ASV125 Weeksellaceae Bergeyella NA 
ASV126 Neisseriaceae Neisseria oralis 
ASV127 Lachnospiraceae Oribacterium asaccharolyticum 
ASV128 Mycoplasmataceae Mycoplasma falconis/faucium/hyosynoviae 
ASV129 Family_XIII Mogibacterium diversum/neglectum/pumilum/vescum 
ASV130 Pasteurellaceae Actinobacillus NA 
ASV131 Fusobacteriaceae Fusobacterium NA 
ASV132 Prevotellaceae Prevotella NA 
ASV133 Prevotellaceae Prevotella NA 
ASV134 Carnobacteriaceae Granulicatella elegans 
ASV135 Family_XI Parvimonas micra 
ASV136 Veillonellaceae Selenomonas sputigena 
ASV137 Campylobacteraceae Campylobacter gracilis 
ASV138 Peptostreptococcaceae Peptostreptococcus stomatis 
ASV139 Prevotellaceae Prevotella oulorum 
ASV140 Veillonellaceae Dialister invisus 
ASV141 Prevotellaceae Prevotella NA 
ASV142 Lachnospiraceae Oribacterium parvum 
ASV143 Corynebacteriaceae Corynebacterium durum 
ASV144 Lactobacillaceae Lactobacillus crispatus/gasseri/helveticus/hominis/iatae/johnsonii/kefiranofaciens/prophage/taiwanensis 
ASV145 Lentimicrobiaceae NA NA 
ASV146 Prevotellaceae Prevotella NA 
ASV147 Family_XI Parvimonas micra 




ASV148 Prevotellaceae Prevotella_2 conceptionensis 
ASV149 Prevotellaceae Prevotella_7 melaninogenica 
ASV150 Pasteurellaceae Haemophilus NA 
ASV151 Leptotrichiaceae Leptotrichia NA 
ASV152 Prevotellaceae Prevotella_7 baroniae 
ASV153 Listeriaceae Listeria innocua/ivanovii/marthii/monocytogenes/phage/seeligeri/welshimeri 
ASV154 Prevotellaceae Prevotella NA 
ASV155 Veillonellaceae Veillonella denticariosi/parvula 
ASV156 Neisseriaceae Neisseria NA 
ASV157 Campylobacteraceae Campylobacter showae 
ASV158 Veillonellaceae Selenomonas_3 infelix 
ASV159 Veillonellaceae Veillonella NA 
ASV160 Aerococcaceae Abiotrophia defectiva 
ASV161 Cardiobacteriaceae Cardiobacterium hominis 
ASV162 NA NA NA 
ASV163 Neisseriaceae Neisseria NA 
ASV164 Leptotrichiaceae Leptotrichia wadei 
ASV165 Prevotellaceae Prevotella_7 NA 
ASV166 Spirochaetaceae Treponema_2 NA 
ASV167 Prevotellaceae Prevotella_7 veroralis 
ASV168 Leptotrichiaceae Leptotrichia hongkongensis 
ASV169 Spirochaetaceae Treponema_2 lecithinolyticum 
ASV170 Prevotellaceae Prevotella_7 multiformis 
ASV171 Neisseriaceae Neisseria mucosa/pharyngis 
ASV172 NA NA NA 
ASV173 Peptococcaceae Peptococcus NA 




ASV174 Weeksellaceae Bergeyella NA 
ASV175 Lachnospiraceae Stomatobaculum NA 
ASV176 Enterobacteriaceae NA NA 
ASV177 Lachnospiraceae Butyrivibrio_2 NA 
ASV178 Veillonellaceae Veillonella NA 
ASV179 Pasteurellaceae Haemophilus haemolyticus/influenzae/quentini 
ASV180 Veillonellaceae Selenomonas_3 noxia 
ASV181 Pasteurellaceae Rodentibacter NA 
ASV182 Enterococcaceae Enterococcus NA 
ASV183 Pasteurellaceae Haemophilus NA 
ASV184 Veillonellaceae Veillonella NA 
ASV185 Prevotellaceae Prevotella maculosa 
ASV186 Leptotrichiaceae Leptotrichia shahii/wadei 
ASV187 Porphyromonadaceae Porphyromonas catoniae 
ASV188 Tannerellaceae Tannerella NA 
ASV189 Tannerellaceae Tannerella forsythia 
ASV190 Spirochaetaceae Treponema_2 amylovorum 
ASV191 Spirochaetaceae Treponema_2 NA 
ASV192 Prevotellaceae Prevotella intermedia 
ASV193 Pasteurellaceae Haemophilus NA 
ASV194 NA NA NA 
ASV195 Fusobacteriaceae Fusobacterium NA 
ASV196 Neisseriaceae Neisseria NA 
ASV197 Prevotellaceae Prevotella_7 dentalis 
ASV198 Prevotellaceae Prevotella NA 
ASV199 Actinomycetaceae F0332 NA 




ASV200 Tannerellaceae Tannerella NA 
ASV201 Weeksellaceae Bergeyella NA 
ASV202 Neisseriaceae Alysiella NA 
ASV203 Prevotellaceae Prevotella NA 
ASV204 Veillonellaceae NA NA 
ASV205 Mycoplasmataceae Mycoplasma salivarium 
ASV206 Pasteurellaceae Rodentibacter trehalosifermentans 
ASV207 Campylobacteraceae Campylobacter NA 
ASV208 Carnobacteriaceae Granulicatella NA 
ASV209 Prevotellaceae Prevotella_7 NA 
ASV210 Weeksellaceae Bergeyella NA 
ASV211 Staphylococcaceae Staphylococcus argenteus/aureus/capitis/caprae/devriesei/epidermidis/equorum/haemolyticus/hominis/lugdunensis/pasteuri/petrasii/phage/saccharolyticus 
ASV212 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV213 Streptococcaceae Streptococcus NA 
ASV214 Veillonellaceae Veillonella NA 
ASV215 Synergistaceae Fretibacterium fastidiosum 
ASV216 Prevotellaceae Alloprevotella tannerae 
ASV217 Leptotrichiaceae Leptotrichia buccalis 
ASV218 Fusobacteriaceae Fusobacterium NA 
ASV219 Prevotellaceae Prevotella_7 NA 
ASV220 Neisseriaceae Neisseria NA 
ASV221 Veillonellaceae Selenomonas_3 NA 
ASV222 Prevotellaceae NA NA 
ASV223 NA NA NA 
ASV224 Neisseriaceae Neisseria meningitidis 
ASV225 Spirochaetaceae Treponema_2 vincentii 




ASV226 Veillonellaceae Selenomonas_3 flueggei/flueggei-like 
ASV227 Prevotellaceae Prevotella_7 NA 
ASV228 Porphyromonadaceae Porphyromonas NA 
ASV229 Burkholderiaceae Comamonas NA 
ASV230 Porphyromonadaceae Porphyromonas gingivalis 
ASV231 Leptotrichiaceae Leptotrichia NA 
ASV232 Prevotellaceae Alloprevotella NA 
ASV233 Neisseriaceae Neisseria NA 
ASV234 Flavobacteriaceae Capnocytophaga NA 
ASV235 Pasteurellaceae Haemophilus NA 
ASV236 Neisseriaceae Eikenella corrodens 
ASV237 Spirochaetaceae Treponema_2 medium 
ASV238 Lachnospiraceae Catonella morbi 
ASV239 Cardiobacteriaceae Cardiobacterium valvarum 
ASV240 Spirochaetaceae Treponema_2 NA 
ASV241 Neisseriaceae NA NA 
ASV242 Lachnospiraceae Oribacterium NA 
ASV243 Lachnospiraceae Johnsonella NA 
ASV244 Synergistaceae Fretibacterium NA 
ASV245 NA NA NA 
ASV246 Spirochaetaceae Treponema_2 NA 
ASV247 Streptococcaceae Streptococcus anginosus/constellatus/intermedius 
ASV248 Prevotellaceae Prevotella_7 NA 
ASV249 Pasteurellaceae Haemophilus NA 
ASV250 Veillonellaceae Selenomonas_3 artemidis 
ASV251 Prevotellaceae Alloprevotella NA 




ASV252 Veillonellaceae Selenomonas NA 
ASV253 Leptotrichiaceae Leptotrichia NA 
ASV254 Atopobiaceae Atopobium NA 
ASV255 Prevotellaceae Prevotella_7 NA 
ASV256 Leptotrichiaceae Leptotrichia NA 
ASV257 Prevotellaceae Prevotella_7 NA 
ASV258 Leptotrichiaceae Leptotrichia NA 
ASV259 Flavobacteriaceae Capnocytophaga NA 
ASV260 Streptococcaceae Streptococcus anginosus/constellatus/intermedius/lutetiensis 
ASV261 Prevotellaceae Prevotella_2 loescheii 
ASV262 Leptotrichiaceae Leptotrichia hofstadii 
ASV263 Saccharimonadaceae NA NA 
ASV264 Prevotellaceae Prevotella intermedia 
ASV265 Leptotrichiaceae Leptotrichia NA 
ASV266 Streptococcaceae Streptococcus anginosus/constellatus/intermedius/milleri/mitis/sanguinis/suis 
ASV267 Prevotellaceae Prevotella_7 NA 
ASV268 Family_XIII NA NA 
ASV269 Campylobacteraceae Campylobacter showae 
ASV270 Streptococcaceae Streptococcus mutans 
ASV271 Lentimicrobiaceae NA NA 
ASV272 Porphyromonadaceae Porphyromonas NA 
ASV273 Prevotellaceae Prevotella aurantiaca 
ASV274 Prevotellaceae Prevotella_7 NA 
ASV275 Spirochaetaceae Treponema_2 NA 
ASV276 Campylobacteraceae Campylobacter NA 
ASV277 Streptococcaceae Streptococcus mitis/phage/pneumoniae/pseudopneumoniae 




ASV278 Clostridiales_vadinBB60_group NA NA 
ASV279 Neisseriaceae Kingella NA 
ASV280 Fusobacteriaceae Fusobacterium NA 
ASV281 Fusobacteriaceae Fusobacterium NA 
ASV282 Prevotellaceae Prevotella_2 NA 
ASV283 Prevotellaceae Prevotella_2 saccharolytica 
ASV284 Fusobacteriaceae Fusobacterium nucleatum 
ASV285 Prevotellaceae Prevotella_7 NA 
ASV286 Pasteurellaceae Haemophilus NA 
ASV287 Spirochaetaceae Treponema_2 NA 
ASV288 Prevotellaceae Prevotella_7 NA 
ASV289 Spirochaetaceae Treponema_2 NA 
ASV290 Prevotellaceae Prevotella_7 NA 
ASV291 Pasteurellaceae Aggregatibacter NA 
ASV292 Prevotellaceae Prevotella NA 
ASV293 Pasteurellaceae Haemophilus NA 
ASV294 Porphyromonadaceae Porphyromonas NA 
ASV295 Prevotellaceae Alloprevotella NA 
ASV296 Veillonellaceae Anaeroglobus geminatus 
ASV297 Pasteurellaceae Aggregatibacter NA 
ASV298 Neisseriaceae Eikenella NA 
ASV299 Mycoplasmataceae Mycoplasma indiense/orale 
ASV300 Lachnospiraceae Oribacterium NA 
ASV301 Flavobacteriaceae Capnocytophaga NA 
ASV302 Actinomycetaceae Actinomyces johnsonii/naeslundii/oris 
ASV303 Peptostreptococcaceae Filifactor alocis 




ASV304 Peptostreptococcaceae Peptoanaerobacter NA 
ASV305 Fusobacteriaceae Fusobacterium massiliense 
ASV306 Actinomycetaceae Actinomyces NA 
ASV307 Leptotrichiaceae Leptotrichia NA 
ASV308 Porphyromonadaceae Porphyromonas NA 
ASV309 Flavobacteriaceae Capnocytophaga granulosa 
ASV310 Flavobacteriaceae Capnocytophaga NA 
ASV311 Pasteurellaceae Haemophilus NA 
ASV312 Porphyromonadaceae Porphyromonas NA 
ASV313 Fusobacteriaceae Fusobacterium NA 
ASV314 Spirochaetaceae Treponema_2 NA 
ASV315 Prevotellaceae Prevotella_7 NA 
ASV316 Pasteurellaceae Aggregatibacter actinomycetemcomitans 
ASV317 Veillonellaceae Veillonella NA 
ASV318 Flavobacteriaceae Capnocytophaga NA 
ASV319 Prevotellaceae Alloprevotella NA 
ASV320 Bifidobacteriaceae Scardovia wiggsiae 
ASV321 Spirochaetaceae Treponema_2 maltophilum 
ASV322 Leptotrichiaceae Leptotrichia NA 
ASV323 Prevotellaceae Prevotella_7 NA 
ASV324 Synergistaceae Fretibacterium NA 
ASV325 Family_XIII NA NA 
ASV326 Porphyromonadaceae Porphyromonas NA 
ASV327 Leptotrichiaceae Leptotrichia NA 
ASV328 Campylobacteraceae Campylobacter NA 
ASV329 Pasteurellaceae Haemophilus NA 




ASV330 Streptococcaceae Streptococcus NA 
ASV331 Lachnospiraceae Oribacterium NA 
ASV332 Flavobacteriaceae Capnocytophaga ochracea 
ASV333 Fusobacteriaceae Fusobacterium NA 
ASV334 Prevotellaceae Prevotella oralis/phocaeensis 
ASV335 Bifidobacteriaceae Parascardovia denticolens 
ASV336 Streptococcaceae Streptococcus NA 
ASV337 Lachnospiraceae Catonella NA 
ASV338 Campylobacteraceae Campylobacter NA 
ASV339 Spirochaetaceae Treponema_2 medium 
ASV340 Spirochaetaceae Treponema_2 NA 
ASV341 Spirochaetaceae Treponema_2 NA 
ASV342 Fusobacteriaceae Fusobacterium NA 
ASV343 Spirochaetaceae Treponema_2 vincentii 
ASV344 Prevotellaceae Prevotella NA 
ASV345 Spirochaetaceae Treponema_2 medium/pallidum 
ASV346 Micrococcaceae Rothia NA 
ASV347 Leptotrichiaceae Leptotrichia NA 
ASV348 Paludibacteraceae F0058 NA 
ASV349 Spirochaetaceae Treponema_2 socranskii 
ASV350 Prevotellaceae Prevotella_7 NA 
ASV351 Pasteurellaceae Haemophilus NA 
ASV352 Leptotrichiaceae Leptotrichia NA 
ASV353 Pasteurellaceae Haemophilus NA 
ASV354 Fusobacteriaceae Fusobacterium NA 
ASV355 Weeksellaceae Bergeyella NA 




ASV356 Prevotellaceae Prevotella NA 
ASV357 Flavobacteriaceae Capnocytophaga NA 
ASV358 Spirochaetaceae Treponema_2 NA 
ASV359 Flavobacteriaceae Capnocytophaga gingivalis 
ASV360 Streptococcaceae Streptococcus NA 
ASV361 Pasteurellaceae Haemophilus haemolyticus 
ASV362 Prevotellaceae Prevotella_7 NA 
ASV363 Prevotellaceae Alloprevotella NA 
ASV364 Lachnospiraceae Catonella NA 
ASV365 Lachnospiraceae Catonella NA 
ASV366 Weeksellaceae Bergeyella NA 
ASV367 Enterobacteriaceae Klebsiella NA 
ASV368 Prevotellaceae Alloprevotella NA 
ASV369 Acholeplasmataceae Acholeplasma NA 
ASV370 Pasteurellaceae Actinobacillus NA 
ASV371 Weeksellaceae Bergeyella NA 
ASV372 Veillonellaceae Veillonella NA 
ASV373 Neisseriaceae Conchiformibius NA 
ASV374 Micrococcaceae Rothia mucilaginosa 
ASV375 Veillonellaceae Veillonella NA 
ASV376 Prevotellaceae Alloprevotella NA 
ASV377 Bifidobacteriaceae Alloscardovia omnicolens 
ASV378 Spirochaetaceae Treponema_2 NA 
ASV379 Spirochaetaceae Treponema_2 NA 
ASV380 Bacteroidales_Incertae_Sedis Phocaeicola abscessus 
ASV381 Rikenellaceae Rikenellaceae_RC9_gut_group NA 




ASV382 Veillonellaceae Veillonella NA 
ASV383 Actinomycetaceae Actinomyces NA 
ASV384 Prevotellaceae Alloprevotella NA 
ASV385 Prevotellaceae Prevotella_7 NA 
ASV386 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV387 Pasteurellaceae Haemophilus NA 
ASV388 Fusobacteriaceae Fusobacterium NA 
ASV389 Pasteurellaceae Haemophilus NA 
ASV390 Prevotellaceae Alloprevotella NA 
ASV391 Leptotrichiaceae Leptotrichia NA 
ASV392 Veillonellaceae Centipeda NA 
ASV393 Flavobacteriaceae Capnocytophaga haemolytica 
ASV394 Prevotellaceae Prevotella NA 
ASV395 Pasteurellaceae Haemophilus NA 
ASV396 Fusobacteriaceae Fusobacterium NA 
ASV397 Spirochaetaceae Treponema_2 maltophilum 
ASV398 Prevotellaceae Alloprevotella NA 
ASV399 Neisseriaceae NA NA 
ASV400 Pasteurellaceae Haemophilus NA 
ASV401 Prevotellaceae Prevotella NA 
ASV402 Veillonellaceae Anaeroglobus NA 
ASV403 Prevotellaceae Prevotella NA 
ASV404 Prevotellaceae Prevotella_2 saccharolytica 
ASV405 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV406 Veillonellaceae Anaeroglobus NA 
ASV407 Fusobacteriaceae Fusobacterium NA 




ASV408 Prevotellaceae Prevotella NA 
ASV409 Neisseriaceae Neisseria NA 
ASV410 Carnobacteriaceae Granulicatella NA 
ASV411 Pasteurellaceae Aggregatibacter NA 
ASV412 Spirochaetaceae Treponema_2 NA 
ASV413 Peptostreptococcaceae NA NA 
ASV414 Prevotellaceae Prevotella_2 marshii 
ASV415 Weeksellaceae Bergeyella NA 
ASV416 Prevotellaceae Alloprevotella NA 
ASV417 Atopobiaceae Atopobium rimae 
ASV418 Erysipelotrichaceae Bulleidia extructa 
ASV419 Prevotellaceae Prevotella_7 NA 
ASV420 Leptotrichiaceae Leptotrichia goodfellowii 
ASV421 Veillonellaceae Selenomonas_3 NA 
ASV422 Pasteurellaceae Haemophilus NA 
ASV423 Veillonellaceae Veillonella NA 
ASV424 Neisseriaceae Neisseria NA 
ASV425 Fusobacteriaceae Fusobacterium NA 
ASV426 Prevotellaceae Prevotella micans 
ASV427 Flavobacteriaceae Capnocytophaga ochracea 
ASV428 Spirochaetaceae Treponema_2 NA 
ASV429 Prevotellaceae Prevotella_7 NA 
ASV430 Pasteurellaceae Haemophilus NA 
ASV431 Pasteurellaceae Haemophilus NA 
ASV432 Prevotellaceae Prevotella_7 NA 
ASV433 Neisseriaceae Neisseria NA 




ASV434 Neisseriaceae Neisseria NA 
ASV435 Campylobacteraceae Campylobacter NA 
ASV436 Campylobacteraceae Campylobacter curvus 
ASV437 Weeksellaceae Bergeyella NA 
ASV438 Prevotellaceae Prevotella_7 NA 
ASV439 Prevotellaceae Prevotella_2 NA 
ASV440 Pasteurellaceae Mannheimia NA 
ASV441 Pasteurellaceae Haemophilus haemolyticus/influenzae 
ASV442 Lentimicrobiaceae NA NA 
ASV443 Leptotrichiaceae Leptotrichia NA 
ASV444 Prevotellaceae Alloprevotella NA 
ASV445 Leptotrichiaceae Leptotrichia NA 
ASV446 Spirochaetaceae Treponema_2 NA 
ASV447 Streptococcaceae Streptococcus NA 
ASV448 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV449 Lachnospiraceae Oribacterium NA 
ASV450 Prevotellaceae NA NA 
ASV451 Pasteurellaceae Haemophilus NA 
ASV452 Veillonellaceae Veillonella NA 
ASV453 Leptotrichiaceae Leptotrichia NA 
ASV454 Prevotellaceae Prevotella_7 NA 
ASV455 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV456 Fusobacteriaceae Fusobacterium NA 
ASV457 Neisseriaceae Neisseria NA 
ASV458 Prevotellaceae Prevotella_6 NA 
ASV459 Streptococcaceae Streptococcus NA 




ASV460 Neisseriaceae Neisseria NA 
ASV461 Fusobacteriaceae Fusobacterium NA 
ASV462 Veillonellaceae Selenomonas_4 NA 
ASV463 Leptotrichiaceae Streptobacillus NA 
ASV464 Peptostreptococcaceae Peptoanaerobacter stomatis 
ASV465 Prevotellaceae Alloprevotella NA 
ASV466 Leptotrichiaceae Leptotrichia NA 
ASV467 Fusobacteriaceae Fusobacterium NA 
ASV468 NA NA NA 
ASV469 Veillonellaceae Veillonella NA 
ASV470 Fusobacteriaceae Fusobacterium necrophorum 
ASV471 Fusobacteriaceae Fusobacterium NA 
ASV472 Prevotellaceae Prevotella_7 NA 
ASV473 Neisseriaceae Simonsiella muelleri 
ASV474 Prevotellaceae Prevotella NA 
ASV475 Streptococcaceae Streptococcus NA 
ASV476 Veillonellaceae Veillonella NA 
ASV477 Neisseriaceae Neisseria NA 
ASV478 Flavobacteriaceae Capnocytophaga NA 
ASV479 Fusobacteriaceae Fusobacterium NA 
ASV480 Prevotellaceae Alloprevotella NA 
ASV481 Family_XIII Mogibacterium timidum 
ASV482 Prevotellaceae Prevotella_7 NA 
ASV483 Flavobacteriaceae Capnocytophaga ochracea 
ASV484 Neisseriaceae Neisseria NA 
ASV485 Atopobiaceae Atopobium parvulum 




ASV486 Pasteurellaceae Aggregatibacter NA 
ASV487 Prevotellaceae Prevotella_6 NA 
ASV488 Weeksellaceae Bergeyella NA 
ASV489 Lactobacillaceae Lactobacillus vaginalis 
ASV490 Prevotellaceae Prevotella_7 NA 
ASV491 Carnobacteriaceae Granulicatella NA 
ASV492 Prevotellaceae Prevotella_7 NA 
ASV493 Bifidobacteriaceae Bifidobacterium breve/kashiwanohense/longum/saguini 
ASV494 Flavobacteriaceae Capnocytophaga NA 
ASV495 Pasteurellaceae Haemophilus NA 
ASV496 Spirochaetaceae Treponema_2 NA 
ASV497 Lactobacillaceae Lactobacillus casei/helveticus/paracasei/plantarum/rhamnosus/zeae 
ASV498 Leptotrichiaceae Oceanivirga NA 
ASV499 Prevotellaceae Prevotella NA 
ASV500 Actinomycetaceae F0332 NA 
ASV501 Pasteurellaceae Haemophilus NA 
ASV502 Prevotellaceae Prevotella_7 NA 
ASV503 Lachnospiraceae Lachnoanaerobaculum NA 
ASV504 Prevotellaceae Prevotella_6 NA 
ASV505 Pasteurellaceae Haemophilus aegyptius/influenzae/phage 
ASV506 Pasteurellaceae Haemophilus NA 
ASV507 Veillonellaceae Veillonella NA 
ASV508 Campylobacteraceae Campylobacter NA 
ASV509 Lactobacillaceae Lactobacillus NA 
ASV510 Fusobacteriaceae Fusobacterium NA 
ASV511 Bifidobacteriaceae Bifidobacterium dentium/moukalabense 




ASV512 Veillonellaceae Selenomonas_4 NA 
ASV513 NA NA NA 
ASV514 Fusobacteriaceae Fusobacterium NA 
ASV515 Spirochaetaceae Treponema_2 NA 
ASV516 Streptococcaceae Streptococcus salivarius 
ASV517 Prevotellaceae Alloprevotella NA 
ASV518 Prevotellaceae Prevotella_7 NA 
ASV519 Neisseriaceae Neisseria NA 
ASV520 Leptotrichiaceae Leptotrichia NA 
ASV521 Porphyromonadaceae Porphyromonas gingivalis 
ASV522 Fusobacteriaceae Fusobacterium NA 
ASV523 Mycoplasmataceae Mycoplasma NA 
ASV524 Veillonellaceae Veillonella NA 
ASV525 Fusobacteriaceae Fusobacterium NA 
ASV526 Desulfovibrionaceae Desulfovibrio NA 
ASV527 Actinomycetaceae Actinomyces massiliensis 
ASV528 Prevotellaceae Prevotella_6 NA 
ASV529 Veillonellaceae Veillonella NA 
ASV530 Veillonellaceae Veillonella NA 
ASV531 Leptotrichiaceae Leptotrichia NA 
ASV532 Flavobacteriaceae Capnocytophaga NA 
ASV533 Prevotellaceae Alloprevotella NA 
ASV534 Prevotellaceae Prevotella_7 NA 
ASV535 Tannerellaceae Tannerella NA 
ASV536 Prevotellaceae Prevotella_6 NA 
ASV537 Prevotellaceae Prevotella_7 buccae 




ASV538 Fusobacteriaceae Fusobacterium NA 
ASV539 Family_XIII NA NA 
ASV540 Veillonellaceae Veillonella NA 
ASV541 Prevotellaceae Prevotella_7 NA 
ASV542 Leptotrichiaceae Leptotrichia NA 
ASV543 Campylobacteraceae Campylobacter curvus 
ASV544 Prevotellaceae Alloprevotella NA 
ASV545 Veillonellaceae Selenomonas_3 NA 
ASV546 Actinomycetaceae Actinomyces gerencseriae 
ASV547 Pasteurellaceae Haemophilus NA 
ASV548 Fusobacteriaceae Fusobacterium NA 
ASV549 Lactobacillaceae Lactobacillus phage/reuteri/salivarius 
ASV550 Prevotellaceae Prevotella_7 NA 
ASV551 Lachnospiraceae Lachnoanaerobaculum NA 
ASV552 Pasteurellaceae Haemophilus NA 
ASV553 Streptococcaceae Streptococcus NA 
ASV554 Pasteurellaceae Haemophilus NA 
ASV555 Spirochaetaceae Treponema_2 NA 
ASV556 Spirochaetaceae Treponema_2 NA 
ASV557 Prevotellaceae Prevotella NA 
ASV558 Fusobacteriaceae Fusobacterium NA 
ASV559 Fusobacteriaceae Fusobacterium periodonticum 
ASV560 Peptostreptococcaceae NA NA 
ASV561 Pasteurellaceae Haemophilus NA 
ASV562 Lachnospiraceae NA NA 
ASV563 Prevotellaceae Alloprevotella NA 




ASV564 Campylobacteraceae Campylobacter NA 
ASV565 Veillonellaceae Selenomonas_3 NA 
ASV566 Flavobacteriaceae Capnocytophaga NA 
ASV567 Weeksellaceae Bergeyella NA 
ASV568 Neisseriaceae Kingella NA 
ASV569 Prevotellaceae Prevotella_7 pleuritidis 
ASV570 Prevotellaceae Prevotella NA 
ASV571 Spirochaetaceae Treponema_2 NA 
ASV572 Leptotrichiaceae Leptotrichia NA 
ASV573 Fusobacteriaceae Fusobacterium NA 
ASV574 Prevotellaceae Alloprevotella NA 
ASV575 Lactobacillaceae Lactobacillus acidophilus/brevis/casei/delbrueckii/fabifermentans/fermentum/helveticus/japonicus/paracasei/paraplantarum/pentosus/plantarum 
ASV576 Prevotellaceae Prevotella_7 NA 
ASV577 Neisseriaceae NA NA 
ASV578 Fusobacteriaceae Fusobacterium NA 
ASV579 Neisseriaceae Neisseria NA 
ASV580 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV581 Prevotellaceae Prevotella_7 NA 
ASV582 Prevotellaceae Prevotella_7 NA 
ASV583 Leptotrichiaceae Leptotrichia NA 
ASV584 Leptotrichiaceae Leptotrichia NA 
ASV585 Prevotellaceae Alloprevotella NA 
ASV586 Flavobacteriaceae Capnocytophaga ochracea 
ASV587 Carnobacteriaceae Granulicatella NA 
ASV588 Spirochaetaceae Treponema_2 NA 
ASV589 Porphyromonadaceae Porphyromonas NA 




ASV590 Leptotrichiaceae Leptotrichia NA 
ASV591 Prevotellaceae Prevotella_6 NA 
ASV592 Lachnospiraceae NA NA 
ASV593 Prevotellaceae Prevotella NA 
ASV594 Spirochaetaceae Treponema_2 NA 
ASV595 Leptotrichiaceae Streptobacillus NA 
ASV596 Flavobacteriaceae Capnocytophaga NA 
ASV597 Neisseriaceae Kingella NA 
ASV598 Prevotellaceae Alloprevotella NA 
ASV599 Lachnospiraceae Lachnoanaerobaculum NA 
ASV600 Fusobacteriaceae Fusobacterium NA 
ASV601 Pasteurellaceae Haemophilus NA 
ASV602 Prevotellaceae Prevotella_7 NA 
ASV603 Lachnospiraceae Johnsonella NA 
ASV604 Leptotrichiaceae Leptotrichia NA 
ASV605 Acholeplasmataceae Acholeplasma NA 
ASV606 Actinomycetaceae Actinomyces dentalis/orihominis 
ASV607 Veillonellaceae Anaeroglobus geminatus 
ASV608 Lachnospiraceae Johnsonella NA 
ASV609 Leptotrichiaceae Leptotrichia NA 
ASV610 Veillonellaceae Veillonella NA 
ASV611 Streptococcaceae Streptococcus anginosus 
ASV612 Veillonellaceae Dialister NA 
ASV613 Veillonellaceae Anaeroglobus NA 
ASV614 Prevotellaceae Alloprevotella NA 
ASV615 Veillonellaceae Veillonella NA 




ASV616 Cardiobacteriaceae Cardiobacterium NA 
ASV617 Porphyromonadaceae Porphyromonas NA 
ASV618 Fusobacteriaceae Fusobacterium nucleatum 
ASV619 Leptotrichiaceae Streptobacillus NA 
ASV620 Streptococcaceae Streptococcus NA 
ASV621 Porphyromonadaceae Porphyromonas gingivalis/gulae 
ASV622 Veillonellaceae Veillonella NA 
ASV623 Lachnospiraceae Johnsonella NA 
ASV624 Weeksellaceae Bergeyella NA 
ASV625 Pasteurellaceae Haemophilus NA 
ASV626 Porphyromonadaceae Porphyromonas NA 
ASV627 Prevotellaceae Prevotella_7 NA 
ASV628 Pasteurellaceae Actinobacillus NA 
ASV629 Leptotrichiaceae Leptotrichia NA 
ASV630 Enterobacteriaceae Klebsiella NA 
ASV631 Spirochaetaceae Treponema_2 NA 
ASV632 Neisseriaceae NA NA 
ASV633 Fusobacteriaceae Fusobacterium NA 
ASV634 Veillonellaceae Veillonella NA 
ASV635 Veillonellaceae Veillonella NA 
ASV636 Lachnospiraceae Johnsonella ignava 
ASV637 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV638 Pasteurellaceae Haemophilus NA 
ASV639 Veillonellaceae Veillonella NA 
ASV640 Fusobacteriaceae Fusobacterium NA 
ASV641 Campylobacteraceae Campylobacter NA 




ASV642 Prevotellaceae Prevotella_7 NA 
ASV643 Pasteurellaceae Haemophilus NA 
ASV644 Actinomycetaceae Actinomyces georgiae/hongkongensis 
ASV645 Lachnospiraceae Johnsonella NA 
ASV646 Prevotellaceae Alloprevotella NA 
ASV647 Micrococcaceae Rothia NA 
ASV648 Prevotellaceae Prevotella_6 NA 
ASV649 Prevotellaceae Alloprevotella NA 
ASV650 Veillonellaceae Veillonella NA 
ASV651 Prevotellaceae Alloprevotella NA 
ASV652 Neisseriaceae Neisseria NA 
ASV653 Prevotellaceae Prevotella_7 NA 
ASV654 Spirochaetaceae Treponema_2 pectinovorum 
ASV655 Pasteurellaceae Haemophilus NA 
ASV656 Corynebacteriaceae Corynebacterium argentoratense/sputi 
ASV657 Burkholderiaceae Comamonas NA 
ASV658 Prevotellaceae Prevotella_7 NA 
ASV659 Weeksellaceae Bergeyella NA 
ASV660 Weeksellaceae Bergeyella NA 
ASV661 Prevotellaceae Prevotella_6 NA 
ASV662 Veillonellaceae Veillonella NA 
ASV663 Prevotellaceae Prevotella_7 NA 
ASV664 Prevotellaceae Prevotella NA 
ASV665 Lachnospiraceae NA NA 
ASV666 Prevotellaceae Prevotella NA 
ASV667 Prevotellaceae Alloprevotella NA 




ASV668 Veillonellaceae Veillonella NA 
ASV669 Mycoplasmataceae Mycoplasma NA 
ASV670 Prevotellaceae Prevotella NA 
ASV671 Prevotellaceae Prevotella_7 multisaccharivorax 
ASV672 Porphyromonadaceae Porphyromonas NA 
ASV673 Fusobacteriaceae Fusobacterium NA 
ASV674 Streptococcaceae Streptococcus NA 
ASV675 Prevotellaceae Alloprevotella NA 
ASV676 Weeksellaceae Bergeyella NA 
ASV677 Streptococcaceae Streptococcus NA 
ASV678 Prevotellaceae Prevotella_7 NA 
ASV679 Prevotellaceae Alloprevotella NA 
ASV680 Neisseriaceae Neisseria NA 
ASV681 Fusobacteriaceae Fusobacterium NA 
ASV682 Spirochaetaceae Treponema_2 parvum 
ASV683 Neisseriaceae Kingella NA 
ASV684 Prevotellaceae Alloprevotella NA 
ASV685 Family_XIII NA NA 
ASV686 Streptococcaceae Streptococcus dentirousetti/downei/sobrinus 
ASV687 Actinomycetaceae Actinomyces israelii 
ASV688 Tannerellaceae Tannerella NA 
ASV689 Veillonellaceae Veillonella NA 
ASV690 Veillonellaceae Veillonella NA 
ASV691 Prevotellaceae Prevotella_7 buccae/denticola 
ASV692 Streptococcaceae Streptococcus NA 
ASV693 Leptotrichiaceae Leptotrichia NA 




ASV694 Lachnospiraceae NA NA 
ASV695 Neisseriaceae Kingella NA 
ASV696 Campylobacteraceae Campylobacter NA 
ASV697 Lachnospiraceae Butyrivibrio_2 NA 
ASV698 Lentimicrobiaceae NA NA 
ASV699 Family_XIII Family_XIII_UCG-001 NA 
ASV700 Neisseriaceae Kingella NA 
ASV701 Pasteurellaceae Haemophilus NA 
ASV702 Prevotellaceae Prevotella_7 NA 
ASV703 Pasteurellaceae Haemophilus NA 
ASV704 Leptotrichiaceae Leptotrichia NA 
ASV705 Prevotellaceae Prevotella_7 NA 
ASV706 Moraxellaceae Moraxella NA 
ASV707 Fusobacteriaceae Fusobacterium NA 
ASV708 NA NA NA 
ASV709 Fusobacteriaceae Fusobacterium NA 
ASV710 Prevotellaceae Alloprevotella NA 
ASV711 Prevotellaceae Alloprevotella NA 
ASV712 Veillonellaceae Veillonella NA 
ASV713 NA NA NA 
ASV714 Bacteroidaceae Bacteroides NA 
ASV715 Pasteurellaceae Haemophilus NA 
ASV716 Actinomycetaceae Mobiluncus NA 
ASV717 Campylobacteraceae Campylobacter NA 
ASV718 Prevotellaceae Alloprevotella NA 
ASV719 Fusobacteriaceae Fusobacterium NA 




ASV720 Neisseriaceae Kingella NA 
ASV721 Weeksellaceae Bergeyella NA 
ASV722 NA NA NA 
ASV723 Micrococcaceae Rothia NA 
ASV724 Weeksellaceae Bergeyella NA 
ASV725 Prevotellaceae Alloprevotella NA 
ASV726 Fusobacteriaceae Fusobacterium NA 
ASV727 Neisseriaceae Neisseria NA 
ASV728 Fusobacteriaceae Fusobacterium NA 
ASV729 Pasteurellaceae Aggregatibacter NA 
ASV730 Leptotrichiaceae Leptotrichia NA 
ASV731 Carnobacteriaceae Granulicatella NA 
ASV732 Carnobacteriaceae Granulicatella NA 
ASV733 Prevotellaceae Prevotella_7 NA 
ASV734 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV735 Prevotellaceae Prevotella NA 
ASV736 Prevotellaceae Prevotella_2 NA 
ASV737 NA NA NA 
ASV738 Fusobacteriaceae Fusobacterium NA 
ASV739 Prevotellaceae Alloprevotella NA 
ASV740 Veillonellaceae Veillonella NA 
ASV741 Leptotrichiaceae Leptotrichia trevisanii 
ASV742 Fusobacteriaceae Fusobacterium NA 
ASV743 Leptotrichiaceae Leptotrichia NA 
ASV744 Neisseriaceae Neisseria NA 
ASV745 Lachnospiraceae Oribacterium NA 




ASV746 Weeksellaceae Bergeyella NA 
ASV747 Lachnospiraceae Shuttleworthia satelles 
ASV748 Fusobacteriaceae Fusobacterium NA 
ASV749 Streptococcaceae Streptococcus NA 
ASV750 Prevotellaceae Prevotella_7 NA 
ASV751 Prevotellaceae Prevotella_7 NA 
ASV752 Prevotellaceae Prevotella NA 
ASV753 Spirochaetaceae Treponema_2 NA 
ASV754 Veillonellaceae Veillonella NA 
ASV755 Mitochondria NA NA 
ASV756 Fusobacteriaceae Fusobacterium NA 
ASV757 Leptotrichiaceae Leptotrichia NA 
ASV758 Atopobiaceae Olsenella NA 
ASV759 Family_XIII NA NA 
ASV760 Family_XI Gemella NA 
ASV761 Tannerellaceae Tannerella NA 
ASV762 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV763 Veillonellaceae Veillonella NA 
ASV764 Prevotellaceae Prevotella_7 NA 
ASV765 Veillonellaceae Veillonella NA 
ASV766 Neisseriaceae Neisseria NA 
ASV767 Lachnospiraceae Catonella morbi 
ASV768 Neisseriaceae Neisseria NA 
ASV769 Moraxellaceae Moraxella NA 
ASV770 Veillonellaceae NA NA 
ASV771 Lentimicrobiaceae NA NA 




ASV772 Prevotellaceae Prevotella_7 NA 
ASV773 Prevotellaceae Prevotella_7 NA 
ASV774 Pasteurellaceae Haemophilus NA 
ASV775 Prevotellaceae Alloprevotella NA 
ASV776 Erysipelotrichaceae Solobacterium NA 
ASV777 Porphyromonadaceae Porphyromonas NA 
ASV778 Prevotellaceae Prevotella_2 NA 
ASV779 Prevotellaceae Prevotella NA 
ASV780 Prevotellaceae Alloprevotella NA 
ASV781 Leptotrichiaceae Leptotrichia NA 
ASV782 Neisseriaceae Neisseria NA 
ASV783 Prevotellaceae Prevotella_7 NA 
ASV784 Streptococcaceae Streptococcus NA 
ASV785 Prevotellaceae Prevotella_7 NA 
ASV786 Prevotellaceae Prevotella_7 NA 
ASV787 Fusobacteriaceae Fusobacterium NA 
ASV788 Lachnospiraceae Lachnoanaerobaculum NA 
ASV789 Desulfobulbaceae Desulfobulbus NA 
ASV790 Prevotellaceae Alloprevotella NA 
ASV791 Porphyromonadaceae Porphyromonas uenonis 
ASV792 Cardiobacteriaceae Cardiobacterium valvarum 
ASV793 Pasteurellaceae Aggregatibacter NA 
ASV794 Cardiobacteriaceae Cardiobacterium NA 
ASV795 Streptococcaceae Streptococcus NA 
ASV796 Family_XIII NA NA 
ASV797 Porphyromonadaceae Porphyromonas NA 




ASV798 Lachnospiraceae Lachnoanaerobaculum NA 
ASV799 Family_XI Gemella NA 
ASV800 Pasteurellaceae Haemophilus NA 
ASV801 Prevotellaceae Prevotella_7 enoeca 
ASV802 Leptotrichiaceae Leptotrichia NA 
ASV803 Veillonellaceae Veillonella NA 
ASV804 Fusobacteriaceae Fusobacterium NA 
ASV805 Weeksellaceae Bergeyella NA 
ASV806 Prevotellaceae Prevotella_7 NA 
ASV807 Fusobacteriaceae Fusobacterium NA 
ASV808 Pasteurellaceae Haemophilus NA 
ASV809 Cardiobacteriaceae Cardiobacterium NA 
ASV810 Porphyromonadaceae Porphyromonas NA 
ASV811 Veillonellaceae Anaeroglobus NA 
ASV812 Leptotrichiaceae Leptotrichia NA 
ASV813 Lachnospiraceae Lachnoanaerobaculum NA 
ASV814 Eggerthellaceae Cryptobacterium curtum 
ASV815 Spirochaetaceae Treponema_2 NA 
ASV816 Lachnospiraceae Johnsonella NA 
ASV817 Family_XI Gemella NA 
ASV818 Micrococcaceae Rothia NA 
ASV819 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV820 Spirochaetaceae Treponema_2 NA 
ASV821 Neisseriaceae Neisseria NA 
ASV822 Pasteurellaceae Actinobacillus NA 
ASV823 Prevotellaceae Prevotella_7 NA 




ASV824 Actinomycetaceae Actinomyces NA 
ASV825 Prevotellaceae Prevotella NA 
ASV826 Atopobiaceae Atopobium NA 
ASV827 NA NA NA 
ASV828 Family_XIII Family_XIII_UCG-001 NA 
ASV829 Fusobacteriaceae Fusobacterium NA 
ASV830 Fusobacteriaceae Fusobacterium NA 
ASV831 Fusobacteriaceae Fusobacterium NA 
ASV832 Lachnospiraceae NA NA 
ASV833 Prevotellaceae Prevotella_6 NA 
ASV834 Veillonellaceae Selenomonas_3 NA 
ASV835 Campylobacteraceae Campylobacter NA 
ASV836 Prevotellaceae Prevotella NA 
ASV837 Fusobacteriaceae Fusobacterium NA 
ASV838 Lactobacillaceae Lactobacillus antri/fermentum/frumenti/gasseri/oris/panis/reuteri/vaginalis 
ASV839 Leptotrichiaceae Leptotrichia NA 
ASV840 Lachnospiraceae NA NA 
ASV841 Neisseriaceae Alysiella NA 
ASV842 Micrococcaceae Rothia NA 
ASV843 Pasteurellaceae Haemophilus NA 
ASV844 Fusobacteriaceae Fusobacterium NA 
ASV845 Spirochaetaceae Treponema_2 NA 
ASV846 Prevotellaceae Prevotella NA 
ASV847 Veillonellaceae Veillonella NA 
ASV848 Leptotrichiaceae Leptotrichia NA 
ASV849 Leptotrichiaceae Leptotrichia NA 




ASV850 Fusobacteriaceae Fusobacterium NA 
ASV851 Pasteurellaceae NA NA 
ASV852 Prevotellaceae Prevotella_6 NA 
ASV853 Leptotrichiaceae Leptotrichia NA 
ASV854 Neisseriaceae NA NA 
ASV855 Veillonellaceae Veillonella NA 
ASV856 Leptotrichiaceae Leptotrichia NA 
ASV857 Lachnospiraceae NA NA 
ASV858 Flavobacteriaceae Capnocytophaga NA 
ASV859 Micrococcaceae Rothia NA 
ASV860 Fusobacteriaceae Fusobacterium NA 
ASV861 NA NA NA 
ASV862 Prevotellaceae Alloprevotella NA 
ASV863 Prevotellaceae Alloprevotella NA 
ASV864 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV865 Prevotellaceae Alloprevotella NA 
ASV866 Pasteurellaceae NA NA 
ASV867 Spirochaetaceae Treponema_2 NA 
ASV868 Micrococcaceae Rothia NA 
ASV869 Prevotellaceae Prevotella_7 NA 
ASV870 Prevotellaceae NA NA 
ASV871 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV872 Prevotellaceae Alloprevotella NA 
ASV873 Leptotrichiaceae Leptotrichia NA 
ASV874 Prevotellaceae Alloprevotella NA 
ASV875 Veillonellaceae Veillonella NA 




ASV876 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV877 Acholeplasmataceae Acholeplasma NA 
ASV878 Prevotellaceae Prevotella_7 NA 
ASV879 Prevotellaceae Prevotella_6 NA 
ASV880 Carnobacteriaceae Granulicatella NA 
ASV881 Leptotrichiaceae Leptotrichia NA 
ASV882 Mycoplasmataceae Mycoplasma NA 
ASV883 Lactobacillaceae Lactobacillus brevis/casei/pantheris/rhamnosus 
ASV884 Veillonellaceae Veillonella NA 
ASV885 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV886 Leptotrichiaceae Leptotrichia NA 
ASV887 Lactobacillaceae Lactobacillus oris 
ASV888 Neisseriaceae Neisseria NA 
ASV889 Pasteurellaceae Haemophilus NA 
ASV890 Prevotellaceae Prevotella_6 NA 
ASV891 Pasteurellaceae Haemophilus NA 
ASV892 Veillonellaceae Megasphaera NA 
ASV893 Family_XI Parvimonas micra 
ASV894 Veillonellaceae Veillonella NA 
ASV895 Veillonellaceae Dialister NA 
ASV896 Leptotrichiaceae Leptotrichia NA 
ASV897 Lachnospiraceae Lachnoanaerobaculum umeaense 
ASV898 Fusobacteriaceae Fusobacterium NA 
ASV899 Actinomycetaceae Actinomyces NA 
ASV900 Campylobacteraceae Campylobacter NA 
ASV901 Prevotellaceae Prevotella NA 




ASV902 Prevotellaceae Alloprevotella NA 
ASV903 Veillonellaceae Selenomonas_3 NA 
ASV904 Bacteroidaceae Bacteroides heparinolyticus 
ASV905 Fusobacteriaceae Fusobacterium NA 
ASV906 Fusobacteriaceae Fusobacterium NA 
ASV907 Streptococcaceae Streptococcus NA 
ASV908 Actinomycetaceae NA NA 
ASV909 Prevotellaceae Prevotella_7 NA 
ASV910 Desulfovibrionaceae Desulfovibrio NA 
ASV911 Fusobacteriaceae Fusobacterium NA 
ASV912 Leptotrichiaceae Leptotrichia NA 
ASV913 Prevotellaceae Prevotella_7 NA 
ASV914 Fusobacteriaceae Fusobacterium NA 
ASV915 Prevotellaceae Prevotella_7 NA 
ASV916 Neisseriaceae Neisseria NA 
ASV917 Veillonellaceae Veillonella NA 
ASV918 Prevotellaceae Alloprevotella NA 
ASV919 Prevotellaceae Prevotella_7 NA 
ASV920 Streptococcaceae Streptococcus NA 
ASV921 Spirochaetaceae Treponema_2 NA 
ASV922 Prevotellaceae Prevotella_6 NA 
ASV923 Lachnospiraceae Stomatobaculum NA 
ASV924 Pasteurellaceae Aggregatibacter NA 
ASV925 Streptococcaceae Streptococcus NA 
ASV926 Actinomycetaceae Actinomyces meyeri 
ASV927 Veillonellaceae Veillonella NA 




ASV928 Leptotrichiaceae Leptotrichia NA 
ASV929 Spirochaetaceae Treponema_2 NA 
ASV930 Pasteurellaceae Haemophilus NA 
ASV931 Porphyromonadaceae Porphyromonas NA 
ASV932 Veillonellaceae Veillonella NA 
ASV933 Prevotellaceae Prevotella_6 NA 
ASV934 Fusobacteriaceae Fusobacterium NA 
ASV935 Fusobacteriaceae Fusobacterium NA 
ASV936 Veillonellaceae Veillonella NA 
ASV937 Carnobacteriaceae Granulicatella NA 
ASV938 Prevotellaceae Alloprevotella NA 
ASV939 Leptotrichiaceae Leptotrichia NA 
ASV940 Lachnospiraceae Oribacterium NA 
ASV941 Veillonellaceae Veillonella NA 
ASV942 Neisseriaceae Neisseria NA 
ASV943 Prevotellaceae Prevotella_7 NA 
ASV944 Lentimicrobiaceae NA NA 
ASV945 Campylobacteraceae Campylobacter NA 
ASV946 Leptotrichiaceae Leptotrichia NA 
ASV947 Prevotellaceae Prevotella_7 NA 
ASV948 Fusobacteriaceae Fusobacterium NA 
ASV949 Streptococcaceae Streptococcus NA 
ASV950 Pasteurellaceae Aggregatibacter NA 
ASV951 Actinomycetaceae Actinomyces cardiffensis 
ASV952 Leptotrichiaceae Leptotrichia NA 
ASV953 Fusobacteriaceae Fusobacterium NA 




ASV954 Pasteurellaceae Rodentibacter NA 
ASV955 Cardiobacteriaceae Cardiobacterium NA 
ASV956 Prevotellaceae Prevotella_7 NA 
ASV957 Prevotellaceae Alloprevotella NA 
ASV958 Veillonellaceae Selenomonas NA 
ASV959 Prevotellaceae Prevotella_7 NA 
ASV960 Lactobacillaceae Lactobacillus NA 
ASV961 Leptotrichiaceae Leptotrichia NA 
ASV962 Leptotrichiaceae Leptotrichia NA 
ASV963 Family_XI Gemella NA 
ASV964 Spirochaetaceae Treponema_2 NA 
ASV965 Desulfovibrionaceae Bilophila wadsworthia 
ASV966 Family_XI Gemella NA 
ASV967 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV968 Leptotrichiaceae Leptotrichia NA 
ASV969 Pasteurellaceae Haemophilus NA 
ASV970 Spirochaetaceae Treponema_2 NA 
ASV971 Neisseriaceae Kingella kingae 
ASV972 Neisseriaceae Neisseria NA 
ASV973 Burkholderiaceae Bordetella holmesii/pertussis 
ASV974 Veillonellaceae Veillonella NA 
ASV975 Pasteurellaceae Haemophilus NA 
ASV976 Prevotellaceae Prevotella_7 NA 
ASV977 Pasteurellaceae Haemophilus NA 
ASV978 Lachnospiraceae Johnsonella NA 
ASV979 Veillonellaceae Veillonella NA 




ASV980 Pasteurellaceae Haemophilus NA 
ASV981 Lentimicrobiaceae NA NA 
ASV982 Porphyromonadaceae Porphyromonas NA 
ASV983 Campylobacteraceae Campylobacter NA 
ASV984 Prevotellaceae Prevotella NA 
ASV985 NA NA NA 
ASV986 Veillonellaceae Veillonella NA 
ASV987 Leptotrichiaceae Leptotrichia NA 
ASV988 Veillonellaceae Veillonella NA 
ASV989 Prevotellaceae Prevotella_7 NA 
ASV990 Prevotellaceae Alloprevotella NA 
ASV991 Carnobacteriaceae Granulicatella NA 
ASV992 Leptotrichiaceae Leptotrichia NA 
ASV993 Campylobacteraceae Campylobacter NA 
ASV994 Carnobacteriaceae NA NA 
ASV995 Desulfomicrobiaceae Desulfomicrobium orale 
ASV996 Peptostreptococcaceae Peptoanaerobacter NA 
ASV997 Lachnospiraceae NA NA 
ASV998 Leptotrichiaceae Leptotrichia NA 
ASV999 Prevotellaceae Prevotella_7 NA 
ASV1000 Pasteurellaceae Aggregatibacter NA 
ASV1001 Leptotrichiaceae Leptotrichia NA 
ASV1002 Prevotellaceae Prevotella NA 
ASV1003 Fusobacteriaceae Fusobacterium NA 
ASV1004 NA NA NA 
ASV1005 Veillonellaceae Allisonella NA 




ASV1006 Veillonellaceae Veillonella NA 
ASV1007 Porphyromonadaceae Porphyromonas NA 
ASV1008 Pasteurellaceae Aggregatibacter NA 
ASV1009 NA NA NA 
ASV1010 Actinomycetaceae Actinomyces NA 
ASV1011 Leptotrichiaceae Leptotrichia NA 
ASV1012 Fusobacteriaceae Fusobacterium nucleatum 
ASV1013 Spirochaetaceae Treponema_2 NA 
ASV1014 Lachnospiraceae Johnsonella NA 
ASV1015 Neisseriaceae Neisseria NA 
ASV1016 Neisseriaceae Neisseria NA 
ASV1017 Weeksellaceae Bergeyella NA 
ASV1018 Leptotrichiaceae Leptotrichia NA 
ASV1019 Flavobacteriaceae Capnocytophaga NA 
ASV1020 Neisseriaceae Kingella NA 
ASV1021 Pasteurellaceae Aggregatibacter NA 
ASV1022 Fusobacteriaceae Fusobacterium NA 
ASV1023 Fusobacteriaceae Fusobacterium NA 
ASV1024 Porphyromonadaceae Porphyromonas NA 
ASV1025 Carnobacteriaceae Granulicatella NA 
ASV1026 Lentimicrobiaceae NA NA 
ASV1027 Prevotellaceae Prevotella_7 NA 
ASV1028 Leptotrichiaceae Leptotrichia NA 
ASV1029 Pasteurellaceae Mannheimia NA 
ASV1030 Neisseriaceae Alysiella NA 
ASV1031 Veillonellaceae Veillonella NA 




ASV1032 Leptotrichiaceae Leptotrichia NA 
ASV1033 Flavobacteriaceae Capnocytophaga NA 
ASV1034 Acholeplasmataceae Acholeplasma NA 
ASV1035 Lachnospiraceae Stomatobaculum NA 
ASV1036 Neisseriaceae Neisseria NA 
ASV1037 Prevotellaceae Prevotella_7 NA 
ASV1038 Prevotellaceae Prevotella_7 NA 
ASV1039 Prevotellaceae Prevotella_6 NA 
ASV1040 Fusobacteriaceae Fusobacterium NA 
ASV1041 Prevotellaceae Prevotella_7 NA 
ASV1042 Lachnospiraceae Johnsonella NA 
ASV1043 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1044 Prevotellaceae Prevotella_2 NA 
ASV1045 Porphyromonadaceae Porphyromonas NA 
ASV1046 Leptotrichiaceae Leptotrichia NA 
ASV1047 Prevotellaceae Prevotella_7 NA 
ASV1048 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1049 Veillonellaceae Veillonella NA 
ASV1050 Tannerellaceae Tannerella NA 
ASV1051 Prevotellaceae Prevotella_7 NA 
ASV1052 Prevotellaceae Prevotella_7 NA 
ASV1053 Prevotellaceae Alloprevotella NA 
ASV1054 Pasteurellaceae Haemophilus influenzae 
ASV1055 Campylobacteraceae Campylobacter NA 
ASV1056 Prevotellaceae Prevotella NA 
ASV1057 Lachnospiraceae Lachnoanaerobaculum NA 




ASV1058 Family_XIII NA NA 
ASV1059 Fusobacteriaceae Fusobacterium NA 
ASV1060 Pasteurellaceae Aggregatibacter NA 
ASV1061 Leptotrichiaceae Leptotrichia NA 
ASV1062 Veillonellaceae Veillonella NA 
ASV1063 Fusobacteriaceae Fusobacterium NA 
ASV1064 Pasteurellaceae Haemophilus NA 
ASV1065 Campylobacteraceae Campylobacter NA 
ASV1066 Veillonellaceae Veillonella NA 
ASV1067 Veillonellaceae Veillonella NA 
ASV1068 Fusobacteriaceae Fusobacterium NA 
ASV1069 Bacteroidaceae Bacteroides NA 
ASV1070 Lactobacillaceae Lactobacillus acidophilus/casei/crispatus/gallinarum/helveticus/kitasatonis 
ASV1071 Neisseriaceae NA NA 
ASV1072 Pasteurellaceae Haemophilus haemolyticus/influenzae 
ASV1073 Carnobacteriaceae Granulicatella NA 
ASV1074 Leptotrichiaceae Leptotrichia NA 
ASV1075 Porphyromonadaceae Porphyromonas NA 
ASV1076 Prevotellaceae Prevotella_7 NA 
ASV1077 Prevotellaceae Prevotella_6 NA 
ASV1078 Flavobacteriaceae Capnocytophaga NA 
ASV1079 Veillonellaceae Veillonella NA 
ASV1080 Spirochaetaceae Treponema_2 NA 
ASV1081 NA NA NA 
ASV1082 Streptococcaceae Streptococcus NA 
ASV1083 Leptotrichiaceae Leptotrichia NA 




ASV1084 Spirochaetaceae Treponema_2 NA 
ASV1085 Actinomycetaceae Actinomyces NA 
ASV1086 Leptotrichiaceae Leptotrichia NA 
ASV1087 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV1088 Veillonellaceae Dialister micraerophilus/microaerophilus 
ASV1089 Carnobacteriaceae Granulicatella NA 
ASV1090 Lachnospiraceae Stomatobaculum NA 
ASV1091 Veillonellaceae Selenomonas NA 
ASV1092 Porphyromonadaceae Porphyromonas NA 
ASV1093 Spirochaetaceae Treponema_2 NA 
ASV1094 Veillonellaceae Veillonella NA 
ASV1095 Veillonellaceae Selenomonas_3 NA 
ASV1096 Atopobiaceae Atopobium NA 
ASV1097 Leptotrichiaceae Leptotrichia NA 
ASV1098 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1099 Fusobacteriaceae Fusobacterium NA 
ASV1100 Prevotellaceae Prevotella_7 NA 
ASV1101 Weeksellaceae Bergeyella NA 
ASV1102 Neisseriaceae Neisseria NA 
ASV1103 Fusobacteriaceae Fusobacterium NA 
ASV1104 Prevotellaceae Prevotella_7 NA 
ASV1105 Porphyromonadaceae Porphyromonas NA 
ASV1106 Prevotellaceae Prevotella_7 NA 
ASV1107 Prevotellaceae Prevotella NA 
ASV1108 Weeksellaceae Bergeyella NA 
ASV1109 Prevotellaceae Prevotella NA 




ASV1110 Veillonellaceae Veillonella NA 
ASV1111 Leptotrichiaceae Leptotrichia NA 
ASV1112 Veillonellaceae Veillonella NA 
ASV1113 Synergistaceae Fretibacterium NA 
ASV1114 Veillonellaceae Veillonella NA 
ASV1115 Leptotrichiaceae Leptotrichia NA 
ASV1116 Atopobiaceae Atopobium NA 
ASV1117 Veillonellaceae Veillonella NA 
ASV1118 Prevotellaceae Prevotella_2 NA 
ASV1119 Pasteurellaceae Mannheimia NA 
ASV1120 Lachnospiraceae Johnsonella NA 
ASV1121 Fusobacteriaceae Fusobacterium NA 
ASV1122 Lentimicrobiaceae NA NA 
ASV1123 Fusobacteriaceae Fusobacterium NA 
ASV1124 Prevotellaceae Prevotella_7 NA 
ASV1125 Eggerthellaceae Slackia exigua 




ASV1128 Prevotellaceae Prevotella_7 NA 
ASV1129 Veillonellaceae Veillonella NA 
ASV1130 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV1131 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1132 Fusobacteriaceae Fusobacterium NA 
ASV1133 NA NA NA 
ASV1134 Fusobacteriaceae Fusobacterium NA 




ASV1135 Helicobacteraceae Wolinella NA 
ASV1136 Prevotellaceae Prevotella NA 
ASV1137 Prevotellaceae Alloprevotella NA 
ASV1138 Neisseriaceae Conchiformibius NA 
ASV1139 Neisseriaceae NA NA 
ASV1140 Prevotellaceae Prevotella NA 
ASV1141 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV1142 Spirochaetaceae Treponema_2 NA 
ASV1143 Prevotellaceae Prevotella_6 NA 
ASV1144 Neisseriaceae Kingella NA 
ASV1145 p-2534-18B5_gut_group NA NA 
ASV1146 Prevotellaceae Prevotella_7 NA 
ASV1147 Fusobacteriaceae Fusobacterium NA 
ASV1148 Spirochaetaceae Treponema_2 NA 
ASV1149 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV1150 Family_XI Parvimonas NA 
ASV1151 Campylobacteraceae Campylobacter NA 
ASV1152 Prevotellaceae Alloprevotella NA 
ASV1153 Fusobacteriaceae Fusobacterium NA 
ASV1154 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1155 Fusobacteriaceae Fusobacterium NA 
ASV1156 Veillonellaceae Veillonella NA 
ASV1157 Pasteurellaceae Haemophilus NA 
ASV1158 Fusobacteriaceae Fusobacterium NA 
ASV1159 Eubacteriaceae Pseudoramibacter alactolyticus 
ASV1160 Fusobacteriaceae Fusobacterium NA 




ASV1161 Prevotellaceae Alloprevotella NA 
ASV1162 Lachnospiraceae NA NA 
ASV1163 Prevotellaceae Prevotella_7 NA 
ASV1164 Leptotrichiaceae Leptotrichia NA 
ASV1165 Prevotellaceae Alloprevotella NA 
ASV1166 Leptotrichiaceae Leptotrichia NA 
ASV1167 Burkholderiaceae Comamonas NA 
ASV1168 Fusobacteriaceae Fusobacterium NA 
ASV1169 Spirochaetaceae Treponema_2 NA 
ASV1170 Fusobacteriaceae Fusobacterium NA 
ASV1171 NA NA NA 
ASV1172 Paludibacteraceae F0058 NA 
ASV1173 Neisseriaceae Neisseria NA 
ASV1174 Coxiellaceae Coxiella NA 
ASV1175 Micrococcaceae Rothia NA 
ASV1176 NA NA NA 
ASV1177 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV1178 Fusobacteriaceae Fusobacterium NA 
ASV1179 Prevotellaceae Prevotella_7 NA 
ASV1180 Prevotellaceae NA NA 
ASV1181 Fusobacteriaceae Fusobacterium NA 
ASV1182 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1183 Prevotellaceae Prevotella NA 
ASV1184 Prevotellaceae Prevotella_7 NA 
ASV1185 Prevotellaceae Prevotella_7 NA 
ASV1186 Rikenellaceae Rikenellaceae_RC9_gut_group NA 




ASV1187 Spirochaetaceae Treponema_2 putidum 
ASV1188 Atopobiaceae Olsenella NA 
ASV1189 Prevotellaceae Alloprevotella NA 
ASV1190 Porphyromonadaceae Porphyromonas NA 
ASV1191 Burkholderiaceae NA NA 
ASV1192 Lachnospiraceae Butyrivibrio_2 NA 
ASV1193 Veillonellaceae Selenomonas NA 
ASV1194 Prevotellaceae Prevotella_7 NA 
ASV1195 Synergistaceae Fretibacterium NA 
ASV1196 Fusobacteriaceae Fusobacterium NA 
ASV1197 Family_XIII NA NA 
ASV1198 Weeksellaceae Bergeyella NA 
ASV1199 Veillonellaceae Veillonella NA 
ASV1200 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1201 Spirochaetaceae Treponema_2 NA 
ASV1202 Prevotellaceae Prevotella_6 NA 
ASV1203 Flavobacteriaceae Capnocytophaga NA 
ASV1204 Campylobacteraceae Campylobacter NA 
ASV1205 Acholeplasmataceae Acholeplasma NA 
ASV1206 Campylobacteraceae Campylobacter NA 
ASV1207 Spirochaetaceae Treponema_2 NA 
ASV1208 Pasteurellaceae Aggregatibacter NA 
ASV1209 Family_XIII NA NA 
ASV1210 Lachnospiraceae Stomatobaculum NA 
ASV1211 Streptococcaceae Streptococcus NA 
ASV1212 Streptococcaceae Streptococcus NA 




ASV1213 Veillonellaceae Selenomonas_3 NA 
ASV1214 Micrococcaceae Rothia NA 
ASV1215 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1216 Streptococcaceae Streptococcus NA 
ASV1217 Prevotellaceae Alloprevotella NA 
ASV1218 Flavobacteriaceae Capnocytophaga NA 
ASV1219 Fusobacteriaceae Fusobacterium NA 
ASV1220 Veillonellaceae Dialister NA 
ASV1221 Flavobacteriaceae Capnocytophaga NA 
ASV1222 Prevotellaceae Prevotella_7 NA 
ASV1223 Spirochaetaceae Treponema_2 NA 
ASV1224 Leptotrichiaceae Leptotrichia NA 
ASV1225 Prevotellaceae Alloprevotella NA 
ASV1226 Prevotellaceae Prevotella NA 
ASV1227 Cardiobacteriaceae Cardiobacterium NA 
ASV1228 Synergistaceae Pyramidobacter piscolens 
ASV1229 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1230 Prevotellaceae Alloprevotella NA 
ASV1231 Spirochaetaceae Treponema_2 NA 
ASV1232 Veillonellaceae Veillonella NA 
ASV1233 Spirochaetaceae Treponema_2 NA 
ASV1234 Pasteurellaceae Actinobacillus NA 
ASV1235 Porphyromonadaceae Porphyromonas NA 
ASV1236 Fusobacteriaceae Fusobacterium NA 
ASV1237 Lactobacillaceae Lactobacillus NA 
ASV1238 Prevotellaceae Prevotella_2 NA 




ASV1239 Spirochaetaceae Treponema_2 NA 
ASV1240 Flavobacteriaceae Capnocytophaga NA 
ASV1241 NA NA NA 
ASV1242 Prevotellaceae Prevotella NA 
ASV1243 Streptococcaceae Streptococcus NA 
ASV1244 Weeksellaceae Bergeyella NA 
ASV1245 Family_XIII Mogibacterium NA 
ASV1246 Erysipelotrichaceae Eggerthia catenaformis 
ASV1247 Streptococcaceae Streptococcus NA 
ASV1248 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1249 Flavobacteriaceae Capnocytophaga NA 
ASV1250 Family_XI Gemella NA 
ASV1251 Streptococcaceae Streptococcus NA 
ASV1252 Veillonellaceae Veillonella NA 
ASV1253 Weeksellaceae Bergeyella NA 
ASV1254 Streptococcaceae Streptococcus NA 
ASV1255 Lachnospiraceae Stomatobaculum NA 
ASV1256 Prevotellaceae Prevotella_7 NA 
ASV1257 Fusobacteriaceae Fusobacterium NA 
ASV1258 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1259 Campylobacteraceae Campylobacter NA 
ASV1260 Family_XIII Mogibacterium NA 
ASV1261 Lachnospiraceae Stomatobaculum NA 
ASV1262 Prevotellaceae Alloprevotella NA 
ASV1263 Streptococcaceae Streptococcus NA 
ASV1264 Lactobacillaceae Lactobacillus acidophilus/amylovorus/ultunensis 




ASV1265 NA NA NA 
ASV1266 Weeksellaceae Bergeyella cardium 
ASV1267 Spirochaetaceae Treponema_2 NA 
ASV1268 Prevotellaceae Prevotella NA 
ASV1269 Leptotrichiaceae Streptobacillus NA 
ASV1270 Neisseriaceae Neisseria NA 
ASV1271 Prevotellaceae Alloprevotella NA 
ASV1272 Prevotellaceae Prevotella_7 NA 
ASV1273 Neisseriaceae Alysiella NA 
ASV1274 Carnobacteriaceae Granulicatella NA 
ASV1275 Streptococcaceae Streptococcus NA 
ASV1276 Family_XI Parvimonas NA 
ASV1277 Prevotellaceae Prevotella NA 
ASV1278 Lactobacillaceae Lactobacillus paraplantarum/plantarum 
ASV1279 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1280 Prevotellaceae Alloprevotella NA 
ASV1281 Lactobacillaceae Lactobacillus amylovorus 
ASV1282 Lactobacillaceae Lactobacillus brevis/buchneri/helveticus/kefiri/otakiensis/parabuchneri/pontis/sunkii 
ASV1283 Fusobacteriaceae Fusobacterium NA 
ASV1284 Neisseriaceae Neisseria NA 
ASV1285 Leptotrichiaceae Leptotrichia NA 
ASV1286 Burkholderiaceae Pelomonas aquatica/puraquae/saccharophila 
ASV1287 Prevotellaceae Prevotella_7 NA 
ASV1288 Spirochaetaceae Treponema_2 NA 
ASV1289 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1290 Campylobacteraceae Campylobacter NA 




ASV1291 Prevotellaceae Alloprevotella NA 
ASV1292 Neisseriaceae Alysiella NA 
ASV1293 Prevotellaceae Prevotella_7 NA 
ASV1294 NA NA NA 
ASV1295 Actinomycetaceae Actinomyces NA 
ASV1296 Acholeplasmataceae Acholeplasma NA 
ASV1297 Prevotellaceae Alloprevotella NA 
ASV1298 Prevotellaceae Alloprevotella NA 
ASV1299 Neisseriaceae NA NA 
ASV1300 Fusobacteriaceae Fusobacterium NA 
ASV1301 Carnobacteriaceae Granulicatella NA 
ASV1302 Family_XI Gemella NA 
ASV1303 Prevotellaceae Prevotella NA 
ASV1304 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1305 Prevotellaceae Prevotella NA 
ASV1306 Pasteurellaceae NA NA 
ASV1307 Prevotellaceae Prevotella_7 NA 
ASV1308 Pasteurellaceae Haemophilus NA 
ASV1309 Streptococcaceae Streptococcus NA 
ASV1310 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1311 Fusobacteriaceae Fusobacterium NA 
ASV1312 Atopobiaceae Olsenella uli 
ASV1313 Family_XIII Mogibacterium NA 
ASV1314 Veillonellaceae Veillonella NA 
ASV1315 Lactobacillaceae Lactobacillus NA 
ASV1316 Xanthobacteraceae NA NA 




ASV1317 Prevotellaceae Prevotella NA 
ASV1318 Leptotrichiaceae Leptotrichia NA 
ASV1319 Leptotrichiaceae Leptotrichia NA 
ASV1320 Streptococcaceae Streptococcus NA 
ASV1321 Flavobacteriaceae Capnocytophaga NA 
ASV1322 Leptotrichiaceae Leptotrichia NA 
ASV1323 Neisseriaceae Kingella NA 
ASV1324 Weeksellaceae Bergeyella NA 
ASV1325 Neisseriaceae Kingella NA 
ASV1326 Veillonellaceae Selenomonas_3 NA 
ASV1327 Lentimicrobiaceae NA NA 
ASV1328 Neisseriaceae Neisseria NA 
ASV1329 Prevotellaceae Prevotella NA 
ASV1330 Neisseriaceae Neisseria NA 
ASV1331 Veillonellaceae Selenomonas_3 NA 
ASV1332 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1333 Lachnospiraceae Howardella NA 
ASV1334 Neisseriaceae Neisseria NA 
ASV1335 Fusobacteriaceae Fusobacterium NA 
ASV1336 Micrococcaceae Rothia NA 
ASV1337 Lachnospiraceae Shuttleworthia satelles 
ASV1338 Lachnospiraceae Stomatobaculum NA 
ASV1339 Carnobacteriaceae Granulicatella NA 
ASV1340 Prevotellaceae Prevotella_7 NA 
ASV1341 Fusobacteriaceae Fusobacterium NA 
ASV1342 Neisseriaceae NA NA 




ASV1343 Spirochaetaceae Treponema_2 NA 
ASV1344 Prevotellaceae Prevotella_7 NA 
ASV1345 Prevotellaceae Prevotella NA 
ASV1346 Prevotellaceae Prevotella_6 NA 
ASV1347 Fusobacteriaceae Fusobacterium NA 
ASV1348 Prevotellaceae Alloprevotella NA 
ASV1349 Prevotellaceae Prevotella NA 
ASV1350 Streptococcaceae Streptococcus NA 
ASV1351 Fusobacteriaceae Fusobacterium NA 
ASV1352 Veillonellaceae Veillonella NA 
ASV1353 Prevotellaceae NA NA 
ASV1354 Lachnospiraceae Oribacterium NA 
ASV1355 Lachnospiraceae Stomatobaculum NA 
ASV1356 Paludibacteraceae F0058 NA 
ASV1357 Prevotellaceae Prevotella NA 
ASV1358 Streptococcaceae Streptococcus NA 
ASV1359 Carnobacteriaceae Granulicatella NA 
ASV1360 Prevotellaceae Alloprevotella NA 
ASV1361 Moraxellaceae Acinetobacter baumannii/bouvetii/haemolyticus/johnsonii/junii/lwoffii/oleivorans/oryzae/schindleri 
ASV1362 Prevotellaceae Prevotella_7 NA 
ASV1363 Spirochaetaceae Treponema_2 NA 
ASV1364 Lachnospiraceae Stomatobaculum NA 
ASV1365 Fusobacteriaceae Fusobacterium NA 
ASV1366 Fusobacteriaceae Fusobacterium NA 
ASV1367 Muribaculaceae NA NA 
ASV1368 Lachnospiraceae NA NA 




ASV1369 Leptotrichiaceae Leptotrichia NA 
ASV1370 Veillonellaceae Veillonella NA 
ASV1371 Streptococcaceae Streptococcus NA 
ASV1372 Prevotellaceae Prevotella NA 
ASV1373 Lachnospiraceae Catonella NA 
ASV1374 Spirochaetaceae Treponema_2 NA 
ASV1375 Leptotrichiaceae Leptotrichia NA 
ASV1376 Leptotrichiaceae Leptotrichia NA 
ASV1377 Carnobacteriaceae Granulicatella NA 
ASV1378 Bifidobacteriaceae Alloscardovia NA 
ASV1379 NA NA NA 
ASV1380 Spirochaetaceae Treponema_2 NA 
ASV1381 Lachnospiraceae Oribacterium NA 
ASV1382 Fusobacteriaceae Fusobacterium NA 
ASV1383 Cardiobacteriaceae NA NA 
ASV1384 Leptotrichiaceae Leptotrichia NA 
ASV1385 Actinomycetaceae Actinomyces NA 
ASV1386 Family_XIII NA NA 
ASV1387 Veillonellaceae Megasphaera NA 
ASV1388 Veillonellaceae Veillonella NA 
ASV1389 Actinomycetaceae Actinomyces NA 
ASV1390 Prevotellaceae Prevotella_6 NA 
ASV1391 Spirochaetaceae Treponema_2 NA 
ASV1392 Lachnospiraceae Oribacterium NA 
ASV1393 Weeksellaceae Bergeyella NA 
ASV1394 Corynebacteriaceae Corynebacterium_1 aurimucosum/pseudogenitalium/tuberculostearicum 




ASV1395 Prevotellaceae Alloprevotella NA 
ASV1396 Campylobacteraceae Campylobacter NA 
ASV1397 Fusobacteriaceae Fusobacterium NA 
ASV1398 Campylobacteraceae Campylobacter NA 
ASV1399 Neisseriaceae Kingella NA 
ASV1400 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1401 Fusobacteriaceae Fusobacterium NA 
ASV1402 Lachnospiraceae Stomatobaculum NA 
ASV1403 Cardiobacteriaceae Cardiobacterium NA 
ASV1404 Veillonellaceae Veillonella NA 
ASV1405 Lachnospiraceae Stomatobaculum NA 
ASV1406 Carnobacteriaceae Granulicatella NA 
ASV1407 Leptotrichiaceae Leptotrichia NA 
ASV1408 Family_XI Gemella NA 
ASV1409 Moraxellaceae Acinetobacter baumannii/beijerinckii/bereziniae/calcoaceticus/courvalinii/gerneri/guillouiae/gyllenbergii/indicus/johnsonii/junii/lwoffii/modestus/parvus/plantarum/proteolyticus/vivianii 
ASV1410 Flavobacteriaceae Capnocytophaga NA 
ASV1411 Actinomycetaceae Actinomyces NA 
ASV1412 Carnobacteriaceae Granulicatella NA 
ASV1413 Veillonellaceae Veillonella NA 
ASV1414 Actinomycetaceae Actinomyces NA 
ASV1415 Lachnospiraceae Howardella NA 
ASV1416 NA NA NA 
ASV1417 Flavobacteriaceae Capnocytophaga NA 
ASV1418 Pasteurellaceae Haemophilus NA 
ASV1419 Leptotrichiaceae Leptotrichia NA 
ASV1420 Leptotrichiaceae Leptotrichia NA 




ASV1421 NA NA NA 
ASV1422 Flavobacteriaceae Capnocytophaga NA 
ASV1423 Family_XI Gemella NA 
ASV1424 Veillonellaceae Veillonella NA 
ASV1425 Porphyromonadaceae Porphyromonas NA 
ASV1426 Fusobacteriaceae Fusobacterium NA 
ASV1427 NA NA NA 
ASV1428 Prevotellaceae Alloprevotella NA 
ASV1429 Veillonellaceae Veillonella NA 
ASV1430 Prevotellaceae Alloprevotella NA 
ASV1431 Prevotellaceae Prevotella_7 NA 
ASV1432 Leptotrichiaceae Leptotrichia NA 
ASV1433 Porphyromonadaceae Porphyromonas NA 
ASV1434 Prevotellaceae Prevotella_7 NA 
ASV1435 Prevotellaceae Prevotella_7 NA 
ASV1436 Prevotellaceae NA NA 
ASV1437 Flavobacteriaceae Capnocytophaga NA 
ASV1438 Neisseriaceae Neisseria NA 
ASV1439 Streptococcaceae Streptococcus NA 
ASV1440 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1441 Pasteurellaceae Haemophilus NA 
ASV1442 Spirochaetaceae Treponema_2 NA 
ASV1443 Neisseriaceae NA NA 
ASV1444 Enterobacteriaceae Raoultella electrica/ornithinolytica/planticola 
ASV1445 Leptotrichiaceae Streptobacillus hongkongensis 
ASV1446 Erysipelotrichaceae Erysipelotrichaceae_UCG-004 NA 




ASV1447 Lachnospiraceae NA NA 
ASV1448 Fusobacteriaceae Fusobacterium NA 
ASV1449 Prevotellaceae Prevotella_7 NA 
ASV1450 Peptostreptococcaceae Peptoanaerobacter NA 
ASV1451 Fusobacteriaceae Fusobacterium NA 
ASV1452 Prevotellaceae Prevotella_6 NA 
ASV1453 Spirochaetaceae Treponema_2 NA 
ASV1454 Porphyromonadaceae Porphyromonas NA 
ASV1455 Fusobacteriaceae Fusobacterium NA 
ASV1456 Flavobacteriaceae Capnocytophaga NA 
ASV1457 Spirochaetaceae Treponema_2 NA 
ASV1458 Peptostreptococcaceae NA NA 
ASV1459 Weeksellaceae Bergeyella NA 
ASV1460 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1461 Prevotellaceae Alloprevotella NA 
ASV1462 Lachnospiraceae Oribacterium NA 
ASV1463 Leptotrichiaceae Leptotrichia NA 
ASV1464 Prevotellaceae Prevotella NA 
ASV1465 Prevotellaceae Prevotella_7 NA 
ASV1466 NA NA NA 
ASV1467 Prevotellaceae Prevotella_6 NA 
ASV1468 Neisseriaceae Kingella NA 
ASV1469 NA NA NA 
ASV1470 Streptococcaceae Streptococcus NA 
ASV1471 Fusobacteriaceae Fusobacterium NA 
ASV1472 Prevotellaceae Prevotella NA 




ASV1473 Prevotellaceae Prevotella_7 NA 
ASV1474 NA NA NA 
ASV1475 Corynebacteriaceae Corynebacterium NA 
ASV1476 Moraxellaceae Acinetobacter bouvetii/haemolyticus/johnsonii/junii 
ASV1477 Family_XI Gemella NA 
ASV1478 Prevotellaceae Prevotella_7 NA 
ASV1479 Streptococcaceae Streptococcus NA 
ASV1480 Neisseriaceae Neisseria NA 
ASV1481 Porphyromonadaceae Porphyromonas NA 
ASV1482 Porphyromonadaceae Porphyromonas NA 
ASV1483 Prevotellaceae Prevotella_7 NA 
ASV1484 Mycoplasmataceae Mycoplasma spermatophilum 
ASV1485 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1486 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1487 Pasteurellaceae Aggregatibacter NA 
ASV1488 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1489 Prevotellaceae Alloprevotella NA 
ASV1490 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1491 Prevotellaceae Alloprevotella NA 
ASV1492 Pasteurellaceae Haemophilus NA 
ASV1493 Enterobacteriaceae NA NA 
ASV1494 Fusobacteriaceae Fusobacterium NA 
ASV1495 NA NA NA 
ASV1496 Neisseriaceae Alysiella NA 
ASV1497 Prevotellaceae Prevotella_2 NA 
ASV1498 Lachnospiraceae Johnsonella NA 




ASV1499 Burkholderiaceae Delftia acidovorans/cf./lacustris/tsuruhatensis 
ASV1500 NA NA NA 
ASV1501 Prevotellaceae Prevotella_6 NA 
ASV1502 Veillonellaceae Selenomonas_3 NA 
ASV1503 Prevotellaceae Prevotella NA 
ASV1504 Leptotrichiaceae Leptotrichia NA 
ASV1505 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1506 Weeksellaceae Bergeyella cardium 
ASV1507 Prevotellaceae Prevotella_7 NA 
ASV1508 Fusobacteriaceae Fusobacterium NA 
ASV1509 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1510 Leptotrichiaceae Leptotrichia NA 
ASV1511 Prevotellaceae Alloprevotella NA 
ASV1512 Atopobiaceae Atopobium NA 
ASV1513 Fusobacteriaceae Fusobacterium NA 
ASV1514 Fusobacteriaceae Fusobacterium NA 
ASV1515 Prevotellaceae Prevotella_7 NA 
ASV1516 NA NA NA 
ASV1517 Streptococcaceae Streptococcus NA 
ASV1518 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1519 Mycoplasmataceae Mycoplasma NA 
ASV1520 Fusobacteriaceae Fusobacterium NA 
ASV1521 Prevotellaceae Prevotella_7 NA 
ASV1522 Prevotellaceae Alloprevotella NA 
ASV1523 Fusobacteriaceae Fusobacterium NA 
ASV1524 Leptotrichiaceae Leptotrichia NA 




ASV1525 Corynebacteriaceae Corynebacterium NA 
ASV1526 Weeksellaceae Bergeyella NA 
ASV1527 Weeksellaceae Bergeyella NA 
ASV1528 Fusobacteriaceae Fusobacterium NA 
ASV1529 Prevotellaceae Prevotella NA 
ASV1530 Streptococcaceae Streptococcus NA 
ASV1531 Veillonellaceae Selenomonas_3 NA 
ASV1532 Prevotellaceae Prevotella NA 
ASV1533 Desulfovibrionaceae Desulfovibrio NA 
ASV1534 Leptotrichiaceae Leptotrichia NA 
ASV1535 Prevotellaceae Alloprevotella NA 
ASV1536 Fusobacteriaceae Fusobacterium NA 
ASV1537 Neisseriaceae Alysiella NA 
ASV1538 Lachnospiraceae Roseburia NA 
ASV1539 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1540 Enterococcaceae Vagococcus NA 
ASV1541 Spirochaetaceae Treponema_2 NA 
ASV1542 Carnobacteriaceae Granulicatella NA 
ASV1543 Prevotellaceae Alloprevotella NA 
ASV1544 Xanthobacteraceae Bradyrhizobium NA 
ASV1545 NA NA NA 
ASV1546 Streptococcaceae Streptococcus NA 
ASV1547 Spirochaetaceae Treponema_2 NA 
ASV1548 Veillonellaceae Veillonella NA 
ASV1549 Veillonellaceae Veillonella NA 
ASV1550 Prevotellaceae Prevotella_7 NA 




ASV1551 Spirochaetaceae Treponema_2 NA 
ASV1552 Prevotellaceae Prevotella_2 NA 
ASV1553 Prevotellaceae Prevotella NA 
ASV1554 Veillonellaceae Dialister NA 
ASV1555 Neisseriaceae Kingella NA 
ASV1556 Veillonellaceae Veillonella NA 
ASV1557 Leptotrichiaceae Leptotrichia NA 
ASV1558 Veillonellaceae Veillonella NA 
ASV1559 Prevotellaceae Prevotella_7 NA 
ASV1560 Prevotellaceae Prevotella NA 
ASV1561 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1562 Prevotellaceae Alloprevotella NA 
ASV1563 Clostridiales_vadinBB60_group NA NA 
ASV1564 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1565 Lachnospiraceae Oribacterium NA 
ASV1566 NA NA NA 
ASV1567 Prevotellaceae Alloprevotella NA 
ASV1568 Veillonellaceae NA NA 
ASV1569 Family_XIII NA NA 
ASV1570 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1571 Erysipelotrichaceae Erysipelotrichaceae_UCG-004 NA 
ASV1572 Lachnospiraceae Stomatobaculum NA 
ASV1573 Fusobacteriaceae Fusobacterium NA 
ASV1574 Lachnospiraceae Stomatobaculum NA 
ASV1575 Spirochaetaceae Treponema_2 NA 
ASV1576 Neisseriaceae NA NA 




ASV1577 Mycoplasmataceae Mycoplasma NA 
ASV1578 Streptococcaceae Streptococcus NA 
ASV1579 Spirochaetaceae Treponema_2 NA 
ASV1580 Veillonellaceae Selenomonas_3 NA 
ASV1581 Prevotellaceae Alloprevotella NA 
ASV1582 Prevotellaceae Prevotella_2 NA 
ASV1583 Prevotellaceae Prevotella_7 NA 
ASV1584 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1585 Carnobacteriaceae Granulicatella NA 
ASV1586 Prevotellaceae Prevotella NA 
ASV1587 Veillonellaceae Veillonella NA 
ASV1588 Family_XIII NA NA 
ASV1589 NA NA NA 
ASV1590 Leptotrichiaceae Leptotrichia NA 
ASV1591 Rs-M59_termite_group NA NA 
ASV1592 Tannerellaceae Tannerella NA 
ASV1593 NA NA NA 
ASV1594 Family_XI Gemella NA 
ASV1595 Lachnospiraceae Stomatobaculum NA 
ASV1596 Streptococcaceae Streptococcus NA 
ASV1597 Veillonellaceae Veillonella NA 
ASV1598 Prevotellaceae Prevotella_7 NA 
ASV1599 Prevotellaceae Prevotella NA 
ASV1600 NA NA NA 
ASV1601 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1602 Carnobacteriaceae Granulicatella NA 




ASV1603 Leptotrichiaceae Leptotrichia NA 
ASV1604 Prevotellaceae Prevotella NA 
ASV1605 Fusobacteriaceae Fusobacterium NA 
ASV1606 Prevotellaceae Prevotella_7 NA 
ASV1607 Corynebacteriaceae Corynebacterium_1 aurimucosum/jeikeium/propinquum/pseudodiphtheriticum 
ASV1608 Prevotellaceae Prevotella_2 NA 
ASV1609 Porphyromonadaceae Porphyromonas NA 
ASV1610 Rhodocyclaceae Propionivibrio NA 
ASV1611 Prevotellaceae Prevotella_2 NA 
ASV1612 Prevotellaceae Prevotella_6 NA 
ASV1613 Family_XI Parvimonas NA 
ASV1614 Prevotellaceae Prevotella NA 
ASV1615 NA NA NA 
ASV1616 Veillonellaceae Veillonella NA 
ASV1617 Lachnospiraceae Stomatobaculum NA 
ASV1618 NA NA NA 
ASV1619 Carnobacteriaceae Granulicatella NA 
ASV1620 Actinomycetaceae Actinomyces NA 
ASV1621 Veillonellaceae Selenomonas_3 NA 
ASV1622 Prevotellaceae Prevotella_6 NA 
ASV1623 Prevotellaceae Prevotella_7 NA 
ASV1624 Leptotrichiaceae Sneathia amnii/sanguinegens 
ASV1625 NA NA NA 
ASV1626 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV1627 Prevotellaceae Alloprevotella NA 
ASV1628 Family_XI Gemella NA 




ASV1629 Peptococcaceae Peptococcus NA 
ASV1630 Fusobacteriaceae Fusobacterium NA 
ASV1631 Leptotrichiaceae Leptotrichia NA 
ASV1632 NA NA NA 
ASV1633 Fusobacteriaceae Fusobacterium NA 
ASV1634 Prevotellaceae Prevotella NA 
ASV1635 Micrococcaceae Rothia NA 
ASV1636 Spirochaetaceae Treponema_2 NA 
ASV1637 Prevotellaceae Alloprevotella NA 
ASV1638 Lactobacillaceae Lactobacillus kalixensis 
ASV1639 Lachnospiraceae Johnsonella NA 
ASV1640 Actinomycetaceae Actinomyces NA 
ASV1641 Family_XIII Mogibacterium NA 
ASV1642 Fusobacteriaceae Fusobacterium NA 
ASV1643 Streptococcaceae Streptococcus NA 
ASV1644 Leptotrichiaceae Leptotrichia NA 
ASV1645 Prevotellaceae Prevotella_6 NA 
ASV1646 Prevotellaceae Prevotella_7 NA 
ASV1647 Fusobacteriaceae Fusobacterium NA 
ASV1648 Prevotellaceae Prevotella_7 NA 
ASV1649 Prevotellaceae Alloprevotella NA 
ASV1650 Atopobiaceae Atopobium NA 
ASV1651 Carnobacteriaceae Granulicatella NA 
ASV1652 Bifidobacteriaceae Scardovia NA 
ASV1653 Veillonellaceae Megasphaera NA 
ASV1654 Veillonellaceae Selenomonas_3 NA 




ASV1655 Leptotrichiaceae Leptotrichia NA 
ASV1656 Lentimicrobiaceae NA NA 
ASV1657 Flavobacteriaceae Capnocytophaga NA 
ASV1658 Carnobacteriaceae Granulicatella NA 
ASV1659 Streptococcaceae Streptococcus NA 
ASV1660 Pasteurellaceae Haemophilus NA 
ASV1661 Tannerellaceae Tannerella NA 
ASV1662 Veillonellaceae Selenomonas_3 NA 
ASV1663 Spirochaetaceae Treponema_2 NA 
ASV1664 Prevotellaceae Prevotella_7 NA 
ASV1665 Flavobacteriaceae Capnocytophaga NA 
ASV1666 Prevotellaceae Prevotella_7 NA 
ASV1667 Prevotellaceae Alloprevotella NA 
ASV1668 Veillonellaceae Selenomonas_3 NA 
ASV1669 Synergistaceae Fretibacterium NA 
ASV1670 Family_XIII Mogibacterium NA 
ASV1671 Veillonellaceae Dialister NA 
ASV1672 Neisseriaceae Kingella NA 
ASV1673 Neisseriaceae Neisseria NA 
ASV1674 Marinifilaceae Odoribacter NA 
ASV1675 Moraxellaceae Acinetobacter baumannii/beijerinckii/bouvetii/calcoaceticus/dispersus/gyllenbergii/haemolyticus/junii/oryzae/parvus/tandoii/tjernbergiae 
ASV1676 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1677 Spirochaetaceae Treponema_2 NA 
ASV1678 Spirochaetaceae Treponema_2 NA 
ASV1679 Actinomycetaceae Actinomyces NA 
ASV1680 Spirochaetaceae Treponema_2 NA 




ASV1681 Veillonellaceae Veillonella NA 
ASV1682 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1683 Family_XI Peptoniphilus lacrimalis 
ASV1684 Veillonellaceae Veillonella NA 
ASV1685 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1686 Fusobacteriaceae Fusobacterium NA 
ASV1687 Fusobacteriaceae Fusobacterium NA 
ASV1688 Pasteurellaceae Haemophilus NA 
ASV1689 Prevotellaceae Prevotella_7 NA 
ASV1690 Mycoplasmataceae Mycoplasma NA 
ASV1691 Veillonellaceae Selenomonas_3 NA 
ASV1692 Leptotrichiaceae Leptotrichia NA 
ASV1693 Pasteurellaceae Actinobacillus NA 
ASV1694 Streptococcaceae Streptococcus NA 
ASV1695 Pasteurellaceae Aggregatibacter NA 
ASV1696 Spirochaetaceae Treponema_2 NA 
ASV1697 Spirochaetaceae Treponema_2 NA 
ASV1698 Lachnospiraceae Oribacterium NA 
ASV1699 Leptotrichiaceae Leptotrichia NA 
ASV1700 Veillonellaceae Veillonella NA 
ASV1701 Prevotellaceae Prevotella_2 NA 
ASV1702 Carnobacteriaceae Granulicatella NA 
ASV1703 Streptococcaceae Streptococcus NA 
ASV1704 Pseudomonadaceae Pseudomonas antarctica/auricularis/azotoformans/brenneri/canadensis/cedrina/cerasi/cf./costantinii/extremaustralis/extremorientalis/fluorescens/gessardii/grimontii/lactis/libanensis/lurida/mandelii/marginalis/meridiana/paralactis/poae/proteolytica/putida/reactans/salomonii/simiae/syncyanea/synxantha/tolaasii/trivialis/veronii 
ASV1705 Family_XIII NA NA 
ASV1706 Fusobacteriaceae Fusobacterium NA 




ASV1707 NA NA NA 
ASV1708 Spirochaetaceae Treponema_2 NA 
ASV1709 Fusobacteriaceae Fusobacterium NA 
ASV1710 Prevotellaceae Prevotella NA 
ASV1711 Flavobacteriaceae Capnocytophaga NA 
ASV1712 Mycoplasmataceae Mycoplasma NA 
ASV1713 Micrococcaceae Rothia NA 
ASV1714 Streptococcaceae Streptococcus NA 
ASV1715 Neisseriaceae Neisseria NA 
ASV1716 Fusobacteriaceae Fusobacterium NA 
ASV1717 Prevotellaceae Prevotella_7 NA 
ASV1718 Veillonellaceae Veillonella NA 
ASV1719 Veillonellaceae Veillonella NA 
ASV1720 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1721 Peptostreptococcaceae Filifactor NA 
ASV1722 Porphyromonadaceae Porphyromonas NA 
ASV1723 Weeksellaceae Bergeyella NA 
ASV1724 Fusobacteriaceae Fusobacterium NA 
ASV1725 Streptococcaceae Streptococcus NA 
ASV1726 Leptotrichiaceae Leptotrichia NA 
ASV1727 Carnobacteriaceae Granulicatella NA 
ASV1728 Neisseriaceae Alysiella NA 
ASV1729 Corynebacteriaceae Corynebacterium_1 kroppenstedtii 
ASV1730 NA NA NA 
ASV1731 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV1732 Ruminococcaceae Ruminococcaceae_UCG-014 NA 




ASV1733 Campylobacteraceae Campylobacter NA 
ASV1734 Prevotellaceae Prevotella_7 NA 
ASV1735 NA NA NA 
ASV1736 Veillonellaceae Veillonella NA 
ASV1737 Leptotrichiaceae Leptotrichia NA 
ASV1738 Prevotellaceae Prevotella_7 NA 
ASV1739 Streptococcaceae Streptococcus NA 
ASV1740 Mycoplasmataceae Mycoplasma NA 
ASV1741 Streptococcaceae Streptococcus NA 
ASV1742 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1743 Spirochaetaceae Treponema_2 NA 
ASV1744 Carnobacteriaceae Granulicatella NA 
ASV1745 Lactobacillaceae Lactobacillus iners 
ASV1746 Prevotellaceae Alloprevotella NA 
ASV1747 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1748 Spirochaetaceae Treponema_2 NA 
ASV1749 Veillonellaceae Megasphaera NA 
ASV1750 Prevotellaceae Prevotella_7 NA 
ASV1751 Lachnospiraceae Johnsonella NA 
ASV1752 Cardiobacteriaceae Cardiobacterium NA 
ASV1753 Lachnospiraceae Butyrivibrio_2 NA 
ASV1754 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1755 Spirochaetaceae Treponema_2 NA 
ASV1756 Streptococcaceae Streptococcus NA 
ASV1757 Corynebacteriaceae Corynebacterium NA 
ASV1758 Pasteurellaceae NA NA 




ASV1759 Mycoplasmataceae Mycoplasma NA 
ASV1760 Flavobacteriaceae Capnocytophaga NA 
ASV1761 Veillonellaceae Selenomonas_3 NA 
ASV1762 Fusobacteriaceae Fusobacterium NA 
ASV1763 Veillonellaceae Veillonella NA 
ASV1764 Veillonellaceae Selenomonas sputigena 
ASV1765 Leptotrichiaceae Leptotrichia NA 
ASV1766 Prevotellaceae Prevotella_7 NA 
ASV1767 Lachnospiraceae Oribacterium NA 
ASV1768 Prevotellaceae Prevotella NA 
ASV1769 Paludibacteraceae F0058 NA 
ASV1770 Campylobacteraceae Campylobacter NA 
ASV1771 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1772 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1773 Spirochaetaceae Treponema_2 NA 
ASV1774 Fusobacteriaceae Fusobacterium NA 
ASV1775 Prevotellaceae Alloprevotella NA 
ASV1776 Streptococcaceae Lactococcus garvieae/lactis/taiwanensis 
ASV1777 Prevotellaceae Prevotella NA 
ASV1778 Lachnospiraceae NA NA 
ASV1779 Burkholderiaceae NA NA 
ASV1780 Flavobacteriaceae Capnocytophaga NA 
ASV1781 Family_XI Gemella NA 
ASV1782 Flavobacteriaceae Capnocytophaga NA 
ASV1783 Lachnospiraceae NA NA 




ASV1784 Synergistaceae Jonquetella anthropi 
ASV1785 Veillonellaceae Veillonella NA 
ASV1786 NA NA NA 
ASV1787 Lachnospiraceae Johnsonella NA 
ASV1788 Veillonellaceae Selenomonas_3 NA 
ASV1789 Fusobacteriaceae Fusobacterium NA 
ASV1790 Micrococcaceae Rothia NA 
ASV1791 Paludibacteraceae F0058 NA 
ASV1792 Veillonellaceae Veillonella NA 
ASV1793 Streptococcaceae Streptococcus NA 
ASV1794 Micrococcaceae Rothia NA 
ASV1795 Carnobacteriaceae Granulicatella NA 
ASV1796 Veillonellaceae NA NA 
ASV1797 Streptococcaceae Streptococcus NA 
ASV1798 Carnobacteriaceae Granulicatella NA 
ASV1799 Veillonellaceae Megasphaera NA 
ASV1800 Campylobacteraceae Campylobacter NA 
ASV1801 Moraxellaceae Moraxella NA 
ASV1802 Flavobacteriaceae Capnocytophaga NA 
ASV1803 Porphyromonadaceae Porphyromonas NA 
ASV1804 Fusobacteriaceae Fusobacterium NA 
ASV1805 Fusobacteriaceae Fusobacterium NA 
ASV1806 Leptotrichiaceae Leptotrichia NA 
ASV1807 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1808 Prevotellaceae Prevotella_7 NA 




ASV1809 Leptotrichiaceae Leptotrichia NA 
ASV1810 Campylobacteraceae Campylobacter NA 
ASV1811 Veillonellaceae Veillonella NA 
ASV1812 Pasteurellaceae Haemophilus NA 
ASV1813 Fusobacteriaceae Fusobacterium NA 
ASV1814 Carnobacteriaceae Granulicatella NA 
ASV1815 Prevotellaceae Alloprevotella NA 
ASV1816 Prevotellaceae Prevotella_7 NA 
ASV1817 Fusobacteriaceae Fusobacterium NA 
ASV1818 Streptococcaceae Streptococcus NA 
ASV1819 Spirochaetaceae Treponema_2 putidum 
ASV1820 Burkholderiaceae Lautropia NA 
ASV1821 Streptococcaceae Streptococcus NA 
ASV1822 Spirochaetaceae Treponema_2 NA 
ASV1823 Leptotrichiaceae Leptotrichia NA 
ASV1824 Tannerellaceae Tannerella NA 
ASV1825 Leptotrichiaceae Leptotrichia NA 
ASV1826 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1827 Neisseriaceae Neisseria NA 
ASV1828 Carnobacteriaceae Granulicatella NA 
ASV1829 Prevotellaceae Prevotella_2 NA 
ASV1830 Flavobacteriaceae Capnocytophaga NA 
ASV1831 Veillonellaceae Veillonella NA 
ASV1832 Flavobacteriaceae Capnocytophaga NA 
ASV1833 Prevotellaceae Alloprevotella NA 
ASV1834 Pasteurellaceae Aggregatibacter NA 




ASV1835 Prevotellaceae Prevotella NA 
ASV1836 Fusobacteriaceae Fusobacterium NA 
ASV1837 NA NA NA 
ASV1838 Streptococcaceae Streptococcus NA 
ASV1839 Carnobacteriaceae Granulicatella NA 
ASV1840 Weeksellaceae Bergeyella NA 
ASV1841 Prevotellaceae Prevotella_7 NA 
ASV1842 Porphyromonadaceae Porphyromonas NA 
ASV1843 Streptococcaceae Streptococcus NA 
ASV1844 Prevotellaceae Alloprevotella NA 
ASV1845 Carnobacteriaceae Granulicatella NA 
ASV1846 Fusobacteriaceae Fusobacterium NA 
ASV1847 Leptotrichiaceae Leptotrichia NA 
ASV1848 Cardiobacteriaceae Cardiobacterium NA 
ASV1849 Prevotellaceae Prevotella_7 NA 
ASV1850 Prevotellaceae Prevotella NA 
ASV1851 Tannerellaceae Tannerella NA 
ASV1852 Family_XI Parvimonas NA 
ASV1853 Leptotrichiaceae Leptotrichia NA 
ASV1854 Flavobacteriaceae Capnocytophaga NA 
ASV1855 Prevotellaceae Prevotella_7 NA 
ASV1856 Mycoplasmataceae Mycoplasma NA 
ASV1857 Halomonadaceae Halomonas aidingensis/alimentaria/cerina/daqiaonensis/desiderata/fontilapidosi/lutea/nitroreducens/rifensis/salina/stenophila/ventosae 
ASV1858 Xanthomonadaceae Stenotrophomonas maltophilia 
ASV1859 Streptococcaceae Streptococcus NA 
ASV1860 Prevotellaceae Prevotella_7 NA 




ASV1861 Lachnospiraceae Stomatobaculum NA 
ASV1862 Lactobacillaceae Lactobacillus NA 
ASV1863 Lactobacillaceae Lactobacillus NA 
ASV1864 Family_XI Parvimonas NA 
ASV1865 Lachnospiraceae Catonella NA 
ASV1866 Lachnospiraceae Butyrivibrio_2 NA 
ASV1867 Prevotellaceae Alloprevotella NA 
ASV1868 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1869 Peptostreptococcaceae Filifactor NA 
ASV1870 Pasteurellaceae Mannheimia NA 
ASV1871 Fusobacteriaceae Fusobacterium NA 
ASV1872 Muribaculaceae NA NA 
ASV1873 Lactobacillaceae Lactobacillus delbrueckii/equicursoris 
ASV1874 Moraxellaceae Acinetobacter baumannii/septicus/ursingii 
ASV1875 Lactobacillaceae Lactobacillus fornicalis/jensenii 
ASV1876 Veillonellaceae Veillonella NA 
ASV1877 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1878 Veillonellaceae Selenomonas_4 NA 
ASV1879 Prevotellaceae Prevotella NA 
ASV1880 Neisseriaceae Simonsiella NA 
ASV1881 Fusobacteriaceae Fusobacterium NA 
ASV1882 Lachnospiraceae Oribacterium NA 
ASV1883 Streptococcaceae Streptococcus NA 
ASV1884 NA NA NA 
ASV1885 Streptococcaceae Streptococcus NA 
ASV1886 Fusobacteriaceae Fusobacterium NA 




ASV1887 Leptotrichiaceae Leptotrichia NA 
ASV1888 Porphyromonadaceae Porphyromonas NA 
ASV1889 Streptococcaceae Streptococcus NA 
ASV1890 Mycoplasmataceae Mycoplasma NA 
ASV1891 Pasteurellaceae Haemophilus NA 
ASV1892 NA NA NA 
ASV1893 Veillonellaceae Megasphaera NA 
ASV1894 Family_XIII NA NA 
ASV1895 Streptococcaceae Streptococcus NA 
ASV1896 NA NA NA 
ASV1897 NA NA NA 
ASV1898 Spirochaetaceae Treponema_2 NA 
ASV1899 Fusobacteriaceae Fusobacterium NA 
ASV1900 Prevotellaceae Alloprevotella NA 
ASV1901 Lachnospiraceae Stomatobaculum NA 
ASV1902 NA NA NA 
ASV1903 Veillonellaceae Veillonella NA 
ASV1904 Weeksellaceae Bergeyella NA 
ASV1905 Lachnospiraceae Oribacterium NA 
ASV1906 Prevotellaceae Alloprevotella NA 
ASV1907 Actinomycetaceae Actinomyces NA 
ASV1908 Peptostreptococcaceae Peptostreptococcus NA 
ASV1909 Burkholderiaceae Limnobacter NA 
ASV1910 Prevotellaceae Prevotella_7 NA 
ASV1911 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1912 Mycoplasmataceae Mycoplasma NA 




ASV1913 Erysipelotrichaceae Bulleidia NA 
ASV1914 Leptotrichiaceae Leptotrichia NA 
ASV1915 Family_XI Parvimonas NA 
ASV1916 Lachnospiraceae Oribacterium NA 
ASV1917 Fusobacteriaceae Fusobacterium NA 
ASV1918 Family_XI Gemella NA 
ASV1919 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1920 Pasteurellaceae Aggregatibacter NA 
ASV1921 Veillonellaceae Veillonella NA 
ASV1922 Pasteurellaceae Actinobacillus NA 
ASV1923 Spirochaetaceae Treponema_2 NA 
ASV1924 Lentimicrobiaceae NA NA 
ASV1925 Fusobacteriaceae Fusobacterium NA 
ASV1926 Veillonellaceae Megasphaera NA 
ASV1927 Leptotrichiaceae Leptotrichia NA 
ASV1928 Spirochaetaceae Treponema_2 NA 
ASV1929 Lachnospiraceae Lachnoanaerobaculum NA 
ASV1930 Prevotellaceae Prevotella_7 NA 
ASV1931 Corynebacteriaceae Lawsonella clevelandensis 
ASV1932 Moraxellaceae Enhydrobacter aerosaccus 
ASV1933 Streptococcaceae Streptococcus NA 
ASV1934 Neisseriaceae Neisseria NA 
ASV1935 Lachnospiraceae Oribacterium NA 
ASV1936 NA NA NA 
ASV1937 Lachnospiraceae Stomatobaculum NA 
ASV1938 Prevotellaceae Prevotella NA 




ASV1939 Prevotellaceae Prevotella_7 NA 
ASV1940 Spirochaetaceae Treponema_2 NA 
ASV1941 Atopobiaceae Olsenella NA 
ASV1942 Lentimicrobiaceae NA NA 
ASV1943 Fusobacteriaceae Fusobacterium NA 
ASV1944 Campylobacteraceae Campylobacter NA 
ASV1945 Lachnospiraceae NA NA 
ASV1946 Lachnospiraceae Stomatobaculum NA 
ASV1947 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1948 Veillonellaceae Megasphaera NA 
ASV1949 Paludibacteraceae F0058 NA 
ASV1950 Fusobacteriaceae Fusobacterium NA 
ASV1951 NA NA NA 
ASV1952 NA NA NA 
ASV1953 Streptococcaceae Streptococcus NA 
ASV1954 Fusobacteriaceae Fusobacterium NA 
ASV1955 Flavobacteriaceae Capnocytophaga NA 
ASV1956 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV1957 NA NA NA 
ASV1958 Streptococcaceae Streptococcus NA 
ASV1959 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1960 Family_XI Anaerococcus NA 
ASV1961 Enterobacteriaceae Yersinia NA 
ASV1962 Leptotrichiaceae Leptotrichia NA 
ASV1963 Spirochaetaceae Treponema_2 NA 
ASV1964 Family_XI Gemella NA 




ASV1965 Desulfomicrobiaceae Desulfomicrobium NA 
ASV1966 Leptotrichiaceae Oceanivirga NA 
ASV1967 Carnobacteriaceae Granulicatella NA 
ASV1968 Leptotrichiaceae Leptotrichia NA 
ASV1969 Actinomycetaceae Actinomyces NA 
ASV1970 NA NA NA 
ASV1971 Prevotellaceae Prevotella_7 NA 
ASV1972 Prevotellaceae Prevotella_2 NA 
ASV1973 Leptotrichiaceae Leptotrichia NA 
ASV1974 Carnobacteriaceae Dolosigranulum pigrum 
ASV1975 Streptococcaceae Streptococcus NA 
ASV1976 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV1977 Fusobacteriaceae Fusobacterium NA 
ASV1978 Prevotellaceae Prevotella_6 NA 
ASV1979 Actinomycetaceae Actinomyces NA 
ASV1980 Pasteurellaceae Haemophilus NA 
ASV1981 Spirochaetaceae Treponema_2 NA 
ASV1982 Leptotrichiaceae Leptotrichia NA 
ASV1983 Veillonellaceae Veillonella NA 
ASV1984 Porphyromonadaceae Porphyromonas NA 
ASV1985 NA NA NA 
ASV1986 Veillonellaceae NA NA 
ASV1987 Streptococcaceae Streptococcus oralis 
ASV1988 Porphyromonadaceae Porphyromonas NA 
ASV1989 NA NA NA 
ASV1990 Carnobacteriaceae Granulicatella NA 




ASV1991 Lactobacillaceae Lactobacillus NA 
ASV1992 Fusobacteriaceae Fusobacterium NA 
ASV1993 Fusobacteriaceae Fusobacterium NA 
ASV1994 Fusobacteriaceae Fusobacterium NA 
ASV1995 Flavobacteriaceae Capnocytophaga NA 
ASV1996 Pseudomonadaceae Pseudomonas aeruginosa/alcaligenes/alcaliphila/asplenii/cf./chengduensis/composti/cuatrocienegasensis/entomophila/fluorescens/fulva/fuscovaginae 
ASV1997 Prevotellaceae Alloprevotella NA 
ASV1998 Fusobacteriaceae Fusobacterium NA 
ASV1999 Prevotellaceae Prevotella_7 NA 
ASV2000 Spirochaetaceae Treponema_2 NA 
ASV2001 Veillonellaceae Selenomonas_3 NA 
ASV2002 Prevotellaceae Prevotella_6 NA 
ASV2003 Spirochaetaceae Treponema_2 NA 
ASV2004 Lachnospiraceae Stomatobaculum NA 
ASV2005 Veillonellaceae Dialister NA 
ASV2006 Porphyromonadaceae Porphyromonas NA 
ASV2007 Prevotellaceae Alloprevotella NA 
ASV2008 Lachnospiraceae Stomatobaculum NA 
ASV2009 Lachnospiraceae Oribacterium NA 
ASV2010 Leptotrichiaceae Leptotrichia NA 
ASV2011 Prevotellaceae Prevotella_7 NA 
ASV2012 Carnobacteriaceae Granulicatella NA 
ASV2013 Actinomycetaceae Actinomyces NA 
ASV2014 Akkermansiaceae Akkermansia NA 
ASV2015 Fusobacteriaceae Fusobacterium NA 
ASV2016 Saccharimonadaceae NA NA 




ASV2017 Lachnospiraceae Oribacterium NA 
ASV2018 Family_XI Gemella NA 
ASV2019 Veillonellaceae Veillonella NA 
ASV2020 Prevotellaceae Prevotella_7 NA 
ASV2021 Burkholderiaceae Comamonas NA 
ASV2022 Veillonellaceae Selenomonas_3 NA 
ASV2023 Lachnospiraceae Johnsonella NA 
ASV2024 Leptotrichiaceae Leptotrichia NA 
ASV2025 Atopobiaceae Atopobium NA 
ASV2026 Prevotellaceae Alloprevotella NA 
ASV2027 Prevotellaceae NA NA 
ASV2028 Tannerellaceae Tannerella NA 
ASV2029 Veillonellaceae Veillonella NA 
ASV2030 Veillonellaceae Selenomonas_3 NA 
ASV2031 Tannerellaceae Tannerella NA 
ASV2032 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2033 Spirochaetaceae Treponema_2 NA 
ASV2034 Lachnospiraceae NA NA 
ASV2035 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2036 Pasteurellaceae Rodentibacter NA 
ASV2037 Lachnospiraceae Catonella NA 
ASV2038 Prevotellaceae Prevotella_7 NA 
ASV2039 Prevotellaceae Prevotella_7 NA 
ASV2040 Leptotrichiaceae Leptotrichia NA 
ASV2041 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2042 Prevotellaceae Alloprevotella NA 




ASV2043 NA NA NA 
ASV2044 Pasteurellaceae Actinobacillus NA 
ASV2045 Prevotellaceae Prevotella_2 NA 
ASV2046 Fusobacteriaceae Fusobacterium NA 
ASV2047 Flavobacteriaceae Capnocytophaga NA 
ASV2048 Fusobacteriaceae Fusobacterium NA 
ASV2049 Lactobacillaceae Lactobacillus NA 
ASV2050 Campylobacteraceae Campylobacter NA 
ASV2051 NA NA NA 
ASV2052 Actinomycetaceae Actinomyces NA 
ASV2053 Lachnospiraceae Catonella NA 
ASV2054 Fusobacteriaceae Fusobacterium NA 
ASV2055 Fusobacteriaceae Fusobacterium NA 
ASV2056 Prevotellaceae Prevotella_6 NA 
ASV2057 Flavobacteriaceae Capnocytophaga NA 
ASV2058 Spirochaetaceae Treponema_2 NA 
ASV2059 Prevotellaceae Alloprevotella NA 
ASV2060 Leptotrichiaceae Leptotrichia NA 
ASV2061 Fusobacteriaceae Fusobacterium NA 
ASV2062 Cardiobacteriaceae Cardiobacterium NA 
ASV2063 Lachnospiraceae Shuttleworthia NA 
ASV2064 Streptococcaceae Streptococcus NA 
ASV2065 Prevotellaceae Alloprevotella NA 
ASV2066 Spirochaetaceae Treponema_2 parvum 
ASV2067 Neisseriaceae Kingella NA 
ASV2068 Campylobacteraceae Campylobacter NA 




ASV2069 Prevotellaceae Alloprevotella NA 
ASV2070 Lachnospiraceae Stomatobaculum NA 
ASV2071 Lachnospiraceae NA NA 
ASV2072 Carnobacteriaceae Granulicatella NA 
ASV2073 Muribaculaceae NA NA 
ASV2074 Atopobiaceae Olsenella NA 
ASV2075 Leptotrichiaceae Leptotrichia NA 
ASV2076 Streptococcaceae Streptococcus NA 
ASV2077 Fusobacteriaceae Fusobacterium NA 
ASV2078 Leptotrichiaceae Leptotrichia NA 
ASV2079 Spirochaetaceae Treponema_2 NA 
ASV2080 Neisseriaceae Neisseria NA 
ASV2081 Streptococcaceae Streptococcus NA 
ASV2082 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2083 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2084 Moraxellaceae Moraxella catarrhalis/nonliquefaciens 
ASV2085 Lactobacillaceae Lactobacillus casei/fermentum/helveticus 
ASV2086 Prevotellaceae Prevotella_7 NA 
ASV2087 Leptotrichiaceae Leptotrichia NA 
ASV2088 Prevotellaceae Prevotella_7 NA 
ASV2089 NA NA NA 
ASV2090 Neisseriaceae Kingella NA 
ASV2091 Lachnospiraceae Stomatobaculum NA 
ASV2092 Lachnospiraceae Oribacterium NA 
ASV2093 Leptotrichiaceae Leptotrichia NA 
ASV2094 Leptotrichiaceae Leptotrichia NA 




ASV2095 Carnobacteriaceae Granulicatella NA 
ASV2096 Lachnospiraceae Oribacterium NA 
ASV2097 Prevotellaceae Prevotella_6 NA 
ASV2098 Pasteurellaceae Haemophilus influenzae 
ASV2099 Leuconostocaceae Weissella bombi/cibaria/confusa/hellenica/koreensis/paramesenteroides/soli 
ASV2100 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2101 Carnobacteriaceae Granulicatella NA 
ASV2102 Prevotellaceae Prevotella_7 NA 
ASV2103 Flavobacteriaceae Capnocytophaga NA 
ASV2104 Lachnospiraceae NA NA 
ASV2105 Fusobacteriaceae Fusobacterium NA 
ASV2106 Lentimicrobiaceae NA NA 
ASV2107 Streptococcaceae Streptococcus NA 
ASV2108 Neisseriaceae Eikenella NA 
ASV2109 Veillonellaceae Selenomonas_4 NA 
ASV2110 Spirochaetaceae Treponema_2 NA 
ASV2111 Fusobacteriaceae Fusobacterium NA 
ASV2112 Prevotellaceae Prevotella NA 
ASV2113 Atopobiaceae Atopobium NA 
ASV2114 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2115 Porphyromonadaceae Porphyromonas NA 
ASV2116 NA NA NA 
ASV2117 Family_XIII Mogibacterium NA 
ASV2118 Porphyromonadaceae Porphyromonas NA 
ASV2119 Leptotrichiaceae Leptotrichia NA 
ASV2120 Veillonellaceae Veillonella NA 




ASV2121 Spirochaetaceae Treponema_2 NA 
ASV2122 Desulfomicrobiaceae Desulfomicrobium orale 
ASV2123 Tannerellaceae Tannerella NA 
ASV2124 Xanthomonadaceae Xanthomonas arboricola/axonopodis/bromi/campestris/cannabis/cassavae/citri/cucurbitae/cynarae/dyei/euvesicatoria/fragariae/gardneri/hortorum 
ASV2125 Mycoplasmataceae Mycoplasma NA 
ASV2126 Lachnospiraceae Stomatobaculum NA 
ASV2127 Erysipelotrichaceae Solobacterium NA 
ASV2128 Prevotellaceae Prevotella NA 
ASV2129 Spirochaetaceae Treponema_2 NA 
ASV2130 Lachnospiraceae Stomatobaculum NA 
ASV2131 Synergistaceae Fretibacterium NA 
ASV2132 Family_XI Gemella NA 
ASV2133 Porphyromonadaceae Porphyromonas NA 
ASV2134 Weeksellaceae Bergeyella NA 
ASV2135 Fusobacteriaceae Fusobacterium NA 
ASV2136 F082 NA NA 
ASV2137 Flavobacteriaceae Capnocytophaga NA 
ASV2138 Prevotellaceae Alloprevotella NA 
ASV2139 Flavobacteriaceae Capnocytophaga NA 
ASV2140 NA NA NA 
ASV2141 Lentimicrobiaceae NA NA 
ASV2142 Pasteurellaceae NA NA 
ASV2143 Lachnospiraceae Oribacterium NA 
ASV2144 Burkholderiaceae Ralstonia detusculanense/insidiosa/mannitolilytica/pickettii/solanacearum/syzygii 
ASV2145 Veillonellaceae Veillonella NA 
ASV2146 Carnobacteriaceae Granulicatella NA 




ASV2147 Leptotrichiaceae Leptotrichia NA 
ASV2148 Veillonellaceae Dialister NA 
ASV2149 Atopobiaceae Atopobium NA 
ASV2150 Spirochaetaceae Treponema_2 NA 
ASV2151 Leptotrichiaceae Leptotrichia NA 
ASV2152 Carnobacteriaceae Granulicatella NA 
ASV2153 Prevotellaceae Prevotella_7 NA 
ASV2154 Veillonellaceae Selenomonas_3 NA 
ASV2155 Family_XIII NA NA 
ASV2156 NA NA NA 
ASV2157 Streptococcaceae Streptococcus NA 
ASV2158 Cardiobacteriaceae Cardiobacterium NA 
ASV2159 NA NA NA 
ASV2160 NA NA NA 
ASV2161 Leptotrichiaceae Leptotrichia NA 
ASV2162 Spirochaetaceae Treponema_2 NA 
ASV2163 Lachnospiraceae Johnsonella NA 
ASV2164 Veillonellaceae Veillonella NA 
ASV2165 Peptostreptococcaceae Peptoanaerobacter NA 
ASV2166 Prevotellaceae Prevotella_7 NA 
ASV2167 Fusobacteriaceae Fusobacterium NA 
ASV2168 Fusobacteriaceae Fusobacterium NA 
ASV2169 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2170 Prevotellaceae Prevotella_7 NA 
ASV2171 Spirochaetaceae Treponema_2 NA 
ASV2172 Weeksellaceae Bergeyella NA 




ASV2173 Tannerellaceae Tannerella NA 
ASV2174 Lachnospiraceae Catonella NA 
ASV2175 Veillonellaceae Selenomonas_4 NA 
ASV2176 Lachnospiraceae Butyrivibrio_2 NA 
ASV2177 Fusobacteriaceae Fusobacterium NA 
ASV2178 Spirochaetaceae Treponema_2 NA 
ASV2179 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2180 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2181 Campylobacteraceae Campylobacter NA 
ASV2182 Leptotrichiaceae Leptotrichia NA 
ASV2183 Leptotrichiaceae Leptotrichia NA 
ASV2184 Streptococcaceae Streptococcus equinus/gallolyticus/infantarius/lutetiensis/salivarius 
ASV2185 Peptostreptococcaceae Peptostreptococcus NA 
ASV2186 Actinomycetaceae F0332 NA 
ASV2187 Veillonellaceae Veillonella NA 
ASV2188 Leptotrichiaceae Leptotrichia NA 
ASV2189 Veillonellaceae Veillonella NA 
ASV2190 Spirochaetaceae Treponema_2 NA 
ASV2191 Lachnospiraceae Oribacterium NA 
ASV2192 Prevotellaceae Prevotella_7 NA 
ASV2193 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2194 Streptococcaceae Streptococcus NA 
ASV2195 Lachnospiraceae Johnsonella NA 
ASV2196 Veillonellaceae Selenomonas_3 NA 
ASV2197 Mycoplasmataceae Mycoplasma NA 
ASV2198 Ruminococcaceae Ruminococcaceae_UCG-014 NA 




ASV2199 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2200 Prevotellaceae Alloprevotella NA 
ASV2201 Corynebacteriaceae Corynebacterium NA 
ASV2202 Veillonellaceae Selenomonas_3 NA 
ASV2203 Paludibacteraceae F0058 NA 
ASV2204 Spirochaetaceae Treponema_2 NA 
ASV2205 Veillonellaceae Dialister NA 
ASV2206 Flavobacteriaceae Capnocytophaga NA 
ASV2207 NA NA NA 
ASV2208 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2209 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2210 Veillonellaceae Centipeda NA 
ASV2211 NA NA NA 
ASV2212 Lachnospiraceae Stomatobaculum NA 
ASV2213 Leptotrichiaceae Leptotrichia NA 
ASV2214 Cardiobacteriaceae NA NA 
ASV2215 NA NA NA 
ASV2216 Lachnospiraceae Stomatobaculum NA 
ASV2217 Prevotellaceae Alloprevotella NA 
ASV2218 Family_XI Parvimonas NA 
ASV2219 Fusobacteriaceae Fusobacterium NA 
ASV2220 Lachnospiraceae Oribacterium NA 
ASV2221 Lentimicrobiaceae NA NA 
ASV2222 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2223 Fusobacteriaceae Fusobacterium NA 
ASV2224 Lachnospiraceae Lachnoanaerobaculum NA 




ASV2225 Prevotellaceae Alloprevotella NA 
ASV2226 Fusobacteriaceae Fusobacterium NA 
ASV2227 Neisseriaceae Neisseria NA 
ASV2228 Veillonellaceae Megasphaera NA 
ASV2229 Streptococcaceae Streptococcus NA 
ASV2230 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2231 Desulfobulbaceae Desulfobulbus NA 
ASV2232 Family_XIII NA NA 
ASV2233 Erysipelotrichaceae Solobacterium NA 
ASV2234 Family_XI Gemella NA 
ASV2235 Weeksellaceae Bergeyella NA 
ASV2236 Veillonellaceae Veillonella NA 
ASV2237 Pasteurellaceae Aggregatibacter NA 
ASV2238 Prevotellaceae Prevotella NA 
ASV2239 Veillonellaceae Veillonella NA 
ASV2240 Family_XIII NA NA 
ASV2241 Fusobacteriaceae Fusobacterium NA 
ASV2242 Mycoplasmataceae Mycoplasma NA 
ASV2243 Porphyromonadaceae Porphyromonas NA 
ASV2244 Prevotellaceae Prevotella NA 
ASV2245 Peptostreptococcaceae NA NA 
ASV2246 Akkermansiaceae Akkermansia muciniphila 
ASV2247 Family_XIII Family_XIII_UCG-001 NA 
ASV2248 Veillonellaceae Selenomonas_4 NA 
ASV2249 Neisseriaceae Neisseria NA 
ASV2250 Burkholderiaceae Aquabacterium NA 




ASV2251 Fusobacteriaceae Fusobacterium NA 
ASV2252 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2253 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2254 Spirochaetaceae Treponema_2 NA 
ASV2255 Lactobacillaceae Lactobacillus acidophilus/delbrueckii/fermentum/helveticus/rhamnosus 
ASV2256 Aerococcaceae Abiotrophia NA 
ASV2257 Spirochaetaceae Treponema_2 NA 
ASV2258 Veillonellaceae Veillonella NA 
ASV2259 Veillonellaceae NA NA 
ASV2260 Carnobacteriaceae Granulicatella NA 
ASV2261 Spirochaetaceae Treponema_2 NA 
ASV2262 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2263 Lachnospiraceae Oribacterium NA 
ASV2264 Family_XI Gemella NA 
ASV2265 Spirochaetaceae Treponema_2 NA 
ASV2266 Mycoplasmataceae Mycoplasma NA 
ASV2267 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2268 Spirochaetaceae Treponema_2 NA 
ASV2269 Burkholderiaceae Lautropia NA 
ASV2270 Actinomycetaceae Actinomyces NA 
ASV2271 Veillonellaceae NA NA 
ASV2272 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2273 Mycoplasmataceae Mycoplasma NA 
ASV2274 Leptotrichiaceae Leptotrichia NA 
ASV2275 Prevotellaceae Prevotella_9 NA 
ASV2276 Lachnospiraceae Johnsonella NA 




ASV2277 Peptostreptococcaceae Peptostreptococcus NA 
ASV2278 Burkholderiaceae Sutterella NA 
ASV2279 Leptotrichiaceae Leptotrichia NA 
ASV2280 Veillonellaceae Veillonella NA 
ASV2281 Fusobacteriaceae Fusobacterium NA 
ASV2282 Burkholderiaceae Brachymonas NA 
ASV2283 Leptotrichiaceae Leptotrichia NA 
ASV2284 Veillonellaceae Veillonella NA 
ASV2285 Veillonellaceae Selenomonas_3 NA 
ASV2286 Carnobacteriaceae Granulicatella NA 
ASV2287 Spirochaetaceae Treponema_2 NA 
ASV2288 Family_XI W5053 NA 
ASV2289 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2290 Pasteurellaceae Actinobacillus NA 
ASV2291 Neisseriaceae Alysiella NA 
ASV2292 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2293 Veillonellaceae Veillonella NA 
ASV2294 Lachnospiraceae Oribacterium NA 
ASV2295 Carnobacteriaceae Granulicatella NA 
ASV2296 Neisseriaceae Bergeriella NA 
ASV2297 Lachnospiraceae NA NA 
ASV2298 Bifidobacteriaceae Aeriscardovia NA 
ASV2299 Family_XI Parvimonas NA 
ASV2300 Kineosporiaceae Kineococcus NA 
ASV2301 Campylobacteraceae Campylobacter NA 
ASV2302 Pasteurellaceae Haemophilus NA 




ASV2303 Peptostreptococcaceae Peptostreptococcus NA 
ASV2304 Erysipelotrichaceae Solobacterium NA 
ASV2305 Corynebacteriaceae Corynebacterium NA 
ASV2306 Spirochaetaceae Treponema_2 NA 
ASV2307 Campylobacteraceae Campylobacter NA 
ASV2308 Atopobiaceae Olsenella profusa 
ASV2309 Veillonellaceae Veillonella NA 
ASV2310 Flavobacteriaceae Capnocytophaga NA 
ASV2311 Enterobacteriaceae NA NA 
ASV2312 Family_XI Gemella NA 
ASV2313 Veillonellaceae Selenomonas NA 
ASV2314 Leptotrichiaceae Leptotrichia NA 
ASV2315 Fusobacteriaceae Fusobacterium NA 
ASV2316 Cardiobacteriaceae Cardiobacterium NA 
ASV2317 Streptococcaceae Streptococcus NA 
ASV2318 Family_XI Gemella NA 
ASV2319 Fusobacteriaceae Fusobacterium NA 
ASV2320 Leptotrichiaceae Leptotrichia NA 
ASV2321 Neisseriaceae NA NA 
ASV2322 Fusobacteriaceae Fusobacterium NA 
ASV2323 Leptotrichiaceae Leptotrichia NA 
ASV2324 Weeksellaceae Bergeyella NA 
ASV2325 Actinomycetaceae Actinomyces NA 
ASV2326 Prevotellaceae Prevotella NA 
ASV2327 Streptococcaceae Streptococcus massiliensis 
ASV2328 Campylobacteraceae Campylobacter NA 




ASV2329 Fusobacteriaceae Fusobacterium NA 
ASV2330 Peptostreptococcaceae Peptostreptococcus NA 
ASV2331 Carnobacteriaceae Granulicatella NA 
ASV2332 Neisseriaceae Neisseria NA 
ASV2333 Actinomycetaceae Actinomyces NA 
ASV2334 Veillonellaceae Veillonella NA 
ASV2335 Veillonellaceae Selenomonas_4 NA 
ASV2336 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2337 NA NA NA 
ASV2338 Anaerolineaceae Flexilinea NA 
ASV2339 Veillonellaceae Dialister propionicifaciens 
ASV2340 Fusobacteriaceae Fusobacterium NA 
ASV2341 Spirochaetaceae Treponema_2 NA 
ASV2342 Prevotellaceae Prevotella NA 
ASV2343 Peptostreptococcaceae Peptostreptococcus NA 
ASV2344 Fusobacteriaceae Fusobacterium NA 
ASV2345 Atopobiaceae Atopobium NA 
ASV2346 Prevotellaceae Prevotella_2 NA 
ASV2347 Lactobacillaceae Lactobacillus rhamnosus/salivarius 
ASV2348 Prevotellaceae Prevotella NA 
ASV2349 Burkholderiaceae NA NA 
ASV2350 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2351 Lachnospiraceae Butyrivibrio_2 NA 
ASV2352 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV2353 Family_XIII Mogibacterium NA 
ASV2354 Veillonellaceae Centipeda NA 




ASV2355 Lachnospiraceae Stomatobaculum NA 
ASV2356 Lachnospiraceae Stomatobaculum NA 
ASV2357 Prevotellaceae Prevotella disiens 
ASV2358 Leptotrichiaceae Leptotrichia NA 
ASV2359 Lachnospiraceae Stomatobaculum NA 
ASV2360 Fusobacteriaceae Fusobacterium NA 
ASV2361 Alcanivoracaceae Alcanivorax gelatiniphagus/marinus/venustensis 
ASV2362 Neisseriaceae Kingella NA 
ASV2363 Lactobacillaceae Lactobacillus pontis 
ASV2364 NA NA NA 
ASV2365 Beijerinckiaceae Methylobacterium aquaticum/platani 
ASV2366 Fusobacteriaceae Fusobacterium NA 
ASV2367 Lachnospiraceae Shuttleworthia NA 
ASV2368 Tannerellaceae Tannerella NA 
ASV2369 Micrococcaceae Rothia NA 
ASV2370 Cardiobacteriaceae Cardiobacterium NA 
ASV2371 Porphyromonadaceae Porphyromonas NA 
ASV2372 Veillonellaceae Selenomonas_3 NA 
ASV2373 Family_XIII NA NA 
ASV2374 Lachnospiraceae Stomatobaculum NA 
ASV2375 Fusobacteriaceae Fusobacterium NA 
ASV2376 Prevotellaceae Prevotella_7 NA 
ASV2377 Cardiobacteriaceae Cardiobacterium NA 
ASV2378 Veillonellaceae Selenomonas_4 NA 
ASV2379 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2380 Spirochaetaceae Treponema_2 NA 




ASV2381 Prevotellaceae Alloprevotella NA 
ASV2382 Leptotrichiaceae Leptotrichia NA 
ASV2383 Lachnospiraceae Oribacterium NA 
ASV2384 Desulfomicrobiaceae Desulfoplanes NA 
ASV2385 Leptotrichiaceae Leptotrichia NA 
ASV2386 Pseudomonadaceae Pseudomonas arsenicoxydans/avellanae/baetica/borealis/brassicacearum/clemancea/ficuserectae/fluorescens/frederiksbergensis/graminis 
ASV2387 Erysipelotrichaceae Solobacterium NA 
ASV2388 Neisseriaceae Kingella NA 
ASV2389 Spirochaetaceae Treponema_2 NA 
ASV2390 Flavobacteriaceae Capnocytophaga NA 
ASV2391 Spirochaetaceae Treponema_2 NA 
ASV2392 Fusobacteriaceae Fusobacterium NA 
ASV2393 Prevotellaceae Prevotella_7 NA 
ASV2394 NA NA NA 
ASV2395 NA NA NA 
ASV2396 Lachnospiraceae Stomatobaculum NA 
ASV2397 Veillonellaceae Centipeda NA 
ASV2398 Spirochaetaceae Treponema_2 NA 
ASV2399 Tannerellaceae Tannerella NA 
ASV2400 Carnobacteriaceae Granulicatella NA 
ASV2401 Burkholderiaceae Lautropia NA 
ASV2402 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2403 Family_XI Parvimonas NA 
ASV2404 Leptotrichiaceae Leptotrichia NA 
ASV2405 Prevotellaceae Prevotella NA 
ASV2406 Leptotrichiaceae Leptotrichia NA 




ASV2407 Micrococcaceae Kocuria dechangensis/flava/himachalensis/polaris/rosea/sediminis/turfanensis 
ASV2408 Prevotellaceae Prevotella_7 NA 
ASV2409 Prevotellaceae Alloprevotella NA 
ASV2410 Mitochondria NA NA 
ASV2411 Prevotellaceae Prevotella NA 
ASV2412 Leptotrichiaceae Leptotrichia NA 
ASV2413 Family_XI W5053 NA 
ASV2414 Spirochaetaceae Treponema_2 NA 
ASV2415 Lachnospiraceae Johnsonella NA 
ASV2416 Peptostreptococcaceae Peptostreptococcus NA 
ASV2417 Family_XIII NA NA 
ASV2418 Tannerellaceae Tannerella NA 
ASV2419 Weeksellaceae Bergeyella NA 
ASV2420 Carnobacteriaceae Granulicatella NA 
ASV2421 Veillonellaceae Veillonella NA 
ASV2422 Lachnospiraceae Butyrivibrio_2 NA 
ASV2423 Prevotellaceae Prevotella NA 
ASV2424 Prevotellaceae Alloprevotella NA 
ASV2425 Weeksellaceae Chryseobacterium culicis/indologenes/joostei/lactis/rhizoplanae/sediminis/tructae 
ASV2426 Campylobacteraceae Campylobacter NA 
ASV2427 Porphyromonadaceae Porphyromonas NA 
ASV2428 Prevotellaceae Alloprevotella NA 
ASV2429 Prevotellaceae Prevotella_7 NA 
ASV2430 Spirochaetaceae Treponema_2 NA 
ASV2431 Prevotellaceae Prevotella NA 
ASV2432 Prevotellaceae Prevotella NA 




ASV2433 Prevotellaceae Prevotella_2 NA 
ASV2434 Caulobacteraceae Brevundimonas diminuta/naejangsanensis/vancanneytii 
ASV2435 Spirochaetaceae Treponema_2 NA 
ASV2436 Lachnospiraceae Stomatobaculum NA 
ASV2437 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV2438 Family_XIII NA NA 
ASV2439 Prevotellaceae Prevotella_7 NA 
ASV2440 Fusobacteriaceae Fusobacterium NA 
ASV2441 Streptococcaceae Streptococcus NA 
ASV2442 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2443 Corynebacteriaceae Corynebacterium NA 
ASV2444 Bifidobacteriaceae Gardnerella vaginalis 
ASV2445 Fusobacteriaceae Fusobacterium NA 
ASV2446 Prevotellaceae Prevotella_7 NA 
ASV2447 Prevotellaceae Alloprevotella NA 
ASV2448 Burkholderiaceae Lautropia NA 
ASV2449 Peptostreptococcaceae Peptostreptococcus NA 
ASV2450 Lachnospiraceae NA NA 
ASV2451 Flavobacteriaceae Capnocytophaga NA 
ASV2452 Enterobacteriaceae Pantoea NA 
ASV2453 Veillonellaceae Dialister NA 
ASV2454 Veillonellaceae Selenomonas_4 NA 
ASV2455 Prevotellaceae Prevotella_6 NA 
ASV2456 Prevotellaceae Alloprevotella NA 
ASV2457 Prevotellaceae Prevotella NA 
ASV2458 Prevotellaceae Prevotella_7 NA 




ASV2459 Lachnospiraceae Butyrivibrio_2 NA 
ASV2460 Veillonellaceae Selenomonas_4 NA 
ASV2461 Veillonellaceae Selenomonas NA 
ASV2462 Peptostreptococcaceae Peptoanaerobacter NA 
ASV2463 Streptococcaceae Streptococcus NA 
ASV2464 Lactobacillaceae Lactobacillus sanfranciscensis 
ASV2465 Family_XIII Mogibacterium NA 
ASV2466 Lachnospiraceae Stomatobaculum NA 
ASV2467 Spirochaetaceae Treponema_2 NA 
ASV2468 Mycoplasmataceae Mycoplasma NA 
ASV2469 Neisseriaceae Kingella NA 
ASV2470 Lachnospiraceae Stomatobaculum NA 
ASV2471 NA NA NA 
ASV2472 Neisseriaceae NA NA 
ASV2473 Veillonellaceae Selenomonas_3 NA 
ASV2474 Ruminococcaceae Candidatus_Soleaferrea NA 
ASV2475 Burkholderiaceae Brachymonas NA 
ASV2476 Erysipelotrichaceae Bulleidia NA 
ASV2477 Carnobacteriaceae Carnobacterium gallinarum/inhibens/jeotgali/maltaromaticum/viridans 
ASV2478 Desulfobulbaceae Desulfobulbus NA 
ASV2479 Mycoplasmataceae Mycoplasma NA 
ASV2480 Erysipelotrichaceae Solobacterium NA 
ASV2481 Spirochaetaceae Treponema_2 NA 
ASV2482 Carnobacteriaceae Granulicatella NA 
ASV2483 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2484 Mycoplasmataceae Mycoplasma NA 




ASV2485 Fusobacteriaceae Fusobacterium NA 
ASV2486 Synergistaceae Jonquetella anthropi 
ASV2487 Peptococcaceae Peptococcus NA 
ASV2488 NA NA NA 
ASV2489 Moraxellaceae Psychrobacter halophilus/marincola/maritimus/psychrophilus/submarinus 
ASV2490 Pseudomonadaceae Pseudomonas antarctica/brenneri/chlororaphis/denitrificans/extremaustralis/fluorescens/gessardii/marginalis/meridiana/palleroniana/panacis/poae 
ASV2491 NA NA NA 
ASV2492 Desulfovibrionaceae Desulfovibrio NA 
ASV2493 Lachnospiraceae Butyrivibrio_2 NA 
ASV2494 Veillonellaceae NA NA 
ASV2495 Rhizobiaceae Brucella NA 
ASV2496 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2497 Spirochaetaceae Treponema_2 NA 
ASV2498 Actinomycetaceae Actinomyces NA 
ASV2499 Lachnospiraceae Catonella NA 
ASV2500 Neisseriaceae Kingella NA 
ASV2501 Peptostreptococcaceae Peptoanaerobacter NA 
ASV2502 Flavobacteriaceae Capnocytophaga NA 
ASV2503 NA NA NA 
ASV2504 Porphyromonadaceae Porphyromonas NA 
ASV2505 Actinomycetaceae Actinomyces NA 
ASV2506 Ruminococcaceae NA NA 
ASV2507 Carnobacteriaceae Granulicatella NA 
ASV2508 Prevotellaceae Prevotella_7 NA 
ASV2509 Leptotrichiaceae Leptotrichia NA 
ASV2510 Leptotrichiaceae Leptotrichia NA 




ASV2511 Neisseriaceae Neisseria lactamica/meningitidis/polysaccharea 
ASV2512 Spirochaetaceae Treponema_2 NA 
ASV2513 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2514 Fusobacteriaceae Fusobacterium NA 
ASV2515 Burkholderiaceae Lautropia NA 
ASV2516 Leptotrichiaceae Leptotrichia NA 
ASV2517 Carnobacteriaceae Granulicatella NA 
ASV2518 Prevotellaceae Prevotella NA 
ASV2519 Spirochaetaceae Treponema_2 NA 
ASV2520 Lachnospiraceae Oribacterium NA 
ASV2521 Leptotrichiaceae Leptotrichia NA 
ASV2522 Neisseriaceae NA NA 
ASV2523 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2524 Prevotellaceae Prevotella_2 NA 
ASV2525 Flavobacteriaceae Capnocytophaga NA 
ASV2526 Family_XIII NA NA 
ASV2527 Prevotellaceae Prevotella NA 
ASV2528 Atopobiaceae Atopobium vaginae 
ASV2529 Prevotellaceae Prevotella_2 NA 
ASV2530 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2531 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2532 Leptotrichiaceae Leptotrichia NA 
ASV2533 Leptotrichiaceae Leptotrichia NA 
ASV2534 Moraxellaceae Acinetobacter idrijaensis/lwoffii 
ASV2535 Campylobacteraceae Campylobacter ureolyticus 
ASV2536 Porphyromonadaceae Porphyromonas NA 




ASV2537 Lachnospiraceae Johnsonella NA 
ASV2538 Leptotrichiaceae Leptotrichia NA 
ASV2539 Family_XI Parvimonas NA 
ASV2540 Psychromonadaceae Psychromonas NA 
ASV2541 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV2542 Spirochaetaceae Treponema_2 NA 
ASV2543 Spirochaetaceae Treponema_2 NA 
ASV2544 Mycoplasmataceae Ureaplasma parvum/urealyticum 
ASV2545 Spirochaetaceae Treponema_2 NA 
ASV2546 Prevotellaceae Prevotella_7 NA 
ASV2547 NA NA NA 
ASV2548 Campylobacteraceae Campylobacter NA 
ASV2549 Lachnospiraceae Stomatobaculum NA 
ASV2550 Carnobacteriaceae Granulicatella NA 
ASV2551 Veillonellaceae Dialister NA 
ASV2552 Lachnospiraceae Shuttleworthia NA 
ASV2553 Family_XIII Mogibacterium NA 
ASV2554 Family_XI Parvimonas NA 
ASV2555 Cardiobacteriaceae Cardiobacterium NA 
ASV2556 Neisseriaceae Kingella NA 
ASV2557 Pseudomonadaceae Pseudomonas monteilii/plecoglossicida/putida/taiwanensis 
ASV2558 Veillonellaceae Selenomonas_4 NA 
ASV2559 Leptotrichiaceae Leptotrichia NA 
ASV2560 Lachnospiraceae Fusicatenibacter saccharivorans 
ASV2561 Leptotrichiaceae Leptotrichia NA 
ASV2562 Prevotellaceae Prevotella NA 




ASV2563 Aerococcaceae Abiotrophia NA 
ASV2564 Neisseriaceae Kingella NA 
ASV2565 Prevotellaceae Alloprevotella NA 
ASV2566 Prevotellaceae Alloprevotella NA 
ASV2567 Caulobacteraceae NA NA 
ASV2568 Flavobacteriaceae Capnocytophaga NA 
ASV2569 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2570 Bifidobacteriaceae Bifidobacterium catenulatum/gallicum/kashiwanohense/pseudocatenulatum 
ASV2571 Spirochaetaceae Treponema_2 NA 
ASV2572 Prevotellaceae Prevotella NA 
ASV2573 Fusobacteriaceae Fusobacterium NA 
ASV2574 Lachnospiraceae Oribacterium NA 
ASV2575 Lachnospiraceae Johnsonella NA 
ASV2576 Lachnospiraceae Oribacterium NA 
ASV2577 Neisseriaceae Kingella kingae 
ASV2578 Veillonellaceae Selenomonas_4 NA 
ASV2579 NA NA NA 
ASV2580 Veillonellaceae Selenomonas_4 NA 
ASV2581 Enterococcaceae Enterococcus NA 
ASV2582 Lachnospiraceae Catonella NA 
ASV2583 NA NA NA 
ASV2584 Fusobacteriaceae Fusobacterium NA 
ASV2585 Spirochaetaceae Treponema_2 NA 
ASV2586 Prevotellaceae Prevotella NA 
ASV2587 Prevotellaceae Prevotella_7 NA 
ASV2588 Lentimicrobiaceae NA NA 




ASV2589 Aeromonadaceae Aeromonas allosaccharophila/aquatica/aquatilis/australiensis/bestiarum/bivalvium/cavernicola/caviae/crassostreae/dhakensis/diversa/encheleia 
ASV2590 Spirochaetaceae Treponema_2 NA 
ASV2591 Spirochaetaceae Treponema_2 NA 
ASV2592 Mycoplasmataceae Mycoplasma NA 
ASV2593 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2594 Lachnospiraceae NA NA 
ASV2595 Weeksellaceae Chryseobacterium arthrosphaerae/contaminans/cucumeris/culicis/gleum/indologenes/jejuense/joostei/lactis/letacus/oncorhynchi/rhizosphaerae/tructae 
ASV2596 Neisseriaceae NA NA 
ASV2597 Leptotrichiaceae Leptotrichia NA 
ASV2598 Leptotrichiaceae Leptotrichia NA 
ASV2599 Spirochaetaceae Treponema_2 NA 
ASV2600 Atopobiaceae Atopobium NA 
ASV2601 Actinomycetaceae Actinomyces NA 
ASV2602 Lentimicrobiaceae NA NA 
ASV2603 Lachnospiraceae Lachnoclostridium NA 
ASV2604 Leptotrichiaceae Leptotrichia NA 
ASV2605 Bifidobacteriaceae Gardnerella vaginalis 
ASV2606 Neisseriaceae Neisseria NA 
ASV2607 Veillonellaceae NA NA 
ASV2608 Prevotellaceae Prevotella_6 NA 
ASV2609 Spirochaetaceae Treponema_2 NA 
ASV2610 Lachnospiraceae Catonella NA 
ASV2611 Veillonellaceae Selenomonas_3 NA 
ASV2612 Lachnospiraceae Catonella NA 
ASV2613 Campylobacteraceae Campylobacter NA 
ASV2614 Beijerinckiaceae Methylobacterium radiotolerans 




ASV2615 Porphyromonadaceae Porphyromonas NA 
ASV2616 Veillonellaceae Veillonella NA 
ASV2617 Mycoplasmataceae Mycoplasma NA 
ASV2618 Mycoplasmataceae Mycoplasma NA 
ASV2619 Spirochaetaceae Treponema_2 NA 
ASV2620 Prevotellaceae Prevotella NA 
ASV2621 Spirochaetaceae Treponema_2 NA 
ASV2622 Desulfovibrionaceae Desulfovibrio NA 
ASV2623 Lachnospiraceae Oribacterium NA 
ASV2624 Rhodobacteraceae Paracoccus aminophilus/aminovorans/caeni/chinensis/communis/denitrificans/halophilus/huijuniae 
ASV2625 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2626 Prevotellaceae Prevotella_2 NA 
ASV2627 NA NA NA 
ASV2628 Spirochaetaceae Treponema_2 NA 
ASV2629 Spirochaetaceae Treponema_2 NA 
ASV2630 Prevotellaceae Prevotella NA 
ASV2631 Flavobacteriaceae Capnocytophaga NA 
ASV2632 Moraxellaceae Psychrobacter cibarius/fozii/glacincola/immobilis/namhaensis 
ASV2633 Prevotellaceae Prevotella_6 NA 
ASV2634 Bifidobacteriaceae Bifidobacterium NA 
ASV2635 Leptotrichiaceae Leptotrichia NA 
ASV2636 Pasteurellaceae Actinobacillus NA 
ASV2637 Spirochaetaceae Treponema_2 NA 
ASV2638 Lachnospiraceae Catonella NA 
ASV2639 Streptococcaceae Streptococcus NA 
ASV2640 Saccharimonadaceae NA NA 




ASV2641 Spirochaetaceae Treponema_2 NA 
ASV2642 Lachnospiraceae Johnsonella NA 
ASV2643 Family_XIII NA NA 
ASV2644 Actinomycetaceae F0332 NA 
ASV2645 Geodermatophilaceae Blastococcus aggregatus/colisei/saxobsidens 
ASV2646 Neisseriaceae Alysiella NA 
ASV2647 Lachnospiraceae Stomatobaculum NA 
ASV2648 Leptotrichiaceae Streptobacillus NA 
ASV2649 Veillonellaceae Veillonella NA 
ASV2650 Fusobacteriaceae Fusobacterium NA 
ASV2651 Weeksellaceae Bergeyella NA 
ASV2652 p-2534-18B5_gut_group NA NA 
ASV2653 Prevotellaceae Prevotella NA 




ASV2656 Prevotellaceae Prevotellaceae_Ga6A1_group NA 
ASV2657 Leptotrichiaceae Leptotrichia NA 
ASV2658 Enterobacteriaceae Serratia NA 
ASV2659 Lachnospiraceae Moryella NA 
ASV2660 Lachnospiraceae Stomatobaculum NA 
ASV2661 Campylobacteraceae Campylobacter NA 
ASV2662 Saccharimonadaceae NA NA 
ASV2663 Moraxellaceae Psychrobacter arcticus/cryohalolentis/fozii/frigidicola/glacialis/glacincola/immobilis/luti/okhotskensis 
ASV2664 Pasteurellaceae Mannheimia NA 
ASV2665 Ruminococcaceae Ruminococcaceae_UCG-014 NA 








ASV2668 Carnobacteriaceae Granulicatella NA 
ASV2669 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2670 NA NA NA 
ASV2671 Atopobiaceae Atopobium NA 
ASV2672 Veillonellaceae Selenomonas NA 
ASV2673 Actinomycetaceae Actinomyces timonensis 
ASV2674 Lachnospiraceae NA NA 
ASV2675 Lachnospiraceae Johnsonella NA 
ASV2676 Mitochondria NA NA 
ASV2677 NA NA NA 
ASV2678 Pseudomonadaceae Pseudomonas alcaliphila/mendocina/oleovorans/putida/songnenensis/stutzeri/xanthomarina 
ASV2679 NA NA NA 
ASV2680 JG30-KF-AS9 NA NA 
ASV2681 Lachnospiraceae Oribacterium NA 
ASV2682 Micromonosporaceae NA NA 
ASV2683 Pseudomonadaceae Pseudomonas alcaligenes 
ASV2684 Veillonellaceae Selenomonas NA 
ASV2685 Akkermansiaceae Akkermansia muciniphila 
ASV2686 Campylobacteraceae Campylobacter NA 
ASV2687 Veillonellaceae Dialister NA 
ASV2688 Bacillaceae NA NA 
ASV2689 NA NA NA 
ASV2690 Mycoplasmataceae Mycoplasma NA 




ASV2691 Prevotellaceae Prevotella timonensis 
ASV2692 Mycobacteriaceae Mycobacterium asiaticum/gordonae/paragordonae 
ASV2693 Prevotellaceae Prevotella_7 NA 
ASV2694 Campylobacteraceae Campylobacter NA 
ASV2695 Family_XIII NA NA 
ASV2696 Spirochaetaceae Treponema_2 NA 
ASV2697 Fusobacteriaceae Fusobacterium equinum/gonidiaformans 
ASV2698 Weeksellaceae Empedobacter brevis 
ASV2699 Prevotellaceae Prevotella NA 
ASV2700 Family_XIII NA NA 
ASV2701 Family_XI Parvimonas NA 
ASV2702 Lachnospiraceae Johnsonella NA 
ASV2703 Bacteroidaceae Bacteroides NA 
ASV2704 Peptostreptococcaceae Filifactor NA 
ASV2705 Rhodocyclaceae Propionivibrio NA 
ASV2706 Prevotellaceae Alloprevotella NA 
ASV2707 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV2708 Family_XI Peptoniphilus asaccharolyticus/grossensis/harei 
ASV2709 Porphyromonadaceae Porphyromonas NA 
ASV2710 Caulobacteraceae Brevundimonas bullata/halotolerans 
ASV2711 Burkholderiaceae NA NA 
ASV2712 Pasteurellaceae Mannheimia NA 
ASV2713 Saccharimonadaceae NA NA 
ASV2714 Moraxellaceae Psychrobacter NA 
ASV2715 Family_XI Parvimonas NA 
ASV2716 Prevotellaceae Prevotella_2 NA 




ASV2717 Lachnospiraceae NA NA 
ASV2718 Lachnospiraceae Agathobacter NA 
ASV2719 Cardiobacteriaceae NA NA 
ASV2720 Acholeplasmataceae Acholeplasma NA 
ASV2721 Veillonellaceae Selenomonas_3 NA 
ASV2722 Christensenellaceae Christensenellaceae_R-7_group NA 
ASV2723 Flavobacteriaceae Capnocytophaga NA 
ASV2724 Spirochaetaceae Treponema_2 NA 
ASV2725 Lachnospiraceae Oribacterium NA 
ASV2726 NA NA NA 
ASV2727 Mitochondria NA NA 
ASV2728 Flavobacteriaceae Capnocytophaga NA 
ASV2729 Leptotrichiaceae Leptotrichia NA 
ASV2730 Lachnospiraceae Johnsonella NA 
ASV2731 Leptotrichiaceae Leptotrichia NA 
ASV2732 Lachnospiraceae Moryella indoligenes 
ASV2733 Spirochaetaceae Treponema_2 NA 
ASV2734 Lachnospiraceae Butyrivibrio_2 NA 
ASV2735 Carnobacteriaceae Granulicatella NA 
ASV2736 Cardiobacteriaceae Cardiobacterium NA 
ASV2737 Burkholderiaceae Ralstonia insidiosa/pickettii/solanacearum/syzygii 
ASV2738 Prevotellaceae Prevotella_7 NA 
ASV2739 Xanthomonadaceae Stenotrophomonas maltophilia/rhizophila 
ASV2740 Lachnospiraceae Oribacterium NA 
ASV2741 Family_XIII Mogibacterium NA 
ASV2742 Prevotellaceae Prevotella_9 copri 




ASV2743 0319-6G20 NA NA 
ASV2744 Veillonellaceae Selenomonas NA 
ASV2745 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2746 NA NA NA 




ASV2749 Pseudomonadaceae Pseudomonas aeruginosa/alkylphenolica/argentinensis/benzenivorans/cremoricolorata/cuatrocienegasensis/flavescens/fluorescens/fulva/glareae 
ASV2750 Lachnospiraceae Oribacterium NA 
ASV2751 Lachnospiraceae Roseburia NA 
ASV2752 Micrococcaceae Renibacterium NA 
ASV2753 Erysipelotrichaceae Bulleidia NA 
ASV2754 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV2755 Tannerellaceae Tannerella NA 
ASV2756 NA NA NA 
ASV2757 Leptotrichiaceae Leptotrichia NA 
ASV2758 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2759 Veillonellaceae Veillonella NA 
ASV2760 Spirochaetaceae Treponema_2 NA 
ASV2761 Bifidobacteriaceae Parascardovia NA 
ASV2762 Lachnospiraceae Johnsonella NA 
ASV2763 Veillonellaceae Selenomonas_3 NA 
ASV2764 Burkholderiaceae Schlegelella aquatica/thermodepolymerans 
ASV2765 Flavobacteriaceae Capnocytophaga NA 
ASV2766 Prevotellaceae Prevotella NA 
ASV2767 Lachnospiraceae Oribacterium NA 




ASV2768 Lactobacillaceae Lactobacillus gastricus 
ASV2769 Ruminococcaceae Ruminococcus_2 bromii 
ASV2770 Clostridiales_vadinBB60_group NA NA 
ASV2771 Xanthomonadaceae Thermomonas NA 
ASV2772 Streptococcaceae Streptococcus agalactiae/pyogenes 
ASV2773 Geodermatophilaceae Modestobacter caceresii/marinus/multiseptatus/versicolor 
ASV2774 Spirosomaceae Dyadobacter NA 
ASV2775 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV2776 Actinomycetaceae Actinomyces NA 
ASV2777 Polyangiaceae Pajaroellobacter NA 
ASV2778 Porphyromonadaceae Porphyromonas NA 
ASV2779 Porphyromonadaceae Porphyromonas NA 
ASV2780 NA NA NA 
ASV2781 Lachnospiraceae NA NA 
ASV2782 Lachnospiraceae Johnsonella NA 
ASV2783 Atopobiaceae Atopobium NA 
ASV2784 Streptococcaceae Streptococcus NA 
ASV2785 Family_XI Parvimonas NA 
ASV2786 Lactobacillaceae Lactobacillus NA 
ASV2787 Spirochaetaceae Treponema_2 NA 
ASV2788 Marinifilaceae Odoribacter NA 
ASV2789 Lachnospiraceae Shuttleworthia NA 
ASV2790 Rikenellaceae Alistipes NA 
ASV2791 Sphingobacteriaceae Sphingobacterium spiritivorum 
ASV2792 Acholeplasmataceae Acholeplasma NA 
ASV2793 Sphingomonadaceae Sphingopyxis alaskensis/bauzanensis/chilensis/fribergensis/ginsengisoli/italica/panaciterrae 




ASV2794 Mycoplasmataceae Mycoplasma NA 
ASV2795 Moraxellaceae Acinetobacter baumannii/calcoaceticus/indicus/radioresistens/refrigeratoris/variabilis 
ASV2796 Moraxellaceae Acinetobacter bouvetii/calcoaceticus/haemolyticus/johnsonii/schindleri 
ASV2797 Erysipelotrichaceae Eggerthia NA 
ASV2798 Pseudonocardiaceae NA NA 
ASV2799 Mycoplasmataceae Mycoplasma NA 
ASV2800 Veillonellaceae NA NA 
ASV2801 Burkholderiaceae NA NA 
ASV2802 Pseudomonadaceae Pseudomonas brassicacearum/chlororaphis/corrugata/fluorescens/jessenii/kilonensis/mohnii/moorei/putida/umsongensis/vancouverensis 
ASV2803 Mitochondria NA NA 
ASV2804 Lentimicrobiaceae NA NA 
ASV2805 Tannerellaceae Tannerella NA 
ASV2806 Streptococcaceae Streptococcus NA 
ASV2807 Lachnospiraceae Blautia NA 
ASV2808 Peptostreptococcaceae Intestinibacter bartlettii 
ASV2809 Actinomycetaceae Actinomyces NA 
ASV2810 Saccharimonadaceae NA NA 
ASV2811 Prevotellaceae Prevotella NA 
ASV2812 Lachnospiraceae Johnsonella NA 
ASV2813 Caulobacteraceae Brevundimonas albigilva/nasdae/vesicularis 
ASV2814 Enterobacteriaceae Escherichia/Shigella NA 
ASV2815 Lachnospiraceae Johnsonella NA 
ASV2816 Rubrobacteriaceae Rubrobacter NA 
ASV2817 Weeksellaceae Cloacibacterium normanense/rupense 
ASV2818 Lentimicrobiaceae NA NA 
ASV2819 Hyphomicrobiaceae Hyphomicrobium NA 




ASV2820 Prevotellaceae Prevotella_7 NA 
ASV2821 Mitochondria NA NA 
ASV2822 Burkholderiaceae NA NA 
ASV2823 Family_XI W5053 NA 
ASV2824 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV2825 Porphyromonadaceae Porphyromonas NA 
ASV2826 Leptotrichiaceae Leptotrichia NA 
ASV2827 Bacteriovoracaceae Peredibacter NA 
ASV2828 Xanthomonadaceae Stenotrophomonas maltophilia 
ASV2829 Lactobacillaceae Lactobacillus NA 
ASV2830 Sphingobacteriaceae Pedobacter agri/alluvionis/borealis/ginsenosidimutans/humicola/jeongneungensis/kyungheensis/roseus/sandarakinus/soli/suwonensis/terrae 
ASV2831 Fusobacteriaceae Fusobacterium NA 
ASV2832 Family_XI Parvimonas NA 
ASV2833 Flavobacteriaceae Capnocytophaga NA 
ASV2834 Veillonellaceae Selenomonas NA 
ASV2835 Micrococcaceae Kocuria NA 
ASV2836 Lentimicrobiaceae NA NA 
ASV2837 Spirochaetaceae Treponema_2 NA 
ASV2838 Veillonellaceae Selenomonas_3 NA 
ASV2839 Lactobacillaceae Lactobacillus NA 
ASV2840 Bifidobacteriaceae Bifidobacterium NA 
ASV2841 Lachnospiraceae Blautia NA 
ASV2842 Micrococcaceae Micrococcus alkanovora/aloeverae/antarcticus/cohnii/endophyticus/flavus/indicus/luteus/lylae/thailandicus/yunnanensis 
ASV2843 Chitinophagaceae NA NA 
ASV2844 Mycoplasmataceae Mycoplasma NA 




ASV2845 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2846 Neisseriaceae Eikenella NA 
ASV2847 Burkholderiaceae Paucibacter NA 
ASV2848 Family_XIII Mogibacterium NA 
ASV2849 Burkholderiaceae Comamonas NA 
ASV2850 Lachnospiraceae Oribacterium NA 
ASV2851 Burkholderiaceae Noviherbaspirillum NA 
ASV2852 Lachnospiraceae Shuttleworthia NA 
ASV2853 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2854 Bifidobacteriaceae Bifidobacterium animalis 
ASV2855 Weeksellaceae Chryseobacterium balustinum/indoltheticum/piscicola/piscium/scophthalmum/soldanellicola 
ASV2856 Weeksellaceae Bergeyella NA 
ASV2857 Mitochondria NA NA 
ASV2858 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2859 Prevotellaceae Prevotella_7 NA 
ASV2860 Enterobacteriaceae Escherichia/Shigella NA 
ASV2861 Alcanivoracaceae Alcanivorax NA 
ASV2862 Erysipelotrichaceae Bulleidia NA 
ASV2863 Lachnospiraceae Catonella NA 
ASV2864 Muribaculaceae NA NA 
ASV2865 Bacteroidaceae Bacteroides pyogenes 
ASV2866 Caulobacteraceae NA NA 
ASV2867 Lachnospiraceae Oribacterium NA 
ASV2868 Burkholderiaceae Curvibacter NA 
ASV2869 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2870 Prevotellaceae Prevotella_2 NA 




ASV2871 Mycoplasmataceae Mycoplasma NA 
ASV2872 Flavobacteriaceae Capnocytophaga NA 
ASV2873 Moraxellaceae Acinetobacter baumannii/calcoaceticus/nosocomialis/radioresistens 
ASV2874 Lachnospiraceae Butyrivibrio_2 NA 
ASV2875 Spirochaetaceae Treponema_2 NA 
ASV2876 
Acidobacteriaceae_(Subgroup_1
) Granulicella NA 
ASV2877 Spirochaetaceae Treponema_2 NA 
ASV2878 Lachnospiraceae Johnsonella NA 
ASV2879 Leuconostocaceae Leuconostoc citreum/mesenteroides/pseudomesenteroides 
ASV2880 Sphingomonadaceae Novosphingobium NA 
ASV2881 Veillonellaceae NA NA 
ASV2882 Neisseriaceae NA NA 
ASV2883 NA NA NA 
ASV2884 Lactobacillaceae Lactobacillus animalis/apodemi/crispatus/faecis/murinus 
ASV2885 Nocardiaceae Rhodococcus baikonurensis/boritolerans/degradans/erythropolis/globerulus/hoagii/opacus/qingshengii/rhodochrous 
ASV2886 Xanthomonadaceae Stenotrophomonas acidaminiphila/humi/maltophilia/pavanii 
ASV2887 Lachnospiraceae Catonella NA 
ASV2888 Family_XI Anaerococcus NA 
ASV2889 Prevotellaceae Prevotella NA 
ASV2890 Desulfomicrobiaceae Desulfomicrobium NA 
ASV2891 Neisseriaceae Alysiella NA 
ASV2892 Actinomycetaceae Actinomyces NA 
ASV2893 Veillonellaceae Selenomonas NA 
ASV2894 Lachnospiraceae Catonella NA 
ASV2895 Campylobacteraceae Campylobacter NA 








ASV2898 Anaerolineaceae Flexilinea NA 
ASV2899 Corynebacteriaceae Corynebacterium_1 accolens/fastidiosum/macginleyi/segmentosum 
ASV2900 Rhodocyclaceae Propionivibrio NA 
ASV2901 Lachnospiraceae Catonella NA 
ASV2902 Gemmatimonadaceae NA NA 
ASV2903 Geodermatophilaceae Blastococcus NA 
ASV2904 Cardiobacteriaceae NA NA 
ASV2905 NA NA NA 
ASV2906 Mitochondria NA NA 
ASV2907 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV2908 Streptococcaceae Streptococcus pneumoniae 
ASV2909 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV2910 Sphingobacteriaceae Sphingobacterium cellulitidis/daejeonense/lactis/mizutaii 
ASV2911 Lachnospiraceae NA NA 
ASV2912 Caulobacteraceae Brevundimonas kwangchunensis 
ASV2913 Family_XIII NA NA 
ASV2914 Neisseriaceae Eikenella corrodens 
ASV2915 Lachnospiraceae Blautia NA 
ASV2916 Lachnospiraceae Anaerostipes hadrus 
ASV2917 Burkholderiaceae Caenimonas NA 
ASV2918 Erysipelotrichaceae Catenibacterium mitsuokai 
ASV2919 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV2920 NA NA NA 




ASV2921 Pseudomonadaceae Pseudomonas deceptionensis/endophytica/fluorescens/fragi/helleri/lundensis/psychrophila/putida/syringae/taiwanensis/weihenstephanensis 
ASV2922 Family_XI Peptoniphilus massiliensis/urinimassiliensis 
ASV2923 Prevotellaceae Alloprevotella NA 
ASV2924 Micrococcaceae Kocuria arsenatis/rhizophila/salsicia 
ASV2925 Acidaminococcaceae Phascolarctobacterium succinatutens 
ASV2926 Lachnospiraceae Oribacterium NA 
ASV2927 Flavobacteriaceae Capnocytophaga NA 
ASV2928 Chthoniobacteraceae Chthoniobacter NA 
ASV2929 Prevotellaceae Prevotella NA 
ASV2930 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2931 Salinisphaeraceae Salinisphaera NA 
ASV2932 Vibrionaceae Vibrio algivorus/casei/litoralis/penaeicida/rumoiensis 
ASV2933 Prevotellaceae Prevotella_7 NA 
ASV2934 Lachnospiraceae Stomatobaculum NA 
ASV2935 Muribaculaceae NA NA 
ASV2936 Staphylococcaceae Staphylococcus arlettae/aureus/cohnii/gallinarum/haemolyticus/nepalensis/saccharolyticus/saprophyticus/succinus/xylosus 
ASV2937 Family_XI Gemella NA 
ASV2938 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2939 Ruminococcaceae Faecalibacterium NA 
ASV2940 Mycoplasmataceae Mycoplasma NA 
ASV2941 Flavobacteriaceae Flavobacterium aquidurense/collinsii/frigidimaris/hydatis/johnsoniae/saccharophilum 
ASV2942 Burkholderiaceae Acidovorax defluvii/temperans 
ASV2943 Weeksellaceae Bergeyella NA 
ASV2944 NA NA NA 
ASV2945 Micrococcaceae Kocuria assamensis/palustris 
ASV2946 Mycoplasmataceae Mycoplasma NA 




ASV2947 Microbacteriaceae Galbitalea NA 
ASV2948 Flavobacteriaceae Capnocytophaga NA 
ASV2949 Bacteroidaceae Bacteroides denticanum/pyogenes 
ASV2950 Veillonellaceae Veillonella NA 
ASV2951 Peptostreptococcaceae NA NA 
ASV2952 Lachnospiraceae Roseburia NA 
ASV2953 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV2954 Saccharimonadaceae NA NA 
ASV2955 Prevotellaceae Prevotella ihumii 
ASV2956 Flavobacteriaceae Capnocytophaga NA 
ASV2957 Burkholderiaceae Achromobacter NA 
ASV2958 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV2959 Streptococcaceae Streptococcus NA 
ASV2960 ML635J-40_aquatic_group NA NA 
ASV2961 Saccharimonadaceae NA NA 
ASV2962 Xanthobacteraceae Tardiphaga NA 
ASV2963 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2964 Prevotellaceae Prevotella NA 
ASV2965 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV2966 Prevotellaceae Prevotella_2 NA 
ASV2967 Lachnospiraceae Lachnoclostridium NA 
ASV2968 Lachnospiraceae Johnsonella NA 
ASV2969 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2970 Xanthobacteraceae Bradyrhizobium NA 
ASV2971 Lactobacillaceae Lactobacillus NA 
ASV2972 Pasteurellaceae Necropsobacter NA 




ASV2973 Lachnospiraceae Lachnoanaerobaculum NA 
ASV2974 Prevotellaceae Alloprevotella NA 
ASV2975 Geodermatophilaceae Blastococcus aggregatus/massiliensis 
ASV2976 Coriobacteriaceae Collinsella intestinalis/stercoris 
ASV2977 Moraxellaceae Acinetobacter harbinensis/lwoffii 
ASV2978 NA NA NA 
ASV2979 Prevotellaceae NA NA 
ASV2980 NA NA NA 
ASV2981 NA NA NA 
ASV2982 Campylobacteraceae Campylobacter NA 
ASV2983 NA NA NA 
ASV2984 Prevotellaceae Prevotella bivia/denticola 
ASV2985 Nocardiaceae Nocardia abscessus/asiatica/asteroides/farcinica/higoensis/kroppenstedtii/otitidiscaviarum/shimofusensis 
ASV2986 Veillonellaceae Selenomonas_4 NA 
ASV2987 NA NA NA 
ASV2988 Lactobacillaceae Lactobacillus NA 
ASV2989 Moraxellaceae Psychrobacter namhaensis 
ASV2990 Sphingomonadaceae Sphingomonas NA 
ASV2991 Gemmatimonadaceae Gemmatimonas NA 
ASV2992 Lachnospiraceae Johnsonella NA 
ASV2993 Prevotellaceae Prevotella_7 NA 
ASV2994 Sphingomonadaceae Sphingomonas NA 
ASV2995 Ruminococcaceae Candidatus_Soleaferrea NA 
ASV2996 Synergistaceae Pyramidobacter piscolens 
ASV2997 Lachnospiraceae Johnsonella NA 
ASV2998 Spirochaetaceae Treponema_2 NA 




ASV2999 Streptococcaceae Streptococcus NA 
ASV3000 Bacillaceae Anoxybacillus amylolyticus/ayderensis/beppuensis/bogrovensis/flavithermus/gonensis/kamchatkensis/kaynarcensis/kestanbolensis/mongoliensis 
ASV3001 Micrococcaceae Nesterenkonia lacusekhoensis 
ASV3002 Pasteurellaceae NA NA 
ASV3003 Lactobacillaceae Lactobacillus reuteri 
ASV3004 Porphyromonadaceae Porphyromonas NA 
ASV3005 Family_XI W5053 NA 
ASV3006 Micrococcaceae Kocuria atrinae/carniphila/gwangalliensis/marina 
ASV3007 Leptotrichiaceae Leptotrichia NA 
ASV3008 Moraxellaceae Acinetobacter albensis/haemolyticus 
ASV3009 Corynebacteriaceae Corynebacterium_1 NA 
ASV3010 NA NA NA 
ASV3011 Saccharimonadaceae NA NA 
ASV3012 Prevotellaceae NA NA 
ASV3013 Lachnospiraceae Johnsonella NA 
ASV3014 Xanthobacteraceae Afipia NA 
ASV3015 Spirochaetaceae Treponema_2 NA 
ASV3016 Veillonellaceae Selenomonas NA 
ASV3017 Moraxellaceae Acinetobacter NA 
ASV3018 Neisseriaceae Eikenella NA 
ASV3019 Bacteroidaceae Bacteroides fragilis/ovatus 
ASV3020 Micrococcaceae Pseudarthrobacter NA 
ASV3021 NA NA NA 
ASV3022 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV3023 Veillonellaceae Selenomonas_4 NA 
ASV3024 Leptotrichiaceae Leptotrichia NA 




ASV3025 Veillonellaceae NA NA 
ASV3026 Lachnospiraceae NA NA 
ASV3027 Bifidobacteriaceae Scardovia NA 
ASV3028 NA NA NA 
ASV3029 Xanthomonadaceae Stenotrophomonas NA 
ASV3030 Moraxellaceae Moraxella bovis/bovoculi/caprae/equi/lacunata 
ASV3031 Fusobacteriaceae Fusobacterium NA 
ASV3032 Streptococcaceae Streptococcus canis/dysgalactiae/pyogenes 
ASV3033 Veillonellaceae Dialister NA 
ASV3034 NA NA NA 
ASV3035 Prevotellaceae NA NA 
ASV3036 Flavobacteriaceae Capnocytophaga NA 
ASV3037 Lachnospiraceae NA NA 
ASV3038 Prevotellaceae Prevotella NA 
ASV3039 Mycoplasmataceae Mycoplasma NA 
ASV3040 Micrococcaceae Rothia NA 
ASV3041 Xanthomonadaceae Stenotrophomonas maltophilia/pavanii 
ASV3042 Moraxellaceae Alkanindiges illinoisensis 
ASV3043 Rikenellaceae Rikenellaceae_RC9_gut_group NA 




ASV3046 Desulfovibrionaceae Desulfovibrio NA 
ASV3047 Sphingomonadaceae Blastomonas natatoria/ursincola 
ASV3048 Clostridiaceae_1 Clostridium_sensu_stricto_1 NA 
ASV3049 Deinococcaceae Deinococcus actinosclerus/arenae/grandis/radiotolerans/soli/xianganensis 




ASV3050 Micrococcaceae Rothia arfidiae/endophytica/marina/mucilaginosa/nasimurium 
ASV3051 Burkholderiaceae NA NA 
ASV3052 Flavobacteriaceae Flavobacterium NA 
ASV3053 Family_XI Peptoniphilus gorbachii/harei/phoceensis/rhinitidis/senegalensis/tyrrelliae 
ASV3054 Mycoplasmataceae Mycoplasma NA 
ASV3055 Burkholderiaceae Hydrogenophaga atypica/bisanensis/defluvii/flava/palleronii/pseudoflava/taeniospiralis 
ASV3056 Listeriaceae Brochothrix thermosphacta 
ASV3057 Spirochaetaceae Treponema_2 NA 
ASV3058 Hymenobacteraceae Hymenobacter NA 
ASV3059 Iamiaceae Iamia NA 
ASV3060 Sphingomonadaceae Sphingomonas alpina/aquatica/aquatilis/insulae/kyungheensis/melonis/sanxanigenens/taxi 
ASV3061 Beijerinckiaceae Methylobacterium bullatum/marchantiae 
ASV3062 Streptococcaceae Streptococcus equi 
ASV3063 Caulobacteraceae Brevundimonas diminuta/terrae 
ASV3064 Mycobacteriaceae Mycobacterium chelonae/insubricum/llatzerense/mucogenicum/phlei/phocaicum/tuberculosis 
ASV3065 Prevotellaceae Prevotella NA 
ASV3066 Mycoplasmataceae Mycoplasma NA 
ASV3067 Bifidobacteriaceae Bifidobacterium NA 
ASV3068 Actinomycetaceae Actinomyces NA 
ASV3069 Actinomycetaceae Actinomyces NA 
ASV3070 Pasteurellaceae NA NA 
ASV3071 Weeksellaceae Chryseobacterium anthropi/haifense 
ASV3072 Prevotellaceae Prevotella_7 NA 
ASV3073 Family_XIII NA NA 
ASV3074 Flavobacteriaceae Flavobacterium NA 
ASV3075 Prevotellaceae Prevotella_7 NA 




ASV3076 Burkholderiaceae Polaromonas NA 
ASV3077 Veillonellaceae Selenomonas_4 NA 
ASV3078 Lachnospiraceae Stomatobaculum NA 
ASV3079 NA NA NA 
ASV3080 NA NA NA 
ASV3081 Bacillaceae Geobacillus kaustophilus/stearothermophilus 
ASV3082 Mitochondria NA NA 
ASV3083 Prevotellaceae Prevotella_7 NA 
ASV3084 NA NA NA 
ASV3085 Prevotellaceae Prevotella_7 NA 
ASV3086 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3087 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV3088 Leptotrichiaceae Leptotrichia NA 
ASV3089 Neisseriaceae NA NA 
ASV3090 Defluviitaleaceae Defluviitaleaceae_UCG-011 NA 
ASV3091 Blastocatellaceae NA NA 
ASV3092 Leptotrichiaceae Leptotrichia NA 
ASV3093 Pedosphaeraceae NA NA 
ASV3094 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV3095 Spirochaetaceae Treponema_2 NA 
ASV3096 Saccharimonadaceae NA NA 
ASV3097 Sphingobacteriaceae Sphingobacterium anhuiense/faecium/kitahiroshimense 
ASV3098 Caulobacteraceae Brevundimonas staleyi/subvibrioides 
ASV3099 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV3100 Veillonellaceae NA NA 
ASV3101 Pasteurellaceae NA NA 




ASV3102 Dermabacteraceae Brachybacterium alimentarium/conglomeratum/faecium/massiliense/paraconglomeratum/sacelli 
ASV3103 NA NA NA 
ASV3104 NA NA NA 
ASV3105 NA NA NA 
ASV3106 NA NA NA 
ASV3107 NA NA NA 
ASV3108 Prevotellaceae Alloprevotella NA 
ASV3109 Veillonellaceae Dialister NA 
ASV3110 Streptococcaceae Streptococcus NA 
ASV3111 Streptococcaceae Streptococcus NA 
ASV3112 Family_XIII NA NA 
ASV3113 Prevotellaceae Prevotella_7 NA 
ASV3114 NA NA NA 
ASV3115 Prevotellaceae Alloprevotella NA 
ASV3116 Peptostreptococcaceae Peptostreptococcus NA 
ASV3117 NA NA NA 
ASV3118 Leptotrichiaceae Leptotrichia NA 
ASV3119 Moraxellaceae Alkanindiges NA 
ASV3120 Neisseriaceae Bergeriella NA 
ASV3121 Family_XI Gemella NA 
ASV3122 Corynebacteriaceae Corynebacterium_1 urealyticum 
ASV3123 Flavobacteriaceae Flavobacterium lindanitolerans 
ASV3124 Alteromonadaceae Rheinheimera NA 
ASV3125 Moraxellaceae Acinetobacter NA 
ASV3126 Bifidobacteriaceae Alloscardovia NA 
ASV3127 Spirochaetaceae Treponema_2 NA 




ASV3128 NA NA NA 
ASV3129 Family_XIII NA NA 
ASV3130 NA NA NA 
ASV3131 Peptostreptococcaceae NA NA 
ASV3132 Pasteurellaceae Rodentibacter NA 
ASV3133 Flavobacteriaceae Capnocytophaga NA 
ASV3134 Succinivibrionaceae NA NA 
ASV3135 Veillonellaceae NA NA 
ASV3136 Corynebacteriaceae Corynebacterium_1 afermentans/coyleae/fournierii/H-EH3/ihumii/mucifaciens/pilbarense/ureicelerivorans 
ASV3137 Saccharimonadaceae NA NA 
ASV3138 Lachnospiraceae Johnsonella NA 
ASV3139 Flavobacteriaceae NA NA 
ASV3140 Dietziaceae Dietzia cercidiphylli/dagingensis/natronolimnaea/psychralcaliphila 
ASV3141 Campylobacteraceae Campylobacter NA 
ASV3142 Veillonellaceae NA NA 
ASV3143 Solirubrobacteraceae Solirubrobacter NA 
ASV3144 NA NA NA 
ASV3145 Prevotellaceae Prevotella NA 
ASV3146 Lachnospiraceae Johnsonella NA 
ASV3147 NA NA NA 
ASV3148 Lachnospiraceae Moryella NA 
ASV3149 Synergistaceae Fretibacterium NA 
ASV3150 Leptotrichiaceae Sneathia sanguinegens 
ASV3151 Veillonellaceae Negativicoccus succinicivorans 
ASV3152 Enterobacteriaceae Hafnia-Obesumbacterium NA 
ASV3153 Weeksellaceae Bergeyella NA 




ASV3154 NA NA NA 
ASV3155 Veillonellaceae Centipeda NA 
ASV3156 Family_XI Parvimonas NA 
ASV3157 Burkholderiaceae Comamonas testosteroni/thiooxydans 
ASV3158 Corynebacteriaceae Corynebacterium variabile 
ASV3159 Family_XI Finegoldia magna 
ASV3160 Burkholderiaceae NA NA 
ASV3161 Spirochaetaceae Treponema_2 NA 
ASV3162 Peptostreptococcaceae Peptostreptococcus NA 
ASV3163 Prevotellaceae Prevotella_2 NA 
ASV3164 Lachnospiraceae NA NA 
ASV3165 Brevibacteriaceae Brevibacterium ammoniilyticum/aureum/casei/celere/epidermidis/iodinum/linens/permense/picturae/sandarakinum/sanguinis/sediminis/siliguriense 
ASV3166 Spirosomaceae Leadbetterella NA 
ASV3167 Weeksellaceae Chishuiella NA 
ASV3168 Pseudomonadaceae Pseudomonas stutzeri/xanthomarina 
ASV3169 Sphingomonadaceae Rhizorhapis NA 
ASV3170 Rhodocyclaceae Azonexus fungiphilus 
ASV3171 Lachnospiraceae Agathobacter NA 
ASV3172 Family_XI Ezakiella massiliensis/peruensis 
ASV3173 Hydrogenophilaceae Hydrogenophilus NA 
ASV3174 Mycoplasmataceae Mycoplasma NA 
ASV3175 Lachnospiraceae Blautia NA 
ASV3176 Fusobacteriaceae NA NA 
ASV3177 Burkholderiaceae NA NA 
ASV3178 NA NA NA 
ASV3179 Moraxellaceae Acinetobacter NA 




ASV3180 NA NA NA 
ASV3181 NA NA NA 
ASV3182 Leptotrichiaceae Leptotrichia NA 
ASV3183 Saccharimonadaceae NA NA 
ASV3184 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV3185 Erysipelotrichaceae Erysipelatoclostridium NA 
ASV3186 NA NA NA 
ASV3187 Rhizobiaceae Ochrobactrum intermedium/pituitosum/rhizosphaerae 
ASV3188 Burkholderiaceae Ralstonia NA 
ASV3189 Deinococcaceae Deinococcus radiopugnans/swuensis 
ASV3190 Lachnospiraceae NA NA 
ASV3191 Solirubrobacteraceae Parviterribacter NA 
ASV3192 Weeksellaceae Bergeyella NA 
ASV3193 Spirochaetaceae Treponema_2 NA 
ASV3194 Flavobacteriaceae Capnocytophaga NA 
ASV3195 Mitochondria NA NA 
ASV3196 Neisseriaceae NA NA 
ASV3197 Pasteurellaceae Cricetibacter NA 
ASV3198 Flavobacteriaceae Capnocytophaga NA 
ASV3199 Lachnospiraceae Johnsonella NA 
ASV3200 Prevotellaceae Prevotella NA 
ASV3201 Porphyromonadaceae Porphyromonas NA 
ASV3202 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3203 Enterobacteriaceae NA NA 
ASV3204 Nocardioidaceae Nocardioides NA 
ASV3205 Pasteurellaceae NA NA 




ASV3206 Leptotrichiaceae Oceanivirga NA 
ASV3207 Rhodobacteraceae Haematobacter massiliensis/missouriensis 
ASV3208 Spirochaetaceae Treponema_2 NA 
ASV3209 Lactobacillaceae Lactobacillus NA 
ASV3210 Lachnospiraceae Stomatobaculum NA 
ASV3211 Leptotrichiaceae Leptotrichia NA 
ASV3212 NA NA NA 
ASV3213 Lachnospiraceae Lachnoclostridium NA 
ASV3214 Lachnospiraceae Butyrivibrio_2 NA 
ASV3215 NA NA NA 
ASV3216 Flavobacteriaceae Capnocytophaga NA 
ASV3217 Pasteurellaceae NA NA 
ASV3218 Brevibacteriaceae Brevibacterium ravenspurgense 
ASV3219 Ruminococcaceae Faecalibacterium CM04-06 
ASV3220 Leuconostocaceae Leuconostoc carnosum/citreum/garlicum/gelidum/holzapfelii/lactis/mesenteroides/palmae/pseudomesenteroides 
ASV3221 Neisseriaceae Bergeriella NA 
ASV3222 Prevotellaceae Prevotella_7 NA 
ASV3223 Lachnospiraceae Blautia NA 
ASV3224 Lachnospiraceae NA NA 
ASV3225 Bifidobacteriaceae Bifidobacterium crudilactis/psychraerophilum 
ASV3226 Porphyromonadaceae Porphyromonas somerae 
ASV3227 Prevotellaceae Prevotella_7 NA 
ASV3228 Caulobacteraceae Brevundimonas NA 
ASV3229 Flavobacteriaceae Capnocytophaga NA 
ASV3230 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV3231 Desulfobulbaceae Desulfobulbus NA 




ASV3232 NA NA NA 
ASV3233 Ruminococcaceae UBA1819 NA 
ASV3234 Fimbriimonadaceae NA NA 
ASV3235 Bifidobacteriaceae Scardovia NA 
ASV3236 NA NA NA 
ASV3237 NA NA NA 
ASV3238 Streptococcaceae Lactococcus piscium/plantarum 
ASV3239 Pseudomonadaceae Pseudomonas japonica/putida 
ASV3240 NA NA NA 
ASV3241 Prevotellaceae Alloprevotella NA 
ASV3242 Aerococcaceae Aerococcus urinaeequi/viridans 
ASV3243 Campylobacteraceae Campylobacter NA 




ASV3246 Peptostreptococcaceae NA NA 
ASV3247 Family_XI Anaerococcus vaginalis 
ASV3248 Lachnospiraceae Blautia NA 
ASV3249 Microbacteriaceae Frigoribacterium faeni 
ASV3250 Rikenellaceae Blvii28_wastewater-sludge_group NA 
ASV3251 NA NA NA 
ASV3252 Pasteurellaceae NA NA 
ASV3253 Rhodocyclaceae Methyloversatilis discipulorum/universalis 
ASV3254 NA NA NA 
ASV3255 Burkholderiaceae NA NA 
ASV3256 Campylobacteraceae Campylobacter NA 




ASV3257 NA NA NA 
ASV3258 NA NA NA 
ASV3259 Atopobiaceae Atopobium NA 
ASV3260 Family_XI Gemella NA 
ASV3261 Tannerellaceae NA NA 
ASV3262 Lachnospiraceae Johnsonella NA 
ASV3263 Campylobacteraceae Campylobacter NA 
ASV3264 Moraxellaceae Acinetobacter baumannii/junii/seohaensis/soli/towneri/venetianus 
ASV3265 Fusobacteriaceae NA NA 
ASV3266 Streptococcaceae Streptococcus NA 
ASV3267 Saccharimonadaceae NA NA 
ASV3268 Peptostreptococcaceae NA NA 
ASV3269 Veillonellaceae Centipeda NA 
ASV3270 NA NA NA 
ASV3271 Xanthomonadaceae Luteimonas NA 
ASV3272 Micrococcaceae Kocuria kristinae/rosea 
ASV3273 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3274 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV3275 Leptotrichiaceae Leptotrichia NA 
ASV3276 Cellulomonadaceae Tropheryma whipplei 
ASV3277 Lachnospiraceae Lachnoanaerobaculum NA 
ASV3278 Bacillaceae NA NA 
ASV3279 NA NA NA 
ASV3280 Geodermatophilaceae Modestobacter marinus/muralis/versicolor 
ASV3281 Lachnospiraceae NA NA 
ASV3282 Spirochaetaceae Treponema_2 NA 




ASV3283 Prevotellaceae NA NA 
ASV3284 Spirochaetaceae Treponema_2 NA 
ASV3285 Prevotellaceae Prevotella_6 bergensis 
ASV3286 Family_XI Gallicola NA 
ASV3287 Prevotellaceae Prevotella NA 
ASV3288 Bacteroidaceae Bacteroides faecichinchillae/faecis/finegoldii/thetaiotaomicron 
ASV3289 Lactobacillaceae Lactobacillus NA 
ASV3290 Family_XIII Mogibacterium NA 
ASV3291 Erysipelotrichaceae Eggerthia NA 
ASV3292 Crocinitomicaceae Fluviicola NA 
ASV3293 Pseudomonadaceae Pseudomonas argentinensis/arsenicoxydans/baetica/borealis/brassicacearum/brenneri/chlororaphis/corrugata/denitrificans/ficuserectae/fluorescens 
ASV3294 Sphingomonadaceae Sphingomonas NA 
ASV3295 NA NA NA 
ASV3296 Paludibacteraceae F0058 NA 
ASV3297 Flavobacteriaceae Capnocytophaga NA 
ASV3298 Saccharimonadaceae NA NA 
ASV3299 Bacteroidales_Incertae_Sedis Phocaeicola NA 
ASV3300 Enterobacteriaceae Buttiauxella brennerae/gaviniae 
ASV3301 Sphingomonadaceae Sphingobium NA 
ASV3302 Family_XII Exiguobacterium acetylicum/aestuarii/alkaliphilum/aquaticum/arabatum/aurantiacum/chiriqhucha/himgiriensis/homiense/marinum/mexicanum 
ASV3303 Nocardioidaceae Nocardioides rubriscoriae 
ASV3304 NA NA NA 
ASV3305 Family_XI Parvimonas NA 
ASV3306 Prevotellaceae Prevotella_7 NA 
ASV3307 Sphingomonadaceae Sphingomonas NA 
ASV3308 Weeksellaceae Chryseobacterium anthropi 




ASV3309 Family_XI Parvimonas NA 
ASV3310 Erysipelotrichaceae Eggerthia NA 
ASV3311 Rhodothermaceae NA NA 
ASV3312 NA NA NA 
ASV3313 Family_XIII NA NA 
ASV3314 Prevotellaceae Prevotella NA 
ASV3315 p-2534-18B5_gut_group NA NA 
ASV3316 Prevotellaceae Alloprevotella NA 
ASV3317 Lachnospiraceae NA NA 
ASV3318 Prevotellaceae Prevotella_2 NA 
ASV3319 Caulobacteraceae Phenylobacterium muchangponense 
ASV3320 Burkholderiaceae Duganella phyllosphaerae/radicis/sacchari/zoogloeoides 
ASV3321 NA NA NA 
ASV3322 Burkholderiaceae Noviherbaspirillum NA 
ASV3323 Corynebacteriaceae NA NA 
ASV3324 Ruminococcaceae Ruminococcus_2 NA 
ASV3325 NA NA NA 
ASV3326 Prevotellaceae Alloprevotella NA 
ASV3327 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3328 Weeksellaceae NA NA 
ASV3329 Family_XI Anaerococcus nagyae 
ASV3330 Corynebacteriaceae Corynebacterium_1 jeddahense 
ASV3331 Lachnospiraceae Shuttleworthia NA 
ASV3332 Lachnospiraceae Johnsonella NA 
ASV3333 Weeksellaceae Bergeyella NA 
ASV3334 Eggerthellaceae Cryptobacterium NA 




ASV3335 Sphingomonadaceae Sphingomonas NA 
ASV3336 Flavobacteriaceae Capnocytophaga NA 
ASV3337 Chitinophagaceae Sediminibacterium salmoneum 
ASV3338 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV3339 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV3340 NA NA NA 
ASV3341 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV3342 Sphingobacteriaceae Sphingobacterium NA 
ASV3343 Desulfobulbaceae Desulfobulbus NA 
ASV3344 NA NA NA 
ASV3345 Cellvibrionaceae NA NA 
ASV3346 Prevotellaceae Alloprevotella NA 
ASV3347 Family_XI Ezakiella NA 
ASV3348 Veillonellaceae NA NA 
ASV3349 NA NA NA 
ASV3350 Prevotellaceae Prevotella NA 
ASV3351 NA NA NA 
ASV3352 Ruminococcaceae Fastidiosipila NA 
ASV3353 Fusobacteriaceae Fusobacterium NA 
ASV3354 NA NA NA 
ASV3355 Flavobacteriaceae Capnocytophaga NA 
ASV3356 Sphingomonadaceae Sphingobium yanoikuyae 
ASV3357 Saccharimonadaceae NA NA 
ASV3358 Acidaminococcaceae Acidaminococcus intestini 
ASV3359 Cardiobacteriaceae Cardiobacterium NA 
ASV3360 Rikenellaceae Rikenellaceae_RC9_gut_group NA 




ASV3361 Nocardiaceae Williamsia faeni/limnetica/muralis 
ASV3362 Sphingomonadaceae Sphingobium japonicum/lactosutens/xenophagum 
ASV3363 Deinococcaceae Deinococcus radiodurans 
ASV3364 Rhizobiaceae Neorhizobium NA 
ASV3365 Endomicrobiaceae Candidatus_Endomicrobium NA 
ASV3366 Neisseriaceae NA NA 
ASV3367 Campylobacteraceae Campylobacter NA 
ASV3368 NA NA NA 
ASV3369 NA NA NA 
ASV3370 NA NA NA 
ASV3371 Porphyromonadaceae Porphyromonas NA 
ASV3372 Lactobacillaceae Lactobacillus fermentum/mucosae 
ASV3373 Pasteurellaceae Cricetibacter NA 
ASV3374 Prevotellaceae NA NA 
ASV3375 NA NA NA 
ASV3376 Family_XIII NA NA 
ASV3377 Solirubrobacteraceae Solirubrobacter NA 
ASV3378 Xanthomonadaceae Arenimonas daechungensis 
ASV3379 Prevotellaceae Prevotella NA 
ASV3380 Lachnospiraceae NA NA 
ASV3381 NA NA NA 
ASV3382 Family_XIII NA NA 
ASV3383 Corynebacteriaceae Corynebacterium_1 NA 
ASV3384 Veillonellaceae Selenomonas_3 NA 
ASV3385 NA NA NA 
ASV3386 Rhodanobacteraceae Tahibacter aquaticus 




ASV3387 Sphingobacteriaceae Pedobacter insulae 
ASV3388 Xanthomonadaceae Pseudoxanthomonas japonensis/mexicana 
ASV3389 Prevotellaceae Prevotella NA 
ASV3390 Spirochaetaceae Treponema_2 NA 
ASV3391 NA NA NA 
ASV3392 NA NA NA 
ASV3393 Ruminococcaceae NA NA 
ASV3394 Porphyromonadaceae Porphyromonas NA 
ASV3395 Ruminococcaceae Fastidiosipila NA 
ASV3396 Family_XI Parvimonas NA 
ASV3397 Family_XIII Anaerovorax NA 
ASV3398 Veillonellaceae NA NA 
ASV3399 p-2534-18B5_gut_group NA NA 
ASV3400 Prevotellaceae Prevotella NA 
ASV3401 Lachnospiraceae Howardella NA 
ASV3402 Family_XI Gemella NA 
ASV3403 Burkholderiaceae Sutterella NA 
ASV3404 Fusobacteriaceae Fusobacterium NA 
ASV3405 Lachnospiraceae Stomatobaculum NA 
ASV3406 Rhodobacteraceae Paracoccus laeviglucosivorans/yeei 
ASV3407 NA NA NA 
ASV3408 Pasteurellaceae NA NA 
ASV3409 Lactobacillaceae Lactobacillus curvatus/graminis/plantarum/sakei 
ASV3410 Neisseriaceae Bergeriella NA 
ASV3411 Leptotrichiaceae Leptotrichia NA 
ASV3412 NA NA NA 




ASV3413 Bifidobacteriaceae Bifidobacterium NA 
ASV3414 Lachnospiraceae Lachnoanaerobaculum NA 
ASV3415 Porphyromonadaceae Porphyromonas NA 
ASV3416 Lachnospiraceae Lachnoanaerobaculum NA 
ASV3417 Peptostreptococcaceae Peptostreptococcus NA 
ASV3418 Tannerellaceae Tannerella NA 
ASV3419 Family_XIII Family_XIII_UCG-001 NA 
ASV3420 Fusobacteriaceae Fusobacterium NA 
ASV3421 Prevotellaceae NA NA 
ASV3422 Saccharimonadaceae NA NA 
ASV3423 NA NA NA 
ASV3424 Prevotellaceae Alloprevotella NA 
ASV3425 Pseudomonadaceae Pseudomonas NA 
ASV3426 Rubrobacteriaceae Rubrobacter NA 
ASV3427 Prevotellaceae NA NA 
ASV3428 NA NA NA 
ASV3429 Porphyromonadaceae Porphyromonas NA 
ASV3430 Erysipelotrichaceae NA NA 
ASV3431 Aerococcaceae Aerococcus NA 
ASV3432 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3433 Family_XI Ezakiella NA 
ASV3434 Family_XIII S5-A14a NA 
ASV3435 Veillonellaceae Centipeda NA 
ASV3436 Pasteurellaceae NA NA 
ASV3437 NA NA NA 
ASV3438 Fusobacteriaceae NA NA 




ASV3439 Prevotellaceae Prevotella_7 NA 
ASV3440 Ruminococcaceae Ruminococcaceae_UCG-014 NA 
ASV3441 Prevotellaceae NA NA 
ASV3442 Bacteriovoracaceae Bacteriovorax NA 
ASV3443 Sphingobacteriaceae Pedobacter NA 
ASV3444 Beijerinckiaceae Bosea eneae/lathyri/massiliensis/thiooxidans/vaviloviae/vestrisii 
ASV3445 Lachnospiraceae Stomatobaculum NA 
ASV3446 Porphyromonadaceae Porphyromonas NA 
ASV3447 Campylobacteraceae Campylobacter NA 
ASV3448 Porphyromonadaceae Porphyromonas asaccharolytica 
ASV3449 Paludibacteraceae F0058 NA 
ASV3450 Methylophilaceae Methylotenera NA 
ASV3451 Prevotellaceae Alloprevotella NA 
ASV3452 Burkholderiaceae Massilia arvi/pinisoli/putida 
ASV3453 Peptococcaceae Peptococcus NA 
ASV3454 NA NA NA 
ASV3455 Desulfovibrionaceae Desulfovibrio desulfuricans/multispirans 
ASV3456 Lactobacillaceae Lactobacillus mali/nagelii/satsumensis/sicerae 
ASV3457 Erysipelotrichaceae Eggerthia NA 
ASV3458 Lachnospiraceae Oribacterium NA 
ASV3459 Propionibacteriaceae Pseudopropionibacterium NA 
ASV3460 Lactobacillaceae Lactobacillus NA 
ASV3461 Staphylococcaceae Staphylococcus auricularis/epidermidis/warneri 
ASV3462 NA NA NA 
ASV3463 Lactobacillaceae Lactobacillus NA 







ASV3465 Mitochondria NA NA 
ASV3466 Prevotellaceae Prevotella_2 NA 
ASV3467 Sphingomonadaceae Blastomonas aquatica 
ASV3468 Pseudomonadaceae Pseudomonas alcaligenes/alkylphenolica/cichorii/donghuensis/filiscindens/japonica/lundensis/multiaromavorans/plecoglossicida/putida/vranovensis 
ASV3469 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3470 Spirosomaceae Rudanella NA 
ASV3471 NA NA NA 
ASV3472 Family_XI Peptoniphilus NA 
ASV3473 Erysipelotrichaceae Erysipelotrichaceae_UCG-006 NA 
ASV3474 Eggerthellaceae Cryptobacterium NA 
ASV3475 Family_XI Peptoniphilus NA 
ASV3476 Acidaminococcaceae Phascolarctobacterium NA 
ASV3477 Mycobacteriaceae Mycobacterium NA 
ASV3478 Azospirillaceae Skermanella aerolata 
ASV3479 Flavobacteriaceae Capnocytophaga NA 
ASV3480 Eggerthellaceae Slackia NA 
ASV3481 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3482 Lachnospiraceae Howardella NA 
ASV3483 NA NA NA 
ASV3484 Xanthomonadaceae Stenotrophomonas NA 
ASV3485 NA NA NA 
ASV3486 TRA3-20 NA NA 
ASV3487 Chthoniobacteraceae Candidatus_Udaeobacter NA 
ASV3488 Leuconostocaceae Leuconostoc gelidum/inhae 




ASV3489 Erysipelotrichaceae Erysipelatoclostridium ramosum 
ASV3490 Prevotellaceae NA NA 
ASV3491 Veillonellaceae Selenomonas_3 NA 
ASV3492 Spirochaetaceae NA NA 
ASV3493 NA NA NA 
ASV3494 Veillonellaceae Dialister NA 
ASV3495 Burkholderiaceae NA NA 
ASV3496 Lachnospiraceae Stomatobaculum NA 
ASV3497 Lachnospiraceae Stomatobaculum NA 
ASV3498 Carnobacteriaceae NA NA 
ASV3499 Bacteroidales_Incertae_Sedis Phocaeicola NA 
ASV3500 Rhodobacteraceae Paracoccus NA 
ASV3501 NA NA NA 
ASV3502 Family_XI Gemella NA 
ASV3503 Erysipelotrichaceae Bulleidia NA 
ASV3504 NA NA NA 
ASV3505 Lachnospiraceae Lachnoanaerobaculum NA 
ASV3506 Beijerinckiaceae Methylobacterium adhaesivum 
ASV3507 Neisseriaceae Bergeriella NA 
ASV3508 Neisseriaceae NA NA 
ASV3509 Lachnospiraceae Lachnoanaerobaculum NA 
ASV3510 Family_XI Parvimonas NA 
ASV3511 Paenibacillaceae Paenibacillus NA 
ASV3512 NA NA NA 
ASV3513 Ruminococcaceae Faecalibacterium prausnitzii 
ASV3514 Leptotrichiaceae Leptotrichia NA 




ASV3515 NA NA NA 
ASV3516 Spirosomaceae Dyadobacter NA 
ASV3517 Sphingomonadaceae Sphingopyxis NA 
ASV3518 Streptococcaceae Streptococcus NA 
ASV3519 NA NA NA 
ASV3520 Prevotellaceae NA NA 
ASV3521 Prevotellaceae Prevotella_6 corporis 
ASV3522 Lachnospiraceae Moryella NA 
ASV3523 Porphyromonadaceae Porphyromonas NA 
ASV3524 Family_XI Anaerococcus NA 
ASV3525 Prevotellaceae Prevotella NA 
ASV3526 NA NA NA 
ASV3527 Pseudomonadaceae Pseudomonas aeruginosa/citronellolis/delhiensis/denitrificans/knackmussii/nitritireducens/nitroreducens/panipatensis/stutzeri 
ASV3528 Flavobacteriaceae Flavobacterium ummariense 
ASV3529 Fusobacteriaceae NA NA 
ASV3530 Xanthomonadaceae Stenotrophomonas acidaminiphila/maltophilia/nitritireducens 
ASV3531 NA NA NA 
ASV3532 Mitochondria NA NA 
ASV3533 Neisseriaceae NA NA 
ASV3534 Mycoplasmataceae Mycoplasma NA 
ASV3535 NA NA NA 
ASV3536 Atopobiaceae Atopobium NA 
ASV3537 Ruminococcaceae NA NA 
ASV3538 Mitochondria NA NA 
ASV3539 Family_XI Anaerococcus mediterraneensis/murdochii 
ASV3540 Prevotellaceae Prevotella buccalis 




ASV3541 NA NA NA 
ASV3542 Reyranellaceae Reyranella soli 
ASV3543 Mycoplasmataceae Mycoplasma NA 
ASV3544 NA NA NA 
ASV3545 NA NA NA 
ASV3546 Xanthobacteraceae Afipia clevelandensis 
ASV3547 Prevotellaceae Alloprevotella NA 
ASV3548 Actinomycetaceae F0332 NA 
ASV3549 NA NA NA 
ASV3550 Lachnospiraceae Stomatobaculum NA 
ASV3551 Pasteurellaceae NA NA 
ASV3552 Erysipelotrichaceae NA NA 
ASV3553 Campylobacteraceae Campylobacter NA 
ASV3554 NA NA NA 
ASV3555 Burkholderiaceae Massilia aurea/brevitalea/cf./namucuonensis/timonae 
ASV3556 Hymenobacteraceae Hymenobacter NA 
ASV3557 Lachnospiraceae Lachnospiraceae_NK3A20_group NA 
ASV3558 Veillonellaceae Selenomonas_4 NA 
ASV3559 Lachnospiraceae Coprococcus_3 comes 
ASV3560 Pasteurellaceae NA NA 
ASV3561 NA NA NA 
ASV3562 Methanobacteriaceae Methanobrevibacter NA 
ASV3563 NA NA NA 
ASV3564 Pseudoalteromonadaceae Pseudoalteromonas NA 
ASV3565 Prevotellaceae NA NA 
ASV3566 NA NA NA 




ASV3567 Leptotrichiaceae Leptotrichia NA 
ASV3568 Leptotrichiaceae Leptotrichia NA 
ASV3569 NA NA NA 
ASV3570 Weeksellaceae Chryseobacterium aahli/defluvii/limigenitum/piperi/soldanellicola/soli/yeoncheonense 
ASV3571 env.OPS_17 NA NA 
ASV3572 NA NA NA 
ASV3573 NA NA NA 
ASV3574 Chitinophagaceae NA NA 
ASV3575 Rikenellaceae Rikenellaceae_RC9_gut_group NA 
ASV3576 Saccharimonadaceae Candidatus_Saccharimonas NA 
ASV3577 Flavobacteriaceae Capnocytophaga NA 
ASV3578 Prevotellaceae NA NA 
ASV3579 NA NA NA 
ASV3580 Family_XI Peptoniphilus NA 
ASV3581 NA NA NA 
ASV3582 Saccharimonadaceae NA NA 
ASV3583 Lachnospiraceae Lachnospiraceae_NK3A20_group NA 
ASV3584 Burkholderiaceae Verticia NA 
ASV3585 NA NA NA 
ASV3586 Prevotellaceae Prevotellaceae_YAB2003_group NA 
ASV3587    
 
  
Appendix E: Chapter 7 
This appendix contains additional relevant work completed after the study presented in 
Chapter 7. In Chapter 7 I have undertaken characterisation of the saliva microbiota of the 
polygenic risk score cohort investigated in the same chapter; here I have applied similar 
methods to the wider TwinsUK saliva microbiota sample to increase the sample size and 
thus power. Some of this work in relation to alpha diversity will not be submitted for 
publication as no association remained after adjustment for multiple testing. However, for 




 Shannon Simpson Observed 
 Estimate P Q Estimate P Q Estimate P Q 
Age 0.00807 0.055 0.442 0.0093 0.025 0.198 -0.00676 0.097 0.195 
Sex M -0.23255 0.189 0.652 -0.2138 0.220 0.439 0.00310 0.986 0.997 
BMI 0.00806 0.326 0.652 0.0136 0.102 0.375 0.00003 0.997 0.997 
Diet -0.00121 0.785 0.785 0.0018 0.684 0.684 -0.00387 0.363 0.580 
Seq. Depth 0.00000 0.589 0.673 0.0000 0.568 0.649 0.000004 0.04 0.160 
Not Fasted -0.17434 0.315 0.652 -0.1686 0.335 0.533 -0.29523 0.076 0.196 
Storage Time 0.00065 0.490 0.654 0.0008 0.400 0.533 0.001914 0.035 0.161 
Supplementary table E 7.1 Alpha diversity of the saliva microbiota association of factors within the 














 Shannon Simpson Observed 
 Estimate P Q Estimate P Q Estimate P Q 
Age 0.011525 0.012 0.107 0.01176 0.010 0.089 -0.0017 0.693 0.813 
Sex M -0.205960 0.275 0.63 -0.15826 0.399 0.695 -0.0538 0.766 0.813 
BMI 0.009602 0.280 0.63 0.01639 0.073 0.218 0.0020 0.813 0.813 
Diet -0.002269 0.643 0.739 0.00096 0.848 0.848 -0.0034 0.456 0.684 
Frailty Index -0.676624 0.105 0.472 -0.76796 0.073 0.218 -0.6745 0.084 0.251 
Seq. Depth 0.000000 0.840 0.84 0.00000 0.617 0.695 0.0000 0.019 0.086 
Storage Time 0.000658 0.523 0.739 0.00063 0.541 0.695 0.0023 0.019 0.086 
Not Fasted -0.090284 0.657 0.739 -0.13859 0.505 0.695 -0.2367 0.214 0.41 
Supplementary Table E 7.2. Alpha diversity of the saliva microbiota association of factors within the 
wider TwinsUK sample. Subsample analysis of participants for whom frailty were available N=511. 
 
There were demographic differences between those with and without frailty data. Those 
missing frailty data had a median age of 51 (IQR 25 – 57), whilst those with frailty data had 
a median age of 67 (IQR 60 – 66). Participants who were missing frailty data were 
significantly younger (p = 1.08e-12). 
 
There may be differences in the these younger participants which drive the lower alpha 
diversity association demonstrated in the full sample (Supplementary Table E 7.1) 
compared to the frailty subsample analysis (Supplementary Table E 7.2). To this end, 
differences in oral hygiene habits were investigated. However, only 180 participants of 689 
had completed the oral hygiene questionnaire. Within this subsample of 180, there was no 
difference in tooth brushing habits between those with and without frailty data. Within 
both groups, 81% of participants brushed their teeth once a day, whilst the remainder 

















Supplementary Figure E 7.1 Association of factors with beta diversity of the saliva microbiota 
Age was significantly associated with beta diversity after adjusting for all other factors listed plus sequencing depth 
(sample n = 529). The frailty subsample includes only participants for whom frailty data were available ( n = 511). 
Bars are annotated with FDR adjusted p values (Q values). 
 
 
Supplementary Figure E 7.2. PCoA ordination of Weighted UniFrac of the saliva microbiota in 
relation to age (n = 529). On ordination there was no clear clustering of age, however there 
was an indication that older participants tended to have lower beta diversity dissimilarity of 
the saliva microbiota than younger participants. 




Across 5 age groups, variation in distribution of beta diversity increased sequentially with 
age, demonstrating that younger participants were more similar in their saliva microbiota 




Supplementary Figure E 7.3 Bray Curtis beta dispersion of age within full cohort sample. 
 A difference in the variance in  across age groups was demonstrated (5.125e-06, ANOVA). 
 
 
A subsample analysis of participants for whom periodontal disease data were available 
(n=124) is presented in Supplementary Table E 7.3  . Periodontal disease was defined as 
presence of either bleeding gums or loose teeth, or having been told by a dentist that they 
have gum disease. These data were collected using self-report questionnaires. In the sub-
sample analysis of participants with periodontal disease data, implementing a multivariate 
model as prior with the addition of periodontal disease, age was associated with Bray 
Curtis dissimilarity (Q = 0.04), but not Weighted Uni Frac (Q = 0.278). The loss of 
association of age with Weighted Unifrac in the periodontal disease subsample analysis 
may potentially be a power issue; the periodontal disease sub-sample was substantially 
smaller (n=124). Periodontal disease was associated with both Bray Curtis dissimilarity (Q 








 Bray Curtis Weighted UniFrac 
 R2 Q R2 Q 
Relatedness 0.013 0.364 0.005 0.627 
Sample Storage Time 0.008 0.363 0.006 0.573 
Fasting Status 0.009 0.281 0.011 0.295 
BMI 0.010 0.208 0.008 0.497 
HEI 0.011 0.140 0.011 0.295 
Frailty 0.012 0.547 0.025 0.060 
Sex 0.006 0.107 0.031 0.060 
Periodontal Disease 0.016 0.01** 0.045 0.03** 
Age 0.038 0.04** 0.016 0.278 
 
Supplementary Table E 7.3  Oral health subsample PERMANOVA including participants with 
data for periodontal disease (n=124).  
 
